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Summary 
The guanine binding nucleotide protein Ras is a small GTPase that controls central 
regulatory processes such as cell differentiation, proliferation and apoptosis by alternating 
between an active, GTP-bound, and an inactive, GDP-bound state. Both, the intrinsic 
hydrolysis of GTP and the exchange reaction from GDP to GTP are very slow. Two classes 
of regulatory proteins called GAP’s and GEF’s are necessary to accelerate these two 
respective reactions. Active Ras interacts also with another class of proteins generally 
called effectors. Using 31P NMR spectroscopy two conformational states that interconvert 
in the millisecond time scale could be directly observed. They are named state 1(T) and 
state 2(T) (T or D, depending whether if Tri- or Di-phosphate is bound) and correspond to 
the GEF and to the effector recognition states, respectively. Their nature is influenced by 
specific mutations and by the type of bound nucleotide. It was verified that specific somatic 
mutations render Ras a very potent oncogene. As consequence, the protein becomes 
insensitive to inactivation by GAP’s and therefore locked in the active state, leading 
ultimately to uncontrolled cellular proliferation. Approximately 30% of all human tumours are 
estimated to harbour mutations in one of the three isoforms (H, K and NRas) at positions 
12, 13 or 61, with KRas being the most preponderant one. Due to its key role in malignant 
transformation, efforts have been made over the years to develop effective inhibitors against 
a seemingly undruggable protein. 
 
In the framework of this thesis, it was demonstrated that KRasWT shows an almost identical 
behaviour to HRasWT in terms of their intrinsic equilibria. Their 31P NMR spectra is 
dominated by two conformational states with an equilibrium constant, K12, of 2.0 measured 
at the g-phosphate of bound GppNHp. The ability to modulate the equilibrium was further 
addressed by elucidating the mode of action of Zn2+-cyclen. It was shown that this 
compound can selectively recognise and stabilise state 1(T), disrupting the affinity of both 
isoforms towards effectors such as Raf-RBD. Titration experiments showed a cooperative 
binding at two different sites with a Hill coefficient of 2 and an apparent dissociation constant 
of 9.9 mM for both isoforms. 
The inhibition of the oncogenic KRasG12D by a library of 15 different small compounds was 
further investigated. 31P NMR showed that at least two of them (#755 and #757) led to a 
significant stabilisation of state 1(T), with more than 70% decrease in the equilibrium 
constant. A 75% decrease in the affinity of the Ras-Raf complex in the presence of 300 µM 
of each drug was obtained from ITC measurements. The screening showed that the 
compounds initially developed for inhibition of Ras bound to GDP are also able to inhibit 
 
 
xii 
Ras in the triphosphate-bound form and are good candidates for further lead optimisation. 
High pressure (HP) 31P NMR was conducted in the isolated GppNHp molecule and in 
several Ras proteins. For all of them, the pressure-dependence of the chemical shifts 
revealed to be non-linear as given by the obtained positive values of the second order 
pressure coefficients, B2. A direct shift of the conformational equilibrium from state 2(T) 
towards state 1(T), given by the decrease in the equilibrium constant from 1.7 at 0.1 MPa 
to 0.24 at 250 MPa was observed for RasWT. Additional transitions were detected involving 
the GAP binding and the nucleotide-free states, named 3(T) and 1(0), respectively. 
State 3(T) was identified by 31P NMR upon titration of Ras with NF1 and assigned to the 
resonance line at d= -3.00 ppm in the spectrum of RasWT•Mg2+•GppNHp. At equimolar 
concentrations saturation was achieved for the g-phosphate but not for the b-phosphate, 
supporting the existence of conformational differences in the local environment of this 
phosphate group upon formation of the protein complex. 
Using site-directed mutagenesis and 31P NMR spectroscopy, it was verified that several 
point mutants (H27E, S39L, E3V and D33K) led to a pronounced modification of the 
conformational equilibrium. The highest effect was observed for RasD33K•Mg2+•GppNHp 
that is almost completely shifted towards state 2(T) as given by the increase of the 
equilibrium constant from 1.7 to 11.3. The mutation is located in the effector-loop region of 
Ras involved in the interaction with different proteins. A 30-fold decreased affinity towards 
Raf-RBD (KD= 10.4 µM) comparatively to RasWT (KD= 0.42 µM) and an impaired affinity 
towards NF1 was observed. The increase of the equilibrium constant from 1.7 to 2.0 in the 
case of RasE3V represents a good example of a typical conformational modulation by an 
allosteric mechanism, as the mutation is located in a distal site relative to the bound 
nucleotide. 
The crystal structures of RasWT and RasD33K were solved for the first time under high 
pressure. Analysis of the unit cell compressibility revealed the existence of a transition zone 
for RasWT between 200 and 270 MPa. A decrease of the main-chain temperature factors 
from 20 Å2 at 0.1 MPa to 13.5 Å2 at 650 MPa, together with the increase in the average 
rmsd values, gave an insight for the possible stabilisation of non-native conformations at 
high pressures. RasD33K, on the other hand, is less sensitive to pressure, with the transition 
zone occurring around 500 MPa and significant rearrangements at 880 MPa. Typical 
pressure-induced modifications involved the helix a2 as part of switch 2, the loop λ7, helix 
a1 at the beginning of switch 1. 
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Zusammenfassung 
Das Guaninnukleotid-bindende Ras Protein ist eine kleine GTPase, die durch den Wechsel 
zwischen dem aktiven, GTP-gebundenen Zustand und dem inaktiven, GDP-gebundenen 
Zustand verschiedene regulatorische Prozesse in der Zelle kontrolliert, wie z.B. 
Zelldifferenzierung, Zellproliferation und Apoptose. Sowohl die intrinsische Hydrolyse von 
GTP als auch die Austauschreaktion von GDP zu GTP sind sehr langsam. Um diese 
Reaktionen zu beschleunigen wird die Hilfe der zwei regulatorischen Proteinklassen GAP’s 
und GEF’s benötigt. Außerdem interagiert Ras in seinem aktiven Zustand mit einer weiteren 
Proteinklasse, den sogenannten Effektoren. Mit Hilfe der 31P-NMR-Spektroskopie können 
die zwei Konformationen, deren Umwandlung nur Millisekunden benötigt, direkt detektiert 
werden. Die beiden Zustände werden als 1(T) und 2(T) bezeichnet (T bzw. D, je nachdem 
ob Tri- oder Diphosphat gebunden ist) und entsprechen jeweils dem GEF und dem Effektor-
erkennenden Zustand. Beeinflusst werden sie durch spezifische Mutationen und durch die 
gebundene Nukleotidform. Außerdem ist bekannt, dass spezifische somatische Mutationen 
Ras zu einem potenten Onkogen machen. Als Folge daraus wird das Protein unempfindlich 
gegen die Inaktivierung durch GAP’s und verbleibt im aktiven Zustand, der zu einer 
unkontrollierten Zellteilung führt. In 30% aller menschlichen Tumore liegen Mutationen in 
einer der drei Ras Isoformen (H, K und NRas) in den Positionen 12, 13 oder 61 vor, von 
denen KRas am häufigsten betroffen ist. Wegen seiner Schlüsselfunktion bei der 
Tumorbildung wurden im Laufe der letzten Jahre viele Versuche unternommen, um 
effektive Inhibitoren gegen das scheinbar unbehandelbare Protein zu finden. 
 
Im Rahmen dieser Arbeit konnte nachgewiesen werden, dass KRasWT und HRasWT ein 
nahezu identisches Verhalten in Bezug auf ihre intrinsischen Gleichgewichte besitzen. Ihre 
31P-NMR-Spektren werden von zwei konformationellen Zuständen dominiert, die eine 
Gleichgewichtskonstante K12 von 2.0 besitzen, die am g-Phosphat des gebundenen 
GppNHp bestimmt wurde. Die Möglichkeit dieses Gleichgewicht zu beeinflussen wurde 
durch den Wirkungsmechanismus von Zn2+-Cyclen verdeutlicht. Es konnte gezeigt werden, 
dass diese Komponente selektiv den Zustand 1(T) stabilisiert und die Affinität beider 
Isoformen gegenüber den Effektoren (z.B. Raf-RBD) stört. Titrationsexperimente haben 
eine kooperative Bindung an zwei verschiedenen Seiten mit einem Hill-Koeffizienten von 2 
und        einer Dissoziationskonstanten von 9.9 mM für beide Isoformen ergeben. 
Die Inhibition von onkogenem KRasG12D durch 15 verschiedene kleine Substanzen wurde 
weiter untersucht und es konnte mit Hilfe der 31P-NMR-Spektroskopie gezeigt werden, dass 
mindestens zwei dieser Komponenten (#755 und #757) zu einer signifikanten Stabilisierung 
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des Zustands 1(T), mit einer Verkleinerung der Gleichgewichtskonstanten von mehr als 
70%, führen. Mittels ITC Messungen konnte eine 75%ige Abnahme der Affinität des Ras-
Raf Komplexes in der Anwesenheit von 300 µM der entsprechenden Komponente bestimmt 
werden. Die Experimente zeigten, dass die Komponenten, die ursprünglich für die Inhibition 
des GDP-gebundenen Ras entwickelt wurden, auch Ras in seiner Triphosphat-gebundenen 
Form inhibieren können und dementsprechend optimale Kandidaten für eine weitere 
Optimierung wären. 
Das isolierte GppNHp Molekül sowie verschiedene Ras Proteine wurden mittels Hochdruck 
31P-NMR-Spektroskopie untersucht. In allen Fällen konnte eine nicht lineare Abhängigkeit 
der chemischen Verschiebung anhand der positiven Werte des Druckkoeffizienten zweiter 
Ordnung (B2) gezeigt werden. Für RasWT konnte eine direkte Verschiebung des 
koformationellen Gleichgewichts von Zustand 2(T) zu Zustand 1(T) anhand der Abnahme 
der Gleichgewichtskonstanten von 1.7 bei 0.1 MPa zu 0.24 bei 250 MPa beobachtet 
werden. Außerdem wurden zwei zusätzliche Übergänge detektiert, die Zustand 3(T) und 
1(0) benannt wurden. Dabei handelt es sich um den GAP-bindenden Zustand und um den 
Nukleotid freien Zustand. 
Der Zustand 3(T) wurde mittels Titrationsexperiment und 31P-NMR-Spektroskopie 
identifiziert, bei dem NF1 zu Ras titriert wurde und die Resonanzlinie bei d= -3.00 ppm dem 
Spektrum von RasWT•Mg2+•GppNHp zugeordnet wurde. Bei equimolarer Konzentration 
wurde eine Sättigung für das g-Phosphat, aber nicht für das b-Phosphat, erzielt. Diese 
Tatsache unterstützt die Existenz der konformationellen Unterschiede in der lokalen 
Umgebung dieser Phosphat Gruppe bei der Bildung des Proteinkomplexes. 
Mit Hilfe von ortsspezifischer Mutagenese und der 31P-NMR-Spektroskopie konnte 
nachgewiesen werden, dass einige Punktmutationen (H27E, S39L, E3V und D33K) zu 
einer starken Modifikation des konformationellen Gleichgewichts führen. Der stärkste Effekt 
wurde bei RasD33K•Mg2+•GppNHp beobachtet. Hier erfolgt eine nahezu komplette 
Verschiebung hin zu Zustand 2(T), wie anhand der Zunahme der Gleichgewichtskonstanten 
von 1.7 zu 11.3 zu erkennen ist. Die Mutation befindet sich an der Effektor-Schleifen Region 
von Ras, die in die Interaktion mit verschiedenen Proteinen involviert ist. Eine 30-fache 
Abnahme der Affinität zu Raf-RBD (KD= 10.4 µM) im Vergleich mit RasWT (KD= 0.42 µM) 
und eine gestörte Affinität zu NF1 konnte beobachtet werden. Die Zunahme der 
Gleichgewichtskonstanten von 1.7 zu 2.0 von RasE3V stellt ein gutes Beispiel einer 
typischen konformationellen Änderung durch einen allosterischen Mechanismus dar, da 
sich die Mutation auf der entfernten Seite des Nukleotid Bindungszentrums befindet. 
 
 
xv 
Die Kristallstrukturen von RasWT und RasD33K wurden erstmals unter Hochdruck ermittelt. 
Die Analyse der Kompressibilität der Einheitszelle zeigte die Existenz einer Übergangszone 
für RasWT zwischen 200 und 270 MPa. Durch die Abnahme der Hauptketten Temperatur 
Faktoren von 20 Å2 bei 0.1 MPa zu 13.5 Å2 bei 650 MPa, zusammen mit der Zunahme der 
Durchschnittwerte von rmsd, konnte ein Einblick in die mögliche Stabilisierung von nicht 
nativen Konformationen bei Hochdruck erhalten werden. Auf der anderen Seite ist RasD33K 
weniger sensitiv zu Druck und besitzt seine Übergangszone bei etwa 500 MPa und 
signifikante Änderungen treten ab 880 MPa auf. Typische Druck induzierte Modifikationen 
involvieren die Helix a2 als Teil des Switch 2, die Schleife λ7 und die Helix a1 am Anfang 
des Switch 1. 
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“No human investigation can be called true science 
without passing through mathematical tests” 
Leonardo Da Vinci 
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1.1   Ras as a Molecular Switch 
This thesis deals with the Ras protein, a prototype member of a large superfamily called 
guanine nucleotide binding proteins (GNBP’s or G proteins, for short) that act as molecular 
switches by cycling between an ‘on’ (active) and an ‘off’ (inactive) state, thus controlling 
diverse regulatory processes of capital importance in the living cells. Ras was identified in 
1964 when Jennifer Harvey observed that a preparation of murine leukaemia virus (MLV) 
induced rat sarcomas in newborn mice [1]. Within the next three years, an additional 
retrovirus containing a new Ras gene, homologous to the first one, was further discovered 
by Werner Kirsten [2]. Ten years later, a third gene was identified in human Neuroblastoma 
cells [3]. The three homologue proteins codified by the three genes were thereafter named 
as H, K and NRas. Their complex structural dynamics and profound biochemical importance 
has been unveiled slowly but steadily for more than half a century, up to the present day. 
Since the last decade there has been an uprising interest by the scientific community in the 
chemistry of Ras (particularly KRas) due to its involvement in tumour formation and 
progression, triggered by an impaired function of the molecular switch mechanism that 
originates the permanent activation of the protein. A renewed scientific endeavour is taking 
place at the moment, in an attempt to find truly effective Ras inhibitors capable of drugging 
a seemingly undruggable protein [4]. 
 
The GNBP superfamily can be grouped by sequence homology into five major subgroups. 
Incidentally the subgroups also define a more or less similar biological function. The Ras 
family is a branch that contains the Ras protein itself, together with the three isoforms and 
is involved in cell proliferation, gene expression, differentiation and apoptosis; the Rho (Ras 
homologous) controls the dynamics of the cytoskeleton; the Rab (Ras in the brain) and Arf 
(ADP ribosylation factor) families regulate the vesicular transport and the Ran (Ras in the 
nucleolus) determines the direction of the nucleocytoplasmic transport and regulates the 
mitotic spindle organization [5]. Altogether they are the masters of the signalling 
transduction pathways, controlling virtually all molecular events by which any chemical or 
physical stimuli is relayed into the nucleus and culminates with an appropriate cellular 
response (e.g. transcription of specific genes). All members have the ability to bind the small 
nucleotides guanosine di-phosphate (GDP) and guanosine tri-phosphate (GTP) with high 
selectivity and affinity (in order of 10 pM), being the binding process strongly dependent of 
Mg2+, which is their natural co-factor.  
With exception of Ran, all G proteins are posttranslationally modified by addition of lipids 
either at their N-terminus by acetylation (myristoylation) or at their C-terminus by prenylation 
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and palmitoylation [6]. Prenylation takes place by addition of farnesyl or geranyl-geranyl 
lipidic groups via a stable thioether linkage, catalysed by the enzyme farnesyltransferase. 
Palmitoylation takes place through the formation of a reversible thioester linkage and is 
used to dynamically regulate membrane localization. These modifications serve as 
important components of their membrane targeting motifs and promote membrane binding. 
GNBP’s can be also regulated by non-lipidic modifications such as phosphorylation, 
nitrosylation, mono- and di-ubiquitination, acetylation and oxidation, all of which alter the 
protein localization and/or interaction with regulatory molecules. An in-depth coverage of 
these topics can be found in excellent recent reviews [7-9]. 
The human Ras superfamily contains 167 proteins, of which 39 belong to the Ras sub-
family and comprise a total of 940 structures deposited in the protein data bank (pdb), as 
of October 2017, either in uncomplexed forms or bound to any regulatory protein or small 
ligand. 
 
1.1.1   Structural and Biochemical Considerations 
The first crystal structure of Ras was solved in 1988 independently by Sung-Hou Kim [10] 
and Alfred Wittinghofer [11] with a 2.1 and 2.6 Å resolution, respectively. In the next year, 
the latter group published a refined structure with a resolution of 1.35 Å that became a 
representative model of the protein and a starting point for many theoretical and 
experimental structural studies in the years to come (pdb: 5p21) [12]. All Ras members 
share the same structural fold, so-called “G domain”, containing the catalytic machinery 
comprised of 6 b-strands (b1-b6) flanked by and 5 a-helices (a1-a5) and 10 connecting loops 
(λ1-λ10, Figure 1.1). The G domain contains five fingerprint regions, named from G1 to G5, 
all of them located in loops: G1, also called the P-loop (aa 10-17; GxxxxGKS, x= any 
aliphatic amino acid) is a glycine-rich loop that twines around the negatively charged 
phosphate groups, binding tightly to them through its main chain positively charged N 
atoms. Lys16 contacts directly the b- and g-phosphates and is crucial for nucleotide binding. 
The OH group of Ser17 contacts the b-phosphate and the Mg2+ ion [13]. The region G2, 
also called switch 1 (switch 1, aa 30-40 in HRas) or “effector region” since is involved in the 
binding of effectors when in the GTP state, is one of the regions that changes conformation 
upon nucleotide exchange. It contains a Thr35 that is totally conserved in all members of 
the superfamily and crucial for sensing the presence of the g-phosphate of GTP, 
establishing a polar contact with it via its NH main chain. The same amino acid also binds 
the Mg2+ ion via its OH side chain [14]. The region G3, also called switch 2 (switch 2, aa 59-
70 in HRas) has no conserved sequence besides a small loop at its beginning called the 
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DxxG motif (aa 57-60) in 
which Gly60 forms a main 
chain H-bond with the g-
phosphate. Another 
important residue in switch 2 
is Gln61 that plays a crucial 
role in the stimulation of GTP 
hydrolysis (section 1.1.4) 
[15]. G4 is the N/TKxD motif 
(aa 116-119), where the 
Asp119 contacts the 
nitrogen atoms from the 
base with a bifurcated H-bond and Asn116 contacts the C=O group from the purine ring, 
thus conferring specificity for the guanidinium base. Lys117 stacks along the plane of the 
base [16]. G5, also called SAK (aa 145-147), is a weakly conserved motif in which the 
backbone NH groups interact with the C=O moiety from the guanine base. These five 
structural elements of the G domain are depicted in Figure 1.2, along with key molecular 
contacts to the nucleotide. 
The three Ras isoforms (H, K and NRas) share more than 90% identity across the catalytic 
domain but differ considerably in the last 25 residues, having less than 15% similarity. 
These residues constitute the C-terminal part of the protein and are called the hypervariable 
region (HVR). They are necessary for interaction with the membrane and play a 
fundamental role in signalling processes. For technical reasons, most of the biochemical 
studies were performed over the years with truncated variants of Ras, comprising only the 
catalytic domain (aa 1-166, 18 kDa). It was demonstrated that the first 166 residues are 
necessary and sufficient for the biochemical properties of the protein [15, 17]. In fact, to the 
present date, there are no crystal structures of the full-length (aa 1-189, 21 kDa) wild type 
Ras deposited in pdb. The only available structure was obtained in 2012 for the mutant 
KRas4bG12D•Mg2+•GDP [18]. FL Ras undergoes crystallization as easy as the truncated 
variant but attempts to retrieve diffraction data from HVR fail consistently due to the lack of 
electron density, which portends the high flexibility of this region. In recent years, however, 
the scientific interest in FL Ras instead of the truncated variant gained much more attention, 
especially after the discovery that the HVR is capable of acting on the catalytic domain, 
modulating its action and being largely responsible for the biological differences across the 
three isoforms [19-21]. 
Figure 1.1. Topology of the G domain. The diagram represents the order 
of secondary structure. Helices are shown as cylinders and marked as 
a1-a5 (helix a3 is slightly distorted) and the b-sheets are shown as arrows 
and marked as b1-b6. Loops are labelled λ1-λ10. The amino acids flanking 
the beginning and the end of each element of secondary structure are 
indicated. 
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Ras is intrinsically capable 
of hydrolysing the GTP 
nucleotide by transferring 
electrons to a water 
molecule strategically 
placed in the catalytic centre 
that promotes the 
nucleophilic attack of the g-
phosphate (Figure 1.2). The 
averaged half-life for this 
process is ca. 25 min.  
(Table 3.14). Very often the 
natural nucleotides need to 
be replaced by more stable, 
non-hydrolysable ones, 
especially when performing 
long term experiments of 
several hours or days, 
common in NMR 
spectroscopy. A frequently 
used analogue is GppNHp, 
being structurally identical to 
GTP except for the oxygen 
atom that mediates the b- 
and g-phosphates that 
becomes replaced by an NH group. Other analogues include GTPgS and GppCH2p [22]. 
Detailed analysis revealed that both GTP and GppNHp bind Ras in the same manner with 
only slight differences in the bridging NH group, indicating that small local changes can still 
lead to drastic differences in the dynamics of the catalytic site [23]. 
The switch mechanism between the active and the inactive states is accompanied by 
prominent structural changes in the switch 1 and switch 2 regions: in GppNHp-bound HRas, 
the g-phosphate forms two H-bonds with Gly60 from switch 2 and Thr35 from switch 1. The 
Mg2+ ion is bidentately coordinated by the non-bridging oxygen atoms of b- and g-
phosphates, Thr35, Ser17 (from the P-loop) and two H2O molecules [24-26]. Quantum 
mechanical (QM) calculations showed that Mg2+ provides a temporary storage for electrons 
Figure 1.2. HRas•Mg2+•GppNHp as the prototype of the G domain: 
structural details of the catalytic centre. A. Schematics of the interaction 
between selected residues and B. their representation in the crystal 
structure (pdb: 5p21). switch 1 and switch 2 are coloured in red and 
green, respectively, the P-loop is coloured in orange and the G4 and G5 
motifs are coloured in blue and yellow, respectively. The position of 
important residues is indicated by small spheres (centred at their a-
carbon) or explicitly by lines. Q61 is implicated in the hydrolysis of the g-
phosphate by interacting transiently with a nearby catalytic water (shown 
as a light blue sphere). Thr32, whose side chain (not represented) can 
bind transiently to the g-phosphate is also indicated. Its neighbor, Asp33, 
is a very important residue in the scope of the work developed in this 
thesis. The Mg2+ ion is shown as a black sphere. The detail of the amide 
group of the non-hydrolysable GppNHp nucleotide is shown in blue 
colour. The nitrogen atom establishes a polar contact with Gly13 from 
the P-loop. This interaction is absent in the case of the natural nucleotide 
GTP. 
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taken from the triphosphate and that after release of the g-phosphate it returns them back 
to GDP, contributing for the process of hydrolysis [27]. 
Upon GTP hydrolysis, the b-phosphate has no direct interactions with Thr35 and Gly60; 
coupled with the loss of coordination between the Mg2+ ion and Thr35. These alterations 
promote an extensive remodelling of switch 1 and switch 2, both adopting now a more 
‘relaxed’ or open conformation and effectively moving away from the nucleotide, as shown 
in Figure 1.3. At the same time the helix a2 (aa 66-74, Figure 1.1) undergoes a large rotation 
together with the unwind of one of its helical turns. This open conformation contributes 
afterwards for the dissociation of GDP, perpetuating the cycle. Another important difference 
upon nucleotide exchange is Tyr32 located in switch 1: in GppNHp-bound Ras, Tyr32 is set 
upwards, pointing to the solvent, whereas in the GDP-bound Ras undergoes a large flip and 
shifts towards the interaction site. The root mean square deviation (rmsd) between the 
whole catalytic domains of GppNHp and GDP-bound HRas is 1.58 Å for the backbone 
Figure 1.3. The switch mechanism in three dimensions. The Ras protein is in a continuous 
cycle of activation/ inactivation defined by the permanent exchange between GTP and GDP 
nucleotides. The crystal structures of the inactive, GDP-bound (blue colour), and active, GTP-
bound, (red colour) HRas protein are shown (pdb: 1q21 and 5p21, respectively). The flexible 
switch 1 and switch 2 regions are coloured in orange and the coordinated Mg2+ ion is shown 
as a black sphere. The two common mutation sites in cancer (G12 and G13) lie close to the 
nucleotide and are represented as grey spheres. The totally conserved Q61 is shown as an 
orange sphere and can be used here to visually understand the movement of the switch 
regions as the protein cycles between GDP and GTP. The activation mechanism is catalysed 
by GEF’s and the intrinsically slow hydrolysis of GTP is catalysed by GAP’s. In the active form, 
Ras interacts with effectors to trigger downstream signaling events. 
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atoms. If the switch regions are excluded, the rmsd is only 0.66 Å [28, 29].  
Ras is an incomplete enzyme: its intrinsic rate of GTP hydrolysis (also called GTPase 
activity) is too slow for many cellular processes and needs to be catalysed by a group of 
proteins called GTPase activating proteins (GAP’s). Similarly, the release of GDP is also 
intrinsically very slow and needs to be catalysed by guanine nucleotide exchange factors 
(GEF’s) [30, 31]. 
Ras is capable of initiating more than 10 different signalling cascades (Figure 1.4) that 
control cell differentiation, proliferation or apoptosis by transducing extracellular ligand-
mediated stimuli to the nucleolus. The general mechanism for transduction can be 
described as follows: upon recognition of the external stimuli, different receptors (tyrosine 
kinases, RTK’s, G-protein-coupled receptors, etc.) hetero-dimerize and auto-phosphorylate 
each other. In the case of the common RTK receptor, additional adaptor proteins called 
Grb2 or Shc bind to one of its domains called SH2. The binding promotes the recruitment 
of GEF’s to the membrane, which, in turn, will activate the Ras protein by stimulating the 
exchange of GDP to GTP. Active Ras can now interact with its multiple downstream targets 
generally called effectors (from more than 10 known effectors of Ras, the most 
representative ones within the framework of this thesis, are Raf-RBD, Ral-GDS, PI3K and 
Byr2 [32, 33]). Each effector will activate specific kinase proteins that will start a series of 
kinase chain reactions through which the signal is relayed down, reaching the cellular 
nucleus and culminating with the transcription of genes that will confer an appropriate 
response to the original stimuli. One of the most common signalling cascades of Ras is the 
Figure 1.4. Schematics of the main Ras signaling pathways. From more than 10 known 
signaling cascades under direct control of Ras, the MAPK (Ras/Raf/MEK/ERK) is the 
best understood. For sake of simplicity the full names for the abbreviations in the 
scheme are not given here. The reader is submitted to the original review [34] from 
where this scheme was adapted. 
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mitogen-activated protein kinase (MAPK) pathway that uses the protein Raf as effector and 
two different MAP kinases: MEK and ERK.  
Phosphorylated ERK translocates to the nucleus and triggers gene transcription [34]. The 
signalling cascade is eventually inactivated by negative feedback from the nucleus after 
gene transcription, which leads to the hydrolysis of g-phosphate of GTP-bound Ras, 
catalysed by GAP’s, as the protein returns to the original (inactive) GDP-bound state [35]. 
 
1.1.2   Interaction with GEF’s: the ‘Switch On’ Reaction 
The direct consequence of the picomolar affinity between Ras and GDP/GTP is that 
nucleotide dissociation is not compatible with the time scale of most cellular processes. The 
activation of Ras needs to be catalysed by GEF’s, a large class of multidomain enzymes 
capable of accelerating the exchange reaction by 3 to 4 orders of magnitude [36, 37]. The 
GEF-catalysed reaction is an intricate multistep process whose kinetics have been 
described in detail only for the HRas•Cdc25 complex. The affinity of binding between the 
two proteins (KD) was found to be 4.6 nM and the maximal acceleration by Cdc25 of the 
rate of nucleotide dissociation was estimated to be more than 105-fold [36]. In general, Ras 
has a similar affinity for both, GDP and GTP, and GEF’s do not favour the re-binding of 
either nucleotide. The direction of the reaction is dictated instead by the concentrations of 
the free nucleotides in the cell at a given time. Since normally the GTP concentration is 10-
fold higher than GDP, the resulting product of the catalytic reaction is Ras loaded with GTP 
[38]. 
GEF’s can be grouped in two different classes. The first one comprises the RasGEF’s which 
are activated by second messengers like Ca2+, calmodulin or diacylglycerol [39]. The 
second class is represented by the son-of-sevenless (SOS). Human SOS1 is a very large 
multiprotein of ~1330 residues (152.4 kDa) containing at least 4 different domains, from 
which the catalytic domain (aa 551-1050, abbreviated as SOScat, 36 kDa) is the one involved 
in Ras binding and catalysis [40, 41]. SOScat comprises the Ras exchanger motif (Rem, aa 
551-750), the Cdc25 motif (aa 751-1050) and a C-terminal region (aa 1051-1333) that 
provides a docking site for the adaptor protein Grb2 (Figure 1.4) [42]. Previous 
investigations have shown that the Rem motif is responsible for the stability of the whole 
catalytic domain and that the Cdc25 motif is necessary and sufficient for nucleotide 
exchange [36, 43]. The first crystal structure of the nucleotide free HRas•SOScat complex 
was solved in 1998 [44] and shows Ras bonded to the Cdc25 motif, with no direct contacts 
to Rem (Figure 1.5A). The primary contact regions are the P-loop, helix a1 and the switch 
regions. The most significant conformational change in HRas is due to the insertion of an 
1. Introduction 
 
10 
helical hairpin composed of 
helices aH and aI from 
Cdc25 that penetrates 
through the catalytic pocket 
and projects switch 1 away 
from the nucleotide binding 
site (Figure 1.5B). The 
hairpin introduces in the 
nucleotide binding site a 
hydrophobic side chain 
(Leu938), which blocks 
magnesium binding by 
interacting with Ser17 from 
Ras, and an acidic side 
chain (Glu942), which 
overlaps with the site where 
the a-phosphate of the 
nucleotide would otherwise 
be bound. At the same time, 
switch 2 is held very tightly 
by SOS and constitutes the heart of the interface between the two proteins. A cluster of 
three residues with hydrophobic side chains from Ras, Tyr64, Met67 and Tyr71, is buried 
into the hydrophobic core of SOS. Surrounding this hydrophobic triad is an array of polar 
interactions between the two proteins making almost all side chains of switch 2 coordinated 
to SOS (for example, Ala59 occupies the previous position of Mg2+ ion and the Glu62 side 
chain interacts with both, the NH group from Gly60 and the side chain of Lys16). As 
consequence, the conformation of switch 2 is very well defined in the complex, contrary to 
the typical poorly ordered conformation in the nucleotide-bound forms of Ras. In summary, 
switch 1 is pushed away from its normal position whereas switch 2 is pulled towards the 
nucleotide binding site [31, 44]. From these structural insights, the mechanism of nucleotide 
association/ dissociation was proposed to be as follows: in the dissociation process, the 
phosphate moieties of GDP are released first after binding of SOS, and then the base and 
ribose moieties are released. In contrast, the association process takes place by binding 
first the base and the ribose moieties of GTP and only then the phosphate groups. 
Significant conformational changes of the switch regions are thought to occur to rebuild the 
Figure 1.5. Structural insights on the Ras•SOS complex (pdb: 1bkd). A. 
Surface and cartoon representation of nucleotide free Ras (coloured in 
grey) bound to the catalytic domain of SOS (coloured in blue). The Rem, 
N-terminal motif (coloured in light purple) is also shown. The hairpin 
formed by the helixes aH and aI from SOS is indicated. B. Details of the 
binding interface between the two proteins. Switch 2 is ‘clamped’ by 
SOS through interaction with hydrophobic residues and switch 1 is 
projected away from the vicinity of the nucleotide upon insertion of the 
helical hairpin. Adapted from [44]. 
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binding sites for the phosphate and Mg2+ and subsequently to displace SOS [31, 37]. 
It is worth mention that a new binding site of Ras to SOScat was found in 2003. This site is 
located between the Rem and the Cdc25 motifs and is in a distal position relative to the 
binding site on the Cdc25 motif [45]. Interestingly, the solved crystal structure is of a ternary 
complex HRas•GppNHp•SOScat:Ras(nucleotide-free) (pdb: 1nvw), where the nucleotide-
bound Ras is located in the newly discovered distal site and the nucleotide-free Ras is 
located at the ‘usual’ place, at the Cdc25 domain. The implications of a second biding site 
are thought to be related to a mechanism of feedback activation of SOS: the binding at the 
distal site has a profound influence in the conformation of the Rem motif, resulting in its 
rotation by about 10° relative to Cdc25. In turn, this rotation echoes the interactions between 
the helical hairpin and switch 1 of nucleotide-free Ras in the active site [45, 46]. 
 
1.1.3   Interaction with Effectors 
In the active state, GTP-bound Ras relays signals to the downstream targets by direct 
association with different proteins generally called “effectors”. There are more than 10 
different known families of effectors capable of interacting with the Ras subfamily alone and 
many more that bind to other GTPases [47-49]. All known effectors differ in their function 
and surprisingly show no homology in their structure despite having a common region of 
~100 amino acids usually named ‘Ras binding domain’ (RBD) that was found to be 
necessary and sufficient for Ras recognition. RBD binds preferentially Ras-GTP with typical 
dissociation constants between 0.01 and 3 µM [48, 50, 51] in contrast with Ras-GDP, whose 
apparent KD values are in the upper µM range, corresponding to an averaged 1000-fold 
decreased affinity [52]. The most representative and well-studied effector of Ras is the Raf 
protein (from rapid accelerated fibrosarcoma), expressed in all mammals as three 
paralogues (ARaf, BRaf and CRaf. CRaf is sometimes called Raf1 and is the variant used 
in the work presented in this thesis) [35]. Raf is a 72 kDa serine-threonine kinase involved 
in the signalling of the MAPK pathway composed of three conserved main regions (Figure 
1.6): the RBD located in its N-terminal segment (aa 55-132, 9.4 kDa), presenting a ubiquitin-
like architecture (bbabbab), followed by a C-kinase homologous (C1 or CRD) domain (aa 
133-184), which is a specialized zinc finger, rich in cysteines and stabilized by two zinc ions. 
Both domains (RBD and CRD) act as a single unit to negatively regulate the activity of the 
protein [53]. They are labelled together as belonging to the CR1 region (conserved region 
1). Between this auto inhibitory CR1 region and the catalytic domain (CR3) there is a hinge 
region, named CR2 (aa 185-349), whose sequence is rich in serine amino acids despite 
being poorly conserved across related Raf genes. CR2 acts as a natural hinge between the 
1. Introduction 
 
12 
rigid auto inhibitory (CR1) and 
catalytic (CR3) domains enabling 
complex movements and 
profound conformational 
rearrangements within the 
molecule [54]. This hinge 
contains a small island of amino 
acids that are responsible for 
recognition of a protein named 14-3-3 when a critical Ser259 (in CRaf) becomes 
phosphorylated. The C-terminal part of Raf, labelled as CR3 (aa 350-648), holds the kinase 
domain and is responsible for its catalytic activity [55]. In many biophysical investigations it 
is a common procedure to express the RBD domain of Raf alone and use it in subsequent 
kinetic and/or thermodynamic Ras-binding experiments. The RBD’s of different effectors 
share very little homology: comparative studies show that no particular sequence pattern is 
recognizable between Raf, AF6, Ral-GDS or Ral-GEF, which envisages the idea that the 
C1 domain is a structural module that appears to have been “shuffled around” in the course 
of evolution [56, 57]. Rather interestingly, their non-similarity constitutes the basis for the 
description of Ras as a master switch of the cell, capable of adapting its surface and 
interacting with a such wide conformational variety of effectors [58]. Despite of the observed 
differences, the topology of RBD is identical for many effectors [59]. The first structural 
insights for the interaction between Ras and Raf were discovered in 1996 by Nassar and 
co-workers, who solved a 2.0 Å crystal structure of the complex between the HRas 
homologue Rap1A bound to GppNHp and Raf-RBD (pdb: 1gua) [60]. Rap1A is highly 
homologous to Ras with more than 57% similarity and shares the same effector interface. 
The complex revealed that Raf-RBD interacts mainly with switch 1, in good agreement with 
previous experiments indicating that specific mutations in HRas switch 1 (Y32F, P34S/G 
T35V, E37A and D38A/N, among others) significantly impaired the association to Raf-RBD 
[61, 62]. The binding interface is thus formed by the antiparallel co-alignment of RBD b2 and 
Rap1A b2 within the switch 1 region. Detailed analysis showed that the crucial contacts stem 
from strong/weak salt bridges formed between Rap1AE31-RafK84, Rap1AD33-RafK84/R73, 
Rap1AE37-RafR59/R67 and Rap1AD38-RafR89. Subsequent molecular dynamics (MD) 
investigations using a model structure of HRasD33A•Mg2+•GTP•Raf-RBD showed that 
Asp33 establishes one of the strongest salt bridges at the interaction surface and that a 
mutation at this position severely impairs the binding between the two proteins [63]. 
The first crystal structure of HRasWT•Mg2+•GppNHp bound to Raf-RBD was solved only in 
Figure 1.6. General architecture of effector proteins representing 
the auto inhibitory domain (CR1), where Ras binds at the RBD 
site, the hinge region (CR2), and the kinase, catalytic, domain 
(CR3). 
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2015 (pdb: 4g0n) [64] and shows the same general features observed for the Rap1A-Raf 
complex at the binding interface involving switch 1. However, this new structure shows 
evidence that other regions of Ras are also involved. Particularly, it was found that Gln61, 
located at switch 2 has a global impact on the conformational dynamics of both Ras and 
Raf during complex formation. This residue interacts with a bridging water (w189), which in 
turn interacts with the side chain of Tyr32, the g-phosphate and the catalytic water (w175). 
More importantly, the same residue was found to be connected to Leu101 and Lys109, both 
located in Raf at a distal position relative to Gln61. MD simulations have shown that the 
connection is through a long-range communication pathway, already previously identified 
in the Raps-Raf-RBD complex [65, 66] that foretells the occurrence of an allosteric 
mechanism for the Ras-Raf interaction. These findings are also in agreement with 
experimental evidence presented in 2010 by our group for the involvement of Gln61 in the 
complex formation [67]. 
The Ras-Raf complex is highly dynamic, exhibiting both fast association and dissociation 
[68]. The association is a two step mechanism governed by an hyperbolic dependence of 
the observed rate constants on increasing concentrations of Raf [69]. The binding initiates 
with a formation of a loosely bound encounter complex that rapidly isomerises into a tightly 
bound complex. An overall affinity of 0.05 µM, a kon= 35.5 µM-1 s-1 and a koff= 1.7 s-1 was 
derived for the effector in complex with RasWT•Mg2+•GppNHp [51]. Due to the fact that the 
Ras-Raf interface is formed by electrostatic interactions, it was proposed that the formation 
of the initial low-affinity complex is mainly driven by electrostatics and allows Ras to 
discriminate binding partners very quickly [70], before isomerizing to the higher affinity 
complex. 
The determination of the crystal structure of full-length Raf proteins has failed so far due to 
the heterogeneity of the purified Raf proteins caused by phosphorylation at numerous 
regulatory sites [71]. The special structure of the multidomain complex is, up to the present 
day, a matter of speculation. Frequent Raf phosphorylation can also happen during the 
expression of the recombinant protein in bacterial systems. For such reason, a 31P NMR 
spectra of Raf alone is normally recorded before any 31P NMR titration experiments 
involving Ras or other GTPases. 
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1.1.4   Interaction with GAP’s: the ‘Switch Off’ Reaction 
Ras is not a GTPase on its own right. The experimentally measured rate of hydrolysis 
(defined as kcat) is 4.7x10-4 s-1 at 310 K [31]. GTPase activating proteins, or GAP’s, 
effectively accelerate this reaction by at least 5 orders of magnitude, with a kcat= 19 s-1 
measured at 298 K [72]. Both, the intrinsic and the GAP-accelerated hydrolysis, are 
complex phosphoryl-transfer reactions still not very well understood. At the basis of the 
mechanism is the transfer of the g-phosphoryl group to a water molecule responsible for the 
nucleophilic attack. During the process the electrophilicity of the g-phosphate is enhanced 
by the Mg2+ ion that acts as a Lewis acid, leading to a decrease in the dipole-moment of the 
P-O bond. The overall mechanism is very much like a typical SN2 reaction at a carbon: the 
nucleophilic water approaches the electrophilic centre from the backside position, opposite 
to the leaving group. As the pair approaches, the geometry at the phosphate centre changes 
from tetrahedral to trigonal bipyramidal at the transition state. As the Pg-O-Pb bond gets 
longer, the geometry around the leaving group returns to its original tetrahedral state, but 
now with an inverted stereochemical configuration [73-75]. The matter of disagreement is 
about the nature of the phosphoryl transfer, which might be associative involving a 
metaphosphate-like PO32-, where bond breaking of the b,g-anhydride linkage takes place 
when the nucleophile approaches, or dissociative, where bond making to the nucleophile 
takes place before bond breaking (Figure 1.7A) [76, 77]. The difference between the 
intrinsic hydrolysis and the GAP-assisted one is in the substrate used to activate the 
catalytic water molecule involved in the nucleophilic attack: the intrinsic reaction relies in a 
substrate-assisted mechanism, in which the g-phosphate itself acts as a base and activates 
the nucleophilic water (w189), which in turn donates a proton to the O3 atom of the g-
phosphate. This primary protonation changes the electrostatic environment and promotes 
a ~1.5 Å movement of the catalytic water (w175) coordinated to Gln61 towards the g-
phosphorous atom. In the new position, this water can form an H-bond with the primary 
hydroxyl ion and exchange a proton with it, thus regenerating the original w189, or could 
contact directly the g-phosphorous atom, forming a secondary hydroxyl ion. In either case 
the result is the formation of the transition state and concomitant hydrolysis of the g-
phosphate (Figure 1.7B, left side) [23, 72, 78]. The influence of GAP in this process has 
been a matter of discussion for a long time. One assumption is that GAP is confined to the 
catalysis of a rate-limiting isomerization step in Ras, which becomes activated only through 
its action but Ras is, on itself, an efficient GTPase [79]. A second assumption is that GAP 
is directly involved in the hydrolysis process, providing crucial residues and stabilizing the 
transition state. 
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The true role of GAP is still 
unknown but it was glimpsed 
in the 90ies by the use of 
metal-fluorides such as AlF3  
[80, 81], or more recently, 
MgF3- [82], both capable of 
mimicking the transition state 
of the phosphor-transfer 
reaction. A representative 
structure for the Ras-GAP 
interaction is the one solved 
for 
HRas•Mg2+•GDP•AlF3•GAP-
334 in 1997 by Alfred 
Wittinghofer and his team 
(pdb: 1wq1) [83] and seems 
to indicate that GAP has an 
active role in the process by 
providing a crucial positive 
charge through the insertion 
of an arginine side chain  
(Arg789), often called 
‘arginine finger’ into the 
catalytic site of Ras, thus 
neutralizing the developing 
negative charges during the transition state (Figure 1.7B, right side) [84-86]. Arg789 
coordinates to the O3 atom of g-phosphate and to the b,g-bridging oxygen. Its carbonyl 
oxygen is H-bonded to the side chain NH of Ras Gln61, which also forms H-bonds to the 
attacking water (w175) along with Thr35. The engagement of Arg789 stabilizes the 
intrinsically mobile switch 2 region and works like a ‘trigger of a gun’ by acting on Gln61, 
positioning it correctly in space and allowing it to extract an hydrogen atom from the catalytic 
water, which can in turn, act as the nucleophilic substrate for the hydrolytic reaction [87]. 
Additional biochemical studies showed that the interplay between Arg789 and Gln61 is 
crucial, as mutants of Gln61 show severely impaired GAP-mediated hydrolysis [88, 89]. It 
is worth mention that the complete mechanism is far from being fully understood. In fact, 
Figure 1.7. Molecular mechanism of the phosphoryl transfer reaction. 
A. There are two possible reaction paths through which the phosphoryl 
transfer reaction can happen, depending if the nucleophile attacks 
before (associative) or after (dissociative) P-O bond breaking B. 
Comparison of Ras catalytic environment for the intrinsic (left) and GAP-
activated (right) GTP hydrolysis. In the first case, w189 makes two H-
bonds, one with the O3 of g-phosphate and another with w175, the latter 
being held in place by Gln61 and Thr35. The second case represents 
the proposed transition sate for the complex 
Ras•Mg2+•GDP•AlF3•GAP-334. No H2O molecule equivalent to w189 is 
described in this structure (pdb: 1wq1). Instead, Arg789 acts as an 
arginine finger that ‘pulls the trigger’ in the reaction by forming two H-
bonds, one with the O3 atom from g-phosphate and another with the 
bridging O atom between b- and g-phosphates. Adapted from [23]. 
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many Ras-like proteins lack the arginine finger during the GAP-assisted reaction. 
RanGAP’s use a tyrosine instead, and RapGAP’s use a tandem switch 1 Tyr and an Asn 
from GAP [90, 91]. 
 
1.1.5   Differential Dynamics of the Switch Mechanism 
The multitude of crystal structures of the G domain tend to confer a misleading picture that 
the switch regions are preponderantly fixed in space, either in a “closed” conformation, as 
in GTP-bound Ras or when bound to effectors, or in an “open” conformation, as in GDP-
bound Ras, that disfavours effector binding. However, this is an inadequate or at least an 
incomplete picture of the overall dynamics. In fact, 3D NMR spectroscopy has shown that 
the switch regions of HRas•Mg2+•GDP are disordered and fluctuate in the nanosecond time 
scale (Figure 1.8A) [92]. The topology of the fold of the solution structure (pdb: 1crp) is 
identical to the crystal structure (pdb: 4q21 [30]), but the segments comprising switch 2 are 
highly flexible (contrary to switch 1 that seems to be moderately restrained), suggesting the 
presence of multiple conformations especially in switch 2 which provide an unprecedented 
insight into the activation of the GTPase activity by GAP’s: when GAP binds to Ras, the 
mobility of switch 2 is restricted and the catalytically active conformation becomes 
stabilized. In its absence, the population of the active conformation is much lower due to 
the continuous conformational fluctuations, hence the slower intrinsic GTP hydrolysis [28, 
93]. Attempts have been made to determine the solution structure of wild type GppNHp-
bound Ras but due to chemical exchange broadening processes, most of the P-loop and 
switch regions are undetectable [94]. However, solution structures of the mutant 
RasT35S•Mg2+•GppNHp in which the slow conformational exchange is eradicated have been 
recently obtained and show 
that contrary to GDP-bound 
Ras, switch 1 displays a 
wide range of 
conformational variety in 
contrast with the moderate 
changes of the switch 2 and 
P-loop (Figure 1.8B) [95]. 
The dynamics of 
RasT35S•GppNHp are 
therefore fundamentally 
different from RasWT•GDP, 
Figure 1.8. Dynamics of the switch regions. A. Cartoon representation 
of the backbone superposition of the first 20 lowest-energy NMR 
structures of GDP-bound HRas (pdb: 1crp). switch 1 and switch 2 are 
coloured in pink and blue, respectively. B. Similar representation for the 
NMR structure of HRasT35S•Mg2+•GppNHp (pdb: 2lcf). Note the different 
mobility of switch 1 between the two structures. Adapted from [28]. 
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an observation that could not be easily done if considering only the ‘static’ crystal structures 
[96]. Frequently, the switch regions are also found to be disordered in the crystal (i.e. they 
do not show appreciable electron density). In some cases, where well-defined electron 
density can be found, they often pack against neighbouring molecules. Such situation 
prompts a careful examination of the structure: if a specific conformation of an intrinsically 
disordered region is stabilized just because of packing forces, it should be regarded as a 
crystallization artefact and not as a true structural feature. This effect is evidenced for 
example by comparing two available structures of Ras•GDP: in the first one (pdb: 4q21, 
[30]) there are extensive contacts with the neighbouring molecules and both switch regions 
are well defined. In the second one (pdb: 1ioz, [97]) switch 2 is located next to a wide solvent 
channel and shows no density. The difference makes evident that crystallization conditions 
and the crystal environment have an influence on the study of mobile regions. The 
equilibrium between the different states of the switch conformations in the GTP form is a 
delicate balance, fine-tuned to transiently stabilize the active Ras sufficiently to allow 
activation of downstream effectors without switching it off again via intrinsic GTP hydrolysis, 
while allowing stabilization of the switch regions into the catalytically competent 
conformation by the GAP proteins [98, 99]. 
 
1.1.6   Consequences of Ras Mutations 
Specific point-mutations at one of three amino acid positions, Gly12, Gly13 and Gln61, are 
able to turn Ras into a potent oncogenic protein, rendering it a driving force in the initiation 
and proliferation of a significant set of human cancers [100]. A survey from the COSMIC 
database shows that mutated Ras is present in more than 30% of all human tumours [101, 
102], with an incidence level of more than 95% in pancreas carcinomas [103], 65% in colon 
cancer [104], 46% in endometrial carcinomas, among many others [105]. The structural 
mechanisms that potentiate oncogenic activity are well known. Glycine is the smallest 
amino acid. Introducing any other side chain (even the small valine) in the confined catalytic 
space leads to a steric clash with both Gln61 from Ras and the arginine finger from GAP, 
disturbing the necessary spatial molecular arrangements for the GAP-assisted hydrolysis 
[83]. This steric hindrance renders the G12 mutants insensitive to GAP, resulting in an 
impaired GTP hydrolysis. The protein becomes then permanently locked in the active, GTP-
bound state, relaying permanent signals its downstream targets that culminate with the 
permanent activation of specific signalling cascades such as MAPK, sustaining permanent 
proliferation and differentiation [102]. The most frequently mutated isoform is KRas (86%), 
followed by NRas (11%) and HRas (3%). The preponderance of KRas and the necessity to 
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develop of isoform specific inhibitors is one of the reasons that led to the revival of the field 
in the recent years [21, 106]. The most prevalent mutations at position 12 are G12D (36%), 
G12V (23%), G12C (14%), G13D (7%) and Q61H (0.6%) [107]. Nevertheless, it was shown 
that except for proline, any amino acid substitution at position 12 renders Ras oncogenic 
[100, 108]. It is notwithstanding that any G12 mutation is in general tolerated in the ground 
state of the Ras-GAP complex, meaning that the binding to GAP can still take place with 
equal or only slightly decreased affinity compared to RasWT. However, the transition state 
cannot be formed due to the above mentioned steric hindrances [109]. 
 
1.1.7   Partial Loss-of-Function Mutants 
All Ras-driven cancers are a consequence of the constitutive activation of this protein. For 
such reason the oncogenic mutants are also sometimes called ‘gain-of-function’. However 
not all Ras mutations are gain-of-function. Particular relevance is given in this thesis to the 
so-called ‘partial-loss-of-function’ mutants, which are capable of interacting only with a 
specific subset of known Ras effectors [61, 110]. A common example is RasT35S: Thr35 is a 
totally conserved residue in switch 1 (Figure 1.2) involved in the coordination to the Mg2+ 
ion and to the g-phosphate. Mutation to serine or alanine impairs the association of Ras with 
the effectors Byr and RalGDS but not with Raf. The basis for such selection lies on the fact 
that Thr35 interacts with the residue Lys52 of both RalGDS and Byr2 but it does not interact 
with Raf [111, 112]. Another example is RasE37G (binds to RalGDS but not to Raf, [113]) and 
the double mutant RasG12V/T35S. These differences are a preposition for the key role that 
specific residues play in effector selectivity when Ras is constrained by a preferred 
interaction site with respect to the membrane. Kinetic and stopped-flow analysis showed 
that the interaction of RasT35S with Raf-RBD still follows a two-step mechanism, like the wild 
type protein. However, the affinity to Raf is lowered more than 60-fold [51]. On the other 
hand, similar experiments done with RasT35A showed that Raf association is a one step 
mechanism and has a linear dependence on the concentration of Raf. The mutant can still 
bind and form the weak complex but isomerization to the high affinity complex is impossible. 
 
1.1.8   Probing the Bound Nucleotide: 31P NMR Spectroscopy 
The main instrumental method used within the work conducted in this thesis is 31P NMR 
spectroscopy. Phosphorous-31 is an active nucleus with a spin quantum number of I=1/2 
and a natural abundance of 100%. 31P NMR is in general a very attractive tool for the study 
of GNBP’s or any other biological molecular system containing phosphate groups. The 
conformational modifications during the operation of the Ras molecular switch are 
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accompanied by structural changes of the regions directly involved in nucleotide binding, 
which can be followed and quantified by modifications observed in the 31P NMR spectra 
such as chemical shift values, linewidths or relaxation characteristics. The peak areas can 
be used as a direct measure of the relative populations of conformational states. The major 
drawbacks of the method, however, are the high amount of protein needed (in the 0.5-1.5 
mM range) and the rather long acquisition times due to the low magnetic susceptibility of 
this nucleus (only 6.64% of 1H) [114, 115]. 
31P NMR performed on Ras bound either to its natural nucleotide, GTP, or to non-
hydrolysable ones such as GppNHp at 310 K originates very simple spectra containing 
three single lines labelled as a, b and g, one for each phosphate group. However, at 278 K 
the situation is different: two distinct conformational sates (named as 1 and 2) represented 
by different chemical shifts are obtained. These conformational states are actually only 
defined when any guanosine triphosphate is bound (T) and may be different when 
guanosine diphosphate is bound (D). To this respect, they are written within the conventions 
of this thesis as states 1(T) and 2(T) or 1(D) and 2(D), whenever the nucleotide ligand is 
concerned [67]. These states are in a dynamic equilibrium with exchange rates in the 
millisecond time scale at low temperature. The relative population of 2(T) over 1(T) varies 
among different Ras isoforms and mutants as it will be demonstrated in this thesis. For 
HRasWT(1-189)•Mg2+•GppNHp state 2(T) was found to be 1.9 times more populated than 
sate 1(T) [51, 116, 117]. At high temperatures (310 K), the exchange process obeys to the 
fast condition and the two split signals of each phosphate coalesce into one, whose 
chemical shift value is located at the population averaged position. The coexistence of the 
two conformational states was also revealed by solid-state 31P NMR performed on Ras 
crystals [118, 119] and 
precipitated Ras [120]. Figure 1.9 
shows a typical 31P NMR spectrum 
of HRasWT(1-189)•Mg2+•GppNHp 
(spectrum a). Upon addition of 
Raf-RBD (spectrum d), s 
tate 1(T) disappears and state 
2(T) becomes stabilised. For such 
reason this state is also described 
as the effector binding state (i.e. it 
corresponds to the population of 
Ras whose conformation is 
Figure 1.9. 31P NMR spectroscopy on HRas•Mg2+•GppNHp 
proteins. The spectrum of Ras wild type is shown (a), together 
with the state 1(T) mutant RasT35S (b). The protein complexes of 
RasWT•SOScat and RasWT•Raf-RBD are shown in (c) and (d), 
respectively. Taken from [125]. 
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selectively recognised by effectors) [117, 121, 122]. In contrast, state 1(T) shows more than 
20-fold lower affinity towards effectors, as shown by 31P NMR, calorimetric and 
fluorescence-based studies [123, 124]. Additional experiments demonstrated that it is 
selectively recognized by GEF proteins, as revealed by strong line broadening of its 
resonance line upon titration with SOS (spectrum c). For this reason, state 1(T) is 
sometimes referred as the weak effector-binding or the GEF interacting state [125]. 
 
 
1.2   Drugging an Undruggable Protein 
The frequency of Ras mutations in three of the four most lethal cancers (lung, colon and 
pancreatic) has spurred an intense interest in developing inhibitors in the form of small 
molecules capable of acting directly or indirectly in the oncogenic protein and quell its 
permanent activation. This necessity was further increased in the 90ies when it was 
discovered that alongside with its involvement in cancer, some KRas mutations in the 
human germinative line can cause severe developmental diseases generally named 
Rasophathies [126] and that result from direct Ras point mutations in different locations 
(some common positions are 12, 13, 61, 14, 22, 26, 34,50, 58, 60, 152, 153, 156, all being 
gain-of-function) [127], leading to conditions known as Noonan syndrome (NS) [128], 
Costello syndrome (CS) [129], cardio-facio-cutaneous syndrome (CFC) [130], among 
others [131, 132]. 
A tremendous effort was indeed devoted to the endeavour of finding effective inhibitors over 
the last half century, with some ups, downs, and many frustrations along the way, dictated 
by the fact this globular protein has no direct or obvious pockets where small molecules can 
bind. For a long time Ras was considered to be undruggable [133]. However, since 2012 a 
renaissance on the topic is taking place and the scientific research has never been as active 
as nowadays, either at academic institutions or pharmaceutical companies. A very concise 
description of the most common strategies used to turn off the aberrant molecular switch 
will be presented in the following section. For an in-depth coverage of this topic the reader 
is referred to a variety of recent and excellent review publications [17, 133-137]. 
 
1.2.1   General Strategies 
Inhibitors of posttranslational modifications 
As stated in section 1.1, these modifications are crucial for the intracellular trafficking and 
attachment of Ras to the plasma membrane. The search of compounds that block its 
lipidation at the C-terminus, catalysed by farnesyl transferase, was intensively pursued in 
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the last century through the creation of specific inhibitors for this enzyme (generally called 
FTI’s). Three of the most potent ones were Lonafarnib [138], Tipifarnib [139] and Salirasib 
[140]. All have shown to be effective in HRas-driven cancer models in the pre-clinical setting 
but ultimately failed in advanced human clinical trials against KRas and showed a serious 
toxicity to normal tissues [141, 142]. The scientific interest for this approach was further 
decreased in 1995 when it was found that cancer cells have mechanisms to bypass 
lipidation on KRas and NRas, contributing to acquired resistance to this class of drugs [143]. 
 
Inhibitors for the interaction with GEF’s 
Several inhibitors of GDP-to-GTP exchange GEF-catalysed reaction have been reported. 
A peptide based on the aH helix of SOS1 was found to bind Ras in a cleft near the switch 
regions with a KD= 158 µM. Although not very potent, further optimization of the helical 
peptide is currently underway [144]. 
In 2012 two independent groups reported several KRas4b binders that were discovered 
using fragment-based screening by NMR and have a similar mode of action [18, 145]: they 
bind close to the a2 helix and b1 sheet in a pocket that is not readily observed in the ligand-
free structure of the protein. The pocket seems to be formed only upon binding of the 
compounds by the movement of Tyr71 and Met67 out of the way, creating a primary and a 
secondary binding cleft. All compounds tested bind to KRasG12D•Mg2+•GDP with KD values 
in the low hundred µM range, and although not very potent, they revealed to be promising 
candidates for further lead optimization. 31P NMR spectroscopic studies were conducted in 
the framework of this thesis with some of these drugs and are presented in detail in section 
3.2 of the results. 
 
Inhibitors for the interaction with effectors 
The direct inhibition of the interaction with effectors is a widely used strategy to prevent 
aberrant signalling in oncogenic Ras. Within this group it is worth mentioning the 
nonsteroidal anti-inflammatory drug called Sulindac sulphide and derivatives [146] which 
were found to bind Ras at the Raf binding site and have a median inhibitory concentration 
(IC) of 30 µM [147, 148]. Due to the fact that both switch regions are not visible in [1H-15N]-
HSQC NMR experiments, the exact binding place of this class of drugs is unknown but 
thought to be close to switch 1 [147]. 31P NMR titration studies involving this drug are 
presented in section 3.2.12 of the results. 
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1.2.2   Recent Breakthroughs 
A major breakthrough in the direct targeting of mutated Ras was achieved five years ago 
when for the first time, small inhibitors that bind specifically and irreversibly to KRasG12C 
were developed [149]. These compounds rely on the mutated cysteine residue for selective 
binding and allosterically alter the preference of KRasG12C to favour GDP over GTP, 
impairing at the same time the binding to Raf-RBD. The feat was achieved by attaching 
different electrophiles to the b-phosphate of GTP that can covalently bind to Cys12 [150]. 
Further structural investigations by X-ray crystallography and affinity measurements 
showed that upon binding of the drug, the switch regions assume an open, inactive 
conformation, which is incompatible with effector binding [151]. The compounds are 
especially relevant in the treatment of lung cancer as the G12C mutation is the most 
prevalent one, occurring in 7% of these tumours [101]. At the same time, they provide a 
useful conceptual framework to develop other compounds that could selectively target other 
common Ras mutations such as G12D and G12V. 
Another emerging area, although not in the scope of direct Ras inhibition, is the 
development of ERK and Raf dimer inhibitors. The dimerization of ERK, triggered by the 
activation of the MAPK pathway, is necessary for its extracellular function. Based on this 
observation, in 2015 a water-soluble small compound named DEL-22379 was identified to 
be capable of blocking the dimerization process and consequently to inhibit growth and 
induced-apoptosis in cultured Ras mutant cancer cell lines [152]. At the same time, it was 
discovered that dimerization of Raf is also required for normal Ras-dependent Raf 
activation. On this basis a small peptide named Vemurafenib was developed and shown to 
be efficient in the inhibition of Raf dimers [153]. Although this drug has limited efficacy 
against tumours that possess constitutive Ras-independent, Raf-activating dimers [154], it 
already has received FDA approval and shows a promising future. 
 
1.2.3   Allosteric Inhibition: the Case of Zn2+-cyclen 
31P NMR spectroscopic investigations revealed the existence of a dynamic equilibrium 
between at least two different conformational states in Ras•Mg2+•GppNHp named 1(T) and 
2(T), as mentioned in section 1.1.7. Based on these findings it was hypothesised that the 
use of small compounds capable of shifting the equilibrium towards state 1(T) would 
represent a novel approach in the antitumoural therapy against Ras. This hypothesises was 
tested using the small drug Zn2+-cyclen, developed at our department and found to be 
capable of recognizing and selectively stabilising state 1(T), impairing therefore Ras-Raf 
association [155, 156]. Structural NMR experiments revealed that the compound binds in 
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two different locations in the surface of the protein, 
one at the nucleotide binding site, near the g-
phosphate and the other at the distal position, close 
to the C-terminus, interacting directly with His166. X-
ray crystallography was also performed for the 
protein-drug complex HRasWT•Mg2+•GppNHp•Zn2+-
cyclen and allowed its direct visualization bound at 
His166 (Figure 1.10) but not at the second binding 
site, close to the nucleotide. Analysis of the crystal 
packing showed that the proteins in the unit cell were 
in contact by means of the effector loops, lying face-to-face next to each other. The 
concentration of Zn2+-cyclen used (25mM) was too low to overcome the crystal forces that 
held the effector loop shut [157, 158]. Due to its ability to selectively recognise and bind a 
specific conformational state, Zn2+-cyclen can be viewed as a parental drug and a lead 
compound that can be used for the development of novel allosteric Ras inhibitors, capable 
of selectively recognising rare conformational and functional states of the protein. 
 
 
1.3   High Pressure Technologies in the Study of Protein Conformation and Dynamics 
Proteins exist in solution in a dynamic equilibrium as an ensemble of conformers; they are 
multiconformational entities designed by natural selection not just for the ground or native 
sate but also for higher energy, non-native states involved in function, folding and unfolding 
events. Multiple conformations are universal rather than exceptional [159]. 
The conformational landscape of a protein can be represented by the folding funnel model 
(Figure 1.11A) [160] upon which the protein energy landscape can also be drawn [161] and 
allows one to correlate conformation with function: the lowest energy state is depicted as a 
global minimum and folding intermediates as local minima that can widely differ in depth 
and shape. High energy intermediates populate the walls of the funnel. From this picture it 
can be reasoned that all functional states of a protein need to be sterically possible and 
have to coexist in solution, that is, the minimum number of folding intermediates is given by 
the number of its functional states (however not all folding intermediates need to be 
necessarily correlated to function) [125]. A similar reasoning arises by generalization of the 
Wyman-Changeux theory for cooperative binding [162]. Despite from the fact that NMR can 
be able to detect signals from the conformational ensemble in solution, the reality is that it 
Figure 1.10. Electron density map showing 
the coordination of Zn2+-cyclen at the C-
terminus of RasWT (pdb: 3l8y). Adapted 
from [157].  
1. Introduction 
 
24 
reports a single structure, 
close to the one in the crystal 
[163] and neglects minor  
conformers either because 
the fluctuation is too rapid 
(>103 s-1) or slow but rare. 
One way to populate and 
consequently detect these 
low-lying intermediate and 
excited states is by varying 
physico-chemical 
parameters such as pH, 
concentration of a 
denaturant, temperature, 
etc. However, the drawback 
is that it cannot be generally 
assured that conformers under extreme conditions represent the same intrinsic conformers 
in the absence of chemical perturbants [164, 165]. The alternative to this approach is to 
apply pressure. Indeed, pressure leads to a shift of the population distribution based on the 
simple ground that it favours a smaller volume for the system, as a direct consequence of 
the Le Châtelier principle (i.e. it favours “excited” states, with lower free energy of 
stabilisation at normal pressure). The effective volume of a protein in solution is given by 
the partial molar volume that includes the volume of hydration water as it is inseparable 
from the volume of the protein alone [166]. There are two ways through which the partial 
molar volume can fluctuate when subjected to pressure (Figure 1.11B): one is within the 
same subensemble of conformers (the case where the high-energy conformers are far 
distant) and leads to a general compression of the system, where the population shifts 
towards the lower-volume microscopic state but within the same subensemble. The second 
case (generally more interesting for identification of rare states in proteins) is a shift of the 
conformational equilibrium from the native subensemble (N) to a different, energetically 
higher subensemble (I), both differing in their topology of folding and function [163, 167]. 
 
 
 
 
Figure 1.11. Physics of high pressure applied to biomolecules. A. 
Functional states of Ras and their relationship with the folding funnel. 
The free energy of the microstates is plotted for the two components of 
the conformational space. The native, lowest energy conformers 
corresponding to states 1(T) and 2(T) lie at the bottom of the funnel (the 
enlarged view of the bottom is depicted) and high energy states such as 
3(T) populate its walls. B. Representation of the two possible ways 
through which a molecular system can attain a lower effective volume: 
by general compression within the same subensemble of conformer N 
or I (top) and/or by a shift of the equilibrium from N to I, in favour of the 
subensemble I with lower volume (bottom). Adapted from [160]. 
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1.3.1   31P HP NMR to Study Nucleotide-bound Ras Proteins 
Pioneering work was done in our department over the years in the field of HP NMR to study 
protein structure, conformation and dynamics. Some examples include the b-amyloid fibril 
tangles [168], the HPr protein [169], the human prion proteins [170] and the Ras protein 
[125, 171]. As shown by 31P NMR (section 1.1.7), HRasWT•Mg2+•GppNHp exists in a 
dynamic equilibrium between at least two conformational subensembles denoted as states 
1(T) and 2(T). Using HP, it could be demonstrated that this equilibrium can be shifted 
towards state 1(T) in a reversible manner (Figure 1.12A): at 200 MPa the relative population 
of state 2(T) over 1(T) at the g-phosphate decreases from 1.9 to 0.44 at 278 K. The 
difference in the specific partial molar volume, DV, for the transition was found to be 17.2 
mL mol-1 [125]. From the instrumental point of view, high hydrostatic pressure can be 
transmitted to the sample inserted in the NMR spectrometer in two ways: either 
automatically using a commercially available piston compressor [172] or manually, using 
an in-house built high pressure line. Technical aspects prevent 31P HP NMR of being 
performed automatically, therefore for the time being, this nucleus can only be recorded 
using the manually operated pressure line whose main components are depicted in Figure 
1.12B and include a water reservoir, a piston with a manually operating lever, a bourdon 
manometer and at least two valves that can be used to open and close different parts of the 
circuit. The protein sample is inserted in an especial NMR tube made of ceramic, capable  
Figure 1.12. 31P HP NMR spectroscopy. A. 31P HP series of HRasWT(1-189)•Mg2+•GppNHp at 278  
K, pH 7.4. The conformational transition from state 2(T) into state 1(T) can be observed at the g-
phosphate by following the evolution of the relative integrals along the pressure series. B. Schematics 
of the in-house built manually operated HP line. C. Photograph of the autoclave and the HP ceramic 
NMR tube that is connected at the end of the line. D. Photograph of the HP line inserted through the 
magnet bore of an 800 MHz spectrometer. Adapted from [125]. 
1. Introduction 
 
26 
of withstanding very high pressures (up to 300 MPa, Figure 1.12C) and then mounted in an 
autoclave which is a small piece of alloy specifically engineered to close the circuit and to 
connect the ceramic tube to the HP line. The end of the line is inserted into the spectrometer 
as shown in Figure 1.12D and pressure is applied by rotating the lever of the piston. 
 
1.3.2   Rare Interaction States Detected by [1H-15N]-HSQC HP NMR Spectroscopy 
Subsequent automated HP NMR investigations using heteronuclear [1H-15N]-HSQC 
experiments were conducted on HRasWT bound to GppNHp [171] and allowed the 
identification of additional rare states from which a more accurate picture of the 
conformational landscape could be drawn: the Ras switch mechanism envisages at least 
three states, corresponding to 
complexes with GEF’s (state 1(T)), 
effectors (state 2(T)) and GAP’s 
(state 3(T)), which could all be 
identified by fitting the 1H and 15N 
pressure-induced chemical shifts and 
cross peak volume changes (i.e. 
distances between components) for 
each amino acid with a second order 
Taylor expansion. From the fitting 
routine a fourth state came out, 
corresponding to the nucleotide-free 
Ras (represented as 1(0)). This 
additional state can be envisaged as 
the one that ‘closes’ the cycle. In 
parallel, the pressure-dependent 
chemical shifts were fitted with a 
thermodynamic model, allowing the 
determination of DG and DV values 
for the transition between any two 
conformational states at a given 
temperature. By gathering the values 
obtained for each amino acid and 
grouping them in specific numeric 
intervals with appropriate margins of 
Figure 1.13. Pressure dependence of the conformational 
transitions. A. amino acids sensing different transitions are 
colour-coded in the crystal structure of Ras (2-to-1, 2-to-3, 2-
to-0 are depicted in yellow, orange and pink, respectively. 
Residues sensing more than one transition at the same time 
are coloured in red. Residues that could not be detected are 
in green and residues showing no pressure response are in 
blue). B. Calculated thermodynamic model for the relative 
evolution of the population of states 1 to 4 with pressure. 
Taken from [171]. 
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error, it was possible to identify the residues that are involved in (or ‘sensing’) a specific 
conformational transition. They were colour coded in the surface of the crystal structure as 
shown in Figure 1.13A and reveal important information about the dynamics of the ‘hidden’ 
conformations. For example, all the orange residues are involved in the transition from the 
ground state 2(T) to the excited state 3(T), whose population is very low at ambient pressure 
(0.1 MPa), as indicated by the diagram in Figure 1.13B. This information constitutes the 
basis of the mutational analysis on Ras performed in this thesis and presented in section 
3.4 of the results: the main idea is that the substitution of an amino acid involved in a 
particular transition (e.g. 2(T)-to-3(T)) could shift of the conformational equilibrium towards 
the lowest populated state (3(T) in the present example), allowing its direct observation at 
ambient pressure in the newly created Ras-mutant. Within this framework, the information 
retrieved from HP guides the search for specific residues on the protein that are prone to 
be involved in some kind of interaction with an otherwise undetectable, high-energy state. 
This represents a novel method to detect conformational ensembles that are often the true 
functional states of a protein and the ones involved in a specific disease or anomaly, instead 
of the native one(s) commonly detected. As in the case of Ras, the development of drugs 
that could directly bind at its surface and promote a shift of the equilibria towards a non-
native, low populated state, such as 3(T) (the GAP recognising state), would promote an 
immediate increase of the GTPase activity of the protein and therefore lead to its 
deactivation in Ras-driven cancer cells. The feasibility of this methodology has already been 
shown with the mode of action of Zn2+-cyclen, capable of selectively binding and recognising 
state 1(T) [157]. 
 
1.3.3   High Pressure Macromolecular Crystallography (HPMX) 
Nowadays HP is used together not only with NMR but with almost all spectroscopic 
techniques available, with the aim to understand the properties of matter and chemical 
reactions. Its relationship with crystallography is also not new: the field has been very active 
for many years in the study of the earth and materials science [173]. However, the situation 
is different regarding biosciences. HPMX of proteins is still a technically challenging and 
complex task that requires a great level of expertise. In Europe, it can be performed in very 
few beamline facilities (Figure 1.14A) and its application was initially confined to the study 
of deep sea organisms until very recently [174, 175]. 
HPMX can be performed either at cryo-temperature or at room temperature (RT). This 
distinction has implications in the physico-chemical state for the protein. In the scope of this 
thesis, the attention will be centred in the second case. RT HPMX can be performed using 
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two techniques: the first one 
is based on a beryllium 
pressure cell [176] and the 
second one is based in the 
diamond anvil cell (DAC, 
Figure 1.14B) [177, 178]. 
The development of the 
DAC was a feat of technical 
engineering, pioneered by 
Roger Fourne, Eric Girard 
and other experts in the field, 
which contributed to the 
routine collection of 
macromolecular crystals in 
the recent years [179-181], 
showing that HPMX is a full-
fledged technique [182, 
183]. During the DAC-based 
data collection, the crystal 
impregnated with mother 
liquor is kept in between the 
culets of the two diamonds 
that constitute the DAC and 
pressure is transmitted and 
constantly maintained using 
an inert gas (typically He). Its 
major drawback lies in the cell geometry that imposes constrains on the data collection. The 
aperture of the cell limits the rotation angle that can be scanned to a maximum of 85º. 
However, this constrain can be compensated by the use of very bright X-ray sources (30-
40 keV) that contribute to increase the accessible reciprocal space and at the same time to 
reduce the absorption of the diamond windows [184, 185]. 
It is worth mention that in the scope of HPMX, protein crystals should not be considered as 
rigid systems. On the contrary, they are biphasic entities in which a solid phase, the protein, 
coexists with a solvent phase made of channels that run across the crystal and represent a 
total of 30-80% of its volume. The channels communicate with the surrounding liquid in 
Figure 1.14. Instrumentation for HPMX. The technique requires 
especial diffractometers engineered to accommodate the high pressure 
cell. A. view of the 6-axis diffractometer located at the Crystal beamline 
in Soleil synchrotron, Paris. The DAC is mounted in the metallic block at 
the centre. The X-ray source (coming from the right side) needs to be 
perfectly aligned with the rotation axis. A close-up of the DAC mounted 
in the goniometer is shown in the right photograph. B. Components of 
the DAC evidencing the two diamond faces and a metallic gasket 
positioned in between the diamond culets. C. Lysozyme protein crystals: 
a) multiple impacts of the X-ray beam into a single crystal by translating 
the DAC by 50 µm every 10º. b) as alternative, multiple crystals can be 
loaded into the compression chamber. c) tiny diamond splinter 
introduced in the compression chamber to modify the orientation of the 
protein crystal with respect to the culets of the diamond. Adapted from 
[177, 178]. 
1. Introduction 
 
29 
which the crystal is grown and ensure that a true hydrostatic pressure is applied to the 
protein. Most of the crystals are grown in low symmetry space groups, in monoclinic or 
orthorhombic, lattices that difficult the generation of high completeness data. Furthermore, 
the low aperture of the DAC poses additional difficulties in the application of the rotation 
method. The problem can sometimes be solved by merging diffraction data from several 
crystals and/or by introducing a tiny, X-ray transparent, diamond splinter (from a broken 
anvil) within the sample cavity to change the orientation of the crystal with respect to the 
diamond culets (Figure 1.14C). 
Despite the large amount of crystallographic studies, HPMX has never been reported on 
Ras. In an attempt to shed light into the unanswered question of why most ambient pressure 
Ras crystals reveal only the “closed” conformation of the switch regions instead the 
observed equilibrium between the “opened” and “closed” subensembles, (roughly 
corresponding to states 1(T) and 2(T)), as detected by liquid and solid-state 31P NMR, 
HPMX on RasWT was conducted in the framework of this thesis. 
 
 
1.4   Research Goals of this Thesis 
The focus of this thesis can be comprehensively divided into five main topics. 
 
• Due to the increasingly interest by the scientific community on the dynamics and inhibition 
of the full-length KRas isoform, a primary concern was to address the conformational 
equilibria of this protein by means of 31P NMR and compare it directly with the wealth of 
experimental data obtained for HRas. The primary intent of the study was to understand if 
some of the structural and biochemical properties of HRas can indeed be transferred to 
KRas. In the follow-up of these investigations, a series of experiments were devised for both 
isoforms in order to gain insight into the perturbation of Ras-effector interaction by a typical 
state 1(T) inhibitor such as Zn2+-cyclen. 
 
• In the sequence of the gathered results, a systematic investigation on the inhibition of the 
oncogenic KRasG12D•Mg2+•GppNHp protein by a series of 15 different compounds was 
pursued. Their effect on the conformational equilibria of the protein was investigated by 31P 
NMR and their ability to disrupt the Ras-Raf complex formation was inspected by ITC. The 
main intent of the study was to shed some light into the mode of action of these drugs, to 
score them according to their ability to modulate the conformational dynamics of the protein 
and to demonstrate the usefulness of 31P NMR as a screening method that can be 
applicable to all GNBP’s. 
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• The investigation of the conformational dynamics of proteins by pressure perturbation is 
a central topic at our department. Given our expertise and recent new instrumentation 
available, a series of HP 31P NMR investigations were envisaged by starting first with the 
study of the pressure effects on the isolated GppNHp nucleotide, in the absence and in the 
presence of the Mg2+ ion, and following up to similar studies on RasWT and the mutants 
T35S, G12V and D33K. Two main goals were set in this extensive study: the first was to 
obtain a framework for the correction of the intrinsic pressure effects arising from the 
nucleotide alone (that would be given by the HP measurements on the isolated GppNHp) 
from the true effects arising from the conformational modification of the nucleotide-bound 
protein under pressure. The second goal was to investigate how different Ras proteins 
respond under pressure in terms of their equilibrium dynamics measured at the nucleotide 
level. 
 
• Taking together the present HP data and the past, 2D [1H-15N]-HSQC HP NMR 
investigations established by our group, specific amino acids on the surface of Ras were 
selected and chosen to perform site directed mutagenesis with the expectation that the 
mutation could shift the conformational equilibria in the same direction as the one observed 
from the HP investigations. A total of seven mutants were created de novo for the purpose. 
Their conformational equilibria was screened by 31P NMR for the GDP-, GppNHp- and GTP-
bound nucleotides and their biochemical properties were analysed by ITC for their affinity 
to bind the effector Raf-RBD and by HPLC for their intrinsic GTPase activity. The mutants 
showing more drastic modifications comparatively to RasWT were further investigated by a 
variety of methods including 31P NMR titrations, 2D [1H-15N]-HSQC NMR, T1 relaxation time 
measurements, nanoDSF and HP 31P NMR. The ultimate goal of the proposed task was to 
give a proof-of-concept for the use of HP as a screening method for rare states and to find 
novel potential allosteric binding sites that could be targeted in the future by state-specific 
Ras inhibitors. 
 
• The last chapter of this thesis deals with a topic of great scientific endeavour: HPMX. The 
motivation to perform HP crystallography on Ras arose in the first place as an attempt to 
complement the HP NMR data and, secondarily, to try to solve an apparently contradictory 
scientific mystery: the observation that Ras exists in solution as an equilibrium between two 
conformational states, 1(T) and 2(T), which are equally detected when Ras crystals are 
subjected to solid state 31P NMR but not detected when the very same crystals are used in 
conventional X-ray crystallography. 
 
  
2. Methods 
 
“The strongest arguments prove nothing so  
long as the conclusions are not verified by experience. 
Experimental science is the queen of sciences and the goal of all speculation” 
Karl Popper
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2.1   Material 
2.1.1   Plasmids 
 pTac 
This vector was provided by Dr. Kühlmann from Max Planck Institute of Molecular 
Physiology, Dortmund, and it was used for the expression in LB media of all Ras proteins 
(WT and mutants). The expression was induced by the presence of isopropyl-β-D-
thiogalactopyranoside (IPTG), which binds the lac repressor, thus allowing the transcription 
by the RNA polymerase. IPTG itself is not metabolized by the bacterial system. 
 pGEX4T1 (GE Healthcare®) 
This vector carries an N-terminal glutathione S-transferase (GST) and a sequence encoding 
ampicillin resistance. The 26 kDa GST-tag was used for purification by affinity 
chromatography and accounts for increasing further the solubility of the expressed protein 
during the purification. The vector was used in the expression of the catalytic domains of 
the effector protein Raf-RBD and the GAP protein Neurofibromatin 1 (NF1-333). The 
constructs were provided by S. Wohlgemuth and P. Stege from the Max Planck Institute of 
Molecular Physiology, Dortmund. 
 pET14b (Novagene®) 
This vector includes a T7lac promoter, ampicilin resistance and an additional N-terminal six 
histidine tag (His6-tag) that allows the efficient purification of the recombinant protein by 
affinity chromatography, being the tag cleavable with thrombin. The vector was used in the 
expression of the GEF protein, Son-of-Sevenless (SOS). 
 
2.1.2   Oligonucleotides 
The nucleotide sequences listed below correspond to the primers designed to perform site 
directed mutagenesis on HRasWT(1-166). They were manufactured either at Metabion AG 
(Planegg) or Mycrosynth AG (Lindau) in the desired quantities and degrees of purity. 
 
Table 2.1. Primers used in site-directed-mutagenesis to obtain the respective mutants. 
Mutation Primer sequence 5’- 3’ Mutant Name 
C79G_T81G_antisense GGTCGTATTCGTCCACAAACTCGTTCTGGATCAGCTGGATG H27E 
C79G_T81G CATCCAGCTGATCCAGAACGAGTTTGTGGACGAATACGACC 
   
G97A_C99G_antisense GGAATCCTCTATAGTGGGCTTGTATTCGTCCACAAAATGGTT D33K 
G97A_C99G AACCATTTTGTGGACGAATACAAGCCCACTATAGAGGATTCC 
   
C78G_antisense GTATTCGTCCACAAAATGCTTCTGGATCAGCTGGATG N26K 
C78G CATCCAGCTGATCCAGAAGCATTTTGTGGACGAATAC 
   
C280G_antisense TGCTCCCTGTACTGGTCGATGTCCTCAAAAGAC H94D 
C280G GTCTTTTGAGGACATCGACCAGTACAGGGAGCA 
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2.1.3   Bacterial Strains Used for DNA Cloning and Amplification 
These strains inhibit the Lac/Tac promoter by the action of the Laclq- gene, preventing any 
unwanted expression of the target gene from the transformed plasmids. They were used to 
achieve high level multiplication of plasmids during the production of the transgenic protein 
constructs. 
E. coli TG1 (Lucigen) 
Genotype: F’[traD36 lacIq Δ(lacZ)M15 proA+B+] glnV (supE) thi-1 Δ(mcrB-hsdSM)5 (rK mK 
McrB-) thi Δ(lac-proAB). 
One Shot® TOP10 Chemically Competent E. coli (Invitrogen) 
Genotype: F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacΧ74 recA1 araD139 Δ(ara-
leu)7697 galU galK rpsL (StrR) endA1 nupG λ-. 
DH5a™-T1® Chemically Competent E. coli (Thermo Fisher), as part of the SDM kit 
Genotype: F- φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1 hsdR17(rk-, mk+) phoA 
supE44 thi-1 gyrA96 relA1 tonA (confers resistance to phage T1). 
 
2.1.4   Bacterial Strains used for Protein Expression 
These strains were used with the purpose of obtaining the highest possible yields of the 
desired constructs upon expression. They are specific protease deficient to avoid 
degradation of the target recombinant proteins. 
 E. coli BL21 (Novagen) 
Genotype: F- ompT hsdSB (RB- MB) gal dcm 
The strain has no Laclq- gene, so that the induction by IPTG is only possible due to the 
properties of the transformed plasmid. Otherwise there would be a basal/permanent 
expression of the target construct, which can become a problem in some cases. 
 E. coli BL21 (DE3) pLysS (Novagen) 
Genotype: F- ompT hsdSB (RB- MB) gal dcm (DE3) pLysS (CAMR) 
As BL21, but with an additional DE3 element which codes for a T7-RNA polymerase and a 
lac repressor. This allows a IPTG inducible expression if the transformed plasmid contains 
a T7 promoter. Additionally, the strain is resistant to chloramphenicol and contains a pLys 
   
G196A_antisense TGGTCCCGCATGGTGCTGTACTCCTCC A66T 
G196A GGAGGAGTACAGCACCATGCGGGACCA 
   
C116T_C117A_antisense ACCTGCTTCCGGTATAAATCCTCTATAGTGGGGTCGTATTCG S39L 
C116T_C117A CGAATACGACCCCACTATAGAGGATTTATACCGGAAGCAGGT 
   
A29T_antisense CCAACAACAACAAGCTTGTATACTGTCATAGAATTCTGTTTCC E3V 
A29T GGAAACAGAATTCTATGACAGTATACAAGCTTGTTGTTGTTGG 
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sequence that codifies the T7 lysozyme, capable of inhibiting the T7 RNA polymerase, 
leading to an even stronger control of basal expression and a more stringent induction by 
IPTG 
 E. coli CK600K (Stratagene) 
Genotype: McrA-, sup E44, thi-1, thr-1, leuB6, lacY1, tonA21 
 
2.1.5   Media and Antibiotics 
2.1.5.1   Lysogeny Broth (LB) 
LB is a rich medium that contains all the nutritional requirements for E. coli to support a high 
cell density and maintaining growth in the logarithmic phase for an extended period, 
resulting in good yields of plasmidic DNA and heterologous protein expression. Tryptone 
and yeast extract are the sources of carbon, nitrogen, vitamins, minerals and amino acids 
essential for growth. 
Composition: 
• 10.0 g bacto-tryptone • 10.0 g NaCl 
• 5.0 g yeast extract • NaOH 0.1 g (pH 7.0) 
Dissolved in 1.0 L Millipore H2O and autoclaved. The medium can be stored at 4 ºC for two 
weeks or longer (if antibiotic is added). For bacterial platting, LB/Agar was prepared by 
adding 15 g/L of bacteriological grade agar to the aforementioned medium. If the medium 
had to be used immediately after autoclaving, care was taken to let it cool down to a 
temperature suitable for addition of antibiotics without causing any degradation to them. 
 
2.1.5.2   Terrific Broth (TB) 
TB was mainly used for the overexpression of SOS. This medium contains slightly more 
bacto-tryptone and 5 times more yeast extract than LB, providing large quantities of growth 
factors and nucleic acid precursors. Glycerol was used as an additional source of 
carbohydrates, having the advantage of not being metabolized into acetic acid, as it 
happens with glucose (which, in some expression systems, also acts as a repressor). The 
presence of phosphate buffer allows a better control of the physiological pH during the 
exponential growth. 
Composition of the TB buffer: 
• 12.0 g bacto-tryptone • 24.0 g yeast extract 
• 4.0 mL glycerine 
Dissolved in 900 mL of Millipore H2O and autoclaved.  
Separately, a phosphate buffer was prepared by dissolving 164.32 g of K2HPO4 and 23.13 
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g KH2PO4 in 1.0 L of Millipore H2O and autoclaved. It Is important to not autoclave the TB 
buffer with the phosphate buffer added to it. Therefore, both components were autoclaved 
separately and mixed afterwards at room temperature. This prevents the precipitation of the 
phosphates, that undergo exothermic dissolution, by ionic metals (brought in trace 
quantities from the yeast extract or tryptone) at high temperatures [186]. 
The final medium was prepared by adding 100 mL of the phosphate buffer to 900 mL of the 
aforementioned TB buffer, to yield 1.0 L of TB medium ready to use. 
 
2.1.5.3   New Minimal Medium (NMM) 
NMM contains the minimum of nutrients that support the proliferation of cells and colony 
growth. All amino acids, nutrients and complex molecules need to be built de novo by the 
cellular machinery [187]. This is the medium of choice to express uniformly 15N and/or 13C-
labeled proteins needed to perform heteronuclear multidimensional NMR experiments. 
In the scope of this thesis, RasWT and selected mutants were uniformly labelled with 15NH4Cl 
with the aim to investigate their conformation and dynamics by 2D [1H-15N]-HSQC NMR. 
Below are described the details of the procedure: 
 A – Preparation of minimal medium 
MM contains a Carbon source which is typically glucose (or sometimes a less energy rich 
sugar such as succinate) and different salts that provide essential elements (e.g. Mg, N, P, 
S) and allow protein and nucleic acid synthesis by the bacteria. 
Composition: 
• 7.5 g Na2HPO4 • 0.25 g MgSO4 x 7H2O 
• 3.0 g KH2PO4 • 0.014 g CaCl2 x 2H2O 
• 0.5 g NaCl 
Dissolved in 1.0 L of Millipore H2O and autoclaved. This medium can be stored for long 
term usage at 4 ºC. Sodium phosphate dibasic and nitrogen dihydrogenophosphate act as 
a source of Na, K and P and are simultaneously buffers for maintaining the pH during the 
bacterial growth. 
 B – Preparation of a micronutrient stock solution (SL6) 
This solution contains all the micronutrients needed for cell growth dissolved in 1.0 L of 
Millipore H2O and autoclaved. The solution can be stored in the dark at 4 ºC for long term 
usage. 
Composition: 
• 100 mg ZnSO4 x7H2O • 10 mg CuCl2 x 2H2O 
• 30 mg MnCl2 • 20 mg NiCl x 2H2O 
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• 300 mg HBO3 • 30 mg Na2MoO4 
• 200 mg CoCl2 x 6H2O 
 
 C – Preparation of the Iron sulphate/EDTA solution (SL4) 
This solution needs to be freshly prepared and used shortly after. 
Composition: 
• 500 mg EDTA • 200 mg FeSO4 x 7H2O 
Dissolved in a total volume of 90 mL of previously autoclaved H2O. 
For a better dissolution and to avoid the occurrence of slight precipitation, the two chemicals 
were dissolved separately and only then mixed together. The final solution is light green 
coloured, typical of aqueous ferrous sulphate (green vitriol). As the oxidative process takes 
place over time, formation of ferric sulphate will give rise to a deep yellow/green colour. At 
such point, the solution should not be used any longer and a freshly one should be 
prepared. 
 D – Preparation of a SL6/SL4 mixture (SL mix) 
In this procedure 1.0 mL of the micronutrient (SL6) solution was added to 0.9 mL of the SL4 
solution. The mixture was filled in up to a final volume of 10 mL using previously autoclaved 
H2O. 
 E – Adding the SL mix to the minimal medium and the N and C sources 
Final composition: 
• 900 mL minimal medium 
• 10 mL SL mix   • 4.0 g Glucose 
Filled up to a final volume of 1.0 L with previously autoclaved H2O. 
NMM was ready to use after filtration. The amount of glucose and ammonium sulphate can 
be adjusted accordingly to the growth demands of the bacterial strain. A minute amount of 
thiamine, taken in the tip of a spatula was added to the medium prior to filtration. The active 
form of this vitamin, thiamine pyrophosphatase, is a cofactor of enzymes involved in the 
synthesis of three amino acids: valine, isoleucine and leucine. Its addition to the medium is 
not essential but it can help to enhance the bacterial growth, especially in the case strains 
such as DH5a, which are knocked out for thiamine synthesis (genotype: thy-) [188, 189]. 
 
2.1.6   Chemicals 
All pro analysis grade chemicals were purchased from the following companies: Fluka (Neu-
Ulm), Merck (Darmstadt), Roche (Mannheim), Novabiochem (Läufelingen, Switzerland), 
Roth (Karlsruhe), Pharma-Waldorf (Düsseldorf), Sigma (Deisenhofen), Serva (Heidleberg) 
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and QIAGEN. They were always analysed and used accordingly to their respective safety 
datasheets. Metal(II)-cyclens were synthesized by the Organic Chemistry Department 
(chair Prof. B. König) at Regensburg University. 
 
2.1.7   Expendable Materials and Common Solutions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2. List of the enzymes used. 
Enzyme Provider 
Alkaline Phosphatase Boehringer/Roche 
DNaseI Boehringer/Roche 
Lysozyme Sigma 
Thrombin Sigma 
Immobilized Alkaline Phosphatase              MoBiTec 
Taq DNA Polymerase Fermentas, Quiagen, NEB  
PierceTM protease inhibitor ThermoFisher 
Table 2.3. List of protein and DNA ladders used. 
Standard Provider 
PageRuler Unstained Protein Ladder Thermo Scientific/Fermentas  
PageRuler Unstained Protein Ladder Low Range Thermo Scientific/Fermentas 
Page Ruler Prestained Protein Ladder (10-180 kDa) Thermo Scientific/Fermentas 
1 kb/ 100 bp DNA Ladder New England Biolabs (NEB) 
Table 2.4. Commonly used buffer solutions. 
   Buffer B 50 mM Tris/HCl pH 7.5; 5 mM EDTA; 5 mM DTE; 1mM PMSF Cell Lysis Ras 
Buffer C 32 mM Tris/HCl pH 7.5; 10 mM MgCl2; 1mM DTE IEX Ras 
Buffer D 64 mM Tris/HCl pH 7.5; 10 mM MgCl2; 400 mM NaCl; 2 mM DTE; 
0.1 mM GDP 
SEC Ras 
Buffer E 50 mM Tris/HCl pH 7.5; 2 mM DTE Nuc. Exchange 
Buffer F 40 mM Tris/HCl pH 7.5; 10 mM MgCl2; 2mM DTE Storage Buff Ras 
   
Table 2.5. List of commonly used expendable materials. 
Material Supplier 
Bradford reagent Rotiquant™ Roth 
Cuvettes UV/Vis, macro, semi-micro and micro Carl Roth 
NMR tubes:  
      • 3 and 5 mm Norell Inc. 
      • 5, 8 and 10 mm Shigemi Co LTD 
Vivaspin ultrafiltration units Vivascience 
Filter unities Steritop™0.22 µM Millipore 
Eppendorf cups 0.5, 1.5 and 2.0 mL VWR 
Falcon tubes 15/50 mL (16000g) VWR 
Vivaspin® 20 concentrators (various sizes) Sartorious 
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2.1.8   Main Instrumentation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.7. Main instrumentation used in this thesis. 
Instrument Supplier 
Incubator EB 53 Juan 
Electrophoretic chambers GE Healthcare 
pH-Meter Φ 32, Φ 340 Beckman Coulter 
Thermocycler Mastercycler Personal Eppendorf 
Sonifier 250/450 Branson 
Ultrasonic machine (cell lysis) Branson 
Water system Purelab® Ultra, Elga Millipore 
J-6B, Avanti J-20, Avanti J-25 Beckman Coulter 
Biofuge Pico, mini Spin Hereaus Instruments 
Analytical Balance CP64, Sartorius PM 600 Mettler 
Beckman HPLC System Gold® 125 Solvent Module  Beckman Coulter  
Beckman HPLC 166 Detector Beckman Coulter 
AKTA™ FPLC system, UPC 900, Frac 900 Amersham Pharmacia 
water systems Purelab Ultra, Elga Millipore 
UV/Vis spectrophotometer LambdaBIO+ PerkinElmer 
Microcal PEAQ-ITC Malvern Instruments 
Monolith NT.115 Series Nanotemper Techologies 
2.0 KBar NMR Ceramic Cell Daedalus Innovations LLC 
2.5 KBar NMR Ceramic Cell Daedalus Innovations LLC 
NMR Spectrometers   
    500 MHz Avance with QXI or 31P broadband probe  Bruker Corporation 
    600 MHz Avance with Prodigy probe Bruker Corporation 
    800 MHz Avance with TCI-Cryoprobe Bruker Corporation 
Beamline ID09 ESRF synchrotron. Grenoble, France 
Beamline ID27 ESRF synchrotron. Grenoble, France 
“Crystal” Beamline Soleil synchrotron. Paris, France 
HP “ELMA” DAC cell Almax 
HP “ELSA” DAC cell Almax 
Table 2.6. Most often used chromatography columns.  
Column Materials Supplier 
Hiload™ 26/10 Q-Sepharose™ Fast-Flow Amersham Pharmacia 
Hiload™ 26/600 Superdex™ 200 prep. grade GE Healthcare 
Hiload™ 16/60 Superdex™ 75 prep. grade GE Healthcare 
Superdex 75 10/300 GL GE Healthcare  
Glutathione Sepharose™ Fast Flow 4 GE Healthcare 
Pierce Glutathione Spin Columns (3 ml) ThermoScientific 
Ni Sepharose™ Superflow/Fast Flow 6 GE Healthcare 
Sephadex™ G25 NAP10/ NAP15/ PD10 Amersham Biosciences 
Nucleosil 100 C18 precolumn Beckman Coulter 
ODS hypersil C18 column Beckman Coulter 
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2.1.9   Software 
 
Table 2.8. Most commonly used software. 
Software Manufacturer/URL Description 
Gold Chromatography 
V1.7  Beckman HPLC control and evaluation 
UNICORN Control system Amersham Biosciences ÄKTA-FPLC control and evaluation 
Topspin 3.2 Bruker NMR acquisition, processing and evaluation 
AUREMOL2.4.1beta Uni-Regensburg/ Kalbitzer NMR processing and evaluation 
MestReNova 10.0  Mestrelab Research NMR processing and evaluation 
GENtle http://gentle.magnusmanske.de DNA and protein sequence analysis 
PyMol https://www.pymol.org/  Protein visualization and structure analysis 
Chimera 1.9  http://www.cgl.ucsf.edu/chi- mera/  Protein visualization 
Microcal Origin 6.0 http://www.originlab.de/  NMR Data analysis and statistics 
Origin 10 http://www.originlab.de/  NMR Data analysis and statistics 
Microsoft Office Microsoft Word processor and data analysis 
CorelDraw 16 Corel corporation Image editor 
Microcal PEAQ ITC Malvern Instruments ITC analysis software 
   Online tools/Databanks Manufacturer/URL Description 
ExPASy Bioinformatic 
portal http://www.expasy.org/  Proteomics tool (very useful) 
PDB Databank http://www.wwpdb.org/  Repository of X-Ray, NMR structures 
Uniprot http://www.uniprot.org/  Protein databank 
BLAST https://blast.ncbi.nlm.nih.gov/Blast.cgi Basic Local Alignment  Search Tool (very usefull) 
 
 
2.2   Methods 
2.2.1   Molecular Biology 
2.2.1.1   Preparation of Chemically Competent Cells 
E. coli can incorporate exogenous circular DNA molecules, commonly referred as plasmids. 
One can take advantage of this feature and build specific plasmids containing genetic 
information for desired proteins or parts of proteins. These can be introduced in bacterial 
cells in a process called transformation. The transformed bacteria are called competent and 
can transcribe the genetic information contained in the plasmid into proteins. Some natural 
prokaryotes are genetically determined to be naturally transformable (e.g. Bacillus subtilis). 
By contrast, many bacteria are poorly transformable, if at all, under natural circumstances. 
E. coli falls in such category [190]. However, if E. coli cells are treated with high 
concentrations of Ca2+ and then chilled, they become adequately competent, increasing 
their ability to intake double stranded DNA. Inducing artificial competence is always a mildly 
efficient process, yielding very few (approx. 106) transformants per µg of plasmidic DNA 
[191]. This technique also makes it possible to transcribe genetic information from other 
organisms into E.coli, a concept that allows, for example, the study of human proteins like 
Ras, without the need of dealing with human material [191]. 
All material (flasks, pipette tips, etc.) were autoclaved and the conditions kept as sterile as 
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possible. The handling of the medium and bacterial growth was done in the absence of 
antibiotics throughout the whole procedure. As result, especial care was taken to avoid 
contaminations. Vortexing or hard shaking of the samples was also avoided to minimize cell 
death. 
Day 1 
With the help of a toothpick, the frozen E. coli strains (BL21 and BL21DE3) from a -80 ºC 
glycerol stock were directly plated in LB/Agar. The bacteria were allowed to grow overnight 
at 37 ºC. 
Day 2 
Upon inspection, an individual (isolated) colony was picked and streaked again in a new 
LB/agar plate. The culture grew overnight once more (this process can be repeated a third 
time, if desired, to ensure that the final population on the plate arises from a truly, isolated 
colony, characterized by a single genotype). 
Day 3 
A 5 mL LB culture was prepared by picking an isolated colony with a toothpick from the 
double (or tripled) streaked plate. The culture was grown overnight at 37 ºC, 220 rpm. 
Day 4 
The overnight grown culture was diluted with 100 mL of LB medium. The corresponding 
OD600 was 0.02. The cells were allowed to grow in the same conditions as before (37 ºC, 
220rpm), until the OD600 reached a value of 0.4-0.5 (ca. 3 h). The growth stage of the 
bacteria has a significant impact for its ability to take up DNA: in the log phase, they are 
metabolically more active and prone to perform efficient DNA repair as compared with their 
activity in the stationary phase. As a result, it is preferred to use bacteria in a log phase. 
• At OD600= 0.4-0.5 the bacterial growth was stopped by keeping the cultures on 
   ice with gentle stirring for ca. 15 min. 
•The cell culture was centrifuged 6-8 min. at 4 ºC, 4000 rpm. The supernatant was 
  discarded and the pellet re-suspended in transformation buffer 1 (TFB1). 
10x TFB1 composition: 
• 1.176 g KOH • 4.8 g RbCl 
• 0.588 g CaCl2 • 4.0 g MnCl2 
The pH was adjusted to 5.8 with 1.0 M HCl, in a final volume of 40.0 mL. Because of the 
small amount of powder to be weighted, this buffer was prepared in a 10x concentration 
stock solution, that can be stored for long periods of time. The buffer was diluted to 1x 
before adding it to the cells. The resuspension of the pellet is a time-consuming process 
and should be done slowly to avoid cell lysis. 
2. Methods 
 
42 
• The re-suspended cells were left shacking on ice ca. 15 min. After the elapse of 
   this time, they were centrifuged again at 4000 rpm, 6-8 min, 4 ºC. 
• The supernatant was discarded and the pellet was re-dissolved in TBF2. 
5x TFB2 composition: 
• 1.1 g CaCl2 
• 0.121 g RuCl 
• 0.21 g MOPS 
The pH was adjusted to 6.5 with 0.1 M NaOH in a final volume of 20.0 mL. 
The presence of CaCl2 accounts for the neutralization of the negative charges at the cell 
surface and therefore to avoid electrostatic repulsion between the cell wall and the DNA 
phosphate groups. At the same time the hypotonic transformation buffer solutions lead to 
cell swelling and to the expulsion of some membranar proteins. Rb2+ and Mn2+ are reported 
to have a complementary and enhanced effect as compared to the one of CaCl2 [192]. All 
the components components become embedded in the cell wall and in the membrane, 
creating “holes” through which the exogenous plasmids can enter the cell. 
• The re-suspended cells were aliquoted in previously cooled Eppendorfs  (100 µl), 
   flash frozen with liquid N2 and stored at -80 ºC. 
 
2.2.1.2   Bacterial Transformation by Heat-Shock 
In this process the exogenous genetic material is taken up by the competent cells by altering 
their membranar fluidity upon a 0ºC-42ºC-0ºC heat shock sequence. The membrane 
becomes momentaneously more fluid when exposed for a short time to a high temperature, 
allowing the entrance of genetic material. The enclosed RbCl2 and MnCl2 salts detached 
from the cell wall and plasma membrane it, leaving the artificially created open “pores”, 
through which the plasmids can access the cytoplasm [190]. The detailed methodology is 
presented below. 
• An aliquot of the previously prepared competent cells was thawed on ice, the desired 
plasmid was added (50-200 ng, corresponding to 2-10 µl) and mixed by inverting the 
Eppendorf cup up and down (care was taken to not abruptly shake the mixture. Polystyrene 
reaction tubes are to be avoided since DNA can adhere to their surface, reducing the 
transformation efficiency). The mixture was incubated on ice for ca. 20 min. and subjected 
to heat shock for about 30-60 seconds at 42 ºC (the exact time depends on the 
characteristics of the bacterial strain used and should be optimized. The water bath should 
be brought to the correct temperature before initiating the experiment). After the heat step, 
the membrane was regenerated by placing the cells on ice for 2-8 min. Following heat 
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shock, the transformed E. coli were cultured in antibiotic free liquid medium for a short 
period to allow expression of antibiotic resistance genes from the recently acquired plasmid. 
Typically, 100 µl competent cells were incubated in 1.0 mL SOC medium and allowed to 
grow at 37 ºC, 500 rpm for 1 hour. Rich media containing glucose and MgCl2, like SOC, is 
recommended in order to maximize the transformation efficiency [192]. Afterwards the cells 
were platted on LB/agar containing Ampicillin 1mg/mL (the plates were pre-warmed at 37 
ºC and free of condensation). Typically, 50-100 µl of E. coli grown in SOC medium were 
platted for BL21 and BL21DE3, as the process was generally very efficient. In other 
situations, and when different bacterial strains were used, the quantity of cells platted was 
optimized to produce a sufficient (but not too numerous) number of individual, distinct 
colonies. When necessary, the cells cultured with SOC were pelleted by centrifugation for 
5 minutes at 600-800 rpm and re-suspended in a smaller volume. 
 
2.2.1.3   Plasmid Isolation and DNA Sequencing 
Plasmids from transformed E. coli were isolated in order to evaluate their degree of 
contamination and to scrutinize the correct DNA sequence of newly created Ras mutants. 
The isolation was carried out using a standard, miniprep kit protocol from Promega™. The 
methodology used strictly follows the protocol presented by the manufacturer of the kit and 
it will not be discussed in detail here. The reader is submitted to the respective online 
miniprep quick protocol [193]. The concentration of the isolated plasmids was typically in 
the range of 20-100 ng/µl. When needed, larger amounts were also isolated (up to 600 
ng/µl) using the midiprep kit from the same manufacturer [194]. 
All the isolated plasmids were sequenced at SeqLab GmbH (Göttingen). The minimum 
amount required was 10 µl (150-350 ng). The sequencing of small constructs (up to 1000 
bp) was performed by the standard Sanger method employing dideoxynucleotides, using a 
5’-3’ (sense direction) primer located prior to the open reading frame (ORF) of the inserted 
sequence. Constructs bigger than 1000 bp were stepwise sequenced, using different 
overlapping primers. 
 
2.2.1.4   Expression of Unlabelled Ras 
Overexpression of wild type and mutants of H, K and NRas, either their truncated (1-166) 
or full length (1-188/189) forms was accomplished according to Tucker et al. [195], using 
either the 6K600K, BL21 or the BL21DE3 strains transformed with the pTac vector 
containing a codifying region for antibiotic resistance to ampicillin. The 6K600K strain 
contains an additional plasmid, accounting for resistance to kanamycin. Experimentally, 
ampicillin was substituted in our laboratory by carbenicilin. The latter is a carboxyl based 
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analogue of the former (which has an amine group instead). The basis of the selective 
growth inhibition is the same: both antibiotics become hydrolysed and therefore inactive by 
b-lactamase, an enzyme expressed from the plasmid-borne bla gene, which is involved in 
the synthesis and crosslinking of the peptidoglycan wall. However, b-lactamase is secreted 
by the bacteria into the medium during their exponential growth and the resulting build-up 
of extracellular b-lactamase can inactivate ampicillin present in the culture medium, thus 
removing the induced selective pressure on the population. This affects liquid cultures 
because there is always a portion of the population that is not transformed with the plasmid 
and also agar platted cultures, as the ampicillin degradation leads to the appearance of 
satellite colonies: very small groups of cells that have not incorporated the plasmid and 
therefore can grow around a larger transformed colony. As the b-lactamase is released by 
the main colony in its vicinity, more ampicillin is degraded by it and the satellite colonies 
tend to strive. Carbenicilin, on the other hand, is not easily degraded by b-lactamase, thus 
being a better choice as antibiotic [196].  
Following is presented the methodology used for the expression of Ras proteins: 
• From a -80 ºC glycerol stock containing the frozen bacteria, 200 mL LB containing 50 
mg/mL of the appropriate antibiotic (carbenicilin and kanamycin in case of 6K600K and 
carbenicilin alone in the case of BL21/ BL21DE3) were inoculated. This so-called pre-
culture was grown overnight, typically at 35-37 ºC (E. coli 6K600K) or 30 ºC (E. coli 
BL21/BL21DE3), with a constant aeration and shaking velocity of 180 rpm. The detailed 
methodology on the preparation of LB medium is described in section 2.1.5.1. 
• In the second day, the overnight pre-culture was used to inoculate 10.0 L of previously 
autoclaved LB medium containing 50 mg/mL of the appropriate antibiotics. For a better 
handling of the volumes, the 10 L were always divided in 4 flasks of 2.5 L each. The cultures 
were grown at constant aeration and speed, 180 rpm, 37 ºC. The OD600 was monitored by 
optical photometry at specific time intervals. When the culture reached the exponential 
growth phase (comprised by a OD600 value between 0.6-0.8 units), protein expression was 
initiated by induction with 1.0 mM or 0.3 mM, depending on the E. coli strain used (6K600K 
or BL21/BL21DE3, respectively) of the non-hydrolysable lactose analogue, IPTG. This 
sugar binds to the lac repressor and promotes a conformational modification that hinders 
its ability to regulate (repress) the promoter. This leads ultimately to the expression of the 
Ras gene that is under control of the promoter sequence [190]. The induced culture was 
allowed to grow overnight at 37 ºC (6K600K) or 30 ºC (BL21/BL21DE3), with a constant 
speed of 180 rpm. 
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• In the third day, the culture now in the log phase, was harvested by centrifugation during 
40-45 min, at 4 ºC, 4000 g. In order to better handle the 10 L volumes, the centrifugation 
process was performed 3 times in fractions of 4 L each. The supernatant was discarded 
and the bacterial pellet was directly stored at -20ºC until further use. 
The studies comprising the mutational analysis of HRas(1-166) (see results section 3.4.2) 
led to the de novo  creation of several Ras mutant constructs using E. coli BL21. For each 
individual construct, the optimal expression conditions related to expression time, IPTG 
concentration of the induction, type of medium, temperature, aeration, and, if necessary, 
the construct per se were optimized as best as possible. 
 
2.2.1.5   Expression of 15N labelled Ras 
Due to the economic costs involved in the expression of labelled proteins (arising 
fundamentally from the high prices of 15N and 13C isotopes), all the HRas(1-166) constructed 
mutants were optimized beforehand for the best possible expression yields. The advantage 
of performing isotopic labelling lies in overcoming the ambiguity of resonance overlaps in 
NMR, allowing an unambiguous assignment of the spectra, which would be impossible 
otherwise for most proteins with a size beyond 10 kDa. Structural studies of large proteins 
(>30 kDa) require triple-labelling 2H/13C/15N for the use of TROSY techniques [197]. In such 
cases, bacteria must grow in D2O, usually causing a significant reduction on the protein 
yield. The strategy taken on the present work to optimize the cell growth of 15N enriched 
Ras focused primarily on increasing the cell density of the bacterial expression, without 
manipulating the expression vector [198]. This was accomplished by selecting high-
expressing colonies and optimizing growth temperatures and times. Parameters such as 
O2 levels, pH and nutrients were disregarded because they can be much better controlled 
using a fermenter. By contrast, they are more difficult to control using a regular incubator 
shaker, as the one used during this work. For this purpose, wild type Ras and selected 
mutants were overexpressed in NMM – a “bare bones food” – containing a single source of 
enriched 15N, added in the form of 15NH4Cl. The details regarding its preparation are 
discussed in section 2.1.5.3. During the optimization process, the expression strategy is 
determined by simulating a “isotope marked” expression in which the composition of the 
media is the same, except for the isotope sources, which are the non-labelled ones, 14N-
ammonium chloride and 12C-glucose. 
In the case of truncated RasWT and mutants such as D33K, H27E, T35S, the optimized 
methodology is similar to the one used for the expression of the bacteria in LB (section 
2.1.5.1). However, the expression of some variants such as the full length wild type KRas 
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isoform, have been more difficult to obtain in the amounts required for NMR spectroscopy, 
despite the very good expression yields obtained in rich LB media. A very thorough 
optimization study of the expression conditions for this protein in NMM is presently an 
ongoing project at our department. 
The typical methodology used for expression of 15N-labelled truncated HRas is as follows: 
• From a -80 ºC glycerol stock containing the frozen bacteria, 100 mL of LB containing 50 
mg/mL of carbenicilin were inoculated. The pre-culture was grown overnight at 30 ºC with 
constant aeration and shaking at 200 rpm. 
• In the second day, the overnight pre-culture was used to inoculate 5 L of sterile NMM 
containing 50 mg/mL of carbenicilin. For a better handling, the volume was divided as 2x2.5 
L in two Erlenmeyer flasks of 5 L maximum capacity. The culture was grown at 30 ºC, 200 
rpm. After reaching an OD600 of 0.8-1.0, protein expression was initiated by induction with 
0.28 mM IPTG. 
Typically, the bacterial growth time is much longer in NMM as compared to the same 
expression in LB. For example, the time necessary to reach an OD of 0.8 is around 3 hours 
in LB and 7 hours in NMM. After induction, the cultures were grown overnight at 30 ºC, 200 
rpm. For some Ras mutants (D33K, H27E) expression tests determined the best growth 
temperature to be 25-28 ºC. 
• At the third day the cells where harvested by centrifugation during 40-45 min, at 4 ºC, 
4000 g. The supernatant was discarded and the bacterial pellet was directly stored at -20 
ºC until further use. Cell lysis and the purification of the 15N labeled Ras proteins was 
accomplished according to the same principle described for the unlabelled proteins (see 
section 2.2.2.1). 
 
2.2.1.6   Expression of the Effector Protein Raf-RBD 
The catalytic domain of Raf-RBD (amino acids 51-131) was expressed in E. coli BL21(DE3) 
as a GST fusion protein using a pGex-4T1 vector. The expression strategy follows the 
methodology described in section 2.2.1.4 with minor modifications. Briefly, 200 mL of an 
overnight grown pre-culture, containing 50 mg/mL of carbenicilin were used to inoculate 10 
L of LB media containing also 50 mg/mL of carbenicilin. The culture was grown at 37 ºC, 
180 rpm, until an OD600 of 0.6-0.8 was reached. At this point the growth was slowed down 
and protein expression initiated by induction of 0.3 mM IPTG. Overnight incubation at 30 ºC 
was followed by centrifugation of the culture media. The bacterial pellet was frozen and 
stored at -20 ºC for further use. The cells were lysed and the protein purified by GST-tag 
affinity chromatography (section 2.2.2.2.2). 
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2.2.1.7   Expression of the GAP Protein Neurofibromatin 1 (NF1) 
The GAP protein NF1 (aa 1198-1531, 35 kDa), a negative regulator of Ras in signal 
transduction, was expressed as a GST-fusion protein in E. coli. BL1DE3. The methodology 
closely follows the one applied to the expression of Raf-RBD. Inoculation volumes, 
incubation times and antibiotic concentrations are identical. The purification was 
accomplished by GST-tag affinity chromatography (section 2.2.2.2.2). 
 
2.2.1.8   Expression of the GEF Protein SOScat(W729E) 
The ubiquitous SOS1 was expressed in E. coli BL21DE3 in the form of a Histidine tag fusion 
protein using the pProEx HTb vector. Only the catalytic domain was engineered into the 
expression vector (aa 566-1049, 55 kDa). The expression was carried in TB medium 
(section 2.1.5.2). 
• A 100 mL pre-culture was prepared by mixing 10.0 mL TB Buffer with 90.0 mL of 
autoclaved TB medium, containing 50 mg/mL of carbenicilin. The medium was inoculated 
with the transformed bacteria and the culture was allowed to grow overnight at 30 ºC, 200 
rpm. 
• 4.5 L of TB medium were autoclaved, followed by the addition of 500 mL of TB buffer, 
while stirring under sterile conditions (using the laminar flow chamber). To the final medium, 
50 mg/mL of carbenicilin were added and the overnight grown pre-culture was used for 
inoculation. The 5 L volume was divided in 2x2.5 L in two Erlenmeyer’s of 5 L maximum 
capacity. Protein expression was initiated at an OD600 of 0.5 by induction with 0.3 mM IPTG. 
The culture grew overnight at room temperature with constant aeration and speed of 200 
rpm. 
• Upon overnight incubation, the cells were pelleted by centrifugation at 4 ºC, 4000 rpm and 
the bacteria stored at -20 ºC until further usage. After cell lysis, the protein was purified by 
Ni-NTA affinity chromatography described in section 2.2.2.3.2. 
 
2.2.1.9   Polymerase Chain Reaction (PCR) 
PCR was mainly used in the scope of this thesis to amplify the DNA sequence of newly 
created Ras mutants through site directed mutagenesis (section 2.2.1.11). The details of 
the amplification process (temperature, number of cycles, etc.) were followed according to 
the instructions provided in the Geneart® Site-Directed Mutagenesis Kit [199]. The reader 
is referred to the online website of the manufacturer (TermoFisher®) for additional 
information. A brief description is present below: 
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• For a single PCR reaction, a pair of 
oligonucleotides containing the desired 
point mutation  in the middle of the 
sequence were used as primers (see 
Table 2.1). They were mixed with 20-25 
ng of plasmidic DNA from RasWT and the 
deoxyribonucleotides (dATP, dCTP, 
dGTP dTTP) were added alongside with 
the thermostable DNA polymerase 
provided with the kit. These four 
components were gently mixed and 
brought to a thermocycler. The general PCR setup is described in Figure 2.1. The 
denaturation of the double helix was carried out for 2 minutes at 94 ºC, followed by the 
annealing of the primers to the single stranded DNA at 57ºC for 30 seconds. The synthesis 
of new DNA took place at 68ºC for 2.5 min. The full cycle was repeated 20 times. The PCR 
reaction proved to be very effective in most cases. The newly amplified DNA was tested by 
Agarose gel electrophoresis, purified if necessary, and used directly in the next stages of 
the site-directed mutagenesis protocol. 
 
2.2.1.10   Agarose Gel Electrophoresis 
DNA electrophoresis was routinely carried to assess the quality of PCR products and the 
purity of isolated plasmids. In this technique, nucleic acids are separated by their molecular 
mass when subjected to a directional electric field. Their negative charge (due to the 
phosphate groups of the DNA backbone) promotes their migration from the cathode 
(negatively charged) to the anode (positively charged). The migration occurs in a polymer 
matrix made of agarose. The presence of the gel meshwork hinders the progress of the 
DNA, and small or compact molecules migrate more rapidly than large molecules. The 
higher the concentration of the gel, the larger molecules are hindered. Consequently, gels 
of different concentrations are used to separate molecules of different sizes. Ethidium 
bromide (EtBr), 0.5 µg/µl, is added to the gel for the revelation of the DNA bands. Later in 
our laboratory it was replaced by Midori green because it is not as health threatening as the 
first one. Both compounds are dyes that can bind to the DNA fragments and fluoresce with 
an orange colour under ultraviolet light. The excitation of EtBr can be done directly at 366 
nm and indirectly at 254 nm. For Midori green, the excitation occurs at 490 nm. The medium 
through which the electric current is conducted is either based on a Tris-borate-EDTA (TBE) 
Figure 2.1. Overview of the PCR reaction used for the 
creation of Ras mutants. Times and temperatures used 
for each step were optimized accordingly to the size of 
the amplified plasmid and led generally to good 
amplification yields. The axes are not up to scale. 
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or on a Tris-acetate-EDTA (TAE) buffer. Both present their own advantages and 
disadvantages. TAE is preferred when the DNA is to be used in subsequent enzymatic 
reactions such as cloning experiments and it is a better conductor of electricity than TBE, 
being ideal in long runs and in the separation of large fragments. Borat salts from TBE are 
often inhibitors of many enzymes, which makes this buffer inappropriate if the DNA is to be 
used in enzymatic reactions. 
• 1% Agarose w/v was prepared by mixing 1.0 g of the powder with 100 mL TBE buffer. 
Upon microwave heating until complete dissolution, the hot liquid was carefully poured in 
an appropriate chamber and left at 4 ºC for faster solidification. TBE was normally prepared 
in a 10x stock solution and diluted before usage to 1x (final 1x concentration: 89 mM Tris-
base pH 7.6, 89 mM Boric acid and 2 mM EDTA). TAE was rarely used (final 1x 
concentration: 40 mM Tris/HCl pH 7.6, 20 mM acetic acid, 2 mM EDTA). The DNA samples 
were mixed with a DNA loading buffer, previously prepared as a 6x stock solution (30% w/v 
glycerol, 0.25% w/v bromophenol blue and 0.25% xylene cyanol FF). The mixture was 
properly loaded into the electrophoretic chamber and the gel was run at a constant voltage 
(100 V for TAE and 200 V for TBE), for approximately 30-40 min. 
 
2.2.1.11   Site-Directed Mutagenesis (SDM) 
In vitro site-directed mutagenesis is an invaluable method for glimpsing the complex 
relationships between protein structure and function, for studying gene expression 
elements, and for carrying out vector modifications. From the different approaches available 
to perform this technique, the one chosen in the present work relies on the PCR 
amplification using the double primer method [200]: for each mutant, two complementary 
primers (30-45 nucleotides) were designed in such a way that they contained the desired 
mutated codon in the middle of their sequence (Table 2.1). These primers were directly 
mixed with the pTac vector containing the codifying sequence for HRasWT(1-166) and with 
all the other necessary elements for the reaction, provided by the Geneart® Site-Directed 
Mutagenesis kit, from Invitrogen® [199]. These included DNTP’s, the taq polymerase, DNA 
methylase and its cofactor S-adenosyl methionine (SAM). All the components were directly 
used and the protocol provided by the manufacturer was strictly followed. The reaction 
yields were generally good and no additional purification steps were required at the end. 
The mutated plasmids were used after the reaction to transform the highly competent 
DH5α™-TTR-E. coli cells, also provided in the same kit. Upon bacterial growth the plasmids 
were isolated and tested for the mutation through DNA sequencing using the Sanger 
method. 
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2.2.2   Protein Biochemistry 
2.2.2.1   Purification of Ras Proteins 
Due to the different isoforms and Ras mutants that were studied in the scope of this thesis, 
it is impossible to provide a detailed purification methodology for each one. Nevertheless, 
most of the methodologies employed are common to all of them, with the exceptions on 
details such as concentrations, temperature, salt gradients used, etc., which were 
sometimes fine-tuned according to the characteristics of a specific mutant or changed more 
drastically from truncated to full length Ras proteins. 
 
2.2.2.1.1   Cell Lysis 
All Ras proteins were expressed, secreted and folded into the bacterial cytoplasm. Because 
they are not directly secreted into the surrounding medium, E. coli must be subjected to 
disruption of their wall and membrane as a means to retrieve them. Some proteins however 
are expressed as a form of inclusion bodies and therefore not secreted directly into the 
cytoplasm or to the exogenous media. Although not being the case with Ras, the reader is 
referred to the possibility of occurrence of this situation. In such cases, a purification in 
denaturing conditions can retrieve the proteins from the inclusion bodies, provided that they 
are able to re-fold into their native conformation [201]. 
In the case of Ras, cell lysis was accomplished by employing firstly a chemical disruption 
strategy, followed by a mechanical disruption one: 
• Using a 500 mL beaker, the frozen bacterial pellet from a 10 L LB culture was dissolved 
in 200 mL of lysis buffer at room temperature, with constant stirring. The lysis buffer (buffer 
B, Table 2.4), is prepared by mixing 32 mM Tris/HCl pH 7.5, 5.0 mM 
Ethylenediaminetetracetic acid (EDTA), 2.0 mM Dithioerythritol (DTE) and 1.0 mM 
phenylmethane sulfonyl fluoride (PMSF).  
EDTA is capable of chelating metal ions with a +2-charge making them unavailable as co-
factors of some proteases and DNAses, leading to a reduction of the catalytic activity of 
those enzymes. PMSF is a serine protease inhibitor. This compound is very unstable in 
aqueous solutions, having a half-life of 110 min. at pH 7 and 25 ºC. Its activity is therefore 
rapidly reversible. For more demanding cell lysates, the reader is referred to the alternative 
AEBSF, an isomer with irreversible inhibitory activity. (Both compounds are neurotoxins and 
should be handled with care) [202]. DTE is a sulphur containing sugar from the 
corresponding saccharide erythrose, capable of reducing disulphide bonds of proteins and, 
more generally, to prevent intramolecular and intermolecular disulphide bonds from forming 
between cysteine residues [203]. DTT, an epimer of DTE with a slightly higher reducing 
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potential, can also be used with the same practicality. As a general rule, DTE was added to 
all the intermediate and final storage buffers (typically in a 0.2 mM concentration). 
• After resuspension of the bacterial cells, the beaker was placed at 4 ºC with constant 
stirring and the chemical lysis process was initiated by adding lysozyme, 1.0 mg/mL. This 
enzyme catalysis the hydrolysis of 1,4-b-linkages between N-acetylmuramic acid (NAM) 
and N-acetyl-D-glucosamide (NAG) that comprise the peptidoglycan, leading to the 
disruption of the bacterial wall [204]. For the next steps of the lysis, ca. 15-20 minutes were 
waited before the addition of the next component to the cell suspension. 
• After the elapse of the above-mentioned time, 8.0 mL of 6% Na-deoxycholic acid were 
added to the 200 mL lysate. Deoxycholate is an anionic detergent that helps in the 
denaturation and solubilisation of highly hydrophobic molecules and membranar proteins. 
Its effect leads to a further disruption of the cell wall [205]. The suspension should have a 
viscous appearance at this stage. 
• In a last step, 20.0 mg per 100 mL of cell suspension of DNAse were added. This enzyme 
catalysis the hydrolytic cleavage of phosphodiester linkages in the DNA backbone, thus 
degrading the nucleic acids [206]. It was sometimes necessary to add a small amount of 
Mg to the cell suspension, normally in the form of MgCl2 (from 2 to 10 µM), because the 
active DNAse requires Mg2+ as co-factor. The cell lysate should have a fluidic, water-like, 
behaviour by the end of this step. Whenever presented still with appreciable viscosity, some 
steps of the chemical lysis were repeated (e.g. adding extra lysozyme and/or Na-
deoxycholate). 
Perhaps because in most of the cases, mechanical and chemical lysis are redundant 
processes, it is common practice when working with cell lysates, to use only one of them 
and, generally, one will suffice for the intended purposes. Nevertheless, in the present work 
a short mechanical disruption was always applied to the cells, to ensure complete 
effectiveness: 
• The beaker containing the suspension was brought on ice to an ultrasonic pulse device. 
This method induces strong pressure changes and shear forces which lead to further 
destruction of the cellular structure. Temporary heat spots on the sample are created in the 
process, which can be harmful for the stability of the overexpressed protein. To prevent 
that, the disruption was accomplished by keeping the cells all the time on ice and by 
applying short pulse bursts (typically 5 pulses of 10 seconds each). 
• Following the mechanical disruption, the bacterial fragments were separated by 
centrifugation from the lysate containing the soluble cellular proteins. The process was 
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carried out at 4 ºC and at 50000-60000 g for ca. 1 hour. The clear, deep yellow supernatant 
was brought to a clean Erlenmeyer and used immediately in the next purification step. 
The lysis of the cells containing uniformly 15N-labelled overexpressed Ras followed the 
exact same methodology. 
 
2.2.2.1.2   Protein Precipitation with (NH4)2SO4 
Cell lysates of overexpressed FL Ras proteins (aa 1-188/189) from a single 10 L cell culture 
were typically subjected to (NH4)2SO4 precipitation to capture Ras at an early stage of the 
process. This method was not applied to truncated Ras variants (aa 1-166) since, from 
experimental evidence, they are not prone to precipitate as easily as the FL ones. 
The solubility of globular proteins is normally increased upon addition of salt (< 0.15 M), an 
effect termed salting in [207]. However, at higher salt concentrations, the protein stability 
decreases leading to precipitation. This is commonly referred as salting out [208]. Salts that 
reduce the solubility of proteins also tend to enhance the stability of the native conformation, 
as opposed to salting-in ions which are usually denaturants. The mechanism of salting-out 
is based on preferential solvation due to exclusion of the co-solvent (salt) from the layer of 
water closely associated with the surface of the protein (hydration layer), which plays a 
critical role in maintaining solubility and the correctly folded native conformation. There are 
three main protein-water interactions: ion hydration between charged side chains (e.g., Asp, 
Glu, Lys), H-bonding between polar groups and water (e.g., Ser, Thr, Tyr, and the main 
chain of all residues), and hydrophobic hydration (Val, Ile, Leu, Phe). In hydrophobic 
hydration, the configurational freedom of water molecules is reduced in the proximity of non-
polar residues. This ordering of water molecules results in a loss of entropy and is thus 
energetically unfavourable. When salt is added to the solution, the surface tension of the 
water increases, resulting in increased hydrophobic interaction between protein and water. 
The protein responds to this situation by decreasing its surface area in an attempt to 
minimize contact with the solvent—as manifested by folding (the folded conformation is 
more compact than the unfolded one) and then self-association leading to precipitation. 
Both folding and precipitation free up bound water, increasing the entropy of the system 
and making these processes energetically favourable [208]. The increase in surface tension 
of water by salt follows the Hofmeister series [209]. As an approximation, those salts that 
favour salting-out raise the surface tension of water the highest. As (NH4)2SO4 has much 
a higher solubility than any of the phosphate salts, it is the reagent of choice for salting-out.  
The methodology is described as follows: 
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• After purification by IEX chromatography, the fractions containing Ras were identified by 
SDS-PAGE and pooled together into a clean Erlenmeyer flask. Typically, their combined 
volume was 400-500 mL. 
• The amount of (NH4)2SO4 necessary to induce precipitation in a 3-3.5 M salt solution was 
calculated (ca. 200-250 g for a 500 mL volume) and added to the pooled fractions in a 
stepwise manner, with an waiting time of 15-20 min. between the next addition, (2-3 spoons 
each time). The entire process took place with continuous slow stirring, at 4 ºC. 
• HRas(1-189) precipitated at its maximum for a salt concentration of 3.1 M. When this 
value was reached, the solution was completely slurry and further addition of salt had no 
effect on the extent of precipitation (care was taken to not overcome too much this this 
value, as the opposite effect – an increase in solubility – can sometimes happen). 
• The slurry was centrifuged at 4 ºC, 20000 g, for ca. 40-50 min. The supernatant was 
decanted and stored for further analysis by SDS-PAGE and the precipitated protein fraction 
was slowly re-dissolved in the smallest possible volume of buffer D (typically 15-18 mL, 
Table 2.4) and immediately used in the next purification step. 
 
2.2.2.1.3   Ion Exchange Chromatography (IEX) 
IEX is based on the electrostatic attraction between proteins in solution and charged groups 
of the ion exchanger (a matrix with acidic or basic functional groups). The strength of such 
interaction depends on the charge of these two partners, the dielectric constant of the 
medium (D) and the competition from other ions for the charged groups of the ion exchanger 
and protein. When the concentration of the competing ions is low, the proteins adsorb to 
the ion exchanger. When it is high, the proteins are desorbed. The most common variation 
of such interplay is the adsorption of target proteins from a buffer of low ionic strength, 
followed by desorption with a buffer of high ionic strength. At higher concentrations of 
competing ions, the proteins with the weakest interaction will be displaced first. There is no 
general rule as to what salt concentration is needed to displace a protein with a certain net 
charge from an ion exchanger. However, most proteins are eluted at salt concentration 
lower than 1.0 M [210]. 
The physical mechanism behind protein binding to charged surfaces is not completely 
understood and can be tentatively explained according to different models: In the simplest 
approach, called the stoichiometric model of Boardman and Partridge [211], a number of 
charged groups bind to the same number of oppositely charged groups of an ion exchanger. 
In this process counter ions are released from both. This model assumes that one group on 
the protein interacts with just one group in the ion exchanger. 
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In chromatography, substances alternate between being bound to the stationary phase and 
moving in the mobile phase. The stationary phase in IEX is a column and the mobile phase 
a buffer. A substance that spends more time in the stationary phase moves slower. 
Substances that do not bind to the adsorbent are constantly in the mobile phase. They pass 
through un-retarded and are, strictly speaking, not submitted to chromatography. This 
happens when the ionic strength is so high that it eliminates the electrostatic attraction to 
the ion exchanger and with molecules with no charge or a charge of the same sign as the 
ion exchanger [210]. Other factors other than the net charge can influence IEX such as the 
charge distribution on the protein surface, the nature of the particular ions on the solvent 
(according to the Hofmeister series [209]) and non-electrostatic interactions with the ion 
exchanger (hydrophobic interactions, H-bonding), the temperature and the presence of 
additives such as organic solvents as for example acetonitrile (ACN) and methanol (MeOH) 
leading to an increase of electrostatic interactions. 
Ion exchangers consist of a matrix with either acidic or basic groups on the attached ligand. 
The matrices can be roughly divided into hydrophilic and hydrophobic. Hydrophilic ones are 
best suited for protein chromatography, since the interaction due to hydrophobic forces is 
weak and proteins are often irreversibly adsorbed (or denatured in the process of 
desorption) to hydrophobic matrices, such as polystyrene. Typical hydrophilic matrixes used 
in IEX separation of proteins are agarose or sepharose. The latter was used in the present 
work and is based on chains of agarose, arranged in bundles and with different degrees of 
cross-linking to give a range of rigid, macroporous matrices with good capacity and low 
nonspecific adsorption. 
The functional groups substituted onto a chromatographic matrix determine the charge of 
an IEX medium: basic ion exchangers are called anion exchangers and contain positive 
groups. Acidic ion exchangers are called cation exchangers and contain negative groups. 
Ras has a negative surface net charge at pH 7.5 and therefore binds to anion exchangers. 
A strong anion exchanger was chosen for Ras purification: the quaternary ammonium (Q), 
based on 90 µm agarose beads, with the –CH2N+-(CH3)3 functional group. Another group, 
DEAE sepharose, (-CH2-CH2-N+-(CH2-CH3)2), is an example of a weak anion exchanger. 
Similarly, weak (carboxymethyl - CM) or strong (sulphopropyl - SP) cation exchangers are 
available, among many others. The reader is advised to consult an updated online list 
provided by manufacturers [212]. 
It is worth mention that despite the ion exchangers being usually classified as weak or 
strong, the name refers to the pKa values of their functional groups, and indicates nothing 
regarding their ability to bind proteins. At pH values far from the pKa protein binding can be 
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equally strong to either a weak or a 
strong ion exchanger. Strong ion 
exchangers show no variation in ion 
exchange capacity with change in 
pH, remaining fully charged over a 
broad pH range. A direct advantage 
of a strong exchanger lies in the 
sample loading (binding) capacity, 
which is maintained at high or low 
pH since there is no loss of charge 
from the ion exchanger. Also, the 
interaction mechanism is simple, as 
there are no intermediate forms of 
charge interaction. Most proteins 
have a pI within the range 5.5 to 7.5 
and can be separated on either 
strong or weak ion exchangers. An 
advantage of a weak ion exchanger, 
such as DEAE (anionic) or CM (cationic) is that they can offer a different selectivity (i.e. the 
ability of the system to separate peaks, the distance between two peaks) compared to 
strong ion exchangers. A disadvantage arises from the fact that weak ion exchangers can 
take up or loose protons with changing pH, their ion exchange capacity varies with pH. 
Normally, the concentration of buffer salts during protein adsorption is low (10–50 mM). 
Proteins adsorbed at a salt concentration too far below desorption concentration can be 
difficult to desorb and some denaturation can occur. A suitable adsorption concentration 
can be determined by simple test tube experiments (1-1.5 mL of ion exchanger were 
equilibrated with the starting buffer and mixed for 1-2 min. with the sample equilibrated in 
the same buffer. After centrifugation the supernatant was assayed for the protein to 
determine the level of binding). The residence time on the column can also affect elution. 
Proteins adsorbed to a column for prolonged periods may be more difficult to elute than 
proteins desorbed shortly after adsorption.  
Below is presented the methodology employed in the purification of Ras proteins: 
• After cell lysis, overexpressed protein was purified using Q-Sepharose® Fast Flow™ from 
GE Healthcare. Two columns of different dimensions were used, depending on the volume 
of cell lysate: FL Ras was generally expressed in 10 L cell culture batches. The 
Figure 2.2. Schematics of the experimental setup mounted for 
the purification of Ras proteins from a 10 L cell culture. After 
loading the 500 mL Q-sepharose column and washing the 
unbound molecules, a linear salt gradient was applied to it with 
aid of a peristaltic pump and at constant stirring: to the low 
ionic strength buffer C (left container) a high ionic strength 
buffer C + 800 mM NaCl (right container) was gradually mixed. 
The elution proceeded overnight using a fraction collector. 
The red line on the chromatogram indicates the percentage of 
NaCl during the overall process. The shaded area represents 
the sample injection volume. The chromatogram does not 
correspond to a real Ras purification, since the present setup 
has no detector for absorbance measurement at 280 nm. 
Adapted from gehealthcare.com 
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corresponding 300-380 mL cell lysates were loaded into a 500 mL column (herein defined 
as column A). Truncated Ras proteins were generally expressed in 5 L batches and the 
corresponding 150-180 mL cell lysates were loaded into a 280 mL column (herein defined 
as column B). Both columns were previously equilibrated with 3-5 column volumes (CV) of 
buffer C (32 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE). 
Column B was mounted on a AKTA-FPLC system. The development of the method was 
done from scratch in this case (from the building of the column to the details of the run) and 
care was taken to make the process as automated as possible. Column A, due to its bigger 
dimensions, could not be mounted on AKTA. In such case, the purification was handled by 
‘manually’ setting up a chromatographic separation system inside a 4 ºC refrigerated room. 
The schematics of the setup are presented in Figure 2.2. 
• The clear cell lysate was loaded at low flow rates (ca. 1.5-2.0 mL/min.) to increase the 
residence time and to avoid high backpressure (especially in column B). Unbound material, 
including neutral or positively charged molecules was washed with 2-4 CV of buffer C. 
• The elution of Ras proceeded by two different methods, according with the type of column 
used. In both cases a salt gradient elution was done by using Buffer C in the presence of 
800 mM NaCl. Column A was eluted with a linear salt gradient mostly due to the limitation 
of the available experimental setup (Figure 2.2) and column B was eluted using a step 
gradient profile, previously optimized. Often, a small-scale test tube experiment was 
performed for a specific Ras mutant and the steps of the gradient were slightly adjusted if 
necessary. Figure 2.3 shows the step gradient used in the purification of truncated HRasD33K 
as general example. The eluted fractions were collected overnight with a fixed volume of 
18-20 mL (column A) and 12 mL (column B).  
• The collected fractions were analysed by SDS-PAGE and immediately used in the next 
purification step. 
• After elution both exchangers contained some material bound (often denatured or 
precipitated proteins). They were regenerated 
by extensively running a 2.0 M NaCl solution at 
low flow rates during 2-3 CV, followed by a 
thorough washing with 5-10 CV of ultrapure 
H2O. Periodically (every 5 runs or so), the 
columns were further cleaned with NaOH 0.5-
1.0 M at room temperature, followed by water 
and 50% ethanol (EtOH) to remove lipoproteins 
and lipids. Blank runs, in which only buffers, but 
Figure 2.3. Representative Ras elution profile 
from IEX using a NaCl step gradient with volume 
fractionation. The peak surrounded by the 
dashed lines corresponds to the elution of 
RasD33K. 
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no sample, are applied to the columns were also performed periodically (every 10 runs) to 
determine the presence of the contaminants after a cleaning protocol 
• Finally, the columns were transferred to 20% EtOH for storage to avoid stagnation and to 
minimize chance of microbial growth. After a long period (more than 5 weeks), they were 
opened on the top and recirculation or agitation of the resin was performed with the aid of 
a glass rod. 
 
2.2.2.1.4   Size Exclusion Chromatography (SEC) 
Gel filtration, also called size exclusion chromatography is a method that separates 
molecules according to their differences in size, as they pass through a matrix packed in a 
column. Unlike ion exchange or affinity chromatography, molecules do not bind to the matrix 
so buffer composition does not directly affect the resolution (degree of separation between 
peaks). In addition to separate molecules by size, SEC has proven to be a valuable tool for 
a variety of applications, especially to determine the molecular mass of macromolecules, 
despite the diversity of available methods (mass spectroscopy, dynamic light scattering, 
analytical centrifugation, etc.) due to its versatility and ease of establishment in a modern 
laboratory by integration with an AKTA system (Figure 2.4). It can also be used for desalting 
a reaction mixture, purification of a monomer from a multimer, and to study protein-protein 
interactions. SEC can be used in group separation mode to remove small molecules from 
a group of larger molecules and as simple solution for buffer exchange or in fractionation 
mode, to separate multiple components on a sample based on their Mw. Different factors 
affect the resolution in SEC (i.e. the degree of separation between peaks): sample volume, 
sample-to-column volume ratio, column dimensions, particle size, packing density, pore 
size of the particles, flow rate and viscosity of the sample and buffer. The sample volume is 
expressed in terms of percentage of the total column volume (packed bed). Generally, the 
application of a sample volume between 0.5-4% of the packed bed is recommended for 
peak fractionation. The capacity of the SEC separation can be increased by concentrating 
Figure 2.4. General schematics of the AKTA FPLC system. Adapted from “GE imagination at work”. 
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the samples to be injected, although concentrations above 70 mg/mL are not 
recommended. The height of the packed bed increases both, resolution and the time of the 
run. However, a common problem of increasing bed height is the build up of back pressure 
due to the tightly packed media. 
The materials presently used for SEC are based on silica, hydrophilized vinyl polymers, or 
highly crosslinked agarose with bead sizes typically between 5 and 50 mm. The selectivity 
of the medium depends solely on its pore size distribution. For the present work, the medium 
of choice was Superdex™, a highly cross-linked porous agarose to which dextran was 
covalently bound. Depending on the sample volume, two SEC columns of different bed 
heights were used for Ras purification: 120 mL Hiload Superdex 26/60 75 PG, with a 
separation range between 3-70 kDa at a flow rate of 1.5 mL/min. and a 300 mL Hiload 
Superdex 26/600 200 PG with a separation range between 10-600 kDa at a flow rate of 2.2 
mL/min. 
Following ion exchange chromatography (section 2.2.2.1.3), the fractions containing the 
Ras protein were pooled and concentrated by ultracentrifugation or subjected to (NH4)2SO4 
precipitation. 
• typically, ca. 5 mL of concentrated sample were manually injected (by using an adequate 
loop) into a superdex 26/60, previously equilibrated with buffer D (40 mM Tris/HCl pH 7.4, 
10 mM MgCl2, 400 mM NaCl, 2 mM DTE, 0.1 mM GDP, Table 2.4). A safety upper pressure 
limit on the AKTA pump system was set to 0.4 MPa and the isocratic elution initiated with 
the same buffer. 3.0 mL fractions were collected after 0.2 CV, until a total length of 1.4 CV. 
This process was repeated 4 or 5 times for the complete purification of the 20-25 mL of the 
initial protein mixture. 
• Typical SEC chromatograms led to the straightforward identification of the Ras proteins, 
in single, narrow peaks. The fractions underlying the peak area were pooled and 
concentrated up to a final value of 3.6 mg/mL (2.0 mM). When the identification of Ras by 
simple evaluation of the chromatogram was ambiguous, a final SDS-PAGE was performed. 
• The pure, concentrated Ras proteins dissolved in buffer D were shock frozen in liquid N2 
and stored at -80ºC in 500-600µl aliquots until further use. 
• The SEC columns were cleaned according to the same protocol used for IEX (section 
2.2.2.1.3). In cases of severe contamination the flow was reversed and the cleaning 
procedure applied. 
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2.2.2.2   Purification of Raf-RBD and NF1 
Raf-RBD and NF1 333 were both expressed as GST-fusion proteins in E. coli BL21DE3. 
The purification methodology used follows the same principles for both proteins 
 
2.2.2.2.1   Cell Lysis 
• The frozen cell pellet from a 10 L cell culture was re-suspended in 200 mL of lysis buffer 
(50mM Tris/HCl pH 7.5, 250 mM NaCl, 5 mM EDTA, 1mM PMSF, 5mM DTE). NaCl is an 
important stabiliser of both proteins. During the lysis, its concentration was gradually 
increased overtime, from 250 mM up to 300 mM. 
• The cell pellet was left stirring at room temperature for ca. 15 min. until complete 
dissolution. The mixture was then kept at 4 ºC with constant, slow stirring. The chemical 
and mechanical cell lysis was carried out as described elsewhere (section 2.2.2.1.1). 
• After lysis, the cell fragments were sedimented by centrifugation at 4 ºC, 25000g for ca. 
30 min. The yellow coloured supernatant was decanted from the bacterial precipitate and 
brought immediately to a 25 mL glutathione sepharose column. 
 
2.2.2.2.2   Affinity Chromatography: GST Fusion Purification 
Glutathione-S-transferase (GST) fusion proteins are purified by affinity chromatography 
using glutathione (GSH) immobilized to a matrix such as sepharose. The binding of a GST-
tagged protein to the GSH ligand is reversible, and the protein can be eluted under mild, 
non-denaturing conditions by the addition of reduced GSH to the elution buffer. This 
technique provides a mild purification process that does not affect a protein’s native 
structure and function. Figure 2.5 shows a schematic representation of the terminal 
structure of GSH sepharose. 
One of the most important parameters affecting the 
binding of the GST protein to the solid matrix is the 
flow rate at which the protein loading is performed. 
The binding kinetics between GSH and GST is slow, 
thus it is important to keep a low flow rate (normally 
lower than 1mL/min.). Washing and elution can be 
performed at a slightly higher flow rates to save time 
(2-3 mL/min. using GST sepharose™). The yield of 
the fusion protein in pure samples can be estimated 
by A280, giving that the concentration of the GST tag 
is approximately 0.5 mg/mL for 1 unit of absorbance. 
Figure 2.5. Terminal structure of 
Glutathione Sepharose. Glutathione is 
specifically and stably coupled to 
Sepharose by reaction of the SH-group 
with oxirane groups obtained by epoxy-
activation of the Sepharose matrix. The 
structure of glutathione is complementary 
to the binding site of glutathione S-
transferase.  Adapted from GE.healthcare. 
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The methodology used for the two proteins is presented bellow: 
• The corresponding cell lysate was loaded into a 25 mL GSH sepharose® fast flow™ 
column, previously equilibrated with 3-4 CV of 50 mM Tris/HCl pH 7.5, 250 mM NaCl and 
5mM DTE. The sample was loaded at a flow rate of 0.8 mL/min. with the help of a peristaltic 
pump. The entire process took place inside of a 4 ºC room. Due to the big volume involved 
(150-200 mL), the AKTA system was not used for the loading of the lysate into the column. 
• After protein loading, unbound material was removed by equilibration with the same buffer 
during 5 CV at 0.8 mL/min. 
• The cleavage of either Raf-RBD or NF1 from the GSH column was done by the addition 
of 10U of thrombin per 2 mg of fusion protein (estimated by A280 - thrombin has a specific 
activity higher than 7500 U per mg of protein. 1U of this protease will digest more than 90% 
of 100 µg of a test fusion protein in 16h at 22ºC). Cleaving of the fusion protein was allowed 
to proceed ‘on the column’, overnight at a very slow rate (0.3 mL/min.). The circuit was 
closed by connecting the top end to the bottom end of the column. The continuous re-
circulation of the mobile phase through the system was ensured by a peristaltic pump. 
• Following up next day, the closed circuit was opened and the final protein (Raf-RBD or 
NF1), now cleaved from GST, was immediately collected into 3 or 4 fractions of 25 mL each, 
using the same buffer as above. 
• The GST bound protein was removed from the column by washing with 6M guanidine 
hydrochloride (GdmCl), 4-5 CV, followed by 5-10 CV of ultrapure H2O. 
• Oxidized GSH sepharose was restored by equilibrating the column with a 30 mM reduced 
GSH solution in 100 mM Tris/HCl pH 7.5, for at least 2 CV. (Note that reduced GSH is 
acidic. The pH was properly adjusted with NaOH during the preparation of this solution). 
Finally, excess of GSH was removed by equilibration with ultrapure H2O, rendering the 
column ready to be re-used. For long term storage, the column was equilibrated with 20% 
EtOH. 
• All the fractions (equilibration, protein loading, elution, column recovery) were stored 
during the entire process and analysed by SDS-PAGE.  
In the final polishing step, both Raf and NF1 were further subjected to SEC chromatography 
to separate them from thrombin and other possible impurities. The pure protein fractions 
were aliquoted in 200 µl fractions, shock frozen in liquid N2 and stored at -80 ºC. Raf-RBD 
is very stable and was stored in high concentrations, up to 6.5 mg/mL (7 mM). However, 
NF1 has a rapid degradation time. In fact, NF1 cannot withstand room temperatures and 
the purification process needs to be accomplished in the shortest time possible to avoid 
further degradation. Care was taken while concentrating the protein to avoid further losses. 
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From experimental evidence, the protein cannot be concentrated to higher values than 0.6-
0.7 mM (21-24 mg/mL), otherwise precipitation will occur. 
 
2.2.2.3   Purification of SOScat(W729E) 
The catalytic domain of SOSW729E was expressed in E. coli BL21DE3 in the form of a 
histidine-tag fusion protein (His-tag). 
 
2.2.2.3.1   Cell Lysis 
The pelleted cells from a 5.0L E. coli culture were dissolved in 100 mL of 25 mM Tris/HCl 
pH 7.5, 500 mM NaCl, 20 mM imidazole, 1mM PMSF and 2 mM b-mercaptoethanol. 
Chemical and mechanical cell disruption was accomplished according to the steps 
described above for the cell lysis of Ras proteins (section 2.2.2.1.1). By the end of the 
process, the cell suspension was subjected to centrifugation at 4 ºC, 50000g for approx. 50 
min. The clear cell lysate was decanted from the bacterial pellet and loaded immediately in 
a Ni-NTA affinity column. 
 
2.2.2.3.2   Affinity Chromatography: Histidine-Tag Methodology 
Recombinant SOS contains a tag with six histidine residues (histidine6) that feature a high 
selective affinity for Ni2+ and several other metal ions (Zn2+, Co2+)   capable of being 
immobilized on a chromatographic media using chelating ligands. Consequently, a protein 
containing a His-tag will be selectively bound to metal-ion-charged media such  as Ni-
Sepharose®, while other cellular proteins will not bind or will bind weakly. Column 
equilibration, protein loading and elution takes place in a similar way as described above 
for GST-fusion proteins (section 2.2.2.2.2). The elution step is performed in the presence 
of imidazole that competes with the recombinant protein for binding to the Ni2+ ions. 
Equilibration and sample buffers are normally complemented with a low concentration of 
imidazole to reduce the non-specific binding of host cell proteins and the elution can be 
done as a linear gradient of Imidazole concentration or as a step-gradient. The method of 
choice should be adjusted beforehand and the final concentration of imidazole to be used 
is dependent on the characteristics of the recombinant protein. As a general rule, 500 mM 
imidazole ensures a complete elution of most His-tagged proteins. An alternative is a pH 
dependent elution that works on the basis that at pH values close to 4.5, the metal ions will 
be stripped out from the medium. The choice of this alternative depends of course on the 
tolerance of the protein for low pH values. Chelating agents such as EDTA and EGTA are 
to be avoided in this chromatographic process as they can strip down the metals from the 
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column. 
The strategy used in SOS purification is described as follows (the complete work was 
performed in a 4 ºC refrigerated room): 
• A 5.0 mL Ni-Sepharose® column connected to a peristaltic pump was equilibrated with the 
lysis buffer above mentioned (25 mM Tris/HCl pH 7.5, 500 mM NaCl, 20 mM imidazole, 
1mM PMSF, 2 mM b-mercaptoethanol), followed by protein loading and removing of 
unbound material (15-20 CV) with the same buffer at a very low flow rate (0.3-0.5 mL/min.). 
• Elution of SOS was accomplished in a single step by preparing a buffer containing 25 mM 
Tris/HCl pH 7.5, 500 mM NaCl, 2mM b-mercaptoethanol and 500 mM imidazole. 
• After elution, the column was regenerated by washing with 10CV of biding buffer.  
All the fractions were collected and analysed by SDS-PAGE. Fractions containing SOS 
were pooled, concentrated and purified by SEC that in this case served two purposes: 
further purification and polishing from minor contaminants and change the final buffer of the 
protein, allowing the removal of the high imidazole concentration. Collected fractions from 
SEC were analysed by SDS-PAGE, pooled, concentrated up to 16 mg/mL (0.3 mM) and 
aliquoted in 200 µl fractions. The protein was shock frozen in liquid N2 and stored at -80 ºC. 
The final storage buffer (after SEC) was 40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE, 
150 mM NaCl. 
 
2.2.2.4   Nucleotide Exchange Reactions 
Recombinant Ras is obtained in the GDP-bound form. Although, to study the structure, 
dynamics and conformational equilibria of other nucleotide-bound forms, a simple but 
reliable methodology for exchanging the nucleotides was developed. The same 
methodology and can also be applied to other GNBP’s such as Rap and Arf. 
 
2.2.2.4.1   GDP Against GppNHp 
There are two different ways to accomplish this task. The first one can be considered the 
‘classical’ method of exchanging the protein and involves an overnight incubation of Ras 
with alkaline phosphatase (AP). Because both proteins are mixed in a solution, the main 
disadvantage of this method lies in the difficulty of completely separating both, Ras and AP, 
by SEC at the end. This was especially problematic for Ras samples that were studied by 
HP NMR, where sometimes fast hydrolysis of the bound GppNHp was observed and 
resulting from contamination with AP, even if residually present in the sample. 
In an attempt to solve this problem, a second methodology was developed, involving the 
use of an immobilised AP into a solid matrix. 
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Exchanging GDP to GppNHp in the ‘classical’ way. 
• Ras has an extremely high affinity for nucleotides (KD ~ 10 pM). This affinity is highly 
dependent of Mg2+ ions and in their absence it decreases by more than 30 times [213]. 
Thus, in the first step of the process, Mg2+ ions were removed from the solution either by 
several ultracentrifugation steps (using 5.0 mL vivaspin concentrators with an adequate 
molecular cut-off) or by a small size exclusion chromatography using PD10 columns. In any 
choosen approach the result was equivalent: Ras-GDP previously stored in buffer D (40 
mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE, 0.1 mM GDP) was exchanged to buffer E 
(40 mM Tris/HCl pH 7.5, 2 mM DTE). 
• The concentration of the GDP-bound protein now in buffer E was calculated by HPLC 
(section 2.2.2.6.3) and a 3-fold excess of the non-hydrolysable analogue GppNHp was 
added, followed by the addition of 200 mM of (NH4)2SO4. Finally, 2U of AP per mg of Ras 
were added. AP catalyses the nucleophilic attack by the water to the phosphate groups, 
facilitating the dephosphorilation of GDP but not GppNHp. As Ras has a low affinity to the 
newly formed GMP, a dynamic equilibrium is established in which the nucleotide-free Ras 
rapidly incorporates the available GppNHp in its binding pocket. 
• After overnight incubation with slow shaking at 4 ºC, the completeness of the reaction was 
verified by HPLC and purification of Ras-GppNHp from by-products (GDP, GMP, 
guanosine) was done by using either a PD10 or a bigger SEC column connected with the 
AKTA systems, which allowed the reincorporation of MgCl2 into the final buffer: 40 mM 
Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE (Buffer F). 
• The final concentration of Ras•Mg2+•GppNHp was adjusted by HPLC to the desired value, 
the exchanged protein shock frozen in liquid N2 and stored at -80 ºC until further use. 
 
Exchanging GDP to GppNHp using immobilized AP. 
This method relied on the use of immobilized AP columns provided by MoBiTec®, which 
were handled according to the manufacturer’s instructions. Ras-GDP proteins were 
exchanged to buffer E, their concentration measured by HPLC and a 3-fold excess of 
GppNHp, together with 200 mM of (NH4)2SO4 were added, exactly as described above. 
However, no AP was added. Instead, the 1.5-2.0 mL final solution was brought to the 
immobilized AP, previously equilibrated in buffer E. Due to the small size of the column, 150 
µl of sample were injected each time with the help of a syringe and a small needle. Between 
each injection a minimum waiting time of 15 min. was held, so that the loaded sample could 
have enough contact time for the reaction to happen. Elution was simply done by loading 
the next 150 µl of sample into the column or by pushing air with a syringe (there is no 
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harmful effect if the column runs dry). The eluted fractions were all collected in the same 
1.5-2.0 mL Eppendorf tube and the completeness of the process was evaluated by HPLC. 
If GDP was still present, the procedure was repeated by passing again the protein through 
the column. The purification of newly GppNHp-bound Ras and the re-incorporation of Mg2+ 
was done using a PD10 column. The final exchanged protein was stored in buffer F, with 
the desired concentration. 
The immobilized AP method allows the exchanged proteins to be virtually free of AP that 
could otherwise affect the stability of the bound nucleotide. The process is also faster than 
the ‘classical’ way since no overnight incubation is needed.  
 
2.2.2.4.2   GDP Against GTP 
Exchanging Ras-GDP to Ras-GTP proceeds in a similar way as the one described above, 
with the exception that AP cannot be added since it would also hydrolyze GTP. Instead, a 
great excess of GTP is added, with the expectation to shift the equilibrium towards the Ras-
GTP complex: 
• After removing Mg2+ from the initial buffer D and adding 200 mM of (NH4)2SO4, as 
described above 20 mM EDTA were added (helping further in the chelation of possible 
residual free Mg2+ ions) along with GTP in a 30 to 50-fold excess relative to GDP. The 
mixture is left for 3-4 hours, slowly shaking, at 4 ºC. 
• After the elapse of this time, the free nucleotides were separated from the protein using 
the same process described above and the GTP-bound/GDP-bound ratio quantified by 
HPLC. Typical RasWT proteins have a 70-80% exchange. Oncogenic mutants such has 
G12D or G12V can achieve 90-95%. It is worth note that, contrary to GppNHp, 100% 
exchange is never possible in this case. 
• The final Ras•Mg2+•GTP was stored in buffer F, at -80 ºC until further use. 
 
2.2.2.5   Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Protein gel electrophoresis was routinely carried to check the success of protein purification. 
In this technique, proteins become denatured in the presence of sodium dodecylsulfate 
(SDS), losing their secondary and tertiary structure. SDS is a strong anionic detergent that 
wraps around the polypeptide backbone when heated at high temperature. The intrinsic 
charges of the polypeptides become negligible when compared with the negative charges 
contributed by SDS. The protein-SDS complexes become rod-like structures with a uniform 
negative charge density and their electrophoretic mobility becomes only a linear function of 
their molecular masses. In the presence of a directional electric field, small size proteins 
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move faster than bigger proteins, from the cathode (negatively charged) towards the anode 
(positively charged). The medium where the electrophoretic movement occurs is a gel made 
of a polymer matrix called polyacrylamide produced in the laboratory by cross-linking 
acrylamide with bisacrylamide. This requires a radical initiator and a catalyst to take place 
in a few minutes instead of several hours. The radical used was normally ammonium 
persulfate (APS) and the catalyst was Tetramethylethylenediamine (TEMED). The latter 
reacts with APS and causes the splitting of persulfate ions into sulphate free radicals 
responsible for initiating the polymerization. 
The proteins were loaded firstly into a stacking (or collecting) gel and subsequently 
separated in a running gel. Typically, the stacking gel has a low concentration of acrylamide 
and a pH of 6.8 and the running gel a higher concentration of acrylamide (that retards the 
movement of proteins) and a pH of 8.3. To conduct the current from the cathode to the 
anode a medium was needed. This medium can be continuous (if the buffer, in the 
electrophoretic tank and in the gel, is the same) or discontinuous (if the buffer is different). 
The continuous method was proposed by Lämmli et al in 1970 [214] and the discontinuous 
method was proposed by Schägger et al in 1987 [215]. The first is more suitable for the 
separation of proteins of an average size higher than 30 kDa, while the second is most 
suitable for best separation of smaller proteins (< 30 kDa). All Ras proteins (truncated and 
full length) together with Raf-RBD were detected by using the Schägger method. NF1 and 
SOS were detected by using Lämmeli. The methodology is presented as follows: 
• 6.0 µl of a 4-fold concentrated SDS solution (150 mM Tris/HCl pH 6.8, 2% m/v SDS, 20% 
w/v glycerol) were added to 18.0 µl of protein sample. 
• The mixture was incubated for 5 min. at 100 ºC to enhance the denaturation process, 
followed by centrifugation for 2 min., 10000 rpm at RT. 10 µl of each sample were then 
directly applied in the top of the stacking gel. 
• In the Schägger method, the composition of the buffer used in the gel was 3.0 M Tris/HCl 
pH 8.4, 0.3% SDS and 0.01% NaN3. The acrylamide content used on the stacking gel was 
5% and in the running gel was 16.5%. The anode buffer (located in the bottom part of the 
electrophoretic chamber) was 200 mM Tris/HCl pH 8.9 (10x stock solutions were prepared 
and stored at 4 ºC for routine use) and the cathode buffer (located in the upper part of the 
chamber) was made by mixing 100 mM Tris/HCl pH 8.9, 100 mM Tricine, 0.1% w/v SDS 
and 0.01% w/v NaN3 (similarly, 10x stock solutions were also prepared). For the Lämmeli 
methodology, the buffer was made of 25 mM Tris-base, 200 mM glycine and 0.1% w/v SDS. 
The acrylamide content used in the stacking gel was 5% and in the running gel 15%. 
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• Schägger gels were run at a constant voltage of 100 V for approx. 120-140 min. and 
Lämmeli gels were run at a constant current of 36 mA for about 50-60 min. 
• The Separated proteins by both electrophoretic methods were stained with coomassie 
solution containing 0.1% w/v of tryphenylmethane brilliant blue G250, 40% v/v methanol 
and 10% v/v acetic acid. Coomassie binds to proteins through ionic and Van der Waals 
interactions between the dye sulfonic groups and positive protein amine groups, staining 
them unspecifically. 
• The staining procedure was accomplished by heating the gel for 1-2 min. in a microwave 
and then shaking it for at least 30 min. at RT. The revealing of the protein bands was 
accomplished by adding a unstaining solution made upon mixing 20% v/v acetic acid, 10% 
MeOH v/v and 70% H2O. The gel was microwaved (1-2 min.) in the presence of this 
unstaining solution and shaken for at least 30 min. 
• In a final step, the revealed gel was transferred to a translucid plastic bag and 
photographed or digitalized, if necessary. 
 
2.2.2.6   Determination of Protein Concentration 
In an attempt to minimize systematic and random errors and, whenever possible, different 
methods were used to find the most correct concentration for the proteins involved in this 
project. The obtained values by different methods were always combined and averaged. 
 
2.2.2.6.1   The Bradford Method 
The Bradford method is based on the proprieties of coomassie brilliant blue (see also 
section 2.2.2.5 for details). This dye binds primarily to the negatively charged amino acids 
of the proteins and changes from a cationic to an anionic state. This is associated with a 
colorimetric change that can be followed by visible spectroscopy at 595 nm. 
• The Bradford assays preformed in this work were all based in a previous calibration curve 
using BSA. The Roti®-Quant assay kit from Roth® was used in the preparation of the curve. 
Briefly, a BSA dilution series from 0.5 mg up to 2 mg/mL was set. 1.0µl of each sample was 
transferred directly into a plastic cuvette and 1.0 mL of Bradford solution was added. Upon 
gentle mixing by pipetting with up-and-down movements, the mixture was left to rest for ca. 
5 min. at 298K and then measured directly at 595 nm (the ‘blank’ or the ‘zero’ was previously 
made by measuring the absorbance of the Bradford solution alone). Using the obtained 
values, a linear dependence between A595 and the mass (in mg or µg) of the protein was 
plotted. Upon linear fitting in the form of y=mx+b (m being the slop and b being the y-
intercept), the protein concentration can be calculated through the equation C=(Abs595-b)/m. 
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The most striking disadvantage of this method is the lack of accuracy by the simple fact that 
the amino acid composition varies greatly between different proteins. The higher the 
number of non-polar, reactive side chains, the higher the concentration this method will 
(inaccurately) deliver. 
 
2.2.2.6.2   UV Absorption at 280 nm Using Nanodrop™ 
This method is based in the simple fact that proteins that contain tryptophan, tyrosine and, 
to a small extent, phenylalanine in their primary sequence will strongly absorb light at 280 
nm. It relies more in the presence of tryptophan than the others because tryptophan is the 
amino acid with the highest absorption efficiency at this wavelength. The direct 
measurement at 280 nm has the advantage of being a very simple and non-destructive 
process (unlike Bradford). Nowadays, instrumental advances in photometry led to the 
development of highly accurate and versatile machines such as the Nanodrop™ that allows 
the determination of protein concentration in less than 30 seconds. 
Within the framework of this thesis, all the measurements were performed using 
Nanodrop™ One (ThermoFisher Scientific) from the department of Biophysics II (chair Prof. 
Dr. Reinhard Sterner), using the single channel mode by sweeping in a 190-850 nm range. 
2.0 µl of protein sample was pipetted directly into the pedestal of the device. The 
concentration can be obtained from the direct application of the Beer-Lambert law, 
A280=c.l.e. When the extinction coefficient, e, of the protein is rigorously known, this is a 
method of choice (provided that the protein absorbs strongly at 280 nm). When there is no 
accurately published literature about e, its value can be estimated by using an online 
application such as ExPAsy ProtParam tool [216]. Because ProtParam only considers the 
linear sequence of the protein and doesn’t take into account the structure (which can affect 
the ‘real’ extinction coefficient value), the protein was always denatured before measuring 
its concentration. 
 
2.2.2.6.3   Analytical High Performance Liquid Chromatography (HPLC) 
Analytical HPLC was the method of choice in this work to measure the concentration of Ras 
proteins, to measure their intrinsic GTPase activity and to follow up nucleotide exchange 
reactions (section 2.2.2.4). Ras concentration was quantified by reverse phase 
chromatography (RPLC), according to Hoffman et al [217]. The system consists of a C18 
nucleosil pre-column, a hypersil C18 reversed-phase column and a UV detector, mounted 
in this respective order. In RPLC, the polarity of the stationary and mobile phases is 
interchanged in comparison to normal-phase chromatography: the mobile phase (HPLC 
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buffer: 100 mM K2HPO4/KH2PO4 pH 6.4, 10 mM tetrabutylammonium (TBA) and 2% up to 
8% acetonitrile (ACN)) is polar and the stationary phase (derivatized silica gel, C18 column) 
is highly hydrophobic. The Ras protein is denatured by the acetonitrile in the mobile phase 
(HPLC buffer) and by the highly hydrophobic properties of the pre-column, becoming 
retained on it as it travels through the system. In the denaturation process the bound-
nucleotide is released and travels subsequently through the C18 reversed-phase column. 
The process of separation of a mixture of different nucleotides happens as follows: the 
positively charged TBA ions from the HPLC buffer bind to the negatively charged phosphate 
groups of the nucleotides, neutralizing their charges. Now, the non-polar nucleotide-TBA 
complexes can interact with the stationary phase, i.e. the C18 reversed-phase column. The 
order of appearance (retention time) of a mixture upon an isocratic elution can be 
rationalized in terms of charges and reversed phase interactions: the retention time of 
increases with increasing number of phosphates - longer non-polar nucleotides can interact 
better with the stationary phase, travelling slower through the column. As consequence, the 
different nucleotides are separated according to their increasing order of molecular mass 
(guanosine, GMP, GDP, GppNHp, GTP). 
The elution profile was determined by a UV detector operating at λ= 254 nm, were 
absorption of the conjugated π-electron ring system of the purine base takes place. A 
calibration of the complete HPLC system was carried out periodically with a GDP stock 
solution of known concentration (λ= 254 nm, ε254nm(GDP)= 13700 M-1 cm-1). Ras proteins 
were typically measured by injecting 20 µl of a 1:10 dilution into the chromatographic 
system. In the isocratic elution method, the concentration of ACN was adjusted in a way 
that the time interval between the elution of each nucleotide was long enough to allow the 
proper integration of the peak areas without peak overlapping. Protein concentration was 
obtained by using directly the values from the integrated areas into the calibration equation. 
 
2.2.3   Nano Differential Scanning Fluorimetry (nanoDSF) 
nanoDSF is a modified differential scanning fluorimetry method in which the fluorescence 
of natural aromatic amino acids of proteins, especially tryptophan and tyrosine, is employed 
to monitor protein unfolding as the protein is subjected to a temperature gradient. Both, the 
fluorescence intensity and the fluorescence maximum depend strongly on the close 
surroundings of the aromatic amino acids [218, 219]. Thus, the ratio of the fluorescence 
intensity at 350 nm over 330 nm (corresponding to the maximum of emission for the 
unfolded and folded cases, respectively) can be plotted as a function of time or temperature 
and used to obtain the melting temperature (Tm) defined as the temperature at which 50% 
2. Methods 
 
69 
of the protein population is unfolded and corresponding to the midpoint of the transition from 
folded to unfolded. By following the shift in fluorescence emission wavelength, an unfolding 
curve can be generated. Calculation of Tm can be performed using different methods. A 
commonly used approach is to determine the maximum of the first derivative of the 
absorbance signal. This method circumvents the subjective determination of baseline levels 
and also allows for the determination of multiple melting points, e.g. for antibody unfolding 
or more complex multi-domain proteins. The method works especially well when one or 
more tryptophan residues are present but can also be employed in the study of proteins 
that have no tryptophan residues as is in the case of the Ras protein [220]. 
In the scope of this work the melting temperature of Ras wild type was compared with the 
mutants H27E, D33K, T35A and T35S. All the samples dissolved in buffer F with 
concentrations ranging between 1.0 and 1.5 mM were loaded into thin capillaries and 
measured in the Prometheus NT.48 from Nanotemper® Technologies (Munich, Germany), 
in a temperature range between 20° and 95°C. Before every Melting Scan a Discover Scan 
of 7 seconds detecting the capillaries that were loaded into the instrument was performed. 
Data analysis was performed using the NT Melting Control software (Nanotemper®). Tm 
values were determined by fitting the tryptophan fluorescence emission at the ratio of 
350/330nm using a polynomial function in which the maximum slope is indicated by the 
peak of its first derivative. 
 
 
2.2.4   Isothermal Titration Calorimetry (ITC) 
ITC is used to determine the thermodynamics of (bio)molecular interactions and the kinetics 
of enzyme-catalysed reactions in solution and is based in the simple principle that any 
chemical reaction or physical process is accompanied by a change in heat or enthalpy (DH) 
of the system under study, that can be measured and quantified. Distinct molecular 
interactions have distinct heat signatures that constitute a unique thermodynamic fingerprint 
for a particular system and can be rationalised to help with the question of why two 
biomolecules can bind to each other. 
ITC is one of the oldest methods used in the field of biophysics to prove molecular 
interactions but still one of the most common due to its robustness. It allows the 
measurement of virtually any molecule in solution without the need of previous labelling, 
contrary to other more modern techniques such as microscale thermophoresis (MST), 
which sometimes requires hydrophobic fluorescence labelling that can cause unspecific 
binding [221]. The emitted or absolved heat is also measured directly in solution, contrary 
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to other methods that require 
immobilisation of one of the partners 
into a solid matrix to derive binding 
parameters (e.g. surface plasmon 
resonance (SPR) and quartz crystal 
microbalance (QCM)) [222]. 
Additional advantages of ITC include 
no molecular mass limitations and no 
restrictions regarding the optical 
properties of the sample, since only 
heat variations are measured. One of 
its greatest limitations is, however, the 
large amount of sample needed, 
despite recent technological 
advances in miniaturizing the reaction 
cell of the instrument [223]. A second 
disadvantage is its low throughput, 
with an averaged time of 1 hour per 
experiment. 
An ITC instrument is a very sensitive device capable of measuring heat effects as small as 
0.4 µJ and allows the determination of binding constants between 1.0 nM and 100 µM. The 
detected heat rates can be as small as 0.4 µJ s-1, permitting for the determination of Km and 
kcat values in the range of 10-2-103 µM and 0.05-500 s-1, respectively [224, 225]. The 
calorimetric experiments conducted in this thesis were performed in a Microcal® PEAQ-ITC 
(Malvern Instruments Ltd.) calorimeter which is based on the compensation of the thermal 
effect generated by the addition of ligand (titrant, located in a syringe) to the sample being 
titrated, located in an adiabatic cell, as shown in Figure 2.6A: close to the sample cell is 
located a reference cell that is periodically filled with Millipore water. A thermoelectric device 
measures the temperature difference between the reference and the sample cells as well 
as between each cell and an adiabatic jacket that isolates the complete chamber. As the 
reaction is developed (i.e. the titrant is stepwise added to the sample being titrated, a 
process that is fully automated), the temperature difference between the two cells 
decreases to zero either by automatically heating the sample cell (if the reaction is 
endothermic) or by heating the reference cell (if the reaction is exothermic). For each 
addition, the heating originates a characteristic spike over (endothermic) or under 
Figure 2.6. ITC as a method to probe molecular interactions. 
A. Representative diagram of a power compensation ITC 
device showing the syringe (green) used to incrementally 
add the ligand to the sample located in the cell (red), whose 
heat variation is constantly monitored and adjusted to a close 
by reference cell (blue). B. The raw heat of the reaction is 
shown by the spikes that develop from the baseline for each 
injection (upper graph). Integration of this area over the 
molar ratio gives the thermogram (lower graph), from which 
the parameters DH, N (binding sites) and KD can be explicitly 
calculated. Adapted from [221, 222]. 
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(exothermic) the baseline. In other words, the generated spikes correspond simply to the 
power compensation (sometimes called raw heat, measured in µJ s-1 or µcal s-1) of the 
calorimeter that is required to keep the sample cell from changing temperature over the 
course of the titration. The plot of the raw heat over time is called a thermogram. When 
designing an ITC experiment it is fundamental to give enough time between each 
consecutive injection to allow the heat spike to return to the baseline. A typical thermogram 
of an exothermic reaction is shown in the upper graph of Figure 2.6B. The integration of the 
individual raw heat over the time for each injection (more specifically, the time needed for 
the control heat power to return to a baseline level) gives the heat change that can be 
plotted as a function of the molar ratio of the two interacting partners. The fitted curve of a 
1:1 binding model is shown in the bottom graph. In this case the enthalpy is fitted at the 
heat of 100% binding and the stoichiometry is intuitively denoted by the midpoint of the 
titration. The slope of the sigmoidal curve is related to the binding constant (Kb and KD= 
1/Kb) and to the sample concentration for a given system. Considering a general binding of 
a ligand [L] to a macromolecule [M], Kb is given by: 
 
 
The Gibbs free energy (in kJ mol-1) of binding is given by: 
 
 
Where R is the gas constant given in J-1 K-1 mol-1 and T the absolute temperature, given in 
K. The entropic contribution, DS, is implicitly calculated from the second law of 
thermodynamics and given in kJ mol-1: 
 
 
A useful parameter is N that defines the number of binding sites per macromolecule and is 
mathematically given by: 
 
 
 
In an ITC experiment, the initial heats are larger than the heats for subsequent additions 
because at the beginning of the titration there is a large excess of empty or unpopulated 
binding sites which leads to a complete reaction when [L] is added to [M]. The heat produced 
is linearly dependent of DH and non-linearly dependent of Kb. The generic thermogram is 
modelled by the following equations: 
M + L! ML Kb =
[ML]
[M ].[L]
(1) 
ΔG = −RT lnKb = RT lnKD (2) 
ΔG = ΔH −TΔS (3) 
N =
[L]b
[M ]T
= [ML]
[M ]+ [ML]
=
Kb[L]
1+ Kb[L]
(4) 
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Eqn. (5) is just a particularization of eqn. (4). Θi is the is the fraction of site i occupied by 
ligand; [L]T is the total ligand concentration, [L] is the free ligand concentration, PT is the 
total macromolecule concentration, Ki is the binding constant of process i and ni is the 
stoichiometric ratio for the injection i. The total heat produced can be calculated from: 
 
 
 
 
 
 
Where V0 is the initial volume of the sample cell and DHi is the molar enthalpy change for 
the process i. The differential heat is defined by eqn. (8) where k is the injection number. A 
non-linear regression algorithm is performed on eqn. (7) to obtain a fit of the experimental 
data. There are different models that explain the binding process (one-set of sites, two 
independent sites, sequential sites). All the interactions measured in the present work 
correspond to a 1:1 binding with the macromolecule having one binding site. In this 
particular case, the equilibrium constant is given by: 
 
 
 
All the titration experiments were performed according to the default setting of the device 
used with a referential power of 10 µcal s-1 and a spacing between injections of 150 s or 
longer, with an injection time of 2 s and a stirring speed of 750 rpm. A total of either 19 or 
31 injections of 2 µl each were applied in the determination of the KD values. For a 
qualitative, rapid assessment of the binding strength a faster run comprised of 13 injections, 
3 µl each, was performed. All the measurements were conducted at 298 K, using 270 µl of 
Ras (always located in the cell) and 70 µl of the titrant (always located in the syringe). 
 
 
 
Q = PTV0 niΘ iΔHi
i=1
j
∑⎛⎝⎜
⎞
⎠⎟
(7) 
ΔQ(k) = Q(k)−Q(k −1) (8) 
K = Θ
(1−Θ).[L]
(9) 
Θ i =
Ki[L]
1+ Ki[L]
(5) 
[L]T = [L]+ PT (niΘ i )
i=1
j
∑ (6) 
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2.2.5   NMR Spectroscopy 
2.2.5.1   Sample Preparation. General Considerations 
All NMR measurements involving different Ras isoforms, variants and mutants were 
performed by dissolving the protein in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 
mM DTE, 0.2-0.4 mM DSS (2,2-dimethyl- 2-silapentane-5-sulfonate) in 5-10% D2O, or 20% 
in the case of HP experiments). For measurements involving the titration of Ras with Raf-
RBD, NF1 or SOS1, a minimum of 150 mM and a maximum of 250 mM NaCl, depending 
on the titrant and general aspect of the mixture, were added prior the titration with the intent 
to stabilize the protein complexes and to avoid dimerization. 
In the NMR investigations performed for GppNHp, the nucleotide was bought from Sigma-
Aldrich (Germany) and used directly, without any additional purification. From the white 
crystalline powder two samples were prepared by dissolving it either in buffer F, which 
included MgCl2 in one case but not in the other. In order to minimise pH dependent chemical 
shift changes during the HP experiments, a pH value for the solutions of ca. 2-3 units above 
the apparent pKa values of the second deprotonation step of the terminal phosphate. This 
corresponded to a final pH of 9.0 for the Mg2+•GppNHp sample and 11.5 for GppNHp 
sample [116, 226]. All NMR measurements performed in this thesis were recorded at either 
278 K or 303 K (or both). The temperature of the NMR probehead was always controlled 
prior to the experiments by using the line separation between methyl and hydroxyl groups 
of external MeOH as a calibration method [227]. 
 
2.2.5.2   Ambient Pressure and HP 31P NMR Data Acquisition 
Ambient pressure and HP 31P NMR was recorded either in one of the two spectrometers 
located at our department: in a Bruker Avance 500 MHz, operating at a 31P frequency of 
202.45 MHz and in a Bruker Avance 600 MHz, operating at a 31P frequency of 242.89 MHz. 
In the first spectrometer either a selective broadband 10 mm 31P probe or a 5 mm QXI probe 
was used. The protein samples were typically measured in high quality grade 5 mm NMR 
tubes or in 5/8 mM Shigemi tubes. The second spectrometer was equipped with a Prodigy™ 
cold probe (Bruker) allowing for the enhanced sensitivity detection of the 31P nucleus. 
Protons were usually decoupled during data acquisition with a GARP sequence operating 
at a B1 field of 830 Hz or 980 Hz, accordingly to the spectrometer used [228]. A 70º-90º 
pulse and a repetition time of 6-7 s was typically used. A 1H spectrum was recorded for 
each 31P spectrum. 
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HP 31P NMR was performed using a home-built online high hydrostatic pressure system 
which includes a bourdon manometer and a manually operated piston compression (for 
details see Figure 1.12 and [229]. Pressure was transmitted via a metal-alloy line filled with 
water to a high pressure ceramic cell connected at the end by an autoclave (Figure 1.12). 
One of two ceramic cells were used in the multiple experiments, a 200 MPa or a 250 MPa 
of maximum permissible pressure. Both have an inner diameter of 3 mm and an outer 
diameter of 5 mm. Recently, a third one was acquired by our department, capable of 
withstanding a maximum pressure of 300 MPa. A flexible membrane, made of polyethylene 
terephthalate (PET), was used to separate the water of the pressure line from the buffer of 
the protein sample. The total volume of both ceramic cells is 320 µl. However, the effective 
volume where the sample can be recorded is considerably smaller. To reduce the 
unnecessary volume and therefore economise protein sample, a cylindrical displacement 
body with a length of ca. 3 cm, made of propylene, was inserted into the ceramic cell. In the 
process, the protein solution that leaked from the cell was collected, stored and used for 
other experiments. 
 
2.2.5.3   [1H-15N]-HSQC NMR Acquisition, Processing and Evaluation 
2D experiments performed in HRasWT(1-166)•Mg2+•GppNHp (1.1 mM) and HRasD33K(1-
166)•Mg2+•GppNHp (1.3 mM). For each protein, a temperature series was recorded ranging 
from 278 K to 303 K in five-degree step intervals. Prior the experiment both proteins were 
extensively dialysed against the same buffer. 1H and 15N data collection was performed in 
a Bruker Avance spectrometer, equipped with a TXI cryoprobe operating at a 1H frequency 
of 800.12 MHz and a 15N frequency of 81.08 MHz. Each 2D spectrum was recorded as a 
complex data matrix comprised of 256 or 512x2048 points using a sweep width of 8400 or 
9600 Hz in the proton dimension and 2400 Hz or 2800 Hz in the 15N dimension. A recycling 
delay of 3.4 s was used with 64 scans/FID. Before each 2D experiment, a standard 1H 
spectrum was recorded. 1H chemical shifts were directly and 15N indirectly referenced to 
DSS as described elsewhere [230]. 
All spectra were processed using the Topspin 3.2 program (Bruker Biospin). The 
assignment of the amide resonances for RasWT•Mg2+•GppNHp was based on the reported 
literature [94] and transferred to the presently obtained spectra using the Auremol software 
[231]. 
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2.2.5.4   31P (HP) NMR Processing and Evaluation 
All 31P NMR spectra were processed using the Topspin® program. Each spectrum was 
baseline corrected, phase corrected and indirectly referenced to DSS with a Ξ-value of 
0.404807356 reported by Maurer and Kalbitzer [232], corresponding to 85% external 
phosphoric acid contained in a spherical bulb. The FID was filtered with appropriate window 
functions, depending on the characteristics of the data and the intended purpose of the 
analysis. Typically, either an exponential multiplication filter (EM) with a line broadening 
(LB) of 4-15 Hz or a Gaussian multiplication filter (GM) was used. The processed data was 
subsequently converted to the ASCII format using the MestreC® (v6.1) program and 
evaluated using the Origin® (v8.9) software. The deconvolution of the spectra was 
performed by application of a standard non-linear least square routine gradient fit procedure 
such as the Levenberg-Marquardt (L-M) method [233, 234]. In this process, an initial 
empirical estimation of the chemical shift position for each resonance line is given and fitted 
with a Lorentzian line that is then optimized by the algorithm, allowing for the obtention of 
accurate chemical shift values, peak intensities, areas and half-width linewidths. 
31P NMR longitudinal relaxation times (T1) were determined by an inversion-recovery pulse 
sequence at 278 K, using a maximum repetition time of 20 s. The obtained integrated areas 
were plotted and fitted according to the following equation: 
 
 
where Mz(t) is the z-magnetization (signal integral) at time t and M0 is the magnetization in 
thermal equilibrium [235]. 
31P NMR studies on the binding of Zn2+-cyclen to HRas and KRas led to the determination 
of the microscopic dissociation constant, KD, as well as to the coefficient of cooperativity, n, 
given by the Hill equation [236, 237]: 
 
 
 
 
 
 
Where df and dc are the chemical shift values of free Ras in state 1(T) and in complex with 
a ligand, respectively. [Ras]0 and [L]0 correspond to the total concentrations of the protein 
and the ligand, respectively. [L]f is the concentration of the free ligand and n is the Hill 
coefficient [156]. 
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Under equilibrium conditions, if a protein occurs in N conformational states, the population 
difference between two states, 1 and 2, in thermodynamic equilibrium is given by their 
differences in the Gibbs free energy, DGi,j, given in kJ mol-1:  
 
 
 
The equilibrium constant K12 is dependent on pressure, P, and absolute temperature, T. 
Given the universal relation DG = DG0 + PDV, the pressure dependence of the Gibbs free 
energy for the two states at constant T is given by: 
 
 
 
Where DV012= DV12(P0)= V2(P0)-V1(P0) is the difference of the partial molar volumes. The 
complete quadratic term of this equation is sometimes abbreviated as Db12 and corresponds 
to the difference of the partial molar compressibilities. In most cases this term is neglected 
and the equation can be simply written as:  
 
 
A phenomenological description of the chemical shift pressure-dependence observed for 
any NMR spectra can be obtained by a model-free approximation of the Taylor expansion 
to the second order: 
 
 
Where d0 is the chemical shift at ambient pressure and B1 and B2 are the first and second 
order pressure coefficients, related with a linear (conformational transition within the same 
ensemble) and non-linear (conformational transition between different ensembles) pressure 
dependence, respectively. The magnitude of their values depends on the magnitude of the 
local structural changes induced by pressure. This relationship is not truly quantitative but 
it can be used at least empirically to evaluate such changes. In some situations, the use of 
a third order (B3) Taylor expansion is required for a proper fit of the data. The actual 
pressure response observed in an NMR spectrum depends on the timescale of the 
exchange between the different states, characterized by the exchange correlation time, τc. 
If there is an equilibrium between M states i, (i=1, N) of the protein and under a fast 
ΔG12(P) = ΔG12
0 + (P − P0 )ΔV12
0 + 1
2
∂ΔV12
0
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exchange condition (|Dωij|=|ωj-ωi|<<1/τc), the observed chemical shift is a combination of 
the chemical shifts of each state given by the general equation: 
 
 
 
 
Where Z is the state sum over all possible structural states of M. For a conformational 
transition between only two states, 1 and 2, the above equation can be greatly simplified:  
 
 
 
Indeed, this was the used equation to fit the pressure-dependent chemical shifts of the 31P 
NMR lines behaving according to the fast exchange regime. 
When the conformational change between states 1 and 2 is slow in the NMR time scale 
(|Dωij|=|ωj-ωi|>>1/τc), the signal areas (in the case of 31P spectra, A) or volumes, V (in the 
case of [1H-15N]-HSQC spectra) are proportional to their respective concentration and the 
equilibrium constant K12 can be calculated according to: 
 
 
 
The relative population pi of a state i in an N system can be calculated from the equilibrium 
constant Kij=[i]/[j] as: 
 
 
 
In terms of 31P NMR, the intrinsic pressure effects arising from the isolated nucleotide were 
separated from the pressure effects ascribed to the nucleotide-bound Ras for the first time 
in this thesis. This was achieved by subtracting the variation of the chemical shift values 
(Dd) measured in the isolated nucleotide to the uncorrected shift values of the Ras protein 
obtained directly from the experimental spectra [226]. 
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2.2.6   High Pressure Macromolecular Crystallography (HPMX) 
Contrary to HP NMR, HPMX is technically more challenging and requires complex 
instrumental skills. Nevertheless, it is a remarkable technique with a bright future. Its 
improvement towards a routinely, user friendly methodology, is dependent on technological 
advances related to the construction of brighter synchrotron radiation sources for faster data 
acquisition, development of, newer high pressure cells, fully automatic analysis of the 
diffraction images and new efficient methods for pressure calibration [173]. 
Conventional, ambient pressure (pamb), X-ray diffraction data was collected for HRasWT(1-
166) and for HRasD33K(1-166). In parallel, a broad crystallographic study involving wild type 
Ras and RasD33K was performed using state-of-the-art high pressure X-ray techniques. 
 
2.2.6.1   Protein Crystallization 
All the proteins studied by HPMX refer to the C-terminal truncated (1-166) and GppNHp-
bound HRas used in a concentration between 1-1.5 mM and dissolved in buffer F (40 mM 
Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE). 
 
Crystallization of RasWT and RasD33K 
The technique requires the use of large crystals, typically bigger than 200 µm in edge-
length. They were produced for the purpose according to the “batch mode” process, using 
an appropriate crystallization chamber containing 3-spot wells made of glass that were 
previously siliconized. To each of these spots, typically 15-30 µl of 80 mM Tris/HCl pH 7.5, 
20 mM MgCl2, 4 mM DTE and 52-60% PEG-400 were placed at their centre. Afterwards, 
30 µl of the protein solution were carefully added in the centre of the previous drop. The two 
solutions were slowly mixed by gentle pipetting. The chambers were immediately sealed at 
the top with transparent adhesive tape and placed in a vibration-free zone, in the dark. 
Nucleation spots were visible under the microscope after ca. 6 h and full crystals were 
grown after 2-3 days. 
 
Crystallization of RasWT in complex with Zn2+-cyclen 
A series of HP experiments were devised with the intent to understand how the binding of 
Zn2+-cyclen at the first binding site, near the nucleotide g-phosphate, is affected upon 
pressure-induced conformational rearrangements of the switch regions. For the purpose, 
the previously grown RasWT crystals were soaked with 10-12 mM of Zn2+-cyclen from a 
highly concentrated (> 20 mM) stock solution (dissolved in the same buffer used for 
crystallisation), for at least 10 hours prior data acquisition. 
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2.2.6.2   Data Collection 
Upon committee approval for beam time, X-ray data was collected at the European 
Synchrotron Radiation Facility (ESRF, Grenoble, France) in the beamlines ID09A and ID27, 
and at the SOLEIL synchrotron (Saint-Aubain, Paris, France) in the “Crystal” beamline. A 
total of 4 runs (2 at ESRF, 2 at SOLEIL) were performed, comprising a total of 20 days of 
synchrotron radiation devoted to the project. The following description on how to acquire 
HPMX can be used as a practical guide to any of the three different beamlines used. 
Although, the reader is advised for the existence of specific instrumental and technical 
details of each beamline that are impossible to cover here in full detail. 
• Two identical DAC’s (named ELSA and ELMA) of the cylinder-piston type were used 
(Figure 1.14) [185], one cell being loaded while the other being used for data collection. The 
first step of sample loading in the DAC was the preparation of a gasket. This is a piece of 
copper or inconel®, with a typical thickness of 200 µm. The gasket was inserted between 
the two diamonds, the cap of the DAC was screwed and the gasket was indented by 
applying a small thrust (achieved by slightly pressurizing the cell with helium gas). 
Afterwards, the cap was removed and a hole was machined in the gasket by electroerosion 
with a diameter of exactly 350 µm. The gasket was then placed on the diamond, using the 
indentation as a guide. A drop of mother liquor (2-3 µl) was deposited in the hole. A crystal 
was fished out of one of the crystallization drops and gently pushed into the cavity, together 
with a tiny ruby sphere (Figure 1.14). The drop was deposited just before the deposition of 
the crystal to reduce evaporation of its most volatile components. The cap of the diamond 
cell was screwed and a moderate thrust applied to it. 
• The slightly pressurized DAC already containing the crystal in its centre was then mounted 
on the goniometer by attaching it to the c-cradle set at w=0. The X-ray beam cross section 
was typically adjusted to 50x50 µm2 at ESRF and 20x20 µm2 at SOLEIL. The pressure was 
ramped until the desired value by slowly increasing thrust. This was either done by using a 
manual pressure setup system or an automatic one. Pressure was generated in both cases 
not by a lever but by a pneumatic mechanism that lets He gas flow into the membrane of 
the DAC [238]. The pressure inside the DAC cannot be assessed by the applied load 
because it is difficult to predict the elastic forces and plastic and elastic deformations in its 
mechanical parts [239]. This determination was performed using the known pressure-
dependence of a laser-excited fluorescence from a ruby (R1 line, l= 694.2 nm at pamb, the 
equipment is a commercial product from Betsa®) [182, 240]. The optical system that is used 
to measure the fluorescence was placed on the X-ray path between the DAC and the 
detector and can be remotely removed when the pressure adjustment is completed. The 
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same device, coupled to a CCD camera was also used to image the sample on TV monitors 
(Figure 1.14). 
• The centre of the cavity where the protein crystal was deposited was accurately located 
in both, the goniometer rotation axis and in the X-ray beam pathway. This was 
accomplished in two steps: first the cell was scanned in the y direction (i.e. perpendicular 
to the beam in the horizontal plane) at ±w angles. The intensity transmitted through the 
cavity was monitored by using a photodiode. The centre of the cavity was perfectly placed 
on the rotation axis when the transmitted signals at ±w were equal. In the second step, the 
centre of the cavity was placed in the X-ray beam by scanning along z (the vertical direction) 
according to the same principle. Afterwards, the optical system which allows to visualize 
the crystal and the ruby chip on a TV monitor was switched on. The X-ray position (now 
located exactly at the centre of the cavity) was marked with a pen by making a dot in the 
TV monitor. This method was used as a guide-trough for the successive irradiation of a 
fresh (i.e. non-irradiated) region of the crystal by performing step translations along the y 
and z directions, spaced between with each other by a distance slightly greater than the 
radius of the collimated beam. This process of “walking” on the crystal is a successful 
strategy to alleviate its rather fast degradation due to the free radical formation (Figure 
1.14). 
• After centring the crystal, a few frames were recorded. From these frames, information 
necessary to undertake data collection (lattice type, cell parameters and orientation matrix) 
was derived. Data collection was performed by the rotation method with the HP cell rotating 
about the vertical axis. 
• Data were collected at a wavelength λ= 0.415 Å in ID09, λ= 0.374 Å in ID27 and λ= 0.510 
Å in the Crystal beamlines. The Detectors used were a MarResearch Mar555 flatpanel 
(ID09), a MarResearch MarCCD165 (ID27) and a Rayonix SX165 (Crystal). The exposure 
times were 5 s, 30 s and 10 s per frame, respectively, with an oscillation of 1º in all cases. 
Crystallographic structures of wild type and RasD33K were previously determined using 
standard cryo-crystallography. However, since HPMX data are collected at room 
temperature (RT), reference data sets at ambient pressure in the same sample environment 
were also collected to minimize potential experimental bias and to provide accurate and 
meaningful comparisons of high pressure effects. 
Diffraction always disappeared anytime the pressure was continuously ramped (i.e. with no 
waiting time) from 0.1 to ca. 300 MPa. However, when Ras crystals were kept pressurized 
at 200-300 MPa overnight, diffraction could be generally maintained. 
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• All data sets were indexed and integrated using XDS. The integrated intensities were 
scaled and merged using SCALA and TRUNCATE and the structures were solved by 
molecular replacement (MR) with MOLREP. In order to minimize any bias in the areas 
involved in the transition between states, MR’s were performed using a model where the 
switch 1 (aa 30-41) and switch 2 (aa 60-76) were removed in addition to all heteroatoms 
and alternate positions. The structure refinements were performed using REFMAC. All 
these programs are part of the CCP4® package. The graphic program Coot® was used to 
visualize |2Fobs–Fcalc| and |Fobs– Fcalc| electron density maps and for manual rebuilding during 
refinement steps. 
Crystal-cell compressibility curves (i.e. unit-cell parameter changes versus the pressure) 
were determined for RasWT in the absence and in presence of Zn2+-cyclen inhibitor, and for 
RasD33 alone. All refined crystals belong to the trigonal space-group P3221. The rmsd values 
and the thermal b-factors were computed using programs from CCP4 package. In the 
following, rmsd’s were always calculated between Ca atoms and average b-factors only for 
main chain atoms to avoid the alternate positions of the side chains. 
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3.1   Dynamics, Equilibrium and Inhibition of Full-Length Ras Studied by 31P NMR 
Until recently most biochemical investigations on full length Ras were rare. The work of the 
past decades was devoted to the truncated variant of 166 amino acids, perhaps because it 
was easier to handle from the experimental point of view. However, owing the change of 
paradigm from HRas to KRas, and from studies on the truncated protein to studies on the 
full length one, a primary concern on our department was to investigate up to which extent 
the conformational equilibrium detected by 31P NMR for HRas in terms of states 1(T) and 
2(T) could be transferred to the KRas protein. 
 
3.1.1   Comparison of the Conformational Equilibrium in HRasWT and KRas4bWT 
A great number of studies assessing the equilibrium between states 1(T) and 2(T) has been 
published for HRas [67, 122, 241, 242] but not as many for KRas. Because the latter is the 
isoform predominantly mutated is most types of cancer [100, 134], an investigation in terms 
of equilibria between for the isoforms KRas4b(1-188) and HRas(1-189), was performed 
herein. Figure 3.1A shows the 31P NMR spectra recorded at 278 K of both proteins bound 
to Mg2+•GppNHp. The corresponding chemical shift values and linewidths are summarized 
in Table 3.1. The obtained spectra are very similar: in both cases (and generally for any 
case within the scope of 31P NMR spectroscopy of Ras proteins) the separation between 
states 1(T) and 2(T) is the greatest for the γ-phosphate signal. The integration of each 
resonance signal upon proper deconvolution is directly proportional to the population of the 
corresponding conformational state at a given pressure and temperature. This can be 
quantitatively defined by the equilibrium constant which is simply the ratio between the two 
areas: K12= Astate 2(T)/Astate 1(T). For KRas4b, K12= 2.0 and for HRas, K12= 1.9. Both values are 
determined with an error of ± 0.2 that arises from the fitting procedure of the partially 
superimposed signals. Qualitatively it can be inferred that under equilibrium conditions at 
278 K, the conformational state 2(T) of KRas is ever so slightly more populated as 
compared with HRas, despite the difference between both being within the limits of the error 
of the measurement. In terms of chemical shifts, the results show that state 2(T) in KRas is 
downfield shifted by a dD of 0.06 ppm compared with HRas (d= -3.30 vs -3.24 ppm), a 
difference that is small but still significant compared with the typical error values of ca. ±0.02 
ppm. 
Figure 3.1B shows the 31P NMR spectra of the titration of KRas4bWT with the Ras binding 
domain of the effector Raf kinase. The effects of the titration can be qualitatively interpreted 
as follows: with increasing amounts of effector new resonance signals close to the ones of 
state 2(T) arise. At the same time, the integrals corresponding to the state 1(T) decrease 
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with increasing concentrations of effector. At equimolar concentrations of Ras-Raf, state 
1(T) disappears completely. The same observations were previously published for HRasWT 
[51, 116, 117]. The b-phosphate resonance line becomes broader as the titration proceeds 
due to the increased molar mass of the complex. This is corroborated by the experimental 
increase of the linewidth values: at a Ras:Raf ratio of 1:1 the molecular mass of the complex 
becomes 1.52-fold greater than the one of Ras alone (18 kDa + 9.4 kDa = 29 kDa). The 
linewidths of the signals representing the conformational state 2(T) become broadened by 
a factor of 1.5, 1.8 and 1.7 for the a-, b- and g-phosphate, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Conformational equilibria of human Ras proteins detected by 31P NMR 
spectroscopy. A. 31P NMR spectra of the wild type isoforms HRasWT(1-189) and 
KRas4bWT(1-188) complexed with Mg2+•GppNHp. The resonances corresponding to the 
a, b and g phosphates are indicated, as well as the conformational states 2(T), coloured 
green, and 1(T), coloured red, respectively. B) Interaction between KRas4bWT and 
effector protein Raf-RBD. To an initial concentration of 1.3 mM of KRas, increasing 
amounts of a highly concentrated Raf-RBD solution were added. The molar ratio of Ras 
to Raf is indicated. The final concentration of Ras is 0.93 mM. 
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There is a wealth of published data on the binding energetics of Ras-effector interactions 
measured mainly by ITC and fluorescence techniques that can be taken as reference [243, 
244]. But because the binding strength is always dependent on the experimental conditions, 
the association of Raf-RBD to HRasWT and KRasWT was presently studied by ITC using the 
same buffer employed for the 31P NMR measurements. The ionic strength is particularly 
important in this case since the affinity is greatly influenced by the concentration of salt 
(studies reported a variation from a KD  of 0.010 µM in the absence of NaCl up to 0.35 µM 
at 125 mM NaCl [245]). The obtained isotherms are presented in Figure 3.2. Raf was placed 
on the syringe of the calorimeter at a typical concentration of 600 µM and a 12-fold diluted, 
50 µM, Ras sample was placed in the cell. The measurements were recorded in duplicate 
at 298 K by using one of the default methods provided by the instrument manufacturer. All 
the interaction partners were previously dialyzed against the same buffer ((buffer F: 40 mM 
Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with additionally 150 mM NaCl). The obtained 
results are shown in two forms: the differential raw power recorded by the instrument, 
originated after each successive addition of 2.0 µl of Raf to Ras as a function of time is 
presented in the upper graphs of Figure 3.2 The integration of this heat signature with 
respect to the Ras:Raf molar ratio over the course of the titration was also plotted (middle 
graphs). The sigmoidal distribution was fitted with a 1:1 binding model (experimental section 
Table 3.1. 31P chemical shift values and linewidths for H and KRasWT(1-
188/189)•Mg2+•GppNHp and their titration with the effector Raf-RBD. 
      protein 
complex P:l 
a-phosphate b-phosphate g-phosphate  
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
K12b 
                  FLHRasWT -- -11.25 -11.71 -0.26 -0.16 -2.54 -3.24 1.9 
 --        FLKRasWT -- -11.27 -11.73 -0.32 -0.21 -2.58 -3.30 2.0 
+150 mM NaCl -- -11.20 -11.74 -0.33 -0.20 -2.57 -3.29 2.0 
+ Raf-RBD  1:0.4 -11.21 -11.71  -0.24 -2.55 -3.37 4.5 
 1:0.8 -11.19 -11.68  -0.23 -2.57 -3.46 6.9 
 1:1.2 -- -11.61  -0.27 -- -3.51 -- 
                    Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T)/2(T)
a
 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] -- 
                  FLHRasWT -- 136.4 80.5 57.5 94.6 58.5  
 --       FLKRasWT -- 113.0 87.2 54.4 69.0 60.2  
+150 mM NaCl -- 125.6 87.6 46.8 80.2 75.4  
+ Raf-RBD 1:0.4 117.2 108.7 54.9 117.2 104.0  
 1:0.8 -- -- 64.6 106.6 119.0  
 1:1.2  130.0 89.3  128.3  
All values are fitted from the experimental spectra recorded at 278 K, pH 7.5 with 40 mM 
Tris/HCl pH 7.5,10 mM MgCl2, 2 mM DTE and 150 mM NaCl. 
a The given linewidth values for b-phosphate were fitted as a single Lorentzian line. 
b K12 is given by the ratio of the areas of state 2(T) over state 1(T), calculated at the g-
phosphate. The estimated error is ± 0.2. This data is published in ref. [156]. Comparable 
values are available in the literature in refs. [116,117]. 
3. Results 
 
88 
2.2.4, eqn. n°5) and the obtained thermodynamic parameters are presented here as the 
unchanged output of the fitting routine. From the fitted data, a binding ratio of 0.971 and 
1.07 was obtained for HRasWT and KRasWT, respectively. The concomitantly obtained KD 
values are 0.24 µM (HRas) and 0.72 µM (KRas). 
The most interesting finding taken from these measurements is the different affinity of 
binding measured for both Ras isoforms: the dissociation constant for KRas is 3-fold higher 
than for HRas, leading to the conclusion that HRas has a greater affinity towards Raf than 
KRas. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Interaction between RasWT•Mg2+•GppNHp and the effector kinase 
Raf-RBD studied by ITC. A. Measurement performed for HRasWT(1-189). B. 
Measurement performed for KRasWT(1-188). The upper graphs show raw heat 
of the reaction with respect to time. The integration of such curve with respect 
to the molar ratio of Ras:Raf gives the typical sigmoidal curve for the binding 
process. The experiments were recorded at 298 K. All the proteins were 
dissolved in the same buffer F with additionally 150 mM NaCl. The signature 
plots for each interaction are shown alongside with the fitted thermodynamic 
values. They represent an easy way to understand qualitatively how the 
reaction is driven (blue: DG, green: DH, red: -TDS). 
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3.1.2   Modulation of the Conformational Equilibrium in KRas4bWT by Zn2+-cyclen 
Having in consideration the body of work with metal-cyclens and due to the present results 
showing the similarities of states 1(T) and 2(T) determined for HRasWT and KRas4bWT, it 
was hypothesized that wild type KRas4bWT could be modulated by Zn2+-cyclen in a similar 
way as the one reported for HRasWT. To test if this is the case, a titration of both proteins 
with this drug was performed. The experiment was already reported in 2005 by our group 
for HRasWT [155] but it was repeated herein in order to have identical conditions for 
comparison with KRas. The titration of KRas4bWT was performed for the first time in the 
framework of this thesis. Meanwhile, both experiments were published in 2014 [156]. Figure 
3.3A shows the titrated complexes. In both cases the integrals of the populations 
corresponding to state 2(T) decrease with increasing concentrations of the inhibitor, 
whereas the integrals of the populations for state 1(T) increase. At the same time the a- 
and g-phosphates shift downfield and the b-phosphate shifts upfield. More specifically it can 
be observed that the interaction of the ligand with Ras in state 1(T) follows the fast exchange 
condition in the NMR time-scale because one obtains only one shifting resonance with 
increasing concentrations of the ligand for this particular signal (red coloured line at the g-
phosphate, Figure 3.3A). Considering the titration of HRas, for example, the chemical shift 
value for state 1(T) in the ligand free protein is d= -2.53 ppm and the chemical shift value 
for the same state when the ligand is bound to the protein (at a ratio of 1:30) is d= -1.61 
ppm (see Table A, appendix section). The chemical shift difference between the free and 
Zn2+-cyclen bound states is therefore Dd= -1.66+2.52= 0.90 ppm. This corresponds to a Dν≈ 
200 s-1. A similar value can be found also in the case of KRas (Table A, appendix). As 
consequence, it can be estimated that in the limit, the off-rate between Zn2+-cyclen and both 
isoforms in state 1(T) needs to be much faster than 200 s-1 (i.e. koff >> 200 s-1). 
Regarding state 2(T), no significant shift changes are detected in the course of the titration, 
indicating that the slow exchange condition operates in this case. As for the a-phosphate, 
a downfield shift of both states is observed during the titration. In the case of b-phosphate, 
dramatic changes occur: in the Ras proteins alone, both states cannot be separated at the 
magnetic field used. They are detected as a single resonance line centred at d= -0.24 ppm 
for HRasWT and d= -0.21 ppm for KRas4bWT. However, as the titration proceeds, states 1(T) 
and 2(T) become clearly separated, with state 1(T) shifting upfield and state 2(T) shifting 
downfield. At 30 molar equivalents of Zn2+-cyclen (last titration step on Figure 3.3), the 
separation between them is of Dd= 1.0 ppm for HRasWT and Dd= 0.77 ppm for KRas4bWT, 
respectively (note that the corresponding Dd of 1.0 ppm in this case is equal to the one 
obtained above for state 1(T) at the g-phosphate). 
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In an attempt to understand the kinetics of the binding mechanism, the chemical shift 
change of state 1(T) on the g-phosphate resonance line induced by the addition of Zn2+-
cyclen was plotted as a function of ligand concentration. The result is presented in Figure 
3.3B. For both Ras isoforms, very similar results were obtained: the plotted values describe 
a sigmoidal behaviour that is indicative of a cooperative binding mechanism: upon binding 
of the first molecules of Zn2+-cyclen, an allosteric modulation of the conformation of the 
protein is very likely to take place, changing the subsequent affinity of Ras. The data was 
Figure 3.3. Titration of RasWT•Mg2+•GppNHp with Zn2+-cyclen followed by 31P NMR spectroscopy. A. 
Titration of KRas (left) and HRas (right) with increasing concentrations of Zn2+-cyclen (the concentrations 
are indicated for each step). Both proteins have the same initial concentration of 1.3 mM. The 
measurements were carried out at 278 K in 40 mM Tris/HCl pH 7.5; 10 mM MgCl2; 2mM DTE; 150 mM 
NaCl; 0.1 mM DSS; 5%D2O. At high concentrations of Zn2+-cyclen (above 12 mM) additional small NMR 
signals arise at chemical shifts of 0.3, -6.5 and -10 ppm, corresponding to the g-, b- and a-phosphates, 
respectively from free Mg2+•GppNHp. No Zn2+-cyclen•Mg2+•GppNHp was detected. B. Plot of the obtained 
chemical shift changes of the g-phosphate resonance in state 1(T) induced by Zn2+-cyclen as a function of 
ligand concentration. The sigmoidal pattern of the points was fitted with the Hill equation (eqn. nº11, section 
2.2.5.4). The obtained Ddmax value for KRas is 200 ± 3 Hz. The obtained microscopic dissociation constant 
(KD) is 9.9 ± 0.2 mM, and the Hill coefficient (n) is 2.0 ± 0.1. The corresponding values obtained for HRas 
are 200 ± 3 Hz; 10.4 ± 0.3 Hz; 1.9 ± 0.1, respectively. C. Optimized structure of Zn2+-cyclen (1,4,7,10-
tetraazacyclododecane.Zn2+) complex with chloride counterions. The optimized structure was calculated 
for the isolated molecule at the DFT/mP1WPW91 level of theory. The detail of the non-planarity of the 
cyclen ring is shown. Adapted from [156]. 
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fitted with the Hill equation (experimental section 2.2.5.4, eqn. nº11) leading to Hill 
coefficients of 1.9 ± 0.1 and 2.0 ± 0.1 for HRasWT and KRas4bWT, respectively and to an 
apparent KD of 9.9 ± 0.1 mM in both cases. The Hill coefficient is a measure of the degree 
of cooperativity, and normally, a number close to the number of binding sites is 
characteristic of a large positive cooperativity. 
Finally, at high concentrations of Zn2+-cyclen additional small resonance lines are observed 
in the spectra (this is clearly observed in the last titration step on Figure 3.3A), at d= 0.3, -
6.5 and -10.0 ppm, corresponding to the chemical shift of g-, b- and a-phosphates, 
respectively, of the free nucleotide that becomes dissociated from the protein. This is due 
most likely to the lowered affinity between Ras and the nucleotide as Zn2+-cyclen 
concentration increases the koff (a factor of 3 was observed at 20 mM Zn2+-cyclen). In the 
equilibrium (there was no additional nucleotide added to the buffer) this would lead to a 
small fraction of nucleotide-free Ras that is less stable and tend to precipitate, during the 
rather time consuming 31P NMR experiments (5 to 6 hours per titration step). 
 
3.1.3   Effect of Raf-RBD Titration on the Displacement of Zn2+-cyclen From HRasWT 
The displacement of the Ras-Raf interaction by the presence of Zn2+-cyclen is regulated by 
an allosteric mechanism. Since in such mechanism the two binding sites are cooperative 
and directly coupled it is possible, in principle, to release Ras-bound Zn2+-cyclen from Ras 
at high concentrations of effector Raf-RBD. To prove this hypothesis a 31P NMR titration 
experiment was performed, starting with the HRasWT•Mg2+•GppNHp•Zn2+-cyclen protein-
drug complex, to which increasing amounts of effector Raf-RBD were added, up to a 1.5-
fold excess. The titration steps are presented in Figure 3.4 and the fitted values for chemical 
shift and linewidths are presented in Table B of the appendix section. Initially the Ras-Zn2+-
cyclen complex exists in a conformational state 1(T), with a remaining fraction of state 2(T), 
showing a small upfield shift. Upon addition of increasing amounts of Raf-RBD the integral 
of the resonance line corresponding to state 1(T) decreases. It is worth note, however, that 
its chemical shift and linewidth remains unperturbed (the small deviations presented on 
table B for these parameters are within the limits of the error of the fitting procedure). At the 
same time, the signal intensity of state 2(T) increases. The final chemical shift values 
obtained by line fitting procedures are d= -11.61, -0.19 and -3.56 ppm for a, b and g-
phosphates, respectively. These values are in close similarity with the ones found for the 
HRas-Raf complex (Table 3.1). The chemical shift values for Zn2+-cyclen bound state 1(T) 
are unperturbed over the whole concentration range of the titration experiment. 
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Figure 3.4. Displacement of Zn2+-cyclen from HRasWT upon titration with Raf-RBD followed by 31P 
NMR spectroscopy. To an initial 1.3 mM Ras protein solution in buffer F (40 mM Tris/HCl pH 7.5; 
10 mM MgCl2; 2 mM DTE) with additionally 150 mM NaCl, a great excess of Zn2+-cyclen was 
added. The concentration of this ligand was kept constant during all the titration steps and equal 
to 32 mM. The Ras•Zn2+-cyclen complex thereby formed was titrated with increasing amounts of 
Raf-RBD up to a final concentration of 2.0 mM. The final Ras concentration was 0.8 mM. The 
dotted lines indicate the chemical shift position corresponding to Ras in the effector-bound 
conformational state 2(T)*. Additional small signals are visible when Ras becomes saturated with 
Zn2+-cyclen, corresponding to the g-, b-, a-phosphate groups of the free nucleotide, located at d= 
0.3, -6.5 and -10.0 ppm, respectively. All the experiments were performed at 278 K and data fitted 
with an artificial Lorentzian line broadening of 15 Hz. For a better assessment of the evolution of 
the conformational equilibria during the titration, state 1(T) was coloured red and state 2(T) was 
coloured green. This data is published in ref [156]. 
3. Results 
 
93 
3.1.4   Conformational Equilibria of KRasG12D•GTP and KRasG12V•GTP 
The equilibrium of the GTP-bound KRasWT, together with the two oncogenic mutants 
KRasG12D and KRasG12V was investigated by 31P NMR. The experimental spectra are shown 
in Figure 3.5 and the fitted chemical shifts and linewidths are listed in Table 3.2. 
Experimentally, the nucleotide exchange from GDP to GTP is a statistical process solely 
based in the great excess of the GTP nucleotide that is added to Ras-GDP bound protein 
(20 to 30-fold). This is the reason why the exchange is typically incomplete and the two 
resonance lines located at d= -10.58 and -2.00 ppm, corresponding to the a- and b-
phosphates of GDP-bound Ras, are observed in the spectra. For RasWT, about 74% 
exchange was obtained. For the oncogenic variants the value is usually higher as they tend 
to be less prone to release the nucleotide, with a 82% exchange for KRasG12D and, 100%, 
exchange for KRasG12V. The most striking difference between the three proteins, however, 
is related with the dynamics observed at the g-phosphate. In fact, the spectra of KRasWT 
and KRasG12D shows that state 1(T) is almost non-detectable and lies in the limits of the 
noise. For both proteins, the equilibrium constant, K12, cannot be determined as only state 
2(T) is detectable. On the other hand, state 1(T) can be directly observed in KRasG12V at d= 
-6.01 ppm. The corresponding equilibrium constant is K12= 11.60. A similar value is reported 
elsewhere [123]. From the present data it is also observed a significant downfield shift of 
state 2(T) in RasG12V (d= -7.51 ppm) compared with RasWT (d= -7.94 ppm) and RasG12D (d= 
-7.93 ppm). From the calculation 
of the linewidths (Table 3.2) it is 
detected a general broadening 
of the lines in the case of both 
mutants, as compared to the 
wild type, which can be 
explained by different time 
scales of the exchange 
broadening process between 
conformational sates on RasWT 
as compared to RasG12D and 
RasG12V. 
Figure 3.5. Comparison between the 31P NMR spectra of GTP-
bound full length KRasWT (bottom), KRasG12D (middle) and KRasG12V 
(top). The a-, b- and g-phosphates are indicated, along with the 
corresponding states 1(T) (red colour) and 2(T) (green colour). The 
samples were dissolved in buffer F with additionally 0.2 mM DSS 
and 5% D2O. Measurements were carried at 278 K at a 31P 
frequency of 202.456 MHz. The concentration of the three proteins, 
from the bottom to the top, is 1.5 mM, 2.7 mM and 0.65 mM, 
respectively. The dashed lines mark the chemical shift position of 
the wild type protein. 
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3.1.5   Modulation of the Equilibrium in KRasG12D•Mg2+•GppNHp by Zn2+-cyclen 
It can be generalized in principle, that the mode of action of state 1(T) inhibitors can be 
extended from wild type Ras to partial-loss-of-function mutants and to oncogenic variants. 
To test this hypothesis a titration of KRasG12D with Zn2+-cyclen was performed. The results 
are presented graphically in Figure 3.6 and the fitted shift values and linewidths are given 
in Table C in the appendix section. The experiment follows the same features reported for 
KRasWT in section 3.1.2 and leads to the same general result: upon addition of increasing 
amounts of the drug, state 1(T) is stabilised (its relative area increases) and the population 
of the conformational state 2(T) decreases. At the same time state 1(T) shifts downfield (the 
corresponding Dd is 0.78 ppm, from d= -2.48 to d= -1.70 ppm, Table C appendix) and state 
2(T) shifts slightly upfield (Dd= -0.08 ppm, from d= -3.54 to d= -3.62 ppm). Similar shifts are 
observed in the case of KRasWT (note that the highest molar ratio of Ras:Zn2+-cyclen is not 
the same in the two  experiments. In the case of KRasWT the last step corresponds to a ratio 
of 1:30 and in the case of KRasG12D the ratio is only 1:9). In the last titration step (ratio 1:9) 
of KRasG12D, the appearance of sharp resonance lines corresponding to the existence of 
free nucleotide in solution is again observed for the afree and bfree-phosphates at d= -10.02 
ppm and d= -6.22 ppm, respectively. The chemical shift of the gfree-phosphate (occurring 
normally at ca. d= -1.08 ppm) is presently superimposed with state 1(T) and therefore 
cannot be detected. The presence of inorganic phosphate (Pi) and GMP can also be 
identified at d= 3.80 and d= 2.34 ppm, respectively. It is worth mention that the 31P NMR 
spectra of both proteins in the absence of the drug (bottom spectra in Figures 3.4 and 3.6) 
Table 3.2. 31P NMR chemical shift values and linewidths of the full length (1-188/189) Mg2+•GTP-
bound proteins KRasWT, KRasG12D and KRasG12V. 
       
Protein 
a-phosphate b-phosphate g-phosphate aGDP bGDP Pi 
d1(T)/2(T) 
[ppm] 
d1(T)/2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d 
[ppm] 
d 
[ppm] 
d 
[ppm] 
                KRasWT -11.68 -14.87 -- -7.94 -10.58 -2.00 2.64 
KRasG12D -11.56 -14.76 -- -7.93 -10.59 -2.26 2.48 
KRasG12V -11.56 -14.74 -6.01 -7.51 -- -- -- 
                 a-phosphate b-phosphate g-phosphate aGDP bGDP Pi 
 Dn1/2 1(T)/2(T) 
[Hz] 
Dn1/2 1(T)/2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 
[Hz] 
Dn1/2 
[Hz] 
Dn1/2 
[Hz] 
                KRasWT 64.20 45.74 -- 40.88 44.67 31.32 2.16 
KRasG12D 75.20 75.20 -- 48.79 63.27 43.35 7.33 
KRasG12V 98.06 71.74 33.03 63.90 -- -- -- 
        The calculated shift values and linewidths have an error of ±0.001 and ±0.1, respectively. An 
exponential filter of 15 Hz was applied to the FID and subtracted afterwards from the fitted linewidths. 
a States 1(T) and 2(T) cannot be separated at the magnetic field used and are therefore represented 
as single resonance line. 
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show also a different equilibria between states 1(T) and 2(T): for KRasWT, K12= 1.9 and for 
KRasG12D K12= 0.7 (measured at the g-phosphate, Tables A and C in the appendix section, 
respectively). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Titration of KRasG12D(1-188)•Mg2+•GppNHp with Zn2+-cyclen followed by 31P 
NMR spectroscopy at 278 K. To an initial amount of 1.4 mM of protein dissolved in buffer 
F (40 mM Tris/HCl pH 7.5; 10 mM MgCl2; 2mM DTE; 0.1 mM DSS; 5% D2O) with 
additionally 150 mM NaCl, increasing amounts of Zn2+-cyclen were added (the 
concentrations are indicated for each step). In the course of the titration, state 2(T) 
(indicated in green) shifts slightly upfield by a Dd= -0.08 ppm and state 1(T) (indicated in 
red) shifts downfield by a  Dd= 0.78 ppm. New additional signals appear in the last steps 
of the titration, comprising the b- and a-phosphates from the free nucleotide, at d= -6.22 
and d= -10.02 ppm, respectively. Inorganic phosphate (Pi) is also visible at d= 3.80 ppm. 31P resonances were recorded in a magnetic field operating at a frequency of 202.456 
MHz. An EM window with LB= 15 Hz was used during the processing of the FID. 
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3.2   Inhibition of KRasG12D(1-188)•Mg2+•GppNHp Investigated by 31P NMR and ITC 
Direct inhibition of KRas along with the inhibition of Ras-effector and Ras-GEF interactions, 
are presently topics of very active and intensive research, not only in academia but also at 
the pharmaceutical industry. 31P NMR was used herein to screen for modifications on the 
conformational equilibria of oncogenic KRasG12D(1-188) bound to GppNHp upon interaction 
with a library of 15 different small drugs. The work reported in this section was performed 
in collaboration with Boheringer Ingelheim GmbH. The compounds were kindly provided by 
the R&D department of the company and tested by our group. Some of them were already 
disclosed to the public domain. 
In order to achieve good reproducibility all the KRasG12D•Mg2+•GppNHp samples used were 
exchanged to the same buffer F (40 mM Tris/HCl pH 7.5; 10 mM MgCl2; 2 mM DTE; 0.2 
mM DSS) in 10% D2O, aliquoted in equal fractions of 1.0 mM each and frozen at -80 ºC. All 
31P NMR experiments were performed at 278 K in a magnetic field operating at 202.456 
MHz, using a selective 31P 10 mm probe with either 8 or 10 mm Shigemi tubes. For each 
measurement, 500 µl, 1mM of protein were used. A 70º degree pulse was applied with a 
total repetition time of 7 seconds. Three spectra with 1600 scans each were recorded, 
combined and summed up. All the compounds tested were provided by Boheringer as a 
powder. They were afterwards dissolved in deuterated DMSO with a final concentration of 
50 mM. KRasG12D was titrated in two steps: by adding in total 15 µl (first step) followed by 
30µl (second step) of the compound stock. This corresponds to a 1.5 mM and 3.0 mM drug 
concentration, respectively. The KRasG12D concentration was always kept at 1.0 mM. 
For all the screened compounds, the equilibrium constant K12 was calculated after fitting of 
the data. An exponential line broadening of 15 Hz was applied to all spectra and subtracted 
at the end from the fitted linewidth values. Following are presented the obtained results from 
this study. 
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3.2.1   Effect of DMSO 
Because all compounds were dissolved in perdeuterated DMSO, the influence of this 
solvent alone in the conformational equilibrium was firstly tested. Ras was dissolved in 6% 
DMSO, corresponding to the highest concentration used in this work, and the 31P NMR 
spectra were recorded. The analysis was made for the g-phosphate to which the states are 
best separated. The result is presented in Figure 3.7. Addition of DMSO leads to chemical 
shift changes that cannot be neglected. Both states, 1(T) and 2(T) undergo a upfield shift, 
with a Dd of -0.08 ppm for the former and -0.04 ppm for the latter. The a- and b-phosphates, 
on the other hand, remain unperturbed. DMSO also leads to a general broadening of all 
spectral lines of ca. 8.0 Hz, except for state 2(T) that remains unaltered. The obtained 
equilibrium constant decreases from 0.70 to 0.64, corresponding to a 10% difference, 
which, although small, needs to be accounted in the subsequent titration experiments. All 
the fitted chemical shift values for all the tested compounds are shown in Table 3.3 at the 
end of section 3.2. The fitted linewidths are presented in Table 3.4. In all experiments, the 
a- and b-phosphates were fitted as a single resonance line. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Influence of 6% DMSO on the conformational equilibria 
of KRasG12D•Mg2+•GppNHp. 
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3.2.2   Compound #16324643 
Upon titration with #643, a slight line 
broadening was observed for state 
1(T). At 3.0 mM, K12 decreases from 
0.64 to 0.57, indicating a shift of the 
equilibrium towards state 2(T), which 
is unexpected since in the presence 
of the drug, the weak effector binding 
state 1(T) should in principle be 
favoured. The 11% difference might 
be not significant due to the spectral 
noise and the inherent uncertainty of 
the fitting process. 
 
 
 
3.2.3   Compound #16328098 
Compound #098 promotes a change 
in the equilibrium constant from 0.64 
to 0.72, with state 2(T) being slightly 
favoured over state 1(T). This 
corresponds to a small difference of 
12% in K12 when compared with Ras 
in 6% DMSO. The fitted chemical 
shifts and linewidths remain 
unperturbed. 
 
 
3.2.4   Compound #35127727 
This drug was identified as an inhibitor of the SOS-catalysed KRas activation by the Fesik 
group upon a fragment-based screening using NMR methods [145]. It was determined that 
the molecule binds directly to KRasG12D•Mg2+•GDP but also to H- and KRasWT in a 
hydrophobic pocket formed by Val7, Leu56 and Tyr71. H-bond contacts are established 
between the N1 atom of the imidazopyridine ring and the side chain of Ser37 and between 
indole -NH groups and the side chain of Asp54. Figure 3.10 shows the cartoon and 
Figure 3.8. Titration of KRasG12D•Mg2+•GppNHp with 
compound #643. 
Figure 3.9. Titration of KRasG12D•Mg2+•GppNHp with 
compound #098. 
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molecular surface representation of the Ras•#727 complex (pdb: 4epv) and the 31P NMR 
titration. The equilibrium constant decreases 40% at a 3.0 mM concentration, leading to a 
pronounced effect in the dynamics of states 1(T) and 2(T). There are significant chemical 
shift changes observed for b-phosphate that shifts upfield by a Dd= -0.07 ppm and for state 
1(T) that shifts downfield by a Dd= 0.08 ppm at a 3.0 mM of the Drug (Table 3.3). A 22 Hz 
decrease in line broadening is observed for state 1(T) (from Dn1/2=154 to Dn1/2= 138 Hz) 
and, at the same time, an increase of 38 Hz is observed for state 2(T) (from Dn1/2= 69 to 
Dn1/2= 106 Hz, Table 3.4). 
 
 
 
 
 
 
 
 
 
Figure 3.10. A. Surface representation of the crystal structure of KRas•Mg2+•GDP complexed with the 
compound #727. The switch 1 and switch 2 regions are represented in dark-red and green, respectively. 
The spatial localization of the small drug relative to the nucleotide position is shown (pdb: 4epv, [145]). 
B. Zoom around the binding site evidencing the hydrophobic region were the compound fits. C. Titration 
of KRasG12D•Mg2+•GppNHp with the drug followed by 31P NMR spectroscopy. The 2D structure of the 
compound (an indole derivate) is shown. 
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3.2.5   Compound #35139703 
The compound #703 was not 
completely soluble when mixed with 
the protein. A slight precipitation was 
observed in the NMR tube which is 
reflected by the decrease of intensity 
on the spectra presented in Figure 
3.11 (the spectra was “stretched” 
vertically – note the difference in the 
noise level compared with KRasG12D 
in DMSO). No considerable chemical 
shift changes are observed except for 
the a-phosphate that moves upfield 
by Dd= -0.1 ppm. The difference in 
the K12 values is not meaningful (from 0.64 to 0.68 at a drug concentration of 3.0 mM). 
 
 
3.2.6   Compound #35141449 
Upon addition of the compound #449 
to Ras, slight precipitation was 
observed. The equilibrium constant at 
3.0 mM is 0.68, corresponding to an 
6% increase compared to Ras alone 
in 6% DMSO. The difference is within 
the limits of the error for the 
measurement and is not significant. 
An average line broadening of ca. 24 
Hz is also observed at 3.0 mM for all 
the resonance lines, except for the b-
phosphate that remains unperturbed. 
An upfield shift of -0.09 and -0.06 ppm is observed for the a- and b-phosphates, 
respectively. The g-phosphate remains unperturbed. 
 
 
 
Figure 3.12. Titration of KRasG12D•Mg2+•GppNHp with 
compound #449. 
Figure 3.11. Titration of KRasG12D•Mg2+•GppNHp with 
compound #703. 
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3.2.7   Compound #35145071 
This drug is a cyclic peptide obtained by Pei and co-workers through application of the 
“rapalog” methodology upon screening of a large combinatorial library against 
KRasG12V•Mg2+•GDP [246]. Interaction studies using fluorescence polarization and SPR 
showed that #071 binds to KRasG12V with high affinity (KD=0.83 µM) and is also able to 
disrupt the Ras-Raf interaction with an IC50 of 0.2 µM [247]. 
The 31P NMR titration experiments showed that the addition of this compound to KRasG12D 
led to protein precipitation in the NMR tube. This is also noticeable by the reduction of the 
spectral intensity in Figure 3.13B. The equilibrium constant at 1.5 mM is 0.58, which is not 
significantly different from the K12 value for Ras in 6% DMSO (due to the poor spectral 
quality, the calculation of K12 has a greater associated error of ± 0.4). At a drug 
concentration of 3.0 mM, the resonance lines are broadened almost behind detection and 
most of the protein became precipitated, rendering impossible the analysis of this titration 
step. A general increase in the line broadening is observed, especially for state 1(T) 
(Dn1/2=105 Hz, Table 3.4). 
 
 
 
 
 
 
 
 
Figure 3.13. A. Representation of the “rapalog” cyclic peptide #071. B. Titration of 
KRasG12D•Mg2+•GppNHp with increasing amounts of the compound followed by 31P NMR 
spectroscopy. 
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3.2.8   Compound #35117109  
Contrary to all the compounds tested, 
where a 50 mM stock solution for 
each one was prepared prior to the 
titration, the solubility of compound 
#109 was very limited. Only a 
saturated 25 mM solution was 
prepared in this case. Upon addition of 50 µl to the protein, there were no obvious spectral 
changes (Figure 3.14). At 1.5 mM of drug, K12= 0.70, corresponding to an increase of 10% 
compared to the K12 of Ras in 6% DMSO, a difference that again is not significant. Also, no 
significant chemical shift differences from the values obtained for Ras alone in 6% DMSO can 
be found. The only meaningful effect is an increase of the line broadening for state 2(T) (DDn1/2= 
28 Hz, from Dn1/2= 68 Hz in Ras alone to Dn1/2= 97 Hz in the presence of #109). 
 
3.2.9   Compound #35129755 
#755 is an indol derivative with a methylbutanamide group whose synthesis was previously 
reported by Fesik and co-workers [145]. Its structure is presented in Figure 3.15 (the 
derivatised functional group is indicated by the red circle) along with the corresponding 31P 
NMR titration series. 
Titration of KRasG12D led to a drastic modification in the conformational equilibria of states 
1(T) and 2(T). At 1.5 mM, the equilibrium constant was reduced by 38% and at 3.0 mM it 
decreased by 70% (from 0.64 to 0.19, Table 3.3). Interestingly, no appreciable line 
broadening of the signals or significant chemical shift changes are observed during the 
course of the experiment. There is no information in the literature regarding structural details 
of the binding mechanism to Ras, neither affinity or kinetic data. From the 31P NMR results 
Figure 3.14. Titration of KRasG12D•Mg2+•GppNHp with 
compound #109. 
Figure 3.15 A. Structural representation of 
the compound #755. B. Titration of 
KRasG12D•Mg2+•GppNHp with increasing 
amounts of the compound followed by 31P 
NMR spectroscopy. 
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it seems nevertheless that this small molecule is able to greatly modify the equilibrium 
population by stabilising state 1(T). In light of these results it was decided to test it further 
by measuring its ability to disrupt the Ras-Raf complex formation by ITC, with the 
expectation to retrieve thermodynamic and affinity data. Since in the course of the NMR 
titration the population of state 2(T) decreases through the shift of equilibrium towards state 
1(T), one can hypothesize that the affinity of KRasG12D to Raf should decrease when 
increasing amounts of the drug are added to the system under equilibrium conditions. 
Figure 3.16A-D shows the ITC profile of the experiment that was conducted. All the 
measurements were done at 298 K in buffer F with additionally 150 mM NaCl and 3% 
DMSO. The affinity between KRasG12D and Raf-RBD was initially measured alone (Figure 
3.16A). In this case, a total of 19 injections of Raf-RBD (679 µM, located in the syringe) with 
a volume of 2 µl each were added to KRasG12D•Mg2+•GppNHp (60 µM, located in the cell). 
The thermodynamic parameters were calculated by nonlinear regression analysis using an 
iterative routine (eqn. nº5, experimental section 2.2.4). During the optimization process all 
the parameters were allowed to vary freely and are presented here as the final unchanged 
output from the program. The results indicate a 1:1 binding (N=1) and an obtained apparent 
KD= 0.38 µM. Compared to the obtained values for KRasWT (KD= 0.72 µM, section 3.1.1) 
one can find that the affinity of KRasG12D towards Raf is 2-fold higher than KRasWT. 
The ability to disrupt the Ras-Raf interaction in the presence of the compound #755 was 
tested using the same experimental conditions as described above for Ras-Raf (same 
temperature, buffer and pH). KRasG12D (35 µM) was placed in the adiabatic cell of the 
calorimeter. Raf (always at a concentration of 450 µM) was mixed beforehand with 
compound #755, the mixture was placed in the syringe and the Ras protein was titrated by 
performing 31 injections of 1.3 µl each, with an interval time of 150 s. Three consecutive 
measurements, with increasing concentrations of #755 were tested (Figure 3.16B-150 µM, 
C-300 µM and D-500 µM). 
The first feature observed from the titration conducted in the presence of the drug is related 
to differences in the baseline (Figure 3.16B-D) when compared to the titration of Ras-Raf 
alone (Figure 3.16A): for all the three concentrations tested the differential power plot shows 
strong baseline perturbations over the complete duration of the experiment. These seem to 
be accentuated as the concentration of the drug increases and are not observed in the 
isotherm of Ras-Raf alone, nor for any control experiments performed (buffer-in-buffer, 
buffer-in-Ras, Raf-in-buffer, #755-in-Raf). They are therefore due to the presence of the 
compound. A possible explanation can be related with the existence of microscopically 
precipitated or aggregated Ras or Raf proteins by its presence (although no precipitation 
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was observed when the solutions were being mixed nor during NMR experiments). 
Nevertheless, an initially high heat of injection was obtained in all measurements, which still 
allowed the obtention of a well-defined binding curve. The inhibitory effect of #755 in 
complex formation can be clearly observed: the KD of the Ras-Raf interaction increases by 
a 5-fold factor with increasing concentrations of the drug, from 0.41 µM at 150 mM to 1.94 
µM at 500 mM. The affinity between the two proteins is indeed disrupted by the action of 
#755. 
It is noteworthy the fact that all the four interaction experiments proceed with a very similar 
variation in the Gibbs energy. The presence of the compound has no interference in the 
degree of spontaneity of the association reaction. The Ras-Raf interaction alone has a 
slightly greater enthalpic contribution (DH= -23.4 kJ mol-1) as compared to the entropy 
variation (-TDS= -13.3 kJ mol-1). However, upon addition of #755, the profile changes and 
the entropic contribution is now greater than the enthalpic one. This is observed at all 
concentrations of #755 tested. 
 
 
 
Figure 3.16. Titration of KRasG12D•Mg2+•GppNHp with the effector Raf-RBD in the presence of the compound 
#755 followed by ITC. All the experiments were done at 298 K and in the same buffer F (40 mM Tris/HCl pH 
7.5, 10 mM MgCl2, 2 mM DTE) with additionally 150 mM NaCl and 3% DMSO. A. The Ras-Raf interaction was 
firstly tested alone. The effect of #755 in the affinity of the complex was tested for three different concentrations 
of the drug: 150 µM (B), 300 µM (C), and 500 µM (D). In all the cases Ras was placed in the cell and Raf, 
previously mixed with #755 in the desired concentration, was placed in the syringe of the calorimeter. The 
concentration of both proteins was kept constant while testing the effect of #755. For each experiment, the 
thermogram is represented as heat per unit of time (upper plot) and as the integrated heat for each injection per 
ratio of the Ras-Raf complex (lower plot). The signature plot is also shown along with the obtained 
thermodynamic values. Blue: DG, green: DH, red: -TDS. 
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3.2.10   Compound #35129757 
#757 is an amino acid analogue consisting of a proline linked to an indole-benzimidazole 
moiety that was also developed through derivatization of the same parental compound by 
the Fesik group [145]. Structural studies have shown that #757 binds to 
KRasG12V•Mg2+•GDP with a KD= 340 µM. The indole moiety binds to the primary binding 
cleft, similarly to #727 described in section 3.2.4 and the bezimidazole moiety, being 
positive in nature, binds to a nearby secondary electronegative cleft, with the proline 
nitrogen of #757 interacting with the carboxylic side chain of Asp38 (similarly to #755 
described above) [145]. 
Figure 3.17 shows the X-ray structure of #757 bound to KRasG12V•Mg2+•GDP (pdb: 4epy) 
along with the 31P NMR titration on KRasG12D•Mg2+•GppNHp. Similarly to compound #755, 
dramatic spectral changes are observed in the equilibrium between states 1(T) and 2(T) by 
the action of #757: at 1.5 mM, K12 is reduced by 45% and at 3.0 mM it decreased by 69% 
(from 0.64 to 0.20, Table 3.3). Only state 1(T) undergoes a significant downfield shift of Dd= 
0.1 ppm (from d= -2.56 to d= -2.47 ppm) upon addition of 3.0 mM of the drug, with the other 
resonances remaining unperturbed. 
Figure 3.17. A. Molecular surface representation of KRasG12V•Mg2+•GDP complexed to the compound #757 
(pdb: 4epy, [145]). The relative orientation of #757 and GDP is depicted. The surface of the protein is 
coloured in grey except for the residues comprising switch 1 and switch 2, which are coloured in red and 
green, respectively. B. Detail around the binding site of #757. The indol moiety of the drug is buried in the 
first cleft and contacting the carboxylic chain of Asp54. The benzimidazole moiety is located in the second 
binding cleft and stabilised by polar contacts to Glu38, Ser39 and H2O molecules. C. Titration of 
KRasG12D•Mg2+•GppNHp with #757 followed by 31P NMR spectroscopy. 
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The disruption of the Ras-Raf complex was tested by ITC using the same experimental 
design as described above. Figure 3.18 shows the obtained results for the interaction in the 
presence of 150 µM (B) and 300 µM (C) of #757. From the recorded differential power it 
can be inferred that each injection yields large peaks, even at the end of the titration, when 
all the Ras protein is virtually saturated with an excess of Raf and the heat variation should 
be minimal. As an injection is made into the sample cell, friction force of the ligand being 
injected, slight temperature mismatches between both solutions, and/or any mismatch of 
the Ras and Raf buffers will lead to a heat known as the heat of dilution. In this case, as for 
all the ITC measurements performed within the work of this thesis, all proteins were dialyzed  
against the same buffer prior the experiment. Control tests involving only the injection of 
buffer into buffer yielded a residual heat of mixture below 0.1 µcal s-1. However, it was not 
possible dialyze the drug alone due to its small size and lyophilization was impractical due 
to the presence of DMSO. Therefore, the large peaks from the heat of mixture can be 
ascribed to discrepancies in the composition of the buffer in the syringe caused by its 
presence. Nevertheless, it was still possible to detect binding events as observed by the 
Figure 3.18. Titration of KRasG12D•Mg2+•GppNHp with Raf-RBD in the presence of the compound #757 followed 
by ITC. All the experiments were done at 298 K in the same buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 
mM DTE) with additionally 150 mM NaCl and 3% DMSO. A. The Ras-Raf interaction was firstly tested alone. 
The effect of compound #757 was subsequently studied at two different concentrations: 150 µM (B) and 300 
µM (C). Tests with higher concentrations rendered impossible the determination of a binding curve due to 
excessive drifts detected in the baseline. 
In all experiments, Ras was placed in the cell and Raf, previously mixed with #757 in the desired concentration, 
was placed in the syringe. Note that the Raf concentration is not constant. The raw heat of the reaction is plotted 
in the upper graph and the integrated heat per Ras:Raf ratio is shown in the lower graph. The signature plot is 
also shown with the following colour code: blue: DG, green: DH, red: -TDS. 
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typical sigmoidal behaviour of the integrated heats on Figure 3.18B and C. The presence 
of the compound #757 has a remarkable inhibitory effect on the interaction between the two 
proteins. The KD of the interaction changes from 0.39 µM to 3.54 µM at 300 µM of #757, 
corresponding to a 9-fold decrease on the affinity of the protein complex. 
 
3.2.11   Compound #35131307 
Compound #307 is an analogue of 
the inhibitor Sulindac sulphide [147] 
whose structure and mechanism of 
action towards KRas have not yet 
been disclosed to the scientific 
community. Figure 3.19 shows its 
influence in the equilibrium of the 
conformational states detected by 31P 
NMR. At a concentration of 3.0 mM, 
the equilibrium constant is 0.41, a 
value that compared to the Ras 
sample in 6% DMSO, corresponds to 
a clearly significant reduction of 36%. 
 
3.2.12   Compound #35131308 
Compound #308 is another analogue of Sulindac sulphide developed in parallel with the 
compound #307. Titration of KRasG12D 
showed that significant spectral changes 
are observed for the conformational 
states at the g-phosphate. These 
changes have the same order of 
magnitude as the ones induced by 
compound #307, indicating that they are 
most likely structurally related. At a 3.0 
mM concentration, the equilibrium 
constant is 0.46, corresponding to a 
reduction of 28% compared to Ras in 6% 
DMSO. Also, a downfield shift by a Dd= 
Figure 3.19. Titration of RasG12D•Mg2+•GppNHp with 
compound #307. 
Figure 3.20. Titration of RasG12D•Mg2+•GppNHp with 
compound #308. 
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0.08 and Dd= 0.1 ppm is observed for states 1(T) and 2(T), respectively. The b-phosphate, 
usually unperturbed, also shifts upfield in this case, with a Dd= -0.07 ppm. 
 
3.2.13   Compound #35135612 
#612 is another indol-based molecule containing a methylpentanamide functional group 
synthesized by Fesik and co-workers [145]. The functional derivatised moiety is highlighted 
by the red circle in Figure 3.21A and the titration series is presented in Figure 3.21B. 
Addition of #612 to Ras led to one of the greatest modifications in the equilibrium in terms 
of states 1(T) and 2(T) from all the investigated drugs. At 1.5 mM K12 is reduced by 38% 
and at 3.0 mM it decreases further to 70% (from 0.64 to 0.19, Table 3.3). The observed 
spectral changes are similar to the ones measured for the compound #755. 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.14   Compound #35135613 
#613 is the parental indole-benzimidazole molecule that was used for the initial 
derivatization performed by Fesik and co-workers [145]. Several amino acid-linked 
analogues containing positively charged amine groups were synthesized using this scaffold. 
The point where #613 was derivatised is represented by the red circle on Figure 3.22A. The 
above tested compounds #755 #757 and #612 are its direct analogues obtained by this 
method. Studies conducted by the same group had shown that it binds 
KRasG12D•Mg2+•GDP with the lowest affinity of the series (KD= 1.3 mM) and has no inhibitory 
effect in SOS-catalysed nucleotide exchange assays. Unfortunately, due to the limitations 
in the amount of KRasG12D available it was not possible to perform calorimetric 
measurements with #613. Figure 3.22B shows the 31P NMR titration series and the effect 
Figure 3.21 A. Representation of the 
compound #612. The derivatised moiety is 
highlighted B. Titration of 
KRasG12D•Mg2+•GppNHp with increasing 
amounts of the compound followed by 31P 
NMR spectroscopy. 
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on the conformational equilibrium of KRasG12D. Similarly to its derivatives, #613 promotes a 
drastic decrease in the equilibrium constant from 0.64 to 0.31 at a concentration of 3.0 mM. 
Significant chemical shift changes are also observed, especially for state 1(T) that moves 
downfield by a Dd of 0.17 ppm, accompanied by a decrease in line broadening of ca. 40 Hz. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.15   Compound #35135624 
#624 is a sulfonamide containing an aminopyridin fluorbenzen moiety synthesized by the 
Fesik group [145]. The X-ray structure of the KRasG12D•Mg2+•GDP•#624 complex (pdb: 
4epx) shows that the pyridine nitrogen atom is bound to the side chains of Asp54, Arg41 
and Ser39 through mediated H2O interactions (Figure 3.23A). The 31P NMR experiments 
revealed that, as for all the Fesik compounds, the binding of #624 to KRasG12D leads to 
significant spectral changes. The equilibrium constant at 3.0 mM is reduced to 0.28, 
corresponding to a 60% decrease compared to the Ras protein in 6% DMSO. At the same 
time, the most significant chemical shift changes from all the tested compounds are 
observed herein: the a- and b-phosphates shift downfield and upfield by Dd= ±0.1 ppm, 
respectively and state 2(T) undergoes a very large downfield shift, with a Dd= 0.4 ppm (from 
d= -3.49 to d= -3.09 ppm, Table 3.3). In parallel, a decrease in the linewidth of state 1(T) by 
48 Hz and an increase in the one of state 2(T) by 58 Hz is detected, both indicating a 
modification in the rates of the conformational exchange between states 1(T)/2(T) induced 
by this drug. 
Figure 3.22. A. Representation of the compound #613. This is the parental molecule whose 
derivatization lead to the synthesis of compounds #755, #757 and #612 through an amide 
coupling process at the amine group of the benzoimidazol moiety (red circle). 
B. Titration of KRasG12D•Mg2+•GppNHp with increasing amounts of the compound followed 
by 31P NMR spectroscopy. 
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3.2.16   Compound #35135616 
#616 is another indole derivative containing a dichloro aminoethyl moiety developed by Till 
Maurer and co-workers in collaboration with Genentech Inc. [18]. This small molecule was 
given the abbreviated designation of DCAI and it binds to KRasG12D•Mg2+•GMPCP in the 
same cleft that accommodates the compounds from the Fesik group (pdb: 4dst, Figure 
3.24A and B). Studies had shown that the apparent KD of the interaction with Ras is 1.1 
mM. From the present 31P NMR titration experiments, DCAI leads to a shift in the equilibrium 
constant in the opposite direction of all the other compounds tested, favouring an increase 
of the state 2(T) over state 1(T). At 3.0 mM, K12= 1.05, which corresponds to an increase 
by 65%. At the same time both, the b-phosphate and state 2(T) shift downfield by a Dd of 
0.1 ppm. ITC binding studies performed here showed that the compound is indeed capable 
of inhibiting the formation of the Ras-Raf complex (Figure 3.25). At 300 µM of the drug, the 
affinity of the protein complex decreases 10-fold compared with the obtained values for 
Ras-Raf alone (KD= 3.53 µM vs 0.38 µM). The titration was recorded with a very pronounced 
heat of mixture, which even with the best efforts, was impossible to minimize further. From 
the signature plot one can observe that the reaction proceeds with a negative entropic 
contribution in the presence of DCAI. 
Figure 3.23. A. Molecular surface representation of KRasG12V•Mg2+•GDP complexed to the 
compound #624 (pdb: 4epx, [145]). The relative orientation of #624 and GDP is depicted. The 
surface of the protein is coloured in grey except for the residues comprising the switch 1 and 
switch 2, which are coloured in red and green, respectively. B. Detail around the binding site 
of #624.The blue spheres represent water molecules through which the pyridine NH2, the 
ortho and the sulfonil nitrogen atoms bind. Note that this binding pocket is common for all the 
compounds tested from the Fesik group (#624, #755, #757, #613, #612). C. Titration of 
KRasG12D•Mg2+•GppNHp with #624 followed by 31P NMR spectroscopy. The molecular 
structure of this drug is represented. 
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Figure 3.24 A. Molecular surface representation of KRasG12d•Mg2+•GMPPCP complexed to 
the compound #616 (DCAI, pdb: 4dst, [18]). The relative orientation with respect to the 
nucleotide is depicted. The surface of the protein is coloured in grey except for the residues 
comprising the switch 1 and switch 2, which are coloured in red and green, respectively. B. 
Detail around the binding site of DCAI. C. Titration of KRasG12D•Mg2+•GppNHp with DCAI 
followed by 31P NMR spectroscopy. The molecular structure of this drug is represented. 
Figure 3.25. Binding between KRasG12D•Mg2+•GppNHp and Raf-
RBD in the presence of the compound #616 (DCAI) followed by ITC. 
All the experiments were done in duplicate, at 298K and in the same 
buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with 
additionally 150 mM NaCl and 3% DMSO. The Ras-Raf interaction 
was firstly tested alone (A) and upon addition of 300 µM of the drug 
(B). The raw heat of the reaction is plotted in the upper graph and 
the integrated heat per Ras:Raf ratio is shown in the lower graph. 
The signature plot is also shown with the following colour code: blue: 
DG, green: DH, red: -TDS. 
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Table 3.3. 31P NMR chemical shift values for KRasG12D(1-188)•Mg2+•GppNHp in 6% 
DMSO and in complex with a library of 15 different inhibitors. 
Protein 
Complex p:l 
a-phosphate b-phosphate g-phosphate 
K12b d1(T)/2(T)a 
[ppm] 
d1(T)/2(T)
a
 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
              KRasG12D -- -11.49 -0.37 -2.48 -3.53 0.70 
+ 6% DMSO -- -11.51 -0.40 -2.56 -3.49 0.64 
       + #643 1:1.5 -11.55 -0.36 -2.50 -3.40 0.60 
1:3.0 -11.52 -0.42 -2.57 -3.48 0.57 
       + #098 1:1.5 -11.54 -0.40 -2.46 -3.50 0.69 
 1:3.0 -11.57 -0.45 -2.50 -3.49 0.72 
       + #727 1:1.5 -11.47 -0.42 -2.47 -3.48 0.48 
 1:3.0 -11.50 -0.47 -2.48 -3.48 0.41 
       + #703 1:1.5 -11.56 -0.42 -2.50 -3.51 0.59 
 1:3.0 -11.55 -0.42 -2.51 -3.48 0.68 
       + #449 1:1.5 -11.56 -0.41 -2.56 -3.49 0.62 
 1:3.0 -11.60 -0.46 -2.59 -3.53 0.68 
       + #071 1:1.5 -11.45 -0.40 -2.46 -3.53 0.58 
 1:3.0 -- -- -- -- -- 
       + #109 1:1.5 -11.51 -0.45 -2.53 -3.49 0.72 
 1:3.0 -- -- -- -- -- 
       + #755 1:1.5 -11.44 -0.42 -2.54 -3.48 0.40 
 1:3.0 -11.42 -0.43 -2.55 -3.44 0.19 
       + #757 1:1.5 -11.45 -0.43 -2.49 -3.46 0.29 
 1:3.0 -11.46 -0.44 -2.47 -3.48 0.20 
       + #307 1:1.5 -11.54 -0.45 -2.51 -3.49 0.56 
 1:3.0 -11.53 -0.45 -2.54 -3.45 0.41 
       + #308 1:1.5 -11.50 -0.40 -2.49 -3.47 0.60 
 1:3.0 -11.53 -0.47 -2.48 -3.40 0.46 
       + #612 1:1.5 -11.43 -0.39 -2.51 -3.39 0.40 
 1:3.0 -11.43 -0.41 -2.53 -3.41 0.24 
       + #613 1:1.5 -11.45 -0.43 -2.40 -3.45 0.49 
 1:3.0 -11.45 -0.47 -2.39 -3.45 0.31 
       + #624 1:1.5 -11.47 -0.50 -2.44 -3.25 0.49 
 1:3.0 -11.44 -0.50 -2.44 -3.09 0.28 
       + #616 1:1.5 -11.55 -0.35 -2.53 -3.43 0.84 
 1:3.0 -11.51 -0.30 -2.54 -3.40 1.02 
              All the values were derived from the experimental spectra recorded at 278 K in buffer 
F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE), to which a total of 6% (v/v) 
DMSO was added. The obtained chemical shift values for Ras alone in the presence 
of DMSO are highlighted in light grey and were used as reference when comparing 
the effect of the different compounds. All the 31P resonances were recorded in a 
magnetic field operating at a frequency of 202.456 MHz (500 MHz spectrometer). 
The estimated error for the fitted chemical shift values is ±0.002 ppm at the g-
phosphate. A EM function with LB= 15 Hz was applied during the processing of the 
FID. 
a The a- and b-phosphates were fitted as a single resonance line. 
b The estimated error for the calculated K12 values is ±0.2. 
3. Results 
 
114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.4. 31P NMR linewidths for KRasG12D(1-188)•Mg2+•GppNHp in 6% 
DMSO and in complex with a library of 15 different inhibitors. 
            
Protein 
Complex p:l 
a-phosphate b-phosphate g-phosphate 
Dn1/2 (1),(2)
a Dn1/2 (1),(2)a Dn1/2 (1) Dn1/2 (2) 
[Hz] [Hz] [Hz] [Hz] 
            KRasG12D -- 107.1a 69.0a 146.3 68.1 
+ 6% DMSO -- 117.1 76.8 154.4 68.7 
      + #643 1:1.5 120.1 78.0 150.8 82.3 
 1:3.0 116.8 80.2 158.7 75.4 
      + #098 1:1.5 104.0 75.7 131.7 65.9 
 1:3.0 105.8 74.9 138.4 91.4 
      + #727 1:1.5 112.2 77.0 135.6 79.0 
 1:3.0 120.4 73.1 132.6 106.0 
      + #703 1:1.5 123.0 77.0 140.3 103.9 
 1:3.0 107.0 81.1 167.7 66.0 
      + #449 1:1.5 117.9 72.8 178.2 83.8 
 1:3.0 129.4 75.4 169.7 102.0 
      + #071 1:1.5 140.6 130.0 259.0 104.9 
 1:3.0 -- -- -- -- 
      + #109 1:1.5 129.2 76.16 151.3 97.2 
 1:3.0 -- -- -- -- 
      + #755 1:1.5 106.0 78.9 143.9 101.4 
 1:3.0 106.4 85.4 150.8 65.3 
      + #757 1:1.5 111.7 73.0 150.0 86.7 
 1:3.0 107.8 74.1 142.3 83.1 
      + #307 1:1.5 117.3 71.9 153.5 97.6 
 1:3.0 105.7 77.0 158.6 59.0 
      + #308 1:1.5 112.6 75.8 142.9 76.0 
 1:3.0 111.1 75.8 123.3 116.2 
      + #612 1:1.5 103.9 80.2 125.5 102.9 
 1:3.0 104.1 89.1 140.6 81.92 
      + #613 1:1.5 106.2 73.5 113.5 113.5 
 1:3.0 111.1 74.5 114.9 85.9 
      + #624 1:1.5 112.8 75.7 126.3 100.2 
 1:3.0 107.4 77.7 109.6 127.1 
      + #616 1:1.5 135.3 85.1 143.0 90.9 
 1:3.0 152.1 91.5 190.0 88.4 
            All the values were derived from the experimental spectra recorded at 278 K in 
buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE), to which a total of 
6% (v/v) DMSO was added. The obtained linewidths for Ras alone in the 
presence of DMSO are highlighted in light grey and were used as reference 
when comparing the effect of the different compounds. All the 31P resonances 
were recorded in a magnetic field operating at a frequency of 202.456 MHz (500 
MHz spectrometer). The estimated error for the fitted linewidth values is ±0.02 
ppm at the g-phosphate. A EM function with LB= 15 Hz was applied during the 
processing of the FID and subtracted afterwards from the calculated linewidths 
a The a- and b-phosphates were fitted as a single resonance line. 
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3.3   High Pressure 31P NMR Spectroscopy. 
3.3.1   Studies on GppNHp 
31P NMR spectroscopy is nowadays a very attractive method to study phosphate binding 
proteins and the behaviour of nucleotides in biological systems, especially when applied 
together with high pressure NMR methodologies. The effects of pressure on GTPases, 
particularly Ras, were elucidated in work pioneered at our department [125] but up to now, 
no high pressure data on the isolated nucleotides alone was available. In this section, a 31P 
HP NMR investigation, up to 200 MPa, of the GTP analogue GppNHp is presented with the 
intent of having a reference system that can be applied from now on to virtually all GppNHp-
bond proteins, helping in the distinction of trivial pressure effects occurring in the free 
nucleotides from the more relevant effects that are a consequence of pressure-induced 
conformational changes. 
With the intent of shedding light on the influence of magnesium, which is a common co-
factor of many GNBP’s, the current study was conducted in the presence and in the 
absence of Mg2+ ions. The results presented here were published in the Journal of 
Biomolecular NMR, along with similar HP investigations on GMP, GDP, GTP, GppCH2P 
and GTPgS [226]. In order to avoid variations of pH with pressure, a pH that was 2-3 units 
above the apparent pKa value for the last deprotonation step of the nucleotide was selected. 
This corresponds to a pH of 9.0 for the experiments performed in the presence of Mg2+ and 
to a pH of 11.5 for the experiments performed in its absence. Figure 3.26 shows the 
obtained HP 31P pressure series. The experimental chemical shift values of the three 
phosphate groups were individually plotted against pressure and fitted with a second order 
polynomial from the Taylor expansion series (eqn. nº 15, section 2.2.5.4). The coefficients 
of this equation denoted as B1 and B2 correspond to the first order (linear) and second order 
(non-linear) pressure coefficients. The calculated coefficients for each phosphate group are 
given in Table 3.5. From the obtained data it can be observed that all phosphate groups 
shift upfield with pressure (towards more negative values of d). This shift is rather small for 
the a-phosphate, with a Dd of only -0.03 ppm between pamb and 200 MPa. However, larger 
effects are generally observed for the b- and g-phosphates, with a Dd of -0.25 and -0.2 ppm, 
respectively. Comparing both measurements, in the presence (A) and in the absence (B) of 
Mg2+, it can be observed that the pressure-induced shift changes seem to be more 
pronounced in the second case, especially for the g-phosphate, whose Dd is -0.25 ppm and 
-0.4 ppm, in the presence and in the absence of the ion, respectively. The plots shown in 
Figure 3.26 represent the Dd, i.e. the variation of the chemical shift, (Dd=d200MPa-d0.1MPa). A 
similar plot with the absolute chemical shift values (d) for each phosphate group is shown 
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Figure 3.26. Pressure dependence of GppNHp in the presence (A) and in the absence (B) of Mg2+ followed by 
31P NMR spectroscopy. All measurements were done at 278 K, using a Bruker Avance 600 MHz spectrometer 
operating at a magnetic field of 242.896 MHz. The corresponding phosphate assignments are indicated, as well 
as the pressure values (in MPa) for each step. In all spectra, very small signals are observed, they shift 
continuously downfield, crossing their neighbors, the a- and g-phosphates, as the pressure increases. These 
signals correspond to trace impurities in the sample such as GppNH+. A splitting of the phosphorous resonances 
is observed in the absence of Mg2+ (B). They correspond to the J31P,31P homonuclear coupling. The same 
coupling also exists in the presence of Mg2+ (A) but is weakly recognizable due to the increase of the linewidths 
by the presence of the metal. The last step of the series is the test for reversibility. Samples were prepared by 
dissolving 5 mM of GppNHp in 40 mM Tris/HCl, 0.1 mM DSS, 10% D2O, with pH 9.0 and 15 mM MgCl2 (A) or 
pH 11.0 and 0.5 mM EDTA (B). The observed pressure dependent chemical shift changes (Dd=d(P)-d(P0) for 
the a-, b- and g-phosphates were plotted and the data fitted with a second order Taylor expansion (see 
experimental section 2.2.5.4, eqn. nº 15). The obtained pressure coefficients are listed in Table 3.5. 
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in Figure A of the appendix section, where the different magnitude of the shift changes for 
the two measurements can be better visualised (see also Tables D and E in the appendix). 
The pressure coefficients listed in Table 3.5 indicate that the non-linear pressure 
contribution is greater for GppNHp than Mg2+•GppNHp. Indeed, all B2 values are 
numerically higher in the first case. This portends the idea that Mg2+ has the effect of 
stabilising the ground-state conformation(s) of the nucleotide, rendering it more insensitive 
to a pressure-induced conformational transition. This is supported by a wealth of reported 
studies showing that guanine and adenine nucleotides when in presence of Mg2+ exist in 
solution as a mixture of different states, that is, tridentate complexes, with Mg2+ bound to 
the three phosphates, bidentate complexes with Mg2+ bound to a- and b-phosphates and 
monodentate complexes, with Mg2+ bound to one of the negatively charged oxygens of any 
phosphate group [27, 248]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.5. Pressure dependence of 31P chemical shifts of GppNHp in the presence and 
in the absence of Mg2+ and respective pressure coefficients. 
Nucleotide 31P position d0a /ppm B1 /ppm GPa-1 B2 /ppm GPa-2 
          Mg2+•GppNHp (pH 9) a -10.09 -0.032 ± 0.03 -0.493 ± 0.16 
 b -5.59 -1.380 ± 0.055 0.542 ± 0.275 
 g -1.08 -1.250 ± 0.261 1.470 ± 0.131 
 Pi 2.56 -0.490 ± 0.159 0.969 ± 0.078 
          GppNHp (pH 11.5) a -10.44 -0.797 ± 0.018 1.936 ± 0.074 
 b -7.57 -2.250 ± 0.034 4.843 ±0.141 
 g -0.69 -2.920 ± 0.024 4.984 ± 0.100 
 Pi 4.27 -0.442 ± 0.023 1.056 ± 0.094 
B1 and B2 were obtained by fitting a second order Taylor expansion to the pressure-
dependent chemical shifts (eqn. nº15, section 2.2.5.4). They are a numeric 
representation of the linear and non-linear pressure-induced conformational changes, 
respectively. 
a d0 is the chemical shift value obtained from the fitting at ambient pressure at the 
corresponding pH. 
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3.3.2   31P HP NMR on HRasWT(1-166)•Mg2+•GppNHp 
The results gathered from the studies on GppNHp constitute thereafter the basis for the 
analysis of the pressure-induced chemical shift changes on the Ras protein using 31P NMR 
spectroscopy. The influence of pressure in the intrinsic equilibrium of HRasWT(1-189) was 
previously studied in our department by 31P NMR [125] but only in terms of intensity changes 
of states 1(T) and 2(T) and related equilibrium constants. Shift changes could not be 
evaluated at that time because the pressure effects originating from the nucleotide itself 
were missing. Therefore, in the light of the new data on the isolated nucleotide, a more 
complete description of the dynamics of Ras will be presented in this section. Since the 31P 
NMR GDP, GTP and GppNHp spectra of HRasWT(1-166) and HRasWT(1-189) are almost 
identical, being the only detectable difference a small variation in the equilibrium populations 
(K12=1.7 for HRasWT(1-166)•GppNHp and K12=1.9 for HRasWT(1-189)•GppNHp) the HP 
experiments were performed using the truncated variant and because it was also previously 
studied in our department by HP 2D [1H-15N]-HSQC NMR methods, rendering a wealth of 
information that can now be compared with the present results [171]. The 31P HP series 
were performed at two different temperatures that will be discussed in separate sections. 
 
3.3.2.1   Measurements Conducted at 278 K 
Figure 3.27 shows the 31P NMR pressure series recorded at 278 K for HRasWT(1-166). The 
measurements were carried in a Bruker Avance-600 spectrometer operating at a 31P 
frequency of 242.896 MHz equipped with a prodigy cold probe. High hydrostatic pressure 
was transmitted to the sample with the aid of a manually operated compressor piston (for 
details see sections 1.3.1 and 2.2.5.2). The pressure was continuously increased from 0.1 
MPa up to 250 MPa in 10 MPa steps. For sake of simplicity, only 20 MPa increments are 
depicted in Figure 3.27. The 3.0 mM protein loaded with GppNHp was dissolved in buffer 
F, with additionally 0.4 mM DSS and 20% D2O. For each step, a 1H and a 31P spectra were 
recorded, comprised of 128 and 800 cumulative scans, respectively. 
The interpretation of the pressure induced effects can be done separately in terms of 
chemical shift changes and peak areas for each one of the 31P resonance lines recorded. 
In order to determine the best window function, the HP series was processed separately 
with two different apodization functions: exponential multiplication (EM) and Gaussian 
multiplication (GM) and the obtained shift values were directly compared in Figure 3.28. 
From the analysis, the two functions lead to different degrees of accuracy on retrieving 
chemical shifts. This is especially notorious for state 2(T) on the g-phosphate, to which 
Dd=d250MPa-d0.1MPa= 0.418 ppm, whilst the same variation for state 1(T) is only 0.015 ppm. 
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Figure 3.27. Conformational equilibria of HRasWT(1-166)•Mg2+•GppNHp as a function of pressure 
determined by 31P NMR. The 3.0 mM protein dissolved in buffer F (40 mM Tris/HCl pH 7.5, 10 mM 
MgCl2, 2 mM DTE) with additionally 0.4 mM DSS and 20% D2O was subjected to increasing step-
variations of pressure, up to a maximum of 250 MPa. The pressure values are indicated near each 
step. The evolution of states 1(T) and 2(T) is represented by the red and green lines, respectively. 
The 31P NMR resonances of the free nucleotide observed at higher pressures are also indicated. The 
last step corresponds to the reversibility test of the pressure-induced changes. The fitted chemical 
shift values for all the resonance lines are listed in Table F of the appendix section. 
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This very small variation of g1(T) is within the limits of error of the fitting process and renders 
the accurate chemical shift determination a difficult task, especially when using the EM 
method. For state 2(T) on the a-phosphate, Dd= 0.061 ppm, corresponding to a 4-fold 
greater shift change compared to the g1(T)-phosphate. Nevertheless, the calculated Pearson 
correlation is much smaller for the a2(T)-phosphate (r= 0.752) than for the latter (r= 0.981). 
This is due to the greater overlap between states 1(T) and 2(T) on the a-phosphate as 
compared to the g-phosphate. From the gathered data, it can be generalized that the GM 
filter used in the evaluation of the pressure-induced changes (and ultimately in the 
evaluation of the pressure coefficients) leads to a reduction in the absolute errors and was 
consequently chosen over the EM method. EM was also used in this pressure series to 
evaluate peak areas and linewidths, since GM typically destroys the Lorentzian shape of 
the signals and renders no information about such variables. 
Using the GM method, the 31P chemical shift values of each phosphate were plotted against 
pressure (Figure 3.29, black lines). They represent the uncorrected shift values, as obtained 
directly from the experimentally recorded spectra (Figure 3.27). The fitted pressure 
coefficients are listed on Table 3.6. Except for the b-phosphate, that shifts upfield, all the 
other signals shift downfield with pressure (contrary to the upfield shift of the free 
nucleotide). The largest shifts are observed for g2(T) and a1(T) with a Dd= 0.418 and 0.35 
Figure 3.28. Correlation of the chemical shift values obtained upon fitting with an exponential filter (LB= 10 
Hz) and with a Gaussian filter (selected LB and GB depending on the 31P signals). The parameters were 
selected based in an optimal separation of the lines and/or an homogenous lineshape. For each plot, the 
Pearson correlation coefficient, r, is computed along with the linear regression of the data (straight line). In 
all cases except for the a2(T)-phosphate, there is a strong, positive correlation between the two methods 
used, with r close to 1. However, big discrepancies are observed for the a2(T)-phosphate, and to a smaller 
extent, for the g1(T)-phosphate, due not only to their partially overlapped signals in the 31P NMR spectra, but 
also due to their very small chemical shift variation, Dd=d250MPa-d0.1MPa, leading to difficulties in the proper 
fitting of the data. The dashed line depicts the slope y=x. 
3. Results 
 
121 
ppm, respectively. Considerably smaller changes are observed for states g1(T) and a2(T), with 
Dd= 0.015 and 0.061 ppm, respectively. Qualitatively, the b and g2(T)-phosphates seem to 
show a more linear pressure dependence as compared to states a2(T) and g1(T), which are 
associated with a pronounced sigmoidal and parabolic behaviour. The use of a third order 
polynomial on these two phosphate lines led to a slightly better fit of the dispersion points 
as compared to the use of a second order fit. 
The 31P corrected chemical shift values are plotted against pressure for each phosphate 
group and are shown in Figure 3.29 (blue lines). The calculated B1 and B2 values are shown 
in Table 3.6. Since the free Mg2+•GppNHp and uncorrected HRasWT•Mg2+•GppNHp shift in 
opposite directions (upfield and downfield, respectively) for all 31P resonances except the 
b-phosphate, due to their opposite direction, the contributions from the free nucleotide add 
up to the uncorrected Ras and the final corrected values for the a and g-phosphates shift 
downfield compared to the uncorrected case. The reasoning underlying the behaviour of b-
phosphate is different but the correction process leads to the same final result (its downfield 
shift). For both cases (free nucleotide and uncorrected Ras), the b-phosphate shifts upfield 
with pressure. Since the direction is the same, this implies that the contribution from the 
free nucleotide in the original, uncorrected, values needs to be suppressed (subtracted). 
The final corrected values have now a reversed direction compared to the uncorrected 
ones, shifting therefore downfield. The reason for the reverse of the direction is only due to 
the magnitudes of the values involved (free Mg2+•GppNHp: Dda= 0.039 ppm, Ddb= 0.31 ppm 
and Ddg= 0.22 ppm. For Ras•Mg2+•GppNHp (uncorrected) Dda1(T)= 0.35 ppm, Dda2(T)= 0.06 
ppm, Ddb= 0.18 ppm, Ddg1(T)= 0.014 ppm and Ddg2(T)= 0.42 ppm). 
The direction of the chemical shifts can also be inferred from the calculated pressure 
coefficients (Table 3.6). Both states a1(T) and a2(T) have positive first order coefficients, which 
are correlated with the downfield shift of their respective resonance lines. The small 
difference between their uncorrected B1 and B2 values compared to the corrected ones, 
respectively, is an indication that the local chemical environment surrounding the a-
phosphate is not greatly modified as the pressure increases, at least not as much as the b 
and g-phosphates. 
It can be seen from Figure 3.29 that a2(T)corrected shifts by a maximum of 0.09 ppm between 
0.1 and 200 MPa, corresponding to a very small variation. State a1(T)corrected, on the other 
hand, has a more pronounced downfield shift by a Dd of 0.39 ppm within the same pressure 
interval. State g2(T)corrected shows the largest shift changes between 0.1 and 250 MPa (Dd= 
0.642 ppm), followed by state a1(T) (Dd= 0.389 ppm). It can also be observed from Figure 
3.27 the release of the nucleotide at high pressures (above 200 MPa) from the presence of  
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additional small peaks at d= -1.33, -6.0 and -10.15 ppm, corresponding to the a-, b- and g-
phosphates, respectively. 
 
 
 
 
Figure 3.29. Corrected pressure dependence of 31P NMR chemical shifts of HRasWT(1-166)•Mg2+•GppNHp 
recorded at 278 K. The Ddfreenuc fit were applied as correction factors upon subtraction to dRas uncorrected, leading 
to the final dcorrected values, represented here for each plot as blue triangles (-▲-). The uncorrected shift changes 
are also plotted again as black circles (-●-) for comparison. The second order polynomial fit of the Taylor 
expansion was applied for the determination of B1 and B2 as before. The obtained values are presented on 
Table 3.6. The calculated Dd=d250MPa-d0.1MPa shift differences are shown near the respective curve. Note that the 
vertical scaling is different for each plot due to the different magnitudes of the Dd values. 
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The pressure coefficients B1 and B2 are a useful mathematical concept to quantify the 
magnitude of the observed pressure-induced changes. However, another kind of analysis 
that can be performed is based on the thermodynamic laws that govern the system under 
pressure: the Gibbs free energy (DG) and partial molar volumes (DV). Given two 
conformations in fast exchange, the experimental chemical shift changes can be fitted with 
eqn. nº 17 (section 2.2.5.4), to obtain the corresponding parameters. The only condition 
needed for a proper fitting of the data is that the dispersion plot of the chemical shifts must 
display a clear two-state transition (or higher) characterized by a sigmoidal shape This is 
not the always the case for all the plotted 31P chemical shifts in Figure 3.29 (except for state 
g2(T)) as they show a more linear tendency, which renders the fitting inaccurate and largely 
Table 3.6. Fitted pressure coefficients and thermodynamic molar free energies, DG, and 
volumes, DV, for HRasWT(1-166)•Mg2+•GppNHp at 278 K and pH 7.5. 
            31P position d0a /ppm B1 /ppm GPa-1 B2 /ppm GPa-2 -- --             Uncorrected 
      a1(T) -11.17 2.15 ± 0.08 -3.40 ± 0.32   
a2(T) -11.66 0.82 ± 0.10 -1.95 ± 0.46   
b -0.24 -0.53 ± 0.03 -0.64 ± 0.11   
g1(T) -2.52 -0.38 ± 0.03 1.90 ± 0.11   
g2(T) -3.33 1.94 ± 0.05 -1.06 ± 0.17   
Pi 2.37 0.26 ± 0.03 -1.99 ± 0.10   
            Corrected 
            a1(T) -11.17 2.18 ± 0.08 -2.90 ± 0.32   
a2(T) -11.66 0.85 ± 0.10 -1.46 ± 0.46   
b -0.24 0.85 ± 0.03 -1.20 ± 0.11   
g1(T) -2.52 -0.88 ± 0.03 0.43 ± 0.11   
g2(T) -3.33 3.20 ± 0.05 -2.53 ± 0.18   
             d1b /ppm d2b /ppm DG /kJ mol-1 DV /mL mol-1 Transition 
       Uncorrected 
a1(T) -11.38 -10.82 1.17 ± 1.26 -29.89 ± 7.12 1-to-0 
a2(T) -11.65 -11.58 9.31 ± 0.92 -121.67 ± 12.39 2-to-3 
b -0.23 -0.46 5.50 ± 0.14 -34.03 ± 2.17  
g1(T) -2.53 -2.50 2.55 ± 1.39 -125.85 ± 74.71 1-to-0 
g2(T) -3.38 -2.86 4.0 ± 0.09 -34.68 ± 1.53 2-to-3 
Pi 2.38 2.301 15.0 ± 2.73 -77.33 ± 17.18  
            Corrected 
            a1(T) -11.34 -10.77 1.81 ± 0.08 -29.21 ± 1.86 1-to-0 
a2(T) -11.64 -11.56 8.17 ± 1.25 -85.19 ± 12.3 2-to-3 
b -0.27 -0.10 3.12 ± 0.51 -42.44 ± 2.60  
g1(T) -2.53 -2.25 5.54 ± 0.12 -39.34 ± 1.58 1-to-0 
g2(T) -3.45 -2.68 3.44 ± 0.41 -37.31 ± 1.89 2-to-3 
      a d0 is the chemical shift value obtained at ambient pressure at the corresponding pH. 
b d1 and d2 are the chemical shift values obtained for the first and last pressure steps, 
respectively. Due to the linear tendency of the fitted curves, the obtained values constitute a 
coarse approximation. 
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dependent on the starting values given for d1 and d2 for the initialization of the iteration 
process. The calculated DG and DV values are listed in Table 3.6, although the reader is 
advised for the large intrinsic error of the fitting of DG and DV. 
Under slow exchange conditions, the pressure-induced conformational transition from state 
2(T) to state 1(T) is associated with the relative population of both states, that in turn can 
be quantified by their respective areas. Taking K12 at each pressure and using it 
subsequently in eqn. nº 2 (section 2.2.4), the corresponding DG and DV values for the 2(T)-
to-1(T) transition were calculated as shown in Figure 3.30. The obtained free energy 
difference between the two states is 1.53 kJ mol-1 and the associated volume change is -
18.60 mL mol-1. Identical values were previously reported for HRasWT(1-
189)•Mg2+•GppNHp (DG12= 1.42 kJ mol-1 and DV12= -17.2 mL mol-1) [125]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.30. Plot of LnK12=Astate2(T)/Astate1(T) as a function of pressure. The calculated 
difference of the free energy, DG12 and partial molar volume, DV12 is 1.53 kJ mol-1 and -18.60 
mL mol-1, respectively. The calculated K12 values at each measured pressure point are given 
in the table. Comparable results are given in ref. [125]. 
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3.3.2.2   Measurements Conducted at 303 K 
A similar set of 31P HP NMR experiments was conducted at 303 K for HRasWT(1-
166)•Mg2+•GppNHp. The complete pressure series is shown in Figure 3.31. The increase 
of the temperature has a direct influence in the dynamics of the chemical exchange between 
states 1(T) and 2(T) mostly noticeable for the g-phosphate where the interconversion 
between states at 278 K is slow in the NMR time scale and the corresponding resonances 
are well separated. As the temperature increases the rate of exchange becomes 
numerically similar to the chemical shift difference between states 1(T) and 2(T) (i.e, 
τex≈|d1(T)-d2(T)|), leading to severe line broadening that culminates with their coalescence into 
a single sharp line at high 
temperature. The exchange 
rate constants determined in 
previous studies for the 1(T)-
2(T) interconversion at 278 
and 298 K are 42 s-1 and 387 
s-1, respectively [67]. 
The chemical shift variations 
for each one of the 
phosphate groups 
measured at 303 K follows 
the same general trends as 
the ones measured at 278 K, 
with the a- and g-phosphate 
shifting downfield 
(dishielding) and b-
phosphate shifting upfield 
(shielding) with pressure. 
The release of GppNHp is 
observed again at high 
pressures, especially above 
175 MPa (Figure 3.31). Free 
GppNHp itself seems to be 
rapidly hydrolysed into its 
by-products, namely Pi and 
free GMP, located at d~ 2.50  
Figure 3.31. Conformational equilibria of HRasWT(1-
166)•Mg2+•GppNHp as a function of pressure determined by 31P NMR 
at 303 K. The 5.0 mM protein dissolved in buffer F (40 mM Tris/HCl pH 
7.5, 10 mM MgCl2, 2 mM DTE) with additionally 0.4 mM DSS and 20% 
D2O was subjected to increasing step-variations of pressure, up to a 
maximum of 225 MPa. The chemical shift evolution of the a-, b- and g-
phosphates is represented by the dashed lines. The 31P resonances of 
free GppNHp observed at higher pressures are also indicated.  
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ppm and d~3.35 ppm, respectively. Another resonance line located at d= 1.79 ppm can be 
ascribed to another by-product from the GppNHp hydrolysis, possibly, PO3-NH2 or a related 
species. 
The polynomial fit of the uncorrected chemical shift changes is shown in Figure 3.32 for 
each phosphate group (coloured in green), alongside with the uncorrected data recorded at 
278 K for comparison (coloured in black). The highest pressure point recorded for the 303 
Table 3.7. Fitted pressure coefficients and thermodynamic molar free 
energies, DG, and volumes, DV, for HRasWT(1-166)•Mg2+•GppNHp at 303 K 
and pH 7.5. 
31P position d0a /ppm B1 /ppm GPa-1 B2 /ppm GPa-2 -- 
               Uncorrected 
a -11.52 0.59 ± 0.01 1.22 ± 0.22  
b -0.21 -0.57 ± 0.03 -0.25 ± 0.15  
g -3.05 2.15 ± 0.07 -1.86 ± 0.33  
Pi 2.23 1.15 ± 0.19 -3.80 ± 0.49  
           d1b /ppm d2b /ppm DG /kJ mol-1 DV /mL mol-1 
     Uncorrected 
a -11.52 -11.29 6.39 ± 0.27 -43.92 ± 1.74 
b -0.20 -0.37 5.50 ± 0.23 -43.17 ± 3.48 
g -3.05c -2.66c 5.65 ± 0.37 -54.78 ± 0.82 
Pi 2.22 2.34 2.42 ± 4.69 -107.3 ± 48.0 
     a d0 is the chemical shift value obtained at ambient pressure at the 
corresponding pH. 
b d1 and d2 are the chemical shift values obtained for the first and last 
pressure steps, respectively. Due to the linear tendency of the fitted curves, 
the obtained values constitute a coarse approximation. 
c These values were fixed during the iteration routine. 
Figure 3.32. 31P NMR chemical shift changes of HRasWT(1-166)•Mg2+•GppNHp as a function of pressure. The 
observed chemical shift dependence is plotted individually for the a-, b- and g-phosphates. Measurements were 
performed at 303 K (coloured in green -■-) and are compared here with the corresponding ones performed at 
278 K (coloured in black, -●-, see Figure 3.29 and corresponding text). Only the uncorrected shift changes are 
shown and presently discussed due to the lack of data at 303 K for the isolated Mg2+•GppNHp molecule. Note 
that considerably less pressure points were collected at 303 K as compared to the 278 K series. The obtained 
values for the chemical shift variations, defined as Dd=d225MPa-d0.1MPa, (225 MPa being the highest pressure point 
recorded for the 303 K series), are shown near each curve for comparison. The second order polynomial fit of 
the Taylor expansion was applied for the determination of B1 and B2 as before. The obtained values are 
presented on Table 3.7. Note that the vertical scaling is different for each plot. 
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K series is 225 MPa, therefore the Dd=d250MPa-d0.1MPa values are shown near each respective 
plot. The pressure-dependent chemical shift changes of the free Mg2+•GppNHp were 
obtained only at 278 K (section 3.3.1). Due to the lack of data at 303 K, the corrections for 
this pressure series are not available. Nevertheless, from the uncorrected values several 
inferences can be made: the a-phosphate shows positive B1 and B2 values (left plot on 
Figure 3.32), which are correlated with a downfield change of the chemical shifts and with 
a positive curvature. The chemical shift changes were also fitted with the equation for a two-
state transition model and the calculated Gibbs energies and partial molar values are given 
in Table 3.7. 
 
 
3.3.3   31P HP NMR on HRasT35S(1-166)•Mg2+•GppNHp 
The pressure-dependent 31P NMR chemical shift changes of HRasT35S•Mg2+•GppNHp were 
investigated using the same experimental guidelines described for RasWT in section 3.3.2.1). 
A 4.37 mM protein sample dissolved in buffer F was increasingly subjected to high 
hydrostatic pressure, from 0.1 up to 190 MPa. A total of 19 pressure steps were performed 
and for each one a 1H and a 31P spectrum, comprised of 128 and 500 scans, respectively 
were recorded. Figure 3.33 shows 10 representative spectra of the series. The fitted values 
are presented in Table 3.8. The corrected (coloured in purple) and the uncorrected 
(coloured in black) pressure-dependent shift changes are compared in Figure 3.34. As it 
can be directly observed from the uncorrected values and the stacked spectra (dashed lines 
on Figure 3.33), the effect of pressurizing the protein leads to an upfield shift of the b- and 
g-phosphates and to a downfield shift of the a-phosphate. The same shift directions are 
observed in the case of RasWT, except for the g-phosphate, which moves downfield in the 
later (Figures 3.27 and 3.29). In the course of the experiment, the 31P resonance signal 
corresponding to free Pi (d= 2.38 ppm at 0.1 MPa, 2.35 ppm at 190 MPa) increases, 
especially at high pressures where the dissociation of GppNHp from the protein usually 
takes place. Rather surprisingly, and contrary to the observations for the wild type protein, 
the presence of free nucleotide is not detected in the last pressure steps in RasT35S. All the 
spectra recorded during this pressure series have an interesting feature arising from the 
presence of a very broad peak observed at d~ 3.34 ppm. GMP is observed around this 
value (typically dGMP= 3.83 ppm [226, 249]). However, due to its very large linewidth (124 
Hz at 0.1 MPa, 120 Hz at 190 MPa) its chemical nature is unknown. A close analysis shows 
that Its chemical shift variation seems to be independent of pressure, as well as its linewidth 
and integrated area. The measured properties for the peak remain constant during the  
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complete course of the experiment. From its very broad shape it seems reasonable to 
assume that the phosphorous resonance(s) that encompasses is (are) associated with the 
Ras protein and are not due to the presence of a small molecule (impurity) or nucleotide 
by-product in solution (for which the linewidth would be only 10-20 Hz maximum). The 
possibility of being a contaminant from a large macromolecule (another protein) is also very  
Figure 3.33. Conformational equilibria of HRasT35S(1-166)•Mg2+•GppNHp as a 
function of pressure determined by 31P NMR at 278 K. The 4.37 mM protein dissolved 
in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with additionally 0.4 
mM DSS and 20% D2O was subjected to increasing step-variations of pressure, up to 
a maximum of 190 MPa. The chemical shift evolution of the a-, b- and g-phosphates is 
represented by the dashed lines. The fitted chemical shift values for all the resonance 
lines are listed in Table G of the appendix section. An EM function with LB= 4 Hz was 
applied to the processed FID. 
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unlikely since previous biochemical methods such as PAGE and SEC, performed during 
protein purification, and HPLC, performed on the sample after the HP NMR series (a 
standard procedure done with the intent of quantifying the protein concentration and how 
much precipitation occurred during the NMR experiment) revealed no trace of impurities or 
other protein contaminants. Within the available data, the nature of this peak remains 
unclear. Assumptions accounting for possible phosphorylated Ras can be done. In fact, 
recent studies had shown that HRas can undergo phosphorylation at Thr144 and Thr148 
by the enzyme GSK3b that targets the protein for proteasome-mediated degradation [250]. 
In principle, the same regulation mechanism can take place in E. coli. The only other known 
site of phosphorylation in Ras is specific for full length KRas4b and involves Ser181, located 
at the HVR [5]. Without further experimental evidence using NMR, LCMS or antibody-based 
Figure 3.34. 31P NMR chemical shift changes of HRasT35S(1-166)•Mg2+•GppNHp as a function of pressure 
recorded at 278 K. The observed chemical shift dependence is plotted individually for the a-, b- and g-
phosphates. The Ddfreenuc fit were applied as correction factors to dRas uncorrected, leading to the final dcorrected 
values, represented here for each plot as purple lozenges (-◆-). The uncorrected shift changes are also 
plotted as black circles (-●-) for comparison. The second order polynomial fit of the Taylor expansion was 
applied for the determination of B1 and B2. The obtained values are presented on Table 3.8. The calculated 
shift differences (Dd=d190MPa-d0.1MPa) are shown near the respective curve. Note that the vertical scaling is 
different for each plot to allow a better visualisation of the details from the different curves. 
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methods, the nature of the broad 31P NMR signal cannot be clarified. 
It is interesting to note that although no free nucleotide could be detected in the course of 
the pressure series, the resonance line of Pi is clearly observed even at the beginning of 
the experiment, in the low pressure range. There is no direct explanation for this 
phenomenon so far, despite being also often observed during titration experiments between 
Ras and its effectors and other regulators such as NF1 (Figures. 3.39 and 3.50). 
Interestingly, this peak cannot be found in any of the isolated proteins and is residual in 
RasT35S at ambient pressure (Figure 3.33, d= 2.38 ppm), becoming only detectable when 
they are mixed, or in the present case, subjected to pressure [156]. It is possible that the 
Ras protein carries an additional phosphate molecule which is not detectable due to 
intermediate exchange between the protein-free and the protein-bound states but released 
by the presence of certain regulators or by pressure effects. 
Regarding the uncorrected data (Figure 3.34, black circles), it can be inferred that all 
phosphate groups show a shift in the same direction as the corresponding ones in RasWT 
(Figure 3.30), however the magnitude of the changes is much smaller for the former than 
for the latter. For example, the b- and the g1(T)-phosphates on RasWT have a Dd=d190 MPa-d0.1 
MPa equal to -0.125 and 0.304 ppm, respectively. The corresponding values for RasT35S are 
-0.063 and 0.066 ppm. Qualitatively, and within the information retrieved from HP 31P NMR, 
RasT35S seems less prone to undergo pressure-induced conformational changes between 
different states or more precisely between different subensembles of the same state when 
compared to RasWT. Upon correcting for unspecific pressure effects of the free nucleotide, 
the pressure dependencies (purple colour in Figure 3.34) follow the same trends described 
for RasWT, with all phosphates shifting downfield (just as observed for wild type b-, a1(T)- and 
g1(T)-phosphates in Figure 3.30). Concomitantly, both proteins follow a rather linear pressure 
dependence of the 31P resonances either for the corrected and uncorrected cases, at least 
in the tested pressure range. One exception to this is for example the a-phosphate of 
RasT35S that shows large second order coefficients (B2(corrected)= -2.27 ppm GPa-2, the 
negative sign indicates that the a-phosphate shifts downfield with pressure, as observed in 
Figure 3.34). 
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Table 3.8. Fitted pressure coefficients and thermodynamic molar free 
energies, DG, and volumes, DV, for HRasT35S(1-166)•Mg2+•GppNHp at 278 K 
and pH 7.5. 
          31P position d0a /ppm B1 /ppm GPa-1 B2 /ppm GPa-2  
          Uncorrected  
     a -10.971 0.86 ± 0.03 -2.77 ± 0.12  
b -0.33 -0.29 ± 0.01 -0.14 ± 0.01  
g -2.54 -0.38 ± 0.02 1.67 ± 0.01  
Pi 2.39 0.19 ± 0.01 -2.05 ± 0.15  
          Corrected  
     a -10.97 0.89 ± 0.02 -2.27 ± 0.12  
b -0.33 1.09 ± 0.01 -0.70 ± 0.01  
g -2.54 0.88 ± 0.01 0.20 ± 0.01  
     
      d1b /ppm d2b /ppm DG /kJ mol-1 DV /mL mol-1 
          Uncorrected 
     a -10.98 -10.90 3.20 ± 0.14 -85.18 ± 3.18 
b -0.31 -0.39 3.74 ± 0.21 -46.20 ± 2.11 
g -2.54c -2.55c 9.55 ± 16.16 -36.17 ± 5.98 
Pi 2.40 2.35 14.97 ± 1.46 -105.0 ± 10.1 
          Corrected 
     a -10.98 -10.89 3.49 ± 0.65 -70.69 ± 5.53 
b -0.34 -0.13 4.55 ± 0.15 -50.97 ± 1.46 
g -2.55 -2.37c 5.15 ± 0.23 -57.19 ± 2.32 
     a d0 is the chemical shift value obtained at ambient pressure at the 
corresponding pH. 
b d1 and d2 are the chemical shift values obtained for the first and last pressure 
steps, respectively. Due to the linear tendency of the fitted curves, the obtained 
values constitute a coarse approximation. 
c These values were fixed during the iteration routine. 
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3.3.4   31P HP NMR on KRasG12V(1-189)•Mg2+•GTP 
The body of work performed so far for RasWT and RasT35S was also applied to the oncogenic 
mutant KRasG12V(1-188) bound to its natural ligand, GTP. 
Contrary to HRasWT and HRasT35S, the HP series conducted on KRasG12V•Mg2+•GTP was 
performed in a Bruker Avance 500 MHz spectrometer operating at a 31P frequency of 
202.456 MHz and using a selective 31P 10 mm probe. When this series was recorded, the 
more sensitive Prodigy cold probe was not yet a member at our department. The use of a 
much less sensitive probe intrinsically limited the spectral quality as it can be observed from 
Figure 3.35. Even at a protein concentration of 3.23 mM and 3000 cumulative scans per 
step, the overall spectra are rather noisy, which rendered the proper fitting of low-populated 
states a difficult task. A total of 11 steps were recorded from 1.0 MPa up to 195 MPa are 
shown. Measurements above this value were unfruitful due to severe water leaking and 
consequently instability of the high-pressure line. Contrary to RasWT (and other mutants), 
the GDP-to-GTP nucleotide exchange reaction on RasG12V can be accomplished almost 
completely (i.e. the protein was 100% exchanged to GTP, with no Ras-GTP/Ras-GDP 
mixture). This can be observed from the spectrum at 1.0 MPa, where there are no visible 
31P NMR lines corresponding to the a- and b-phosphate of GDP-bound Ras. 
In the course of the experiment, hydrolysis at the g-phosphate occurs and hence the 31P 
NMR signals from the GDP-bound protein become visible around d= -10.1 ppm (aGDP) and 
d= -2.0 ppm (bGDP). The aGDP resonance shifts downfield with pressure (d70MPa= -10.31 ppm; 
d195MPa= -9.99 ppm) and the bGDP shifts upfield (d70MPa= -1.92 ppm; d195MPa= -2.07 ppm, Figure 
3.36 and Table 3.9). It is worth mention that the increase in the integral area for these two 
signals during the pressure series is dependent of time (as the hydrolysis occurs) and not 
on pressure. The recorded series shown in Figure 3.35 do not correspond to the sequential 
order by which the spectra were recorded (for example, after recording the 50 MPa step, 
the next measurement was performed at 150 MPa, the third one at 100 MPa, and so forth. 
This is valid only for the present HP series. All the others shown in this thesis were recorded 
by the sequential order of pressure in which they are presented). The appearance of the 
aGDP and bGDP signals is concomitant with the increase of Pi, which leads to the sharp line 
located at d= 2.5 ppm. Just as detected before for RasWT and RasT35S, the effect of 
increasing pressure promotes a shift of the equilibrium towards state 1(T), directly observed 
by the decrease of the integrals representing state 2(T) (green lines) and respective 
increase of the integrals representing state 1(T) (red lines), following the slow exchange 
condition. One of the most interesting findings in the series is related with the partial splitting 
of the initial b-phosphate into two lines at high pressures, corresponding to states 1(T) and 
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2(T), respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.35. Conformational equilibria of KRasG12V(1-188)•Mg2+•GTP as a function of pressure 
determined by 31P NMR at 278 K. The 3.23 mM protein dissolved in buffer F (40 mM Tris/HCl 
pH 7.5, 10 mM MgCl2, 2 mM DTE) with additionally 0.4 mM DSS and 20% D2O was subjected 
to increasing step-variations of pressure, up to a maximum of 195 MPa. The pressure value for 
each step is indicated together with the evolution of states 1(T) and 2(T), represented by the red 
and green lines, respectively. The resonance lines corresponding to the phosphate groups of 
the protein bound to GDP are also indicated as aGDP and bGDP. Note that in this series the order 
of acquisition of the spectra does not coincide with the sequential increase of pressure. For 
example, after the 50 MPa, the next step recorded was the 150 MPa, and so on. The fitted 
chemical shift values for all the phosphate groups (corrected and uncorrected) are shown in 
Table H of the appendix section. 
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The two states are too close together to be resolved at 1.0 MPa but, as the pressure 
increases, the initial resonance becomes splitted to a point where the centre of b1(T) can be 
properly defined above 150 MPa. The two states on a-phosphate, on the other hand, 
become only resolved at very high pressures (above 195 MPa), contrary to the 
corresponding a-phosphate of Ras bound to GppNHp. The pressure-dependent chemical 
shift changes are shown in Figure 3.36. The uncorrected values, obtained directly upon 
application of a Gaussian filter to the FID, are coloured in black and the corresponding 
corrected values are coloured in red. For the correction of the data the intrinsic pressure 
dependence of the free Mg2+•GTP nucleotide was subtracted to the uncorrected values. 
The pressure-dependence of free GTP was investigated in our department under similar 
conditions as the ones reported in this thesis for GppNHp (section 3.3.1), with appropriate 
adjustments for the physico-chemical properties of GTP [226]. 
From the RasG12V series, both states 1(T) and 2(T) on the a-phosphate shift downfield with 
pressure. Since the a-phosphate on the free nucleotide shifts on the opposite direction, the 
correction of the data was done by adding the absolute Dd values from free Mg2+•GTP to 
the duncorrected values from RasG12V. The corrected chemical shifts show the same tendency 
as the uncorrected ones, moving even further downfield. Due to the low signal-to-noise ratio 
and to the asymmetry of the peaks, the fitted pressure coefficients have generally large 
associated errors, as in the case of the a1(T)-phosphate, with B2= 16.5 ± 20.0 ppm GPa-2. 
The uncorrected b1(T) and b2(T) phosphates move upfield as the pressure increases. Upon 
correction, their direction is reversed, following the same trend as observed previously for 
RasWT and RasT35S. Qualitatively, b1(T) shows a more linear pressure dependence than b2(T), 
with both developing a negative curvature. The calculated B2(corrected). values are -0.027 ± 
1.90 ppm GPa-2 for the former and -7.428 ± 4.257 ppm GPa-2 for the latter. A proper fitting 
of the b1(T)-phosphate could only be done above 50 MPa and only by using the GM method. 
It would be interesting to repeat this series up to 250-300 MPa in order to study the 
behaviour of this signal at higher pressures. 
In GppNHp-bound Ras, states 1(T) and 2(T) are best separated for the g-phosphate. The 
same is observed for RasG12V•Mg2+•GTP but their pressure-dependent shifts are much less 
pronounced in the second case. The g1(T)-phosphate shows a negative first order 
dependence (B1= -2.02 ppm GPa-1), which becomes largely compensated upon correction 
(B1= 0.158 ± 0.109 ppm GPa-1) and the g2(T)-phosphate, on the other hand, shows a large 
second order dependency, with B2 values of 7.541 ppm GP-2 and 10.741 ppm GPa-2 for the 
uncorrected and corrected cases, respectively. 
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Indeed, the overall second order coefficients presented in Table 3.9 for this pressure series 
are generally higher than the ones obtained either for RasWT or the T35S mutant, portending 
the idea that KRasG12V•GTP is more responsive to pressure, at least in the vicinity of the 
nucleotide, than the other two GppNHp-bound proteins. 
The slow exchange interconversion between states 1(T) and 2(T) was also analysed based 
on the integrated area of each peak. Ln K12 as a function of pressure is plotted in Figure 
3.37 using the b- and g-phosphates. From the fitting routine, a Gibbs energy DG12= 5.865 ± 
0.455 kJ mol-1 for the b-phosphate and DG12= -6.524 ± 0.295 kJ mol-1 for the g-phosphate 
Figure 3.36. Corrected and uncorrected pressure dependence of 31P chemical shifts for 
KRasG12V(1-188)•Mg2+•GTP recorded at 278 K. The Ddfreenuc fit values of free Mg2+•GTP [226] 
were applied as correction factors to dRas uncorrected, leading to the final dcorrected values, 
represented here for each plot as red pentagons (-À-). The uncorrected shift changes are 
also plotted as black hexagons (-Â-) for comparison. The second order polynomial fit of the 
Taylor expansion was applied for the determination of B1 and B2 as before. The obtained 
values are presented on Table 3.9 and the calculated Dd=d195MPa-d1.0MPa values are shown 
near the respective curve. Note that the vertical scaling is different for each plot to allow a 
better visualisation of the details from the different curves. 
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was obtained. The difference in the specific 
volumes for the two states DV12=V2-V1 is -
31.11 ± 3.07 and 26.10 ± 2.19 mL mol-1, 
respectively. Within the limits of error, the 
obtained values from the two phosphate 
groups are numerically similar. They have 
opposite signs due to the different directions of 
the 1(T)-2(T) transition. Their similarity is to be 
expected since they are a measure of a 
conformational transition that affects in 
principle the chemical environment of both a- 
and b-phosphates in a similar way. 
 
 
 
 
 
 
 
Figure 3.37. Plot of LnK12 as a function of 
pressure for KRasG12V(1-188)•Mg2+•GTP. The 
transition was analysed for the g- and b-
phosphates (coloured in black and red, 
respectively). The obtained free energy difference, 
DG12 and partial molar volume, DV12 for the g-
phosphate is -6.524 ± 0.295 kJ mol-1 and 26.10 ± 
2.19 mL mol-1, respectively. For the b-phosphate, 
DG12 = 5.865 ± 0.455 kJ mol-1 and DV12 = -31.11 ± 
3.07 mL mol-1, respectively.
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Table 3.9. Fitted pressure coefficients and thermodynamic molar free energies, DG, and 
volumes, DV, for KRasG12V(1-188)•Mg2+•GTP at 278 K and pH 7.5. 
            31P position d0a /ppm B1 /ppm GPa-1 B2 /ppm GPa-2 -- --             Uncorrected 
      a1(T) -10.91 -4.01 ± 6.57 16.5 ± 20.0   
a2(T) -11.54 0.68 ± 0.15 -0.39± 0.72   
b1(T) -14.95 -3.28 ± 0.48 7.07 ± 1.90   
b2(T) -14.70 -0.68 ± 0.10 -0.33 ± 0.43   
g1(T) -6.00 -2.02 ± 0.11 0.64 ± 0.51   
g2(T) -7,47 -0.06 ± 0.22 7.54 ± 1.02   
Pi 2.34 0.50 ± 0.20 -2.93 ± 0.73   
            Corrected 
            a1(T) -10.91 -3.48 ± 6.57 16.40 ± 20.0   
a2(T) -11.54 1.21 ± 0.15 -0.89 ± 0.72   
b1(T) -14.95 1.52 ± 0.48 -0.03 ± 1.90   
b2(T) -14.70 4.12 ± 0.09 -7.43 ± 4.26   
g1(T) -6.00 0.16 ± 0.11 -2.54 ± 0.51   
g2(T) -7.47 -2.24 ± 0.02 10.74 ± 1.02   
             d1b /ppm d2b /ppm DG /kJ mol-1 DV /mL mol-1 Transition 
       Uncorrected 
a1(T) -11.15 -11.04c 27.42 ± 1.20 -156.66 ± 68.9 1-to-0 
a2(T) -11.53c -11.42 6.77 ± 0.93 -70.00 ± 8.12 2-to-3 
b1(T) -15.10 -15.32c 10.57 ± 2.19 -101.18 ± 15.70 1-to-0 
b2(T) -14.70c -14.85c 5.74 ± 0.75 -56.05 ± 6.04 2-to-3 
g1(T) -6.00c -6.37c 5.97 ± 0.52 -61.42 ± 4.44 1-to-0 
g2(T) -7.47c -7.18c 10.05 ± 1.36 -72.32 ± 9.26 2-to-3 
Pi 2.36 2.33c 23.19 ± 7.06 -137.50 ± 40.0 -- 
            Corrected 
            a1(T) -11.09c -10.96c 27.42 ± 9.98 -157.82 ± 57.44 1-to-0 
a2(T) -11.53 -11.33 6.04 ± 0.57 -62.63 ± 4.93 2-to3 
b1(T) -14.90 -14.63 9.18 ± 1.32 -73.88 ± 10.17 1-to-0 
b2(T) -14.69c -14.18 5.32 ± 0.63 -66.18 ± 9.05 2-to3 
g1(T) -6.00 -6.11 9.96 ± 3.51 -55.23 ± 39.50 1-to-0 
g2(T)
d -- -- -- -- 2-to-3 
      ad0 is the chemical shift value obtained at ambient pressure at the corresponding pH. 
bd1 and d2 are the chemical shift values obtained for the first and last pressure steps, respectively. Due 
to the linear tendency of the fitted curves, the obtained values constitute a coarse approximation. 
c The value was fixed during the fitting routine. 
d No convergence was attained from the fitting routine. 
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3.4   Mutational Analysis of HRasWT(1-166) Studied by 31P NMR and ITC 
The identification of non-conventional binding sites in the surface of Ras can be done by 
analysing the response of its individual amino acids to pressure. In fact specific residues of 
the protein (located either at the surface or at the core) could be identified in previous HP 
NMR experiments as being predominantly influenced by a given conformational transition 
and were colour-coded at the surface of the protein (Figure 1.13, section 1.3.2, [171]). 
These investigations constitute a mapping of the pressure-dependent conformational 
transitions of Ras and were taken in the present thesis as background information 
necessary to select specific amino acids and to perform site directed-mutagenesis on them 
with the expectation that the mutation would shit the conformational equilibrium towards 
one of the two conformational states in which the selected amino acids are involved. The 
correlation between the amino acids and their corresponding conformational transition as 
detected by HP is shown in Table 3.10. The ones selected for site-directed mutagenesis 
and their respective replacement are highlighted in orange colour. The next sections 
describe the results gathered from this mutational study on truncated HRas. An attempt to 
correlate the effect of the mutation with the any observed conformational transition is made 
herein. All mutants were created de novo, by designing the primers with the mutation at the 
centre and using standard PCR techniques (experimental sections 2.2.1.9 and 2.2.1.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.10. List of amino acids according to the associated 
conformational transition as determined by HP NMR and the ones 
chosen for SDM. 
      2(T)-to-3(T) 2(T)-to-1(T) 2(T)-to-1(0) 
Surface Core Surface Core Surface Core 
            His27 Glu Leu56 Asn26 Lys Val9 Ser39 Leu Phe82 
Asp33 Lys Gly115 His94 Asp Val14 Glu3 Val Met111 
Ile46 Thr Thr20 Ala66 Thr  Lys42  
Val44 Leu79 Gly138  Glu49  
Gly48 Val112 Arg Ile139  Arg161  
Leu23    Val45  
His166    Arg135  
Ser127    Tyr137  
Asp132    Tyr141  
Thr124    Glu143  
Asp107    Ala130  
Ala121    Ala134  
Asn85 Ala    Ser136  
Asn86    Ile84  
            1(0), 1(T), 2(T) and 3(T) represent the nucleotide free, the GEF 
recognition, the effector recognition and the GAP recognition states, 
respectively. The listed residues have also generally high B1 and B2 
pressure coefficients, according to [171]. The ones chosen for site-
directed mutagenesis are coloured in orange, together with the 
respective amino acid replacement. Mutagenesis was also attempted in 
the residues coloured in blue but with no success. Only residues involved 
in a two-state transition were considered. 
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3.4.1   Preliminary Considerations About RasWT(1-166) 
Several 31P NMR spectroscopy studies were firstly conducted on RasWT and used 
afterwards as a qualitative and quantitative resource for the assessment and comparison 
of similar studies conducted on the different mutants. 
 
3.4.1.1   Conformational equilibria of H, K and NRasWT(1-166)•Mg2+•GppNHp  
The dynamics of the full-length H and KRasWT(1-188/189) were studied by 31P NMR in 
section 3.1. Similar studies were also conducted herein for the wild type truncated variants 
(1-166), including NRas in terms of 31P chemical shifts and equilibrium constants. The 
obtained spectra are shown in Figure 3.38 and the fitted values are listed in Table 3.11. 
There are obvious differences between the different isoforms: state 2(T) on g-phosphate is 
shifted downfield in K and NRas as compared to HRas. The Dd differences are ca. 0.06 
ppm and 0.09 ppm, respectively. The chemical shift values of the other phosphate groups 
are very similar and their corresponding Dd values are always within ± 0.05 ppm in the three 
proteins, a value close to the limits of the error for the measurements. The most striking 
difference however, arises from the equilibrium populations. The obtained K12 for NRas is 
2.57, about 1.7-fold higher than HRas (K12=1.57). The difference is rather surprising, 
considering that the degree of homology between the three isoforms is more than 90% and 
that their catalytic domain differs only in four residues (aa 151, 153, 165 and 166), none of 
them located at the switch regions [251]. The obtained linewidths on g-phosphate for K and 
NRas are in average numerically larger than the corresponding ones for HRas. The 
obtained KD values for the dissociation of the Ras-Raf complex are 0.42 ± 0.1, 0.60 ± 0.06 
and 0.18 ± 0.05 µM for H-, K- and NRas, respectively. From these interaction studies it 
follows that the affinity of NRas towards Raf is 2.42-fold higher than the one of HRas and 
3.45-fold higher than the one of KRas. These results are in agreement with the equilibrium 
distribution observed for the different isoforms in the 31P NMR spectra, with NRas having 
the highest K12, that is, being more populated in terms of state 2(T) (the effector recognition 
state), followed by KRas and HRas in this respective order. 
The signature plot for the three proteins is very similar (similar DG and DH and -TDS), with 
the NRas-Raf association being slightly more entropically favourable than the other two 
isoforms (-TDS = -38.6 kJ mol-1 vs -28.3 kJ mol-1 (HRas) and -22.3 kJ mol-1 (KRas)). The 
enthalpies of binding, explicitly obtained from the measurements, are also identical (DH= -
8.10, -13.2 and -10.8 kJ mol-1 for H, K and NRas, respectively). 
It is worth mentioning the comparison between the equilibrium distribution of the full length 
(section 3.1.1, Figure 3.1) and the respective truncated H and KRas variants. 
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Figure 3.38. Conformational equilibrium of RasWT(1-166)•Mg2+•GppNHp detected by 31P 
NMR spectroscopy and thermodynamics of association with Raf-RBD detected by ITC. The 
equilibrium between states 1(T) and 2(T) for the truncated H, K and NRas isoforms was 
compared in terms of 31P chemical shifts and equilibrium constants, K12, on g-phosphate. The 
three proteins with concentrations of 1.78, 1.10 and 0.62 mM, respectively were dissolved in 
buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with additionally 0.2 mM DSS 
and 5 or 10% D2O. All the NMR measurements were performed at 278 K at 202.456 MHz 
(KRas (6000 scans, LB=15Hz), NRas (7000 scans, LB=15Hz)) or at  242.89 MHz (HRas, 1000 
scans, LB= 8 Hz). The fitted chemical shift values, linewidths and K12 are listed in Table 3.11.  
The interaction with Raf-RBD was measured at 298 K. All the proteins were dissolved in the 
same buffer F with additionally 150 mM NaCl. The signature plots are presented alongside 
with the fitted thermodynamic values (blue: DG, green: DH, red: -TDS) and the respective 
isotherms. 
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The former ones are slightly shifted towards state 2(T) as compared with the truncated 
forms (K12= 1.9 vs 1.6 for FLHRas and cHRas, respectively and K12=2.0 vs 1.8 for FLKRas 
vs cKRas, respectively). The observed differences, even if small, portend the importance of 
the HVR in the modulation of the conformational equilibrium detected in the vicinity of the 
nucleotide by 31P NMR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.1.2   Titration of HRasWT(1-166)•Mg2+•GppNHp with NF1 Followed by 31P NMR 
The catalytic domain of the GAP protein NF1 (aa 1198-1531, 35 kDa) was added to 
HRasWT(1-166) in a titration experiment followed by 31P NMR. The obtained data is shown 
graphically in Figure 3.39 and numerically in Table 3.12. The results gathered herein can 
be taken afterwards for a comparative analysis with similar titrations performed in different 
Ras mutants. In the presence of NF1, the chemical environment of all the three phosphate 
groups is affected, as it can be directly observed from their respective lineshapes on Figure 
3.39. As usual, the most striking modifications are observed for the g-phosphate. The 
interpretation can be done as follows: as NF1 is stepwise added to Ras the integrals of the 
resonance lines corresponding to states 1(T) (red colour) and 2(T) (green colour) decrease 
without any appreciable modification of their corresponding chemical shift values (Table 
3.12), indicating that no major or dramatic structural rearrangements in the vicinity of the 
nucleotide occur upon binding to NF1. At the same time, another resonance line located in 
between states 1(T) and 2(T) becomes visible and its integral increases as the 
concentration of NF1 increases. In the light of the proposed model, this line is ascribed to 
Table 3.11. 31P NMR chemical shift values and linewidths for the truncated 
wild type isoforms of H, K and NRas in complex with Mg2+•GppNHp. 
          
Protein 
a-phosphate b-phosphate g-phosphate 
K12b d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T),2(T)
a 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
            HRasWT -11.16 -11.68 -0.25 -2.56 -3.34 1.57 
KRasWT -11.18 -11.70 -0.23 -2.58 -3.28 1.83 
NRasWT -11.21 -11.72 -0.21 -2.53 -3.26 2.57 
             Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T),2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
-- 
       HRasWT 92.74 84.34 47.06 64.76 51.43  
KRasWT 57.29 102.28 48.19 69.04 55.30  
NRasWT 66.52 94.29 43.15 72.76 47.80  
      All the values are fitted from the experimental spectra recorded at 278 K, pH 
7.5. The estimated errors from the fitting procedure are less than ± 0.01 ppm 
in chemical shift values and ± 0.15 Hz in linewidths at the g-phosphate. An 
LB= 8 Hz was applied to the FID and subtracted afterwards from the final 
fitted linewidth values. 
a The b-phosphate was fitted as a single Lorentzian line because states 1(T) 
and 2(T) cannot be separated at the magnetic field used 
b The equilibrium constant, K12, was calculated using the population 
distribution on the g-phosphate. The associated error is ± 0.2. 
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the conformational state that selectively recognizes GAP proteins and is named 3(T). The 
fitted lines for the three states and their interplay during the titration can be observed in 
Figure 3.39 for the g-phosphate in the third, fourth and fifth steps of the titration. As the 
titration proceeds, the linewidths of states 1(T) and 2(T) (corresponding to unbound Ras) 
do not change appreciable and the linewidth of state 3(T) increases concomitantly with the 
increase of the molecular mass of the complex. Between the first spectrum and the last 
titration step the theoretical size of the complex increases by a factor of 3.0, from 18 kDa 
(Ras alone) to 54 kDa (note that state 3(T) seems to be only saturated in the last step, thus 
the 1:2 ratio was taken as the most representative of a 1:1 binding). The experimentally 
determined increase on the linewidth values for state 3(T) is also of the same magnitude 
(from ca. 65 Hz to 206 Hz, Table 3.12). Note that the line broadening of 65 Hz measured 
for state 2(T) in Ras alone (Table 3.12) is assumed to be also representative of state 3(T). 
A very similar value is obtained when considering the linewidth of state 3(T) in the first 
titration step (1:0.25 ratio, Dn1/2 3(T)= 105.44 Hz) to which the natural line broadening of 45 
Hz for state 2(T) is subtracted (105.44-45= 61 Hz, Table 3.12). The natural line broadening 
of Ras alone can be estimated from previous transverse relaxation experiments given the 
relationship Dn1/2=1/T2.π (T2= 4.1 and 7.1 ms for states 1(T) and 2(T), respectively [116]). 
Thus, the obtained linewidth at 1:1 binding matches nicely the increase in the theoretical 
size of the complex, which is also indicative that there are no additional contributions from 
exchange broadening process in the present titration. The interaction between Ras and 
NF1 follows a slow exchange mechanism, i.e. |Dωτc| >> 1. From the peak separation, Dω, 
between state 3(T) and the other states, one obtains a lower limit of the lifetime of the Ras-
NF1 complex equal to 8.93 ms in state 1(T) and 11.47 ms in state 2(T). Equivalent results 
were previously obtained on the titration of Ras with the protein GAP334 by 31P NMR [117]. 
In principle, the a-phosphate should have a similar response to the presence of NF1 as the 
one observed for the g-phosphate. However, the greater superposition of the NMR lines 
associated with the rapidly decreasing spectral quality due to dilution of Ras rendered 
impossible the proper fitting of the data in this case. Different approaches were attempted, 
including fixing the chemical shift values and linewidths for states 1(T) and 2(T) but with no 
success. Nevertheless, from the fitting of the last titration step, the obtained chemical shift 
value for state 3(T) at the a-phosphate is -11.124 ± 0.07 ppm. 
The analysis of the b-phosphate, on the other hand, shows that as the titration proceeds, 
an additional signal arises at the left side of the original b-phosphate in the unbound Ras. 
This new signal lies at ca. d= 0.07 ppm (Table 3.12) and its relative area increases with 
increasing concentrations of the titrant. 
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Figure 3.39. Protein complex formation between HRasWT(1-166)•Mg2+•GppNHp and NF1 
followed by 31P NMR spectroscopy at 278 K. To an initial 1.3 mM of Ras dissolved in buffer 
F (40 mM Tris/HCl pH 7.5; 10 mM MgCl2; 2 mM DTE) with additionally 150 mM NaCl, 0.2 
mM DSS in 10% D2O, increasing amounts of the GAP protein NF1 (from a 0.65 mM stock 
solution) were added (the corresponding molar ratios for each step are presented). The 
concentration of Ras and NF1 in the final step (1:2 ratio) was 0.26 mM and 0.52 mM, 
respectively. An exponential filter with LB= 10 Hz was applied to the processed FID. Each 
spectra was obtained by accumulation of approximately 15000 scans. The resonance lines 
corresponding to the a-, b- and g-phosphates are indicated as well as the states 1(T), 2(T) 
and 3(T), represented by the red, green and blue colours, respectively. As an example, the 
deconvolution into separated Lorentzian lines is shown for three different titration steps on 
the g-phosphate. The most obvious effect that arises from adding NF1 to Ras is the 
appearance of the third resonance line (coloured in blue), corresponding to the Ras-GAP 
recognizing state 3(T). The obtained chemical shift values for this state at the 1:2 ratio for 
the a-, b- and g-phosphates are -11.12 ppm, 0.07 ppm and -3.00 ppm, respectively (Table 
3.12). 
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In the Ras-NF1 complex, the b-phosphate NMR signal is formed by these two lines that lie 
very close to each other. A remarkable finding can be observed at a ratio of 1:2, were the 
a- and g-phosphates appear saturated, with the equilibria shifted almost completely towards 
state 3(T) and, by contrast, the b-phosphate becomes a very broad peak with an ill-defined 
centre that seems to feature two distinct conformational states that lie very close to each 
other. As result, It can be hypothesized that in the Ras-NF1 complex the b-phosphate is 
characterized by two distinct conformational states and constitute the reason why saturation 
was not achieved, even at a ratio of 1:2. 
 
 
 
 
 
 
 
Table 3.12. 31P NMR chemical shift values and linewidths for the protein-protein complex HRasWT(1-
166)•Mg2+•GppNHp•NF1. 
                    Protein 
complex 
Ras:NF1 
ratio 
a-phosphate b-phosphate g-phosphate 
d1(T) 
[ppm] 
d3(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T),2(T) 
[ppm] 
d3(T) 
[ppm] 
d1(T) 
[ppm] 
d3(T) 
[ppm] 
d2(T) 
[ppm] 
                              HRasWT -- -11.16 -- -11.72 -0.25 -- -2.54 -- -3.36 
    a      +NF1 1:0.25 -11.15 --b -11.71 -0.25 -- -2.53 -3.00 -3.36 
 1:0.5 -11.15 --b -11.73 -0.25d 0.17 -2.54 -3.03 -3.36 
 1:0.9 --c --c --c -0.25d 0.06 -2.54 -3.02 -3.37 
 1:1.25 --c --c --c -0.25d 0.07 -2.54 -3.01 -3.36 
 1:1.50 --e -11.12 --e -0.25d 0.05 -2.55 -3.02 -3.37 
 1:2.0 --e -11.12 --e -0.25d 0.07 -2.58 -3.00 -3.37 
            a-phosphate b-phosphate g-phosphate 
  Dn1/2 1(T) 
[Hz] 
Dn1/2 3(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2
a
 
[Hz] 
Dn1/2 3(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 3(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
                    HRasWT -- 116.74 -- 114.72 66.3 -- 81.47 -- 64.60 
          +NF1 1:0.25 -- --b -- 66.3 -- 80.71 105.44 60.01 
 1:0.5 --c --b --c 65.2d 172.0 96.57 113.3 58.47 
 1:0.9 --c --c --c 65.5d 227.6 82.24 111.44 68.55 
 1:1.25 --c --c --c 65.5d 213.7 89.32 109.22 78.70 
 1:1.50 --c --c --c --c --c 98.65 158.45 68.00 
 1:2.0 --c --c --c --c --c 91.98 206.19 91.98 
          All the values are fitted from the experimental spectra recorded at 278 K, pH 7.5. The estimated errors 
from the fitting procedure are ± 0.02 ppm in chemical shift values and ± 0.25 Hz in linewidths for the 
g-phosphate. An  LB= 10 Hz was applied to the processed FID and subtracted afterwards from the 
final fitted linewidth values. 
a States 1(T) and 2(T) of the b-phosphate in cannot be separated at the magnetic field used and were 
therefore fitted as a single Lorentzian line. 
b State 3(T) could not be appropriately fitted for the indicated titration step. 
c Fitting of the resonance lines with independent Lorentzian functions was not possible due to their 
extreme overlapping at the magnetic field used. 
d These values were fixed during the iteration routine. 
e The a-phosphate was fitted with a single resonance line centred in state 3(T). 
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3.4.2   Site-Directed Mutagenesis 
3.4.2.1   2(T)-to-1(T) Transition: N26K, H94D and A66T 
Following the guidelines presented in section 3.4, the effect of mutating amino acid residues 
involved in the conformational transition to the GEF recognizing state 1(T), was 
investigated. For the purpose, three residues from the list presented in Table 3.10 were 
selected. The amino acid chosen for the replacement was based in opposite physico-
chemical properties relative to the one being replaced. Thus, the uncharged Asn26 was 
replaced by the positively charged Lys, the non-polar Ala66 was replaced by the polar Thr, 
a bulky by a small, a positive by a negative, and so on. The effect of each mutation cannot 
be truly predicted without a computational approach, but as the original amino acid residues 
are involved in the 2(T)-to-1(T) transition, it is expected that their modification would affect 
the population distribution of at least one of these states. 
Figure 3.40. Localization on the RasWT•Mg2+•GppNHp surface of the amino acid residues Asn26, His94 and 
Ala66 that were subjected to SDM (experimental section 2.2.1.11). These residues sense the 2(T)-to-1(T) 
transition upon pressure perturbation and were mutated with the prospect of shifting the equilibrium between 
one of these states. A. Localization of the three residues (coloured in orange) in the structure with a surface 
and a cartoon representation. Switch 1 is coloured in green, switch 2 is coloured in red and the Mg2+ ion is 
coloured in magenta. Key features near each residue, including polar contacts, are shown for Asn26, B., 
His94, C. and Ala66, D. Important –NH and –OH moieties are coloured in blue and red, respectively. H2O 
molecules are coloured in light blue. pdb: 5p21. 
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The localisation of the three residues on the surface of RasWT•Mg2+•GppNHp is depicted in 
Figure 3.40. Asn26 belongs to the loop λ2 that connects the helix a1 to the b2 strand, just at 
the beginning of switch 1. This residue is involved in two polar contacts between its main 
chain NH group to the carboxyl groups of Ile21 and Gln22, both located in the a1 helix 
(Figure 3.40B). His94 is in the middle of the helix a3, with the side chain protruding towards 
helix a2 and establishing a polar contact with the side chain of Tyr137, Glu91 and Glu98 
(C). Mutation to Asp would disrupt the H-bond with Tyr137 which could lead to an increase 
of the distance between a2 and a3. Ala66 is located in the helix a2, at the end of the switch 
2 and establishes a polar contact with Asp69 on the same helix and a H2O molecule (D). 
Replacement to a Thr would introduce an additional polar group that would become oriented 
towards the outward surface of the protein, which could induce in principle significant 
structural modifications. From the three residues under investigation, only Asn26 is reported 
to be an “hot spot” for being involved in a disease of the central nervous system when 
mutated to Gly [252]. 
 
3.4.2.1.1   31P NMR GppNHp and GTP Spectra. Raf Interaction and GTPase Activity 
Figures 3.41 and 3.42 show respectively the 31P NMR spectra of the GppNHp and the GTP-
bound protein complexes. The numerical values for the fitted chemical shifts and linewidths 
are shown in Table 3.13 and the corresponding GDP-bound spectra are shown in Figure B 
of the appendix section. From the obtained data it can be inferred that there are no 
significant differences in terms of shift values and linewidths between the three mutants and 
wild type Ras. The only exception to this statement is state 1(T) on g-phosphate of RasH94D, 
whose linewidth is 20% smaller than the corresponding one in RasWT (Dn1/2 = 59 vs 74 Hz). 
RasN26K shows an additional signal at d= 0.98 ppm, with a linewidth of Dn1/2= 19.2 Hz. The 
signal is most likely due to a contamination during the nucleotide exchange reaction. This 
is corroborated by the 1H spectrum that also shows additional unknown peaks. 
The GTP-bound spectra of the three mutants are also identical to the one of wild type Ras 
(Figure 3.42). The calculated equilibrium constants for RasN26K and RasA66T are respectively 
9.30 and 10.4, somewhat smaller than K12= 11.3 obtained for RasWT. However, the 
difference is not meaningful due to the large associated error (for all cases, including RasWT 
the integration of state 1(T) lies within the baseline noise and is therefore very inaccurate). 
The most interesting feature can be ascribed to the very broad peak (Dn1/2 = 67 Hz) located 
at d= 3.36 ppm in the spectrum of RasH94D•Mg2+•GTP. This chemical shift usually 
corresponds to the NMR line of free GMP (this was confirmed by spiking experiments using 
the same protein sample). However, the peak is too broad to be associated with the free 
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nucleotide in the present case. 
Furthermore, it is also present 
in RasH94D•Mg2+•GDP (d= 3.39 
ppm, Dn1/2 = 73 Hz, Figure B, 
appendix section), but absent 
in the RasH94D•Mg2+•GppNHp 
spectra, which indicates that 
alkaline phosphatase (AP) is 
capable of hydrolysing any 
phosphate group(s) associated 
with the signal. Within the 
available data, it is unclear if 
this peak corresponds to 
phosphorylated Ras. Although 
it is a possibility since neither 
the 1H NMR spectra nor SDS-
PAGE showed sign of potential 
contaminants on the sample. 
From the obtained results, it 
can be generally concluded 
that the direct expectation of 
observing a conformational 
transition towards state 1(T) 
upon mutating the specific 
sensitive residues was not 
achieved. 
However, the same 31P 
chemical shifts and population 
distributions do not necessarily 
mean that the mutants have the 
same biochemical behaviour. 
In an attempt to elucidate if this 
is the case, the time-dependent 
intrinsic hydrolysis rate of each mutant was evaluated using HPLC. In parallel, their affinity 
towards Raf-RBD was also investigated by ITC. The results are shown in Figure 3.43 and  
Figure 3.42. Conformational equilibria of the Ras•Mg2+•GTP 
selected mutants detected by 31P NMR at 278 K, 202.4 MHz and pH 
7.5. The mutants were created by SDM upon choosing specific 
residues associated with the 2(T)-to-1(T) conformational transition. 
All proteins were dissolved in buffer F (see above) at a concentration 
of 1.7 mM (WT, 1200 scans), 0.95 mM (N26K, 2000 scans), 1.96 
mM (H94 D, 700 scans) and 1.00 mM (A66T, 2000 scans). An EM 
filter with LB= 15Hz was used in all spectra. 
Figure 3.41. Conformational equilibria of the Ras•Mg2+•GppNHp 
selected mutants detected by 31P NMR. The mutants were created 
by SDM upon choosing specific residues associated with the 2(T)-
to-1(T) conformational transition. All the measurements were done 
at 278 K in a 202.4 MHz magnetic field (500 MHz spectrometer). The 
proteins were dissolved in buffer F (40 mM Tris/HCl pH 7.5, 10 mM 
MgCl2, 2 mM DTE) with additionally 0.2 mM DSS and 5% D2O at 
concentrations of 1.5 mM (WT, 1700 scans), 1.60 mM (N26K, 3000 
scans), 0.9 mM (H94D, 1000 scans) and 1.44 mM (A66T, 3000 
scans). An EM filter with LB=15 Hz was used in all spectra. 
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Table 3.13. 31P NMR chemical shift values and linewidths obtained for the 
different mutants of HRas(1-166). The mutated residues are involved in 
the conformational transition 2(T)-to-1(T). 
          Protein 
complex 
a-phosphate b-phosphate g-phosphate 
K12b d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T),2(T)
a 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
               Mg2+•GDP 
       WT -10.50 -1.97 -- -- 
N26K -10.15 -1.99 -- -- 
H94D -10.59 -1.99 -- -- 
A66T -10.51 -2.00 -- -- 
       Mg2+•GppNHp 
       WT -11.17 -11.68 -0.25 -2.57 -3.33 1.7 
N26K -11.07 -11.63 -0.25 -2.53 -3.35 1.5 
H94D -11.23 -11.68 -0.25 -2.55 -3.36 1.8 
A66T -11.14 -11.67 -0.28 -2.56 -3.37 1.8 
        Mg2+•GTP 
       WT -11.68 -14.87 -6.63 -7.98 11.3 
N26K -11.63 -14.83 -6.64 -7.97 10.4 
H94D -11.67 -14.83 -- -7.98 -- 
A66T -11.65 -14.83 -6.65 -7.96 9.30 
               a-phosphate b-phosphate g-phosphate 
--  Dn1/2 1(T) [Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T),2(T)
a
 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
               Mg2+•GDP 
       WT 46.89 30.02 --  
N26K 46.77 29.87 --  
H94D 48.71 30.15 --  
A66T 55.57 30.00 --  
        Mg2+•GppNHp 
       WT 105.39 75.15 45.84 74.47 55.07  
N26K 120.31 87.69 55.00 75.04 57.00  
H94D 121.21 58.26 46.23 59.05 57.04  
A66T 104.00 82.01 46.12 74.03 55.11  
        Mg2+•GTP 
       WT 54.74 45.66 20.33 35.44  
N26K 49.46 39.31 78.87   
H94D 43.66 36.54 -- 29.74  
A66T 55.00 43.89 48.00 37.00  
              All the values are fitted from the experimental spectra recorded at 278 K and 
pH 7.5. The maximum estimated errors are ± 0.07 ppm in chemical shift 
values and ± 0.4 Hz in linewidths for the g-phosphate. An LB= 15 Hz was 
applied to the FID and subtracted afterwards from the fitted linewidths. 
a States 1(T) and 2(T) of the b-phosphate in cannot be separated at the 
magnetic field used and were therefore fitted as a single Lorentzian line. 
b The equilibrium constant, K12, was calculated using the population 
distribution on the g-phosphate. The associated error is ± 0.2. 
 
Table 3.14. In principle, if a mutation promotes a shift towards state 1(T), even if this shift 
remains undetected by 31P NMR, biochemical properties such as the GTPase activity 
should reflect the modification. In fact, it is known that state 2(T) (and probably also 3(T)) is 
associated with faster hydrolysis rates compared with for example, partial loss-of-function 
and oncogenic variants, that exist predominantly in state 1(T) such as RasT35S [67]. Figure 
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3.43A shows that under single turnover 
conditions all the three mutants have an 
identical hydrolysis rate, close to the one 
obtained for RasWT (kcat= 0.026 min-1) 
and similar half-life’s (τ= 27-30 min., 
Table 3.14). Using the same 
experimental conditions, the GTPase 
activity was also tested for N26K, H94D 
and A66T in the presence of Raf-RBD. 
Since RasWT•Mg2+•GTP already exists 
mainly in state 2(T), its intrinsic 
hydrolysis is not (or it is only very 
slightly) accelerated by addition of 
effector (kcat= 0.029 min-1), contrary for 
example to the state 1(T) RasT35S whose 
GTPase activity becomes accelerated 
more than 2.5-fold when Raf-RBD is 
added [67]. The situation of RasA66T and 
RasN26K is again similar to the one 
observed for wild type: addition of Raf-
RBD does not change their hydrolysis 
rates and the calculated kcat values are 
virtually identical in the presence and 
absence of the effector. In the case of 
RasH94D, however, addition of effector 
leads to a 1.7-fold increase in its 
GTPase activity, which is significant 
(kcat= 0.035 min-1 and τ= 19.56 min., 
Figure 3.43B). Most likely, state 2(T) is 
further stabilised by Raf binding in H94D 
comparably to N26K or A66T, which 
accounts for the observed difference. 
The obtained affinities of binding between wild type, N26K, H94D, A66T and Raf-RBD are 
all very similar. They proceed with the same averaged DG of -36.5 kJ mol-1 and with similar 
enthalpic and entropic contributions. The formation of the complex between RasWT and Raf 
Figure 3.43. Determination of the intrinsic GTPase 
activity of HRas(1-166)•Mg2+•GTP by HPLC at 310 K. 
Typically 100 µM of protein were dissolved in buffer F. At 
specific time intervals, 50 µl were snap-frozen in liquid N2 
to prevent a continuous hydrolysis reaction. The 
nucleotide concentration equals the protein concentration 
in absence of free nucleotide because Ras binds 
nucleotides in a ratio of 1:1. The HPLC system contains a 
pre-column, a C18 reversed phase column and a UV-
detector measuring the nucleotide absorbance at λ= 254 
nm. The protein precipitates in the mobile phase and is 
retained by the pre-column. At the same time the 
nucleotide is released and separated through the C18 
column. Upon integration of the fluorescence signal from 
GTP, the percentage of Ras-GTP was plotted against 
time and the data fitted with a first order exponential 
decaying function. A. The measurements were conducted 
for the three mutants under study, N26K, H94D and A66T. 
B. The GTPase activity was also measured in the 
presence of Raf-RBD. From the three mutants, only H94D 
shows significant differences upon addition of two-fold 
excess of effector (kcat=0.035 min-1, τ= 19.56 min.). 
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is only ever so slightly enthropically favourable (-TDS= -28.3 kJ mol-1) than the one observed 
for the three mutants. The corresponding dissociation constant, KD, in the case of wild type 
is 0.424 ± 0.12 µM. A similar value was obtained for RasH94D-Raf complex (KD= 0.436 ± 0.07 
kJ mol-1) but a 1.75-fold lower value was obtained in the case of RasN26K and RasA66T, which 
is per se indicative of their slightly higher affinity towards Raf (their KD is numerically more 
similar to the one obtained for the full length RasWT-Raf complex than the one obtained in 
the corresponding truncated Ras variant, Figure 3.2). 
 
 
 
 
 
 
 
 
Table 3.14. Thermodynamics of interaction between HRas•Mg2+•GppNHp and Raf-RBD measured by ITC and 
intrinsic GTPase activities measured by HPLC on the HRas•Mg2+•GTP protein. 
                      Protein T K 
[Ras] 
µM 
[Raf] 
µM 
DG 
kJ mol-1 
DH 
kJ mol-1 
-TDS 
kJ mol-1 
KD 
µM 
T 
K 
kcat 
min-1 
τ 
min. 
        K              HRasWT 298 60 778 -36.4 -8.10 ± 0.23 -28.3 0.424 ± 0.12 310 0.026 26.85 
HRasN26K 298 40 454 -37.7 -16.10 ± 0.17 -21.7 0.248 ± 0.03 310 0.023 30.27 
HRasH94D 298 45 627 -36.3 -11.8 ± 0.19 -24.5 0.436 ± 0.07 310 0.021 32.92 
HRasA66T 298 52 546 -37.8 -14.0 ± 0.29 -23.9 0.239 ± 0.05 310 0.021 32.33 
           kcat represents the hydrolysis rate constant and is calculated as 1/t. τ represents the half-life for the GTP 
hydrolysis (τ=t*ln2). ITC experiments were done according to the experimental section 2.2.4. The 
experimentally obtained thermograms and signature plots are shown in Figure F of the appendix section. The 
N parameter (binding sites) was allowed to vary during the fitting procedure. The greatest deviation from a 1:1 
ratio was obtained for RasH94D with N= 1.0 ± 0.22. The error on all the other measurements was always smaller 
than ± 0.2. 
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3.4.2.2   2(T)-to-1(0) Transition: S39L and E3V 
Ser39 and Glu3 are associated with the 2(T)-to-1(0) transition and show relatively high 
pressure coefficients, with B1,2 ≥ σ0 (σ0 being the standard deviation) [171]. They are not 
involved with any known rasopathy but both constitute the binding site of the small 
compound Zn2+-BPA, as determined previously by paramagnetic relaxation enhancements 
in 31P NMR and [1H-15N]-HSQC experiments [158]. Their location on the surface of HRasWT 
is shown in Figure 3.44. Ser39 lies at the end of the switch 1 in the strand b2 and is involved 
in the interaction with GAP-334 (H-bond to Glu950 [83]), Raf-RBD (H-bond to Arg67 and 
Arg89, [64]) and RalGDS (H-bond to Met30 and Tyr31, [253]). Exchange towards the non-
polar amino acid leucine directly hinders some of these polar contacts due to the absence 
of the side chain hydroxyl group on the mutant. Glu3 is located in the b1 strand and is not 
involved in any interaction with GAP’s, GEF’s or effectors. In the protein, Glu3 establishes 
solvent-mediated polar contacts with Glu76 from helix a2 (Figure 3.44B). Mutation towards 
the non-polar valine very likely interrupts this interaction. Contrary to the other mutants 
investigated so far, E3V is located far away from the catalytic centre. Any shift of the 
equilibrium at the nucleotide-bound level would preclude an interesting result. 
 
Figure 3.44. Localization on the HRasWT•Mg2+•GppNHp surface the amino acid residues 
Ser39 and Glu3 that were subjected to SDM. They are sensitive to the 2(T)-to-1(0) transition 
upon pressure perturbation and were mutated with the prospect of shifting the equilibrium in 
the same direction. A. The localization of both residues is shown in orange. Switch 1 is 
coloured in green, switch 2 is coloured in red and the Mg2+ ion is coloured in magenta. B. Key 
features near each residue, including polar contacts, are highlighted. pdb: 5p21. 
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3.4.2.2.1   31P NMR GppNHp and GTP Spectra. Raf Interaction and GTPase Activity 
Both mutants show notable differences when compared with RasWT in terms of their 
equilibrium between states 1(T) and 2(T). This is directly observed from the GppNHp-bound 
31P NMR spectra shown in Figure 3.45A. The equilibrium constants calculated at the g-
phosphate are 1.5 and 2.0 for RasS39L and RasE3V, respectively. Compared to RasWT (K12= 
1.7), the first mutant is slightly shifted towards state 1(T) and the second one is significantly 
shifted towards state 2(T). 
The increased state 1(T) on 
RasS39L can be observed not 
only for the g- but also for the a-
phosphate and the averaged 
peak linewidths are smaller 
than the corresponding ones in 
RasWT (Table 3.15). There are 
no changes in the positions of 
state 2(T), however when 
compared with RasWT, state 
1(T) is downfield shifted by a Dd 
of 0.1 and 0.07 ppm at the a- 
and g-phosphates, 
respectively. A strong upfield 
shift of ca. -0.1 ppm of the a-
phosphate is also observed in 
the 31P NMR spectra of the 
GDP-bound complex (Figure B, 
appendix). The 31P NMR 
spectra of RasS39L bound to 
GTP is identical to the wild type 
one (Figure 3.45B) in terms of 
chemical shifts, linewidths and 
equilibrium constants (K12= 
11.8 and 11.3, respectively). 
Pronounced effects are 
observed in the case of RasE3V 
if one has in consideration the 
Figure 3.45. Effect of the mutated residues sensing the 
conformational transition 2(T)-to-1(0) in the equilibrium dynamics of 
the bound nucleotide A. Ras•Mg2+•GppNHp (S39L 1.0 mM, 3000 
scans; E3V 1.8 mM, 3000 scans) and B. Ras•Mg2+•GTP (S39L 1.0 
mM, 3000 scans; E3V 1.5 mM, 2000 scans). 
All the measurements were done at 278 K in a 202.4 MHz magnetic 
field (500MHz spectrometer). The proteins were dissolved in buffer 
F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with 
additionally 0.2 mM DSS and 5% D2O. A Lorentzian line broadening 
of 15 Hz was applied to the FID. The calculated shift values, 
linewidths and equilibrium constants are given in Table 3.15. 
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distant localization of this residue with respect to the nucleotide. The mutation leads to a 
18% increase in the population of state 2(T) of g-phosphate but has no effect on the a-
phosphate (Figure 3.45A). These effects are observed only in the GppNHp spectrum, with 
the GTP-bound nucleotide being again virtually identical to the one of RasWT. The only 
additional feature is an intense peak located at d= -5.5 ppm that can be ascribed most likely 
to the presence of impurities during sample preparation (Figure 3.45B). Within the limits of 
error the obtained chemical shifts and linewidths remain unperturbed by the mutation in 
both cases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.15. 31P NMR chemical shift values and linewidths obtained for the 
different mutants of HRas(1-166). The mutated residues were selectively 
chosen according to their involvement in the pressure modulated 2(T)-to-
1(0) conformational transition. 
          Protein 
complex 
a-phosphate b-phosphate g-phosphate 
K12b d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T),2(T)
a 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
               Mg2+•GDP 
       WT -10.50 -1.97 -- -- 
S39L -10.60 -2.03 -- -- 
E3V -10.47 -1.99 -- -- 
       Mg2+•GppNHp 
       WT -11.17 -11.68 -0.25 -2.57 -3.33 1.7 
S39L -11.08 -11.67 -0.25 -2.50 -3.35 1.5 
E3V -11.23 -11.68 -0.27 -2.59 -3.33 2.0 
        Mg2+•GTP 
       WT -11.68 -14.87 -6.63 -7.98 11.3 
S39L -11.65 -14.84 -6.54 -7.97 11.8 
E3V -11.68 -14.85 -- -7.98 -- 
               a-phosphate b-phosphate g-phosphate 
--  Dn1/2 1(T) [Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T),2(T)
a 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
               Mg2+•GDP 
       WT 46.89 30.02 --  
S39L 51.39 35.00 --  
E3V 29.54 33.00 --  
        Mg2+•GppNHp 
       WT 105.39 75.15 45.84 74.47 55.07  
S39L 98.05 62.88 42.55 48.95 50.82  
E3V 122.22 67.33 54.39 78.74 53.00  
        Mg2+•GTP 
       WT 54.74 45.66 20.33 35.44  
S39L 53.36 37.95 41.55 32.43  
E3V 61.71 47.12 -- 43.18  
              All the values are fitted from the experimental spectra recorded at 278 K and 
pH 7.5. The maximum estimated errors are ± 0.07 ppm in chemical shift 
values and ± 0.4 Hz in linewidths for the g-phosphate. An LB=15 Hz was 
applied to the FID and subtracted afterwards from the final fitted linewidths. 
a States 1(T) and 2(T) of the b-phosphate in cannot be separated at the 
magnetic field used and were therefore fitted as a single Lorentzian line. 
b The equilibrium constant, K12, was calculated using the population 
distribution on the g-phosphate. The associated error is ± 0.2. 
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The calculated kcat values (Table 3.16), as well as the associated half-lifes are virtually 
identical. ITC measurements showed that RasS39L binds Raf-RBD with a 5.7-fold higher 
affinity than RasWT (KD= 0.074 vs 0.424 µM). The interaction proceeds with a great enthalpic 
contribution in the case of the mutant (DH= -24.0 vs -8.10 kJ mol-1). Regarding RasE3V, the 
affinity towards Raf is identical to the one measured for wild type. 
In the light of the present results, RasS39L and RasE3V have different and somewhat opposite 
population distributions, despite the mutated residues being involved in the same 
conformational transition (the former stabilises state 1(T) but shows an enhanced binding 
affinity to Raf, the later stabilises state 2(T) and shows an unperturbed affinity to Raf). 
A last set of experiments was conducted using the GppNHp-bound nucleotide RasS39L and 
RasE3V with the aim of further characterise state 1(T). It was hypothesised that both could 
have a hidden contribution from state 1(0), obscured by the overall similarity (same 
chemical shifts, same linewidths) between the 31P NMR spectra of the mutants and the wild 
type protein. To test if this was the case, they were titrated with the small compound Cu2+-
cyclen that binds near the g-phosphate only when Ras exists in state 1(T) and acts as a 
selective sensor for its identification [254]. The results are shown graphically and 
numerically in Figure C and Table I of the appendix section. The effect of Cu2+-cyclen in the 
spectra RasS39L and RasE3V was the same: with increasing amounts of the drug the line 
broadening of state 1(T) increases dramatically up to a point where it disappears beyond 
detection. The effect is due to the paramagnetic influence of the Cu2+ ion that selectively 
collapses the line of state 1(T). Since paramagnetic relaxation is a localized effect, the other 
peaks of the spectra remain unperturbed. If the equilibrium was shifted in the 2(T)-to-1(0) 
direction by the mutations, a close-by, small resonance line corresponding to state 1(0) 
should be visible in the spectrum after collapsing state 1(T). However, the titration with Cu2+-
cyclen reveals no further spectral features. 
Figure 3.16.  Thermodynamics of interaction between HRas•Mg2+•GppNHp and Raf-RBD measured by ITC 
and intrinsic GTPase activities measured by HPLC in the HRas•Mg2+•GTP complex. 
                      Protein T K 
[Ras] 
µM 
[Raf] 
µM 
DG 
kJ mol-1 
DH 
kJ mol-1 
-TDS 
kJ mol-1 
KD 
µM 
T 
K 
kcat 
min-1 
Τ 
min. 
                      HRasWT 298 60 778 -36.4 -8.10 ± 0.23 -28.3 0.424 ± 0.12 310 0.026 26.85 
HRasS39L 298 30 258 -40.8 -24.0 ± 0.33 -16.8 0.074 ± 0.01 310 0.029 24.04 
HRasE3V 298 28 486 -35.6 -19.4 ± 0.43 -16.2 0.603 ± 0.01 310 0.027 27.12 
                      kcat represents the hydrolysis rate constant and is calculated as 1/t. τ represents the half-life for the GTP 
hydrolysis (τ=t*ln2). ITC experiments were done according to the experimental section 2.2.4. The 
experimentally obtained thermograms and signature plots are shown in Figure F of the appendix section. 
The N parameter (binding sites) was allowed to vary during the fitting procedure. The greatest deviation from 
a 1:1 ratio was obtained for RasE3V with N= 1.0 ± 0.22. The error on all the other measurements was always 
smaller than ± 0.2. 
The greatest deviation from a 1:1 ratio was obtained for RasS39L with N= 0.89 ± 0.12. The error on all the 
other measurements was always smaller. 
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3.4.2.3   2(T)-to-3(T) Transition: H27E and D33K 
Stabilising state 3(T) is a very attractive idea from a pharmaceutical point of view, especially 
in the case of oncogenic Ras because promoting the transition would have two immediate 
and assisted effects: the change in conformation would drive away the protein from the 
permanently active state 2(T) and at the same time the high intrinsic GTPase activity of 
state 3(T) would account for an unprecedented re-cycling of Ras towards the guanine 
diphosphate state (from “(T)” to “(D)”). Contrary to the mutants studied above, the two 
residues are located in the switch 1 region and account for the stabilisation of the H2O 
bonding network around the active site. Their localisation on the surface of the protein is 
shown in Figure 3.46, together with the structural details in their vicinity. 
 
 
 
3.4.2.3.1   31P NMR GppNHp and GTP Spectra. Raf Interaction and GTPase Activity 
The GppNHp spectrum of the mutant RasH27E has a significantly lower equilibrium constant 
(K12=1.0) than the wild type counterpart (K12=1.7, Figure 3.47A and Table 3.17). The 
mutation promotes a clear effect by increasing the population of state 1(T), which becomes 
downfield shifted by d= 0.07 and d=0.34 ppm at the g- and a-phosphates, respectively, when 
compared to RasWT A similar downfield shift of d= 0.06 ppm is also observed for the b-
phosphate alongside with a 55% broadening of its resonance line. The corresponding 
RasH27E•GTP spectrum on the other hand, shows no significant differences from RasWT 
(Figure 3.47B), albeit the K12 values are slightly different (10.0 vs 11.3). The GDP spectrum 
Figure 3.46. Localization on the HRasWT•Mg2+•GppNHp surface the amino acid residues His27 and Asp33 
that were subjected to SDM. They are sensitive to the 2(T)-to-3(T) transition upon pressure perturbation and 
were mutated with the prospect of shifting the equilibrium in the same direction. A. The localization of both 
residues is shown in orange. switch 1 is coloured in green, switch 2 is coloured in red and the Mg2+ ion is 
coloured in magenta. B. Key features such as polar contacts are highlighted near each residue. pdb: 5p21. 
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of RasH27E (Figure B, appendix) 
shows a large  downfield shift of 
the a-phosphate, with a Dd= 
0.36 ppm (d= -10.50 ppm in 
RasWT and d= -10.14 ppm in 
RasH27E, Table 3.17). 
The differences observed 
between RasD33K and RasWT 
regarding the GppNHp-bound 
nucleotide are remarkable: the 
population distribution at the g- 
and a-phosphates is collapsed 
and almost completely shifted 
towards state 2(T). State 1(T) 
exists as a residual line located 
within the noise level. The 
equilibrium constant is 11.3 and 
closely resembles the one of 
RasWT•Mg2+•GTP (Table 3.17). 
At the a-phosphate, state 1(T), 
if present, is not clearly 
separated from the main 
resonance line. Additional 
differences between D33K and 
wild type are observed in terms 
of chemical shifts: the 
calculated values for the g1(T)- 
and g2(T)-phosphates  in the 
former are d= -2.47 and d= -
3.40 ppm, respectively and the corresponding ones in the latter are d= -2.57 and d= -3.33 
ppm, respectively. The difference accounts for a Dd of 0.1 ppm for state 1(T) and 0.07 ppm 
for state 2(T). The single resonance line of the a-phosphate lies at d= -11.46 ppm, exactly 
in between the two states observed in RasWT. Contrary to the downfield shift of the a- and 
g-lines, the b-phosphate is shifted upfield by a Dd of -0.06 ppm. The spectra of the state 1(T) 
mutant RasT35S•Mg2+•GppNHp is also shown in Figure 3.47A for comparison of the relative 
Figure 3.47. Effect of the mutated residues sensing the 
conformational transition 2(T)-to-3(T) in the equilibrium dynamics of 
the bound nucleotide A. Ras•Mg2+•GppNHp (H27E 1.57 mM, 2600 
scans; D33K 3.0 mM, 800 scans, T35S 0.75 mM 2000 scans) and 
B. Ras•Mg2+•GTP (H27E 0.8 mM, 3000 scans; D33K 2.94 mM, 3000 
scans). 
All the measurements were done at 278 K in a 202.456 MHz 
magnetic field (500 MHz spectrometer). The proteins were dissolved 
in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with 
additionally 0.2 mM DSS and 5% D2O. A Lorentzian line broadening 
of 15 Hz was applied to the FID. The calculated shift values, 
linewidths and equilibrium constants are given in Table 3.17. 
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positions of the signals. No significant differences are observed between the GTP-bound 
mutants and RasWT. Based on the GppNHp-bound spectra, RasD33K seems to be shifted 
towards state 2(T). However, a significant contribution from state 3(T), which is coupled and 
indistinguishable from state 2(T) by 31P NMR, can also be assumed at this point. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.17. 31P NMR chemical shift values and linewidths obtained for the 
different mutants of HRas(1-166). The mutated residues were selectively 
chosen according to their involvement in the pressure modulated 2(T)-to-
3(T) conformational transition. 
          
Protein 
a-phosphate b-phosphate g-phosphate 
K12b d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T),2(T)
a 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
               Mg2+•GDP 
       WT -10.50 -1.97 -- -- 
H27E -10.14 -1.91 -- -- 
D33K -10.22 -2.20 -- -- 
       Mg2+•GppNHp 
       WT -11.17 -11.68 -0.25 -2.57 -3.33 1.7 
H27E -10.83 -11.67 -0.19 -2.50 -3.25 1.0 
D33K -11.46c -0.31 -2.47 -3.40 11.3 
        Mg2+•GTP 
       WT -11.68 -14.87 -6.63 -7.98 11.3 
H27E -11.65 -14.83 -6.35 -7.94 10.0 
D33K -11.66 -14.92 -- -7.97 -- 
               a-phosphate b-phosphate g-phosphate  
 Dn1/2 1(T) [Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T),2(T)
a 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
-- 
               Mg2+•GDP 
       WT 46.89 30.02 --  
H27E 50.32 32.00 --  
D33K 65.55 31.03 --  
        Mg2+•GppNHp 
       WT 105.39 75.15 45.84 74.47 55.07  
H27E 91.12 120.31 70.00 61.82 56.72  
D33K 77.31c 41.92 73.40 55.07  
        Mg2+•GTP 
       WT 54.74 45.66 20.33 35.44  
H27E 49.73 42.91 45.12 36.57  
D33K 78.05 55.51 -- 49.79  
              All the values are fitted from the experimental spectra recorded at 278 K 
and pH 7.5. The maximum estimated errors are ± 0.07 ppm in chemical shift 
values and ± 0.4 Hz in linewidths for the g-phosphate. An EM function with 
LB=15 Hz was used for processing the FID and subtracted afterwards. 
a States 1(T) and 2(T) of the b-phosphate in cannot be separated at the 
magnetic field used and were therefore fitted as a single Lorentzian line. 
b The equilibrium constant, K12, was calculated using the population 
distribution on the g-phosphate. The associated error is ± 0.2. 
c a-phosphate on RasD33K was fitted with a single Lorentzian line. 
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The measurement of the intrinsic GTPase 
activity shows that RasH27E hydrolyses GTP 
at the same rate as RasWT (kcat= 0.025 min-
1, τ= 28.20 min., Figure 3.48, Table 3.18), 
despite being considerably shifted towards 
state 1(T). RasD33K is surprisingly 1.5 times 
slower than RasWT (kcat= 0.017 vs 0.026 
min-1, Table 3.18) yet the conformational 
equilibria of this mutant is almost 
completely shifted towards a state closely 
resembling 2(T) in RasWT, which is normally 
associated with a faster GTP hydrolysis. 
Addition of Raf-RBD has no influence in the 
catalytic activity of RasH27E (kcat= 0.025 min-
1, τ= 27.39 min.), but induces a slightly 
faster hydrolysis in the case of RasD33K (kcat= 0.019 min-1, τ=36.37 min.), which is yet 
considerably slower than the typical rate of conversion for RasWT alone. 
RasH27E has a slightly higher affinity to the effector (KD= 0.225 ± 0.05 µM) than RasWT (KD= 
0.424 ± 0.12 µM), although the difference is attenuated by the experimental errors of each 
measurement. The associated enthalpy of binding is twice of the recorded for wild type 
(DH= -16.9 ± 0.18 vs -8.10 ± 0.23 kJ mol-1), but both proceed with a similar Gibbs energy. 
The strength of the interaction between RasD33K and Raf is remarkably 26–fold lower than 
RasWT (KD= 10.4 µM). The binding proceeds still with positive enthalpic and entropic 
contributions but the enthalpy variation is much lower than the one of RasWT (DH= -4.24 ± 
0.25 kJ mol-1). 
 
 
Table 3.18. Thermodynamics of interaction between HRas•Mg2+•GppNHp and Raf-RBD measured by 
ITC and intrinsic GTPase activities measured by HPLC in the HRas•Mg2+•GTP complex. 
                      Protein T K 
[Ras] 
mM 
[Raf] 
mM 
DG 
kJ mol-1 
DH 
kJ mol-1 
-TDS 
kJ mol-1 
KD 
µM 
T 
K 
kcat 
min-1 
τ 
min. 
                      HRasWT 298 60 778 -36.4 -8.10 ± 0.23 -28.3 0.424 ± 0.12 310 0.026 26.85 
HRasH27E 298 39.8 637 -38.0 -16.9 ± 0.18 -21.1 0.225 ± 0.05 310 0.025 28.20 
HRasD33K 298 145 1680 -28.5 -4.24 ± 0.25 -24.2 10.4 ± 1.93 310 0.016 41.46 
           kcat represents the hydrolysis rate constant and is calculated as 1/t. τ represents the half-life for the GTP 
hydrolysis (τ=t*ln2). ITC experiments were done according to the experimental section 2.2.4. The 
experimentally obtained thermograms and signature plots are shown in Figure F of the appendix section. 
The N parameter (binding sites) was allowed to vary during the fitting procedure. The greatest deviation 
from a 1:1 ratio was obtained for RasH27E with N= 1.0 ± 0.18. 
           
Figure 3.48. Determination of the intrinsic GTPase 
activity of the GTP-bound mutants RasH27E and 
RasD33K by HPLC at 310K. Upon integration of the 
fluorescence signal, the percentage of Ras-GTP was 
plotted against time and the data fitted with a first 
order exponential decaying function (see Figure 3.43 
for details on the description of the method). The 
obtained rate constants are 0.026, 0.025 and 0.016 
min-1 for WT, H27E and D33K, respectively (see also 
Table 3.18). 
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3.4.3   Interaction Between HRasH27E•Mg2+•GppNHp and Raf-RBD 
A 1.5 mM solution of RasH27E was titrated with increasing amounts of Raf as shown in Figure 
3.49. The experiment shows that for an equimolar concentration of the two proteins, the 
conformational equilibrium is completely shifted towards state 2*(T), characteristic of this 
particular interaction and closely related with state 2(T) (see sections 3.1.1-3 for additional 
details regarding the dynamics of state 2*(T)). This modification is also accompanied by the 
typical upfield shift of the corresponding line by a Dd= -0.27 ppm and with state 2*(T) located 
at d= -3.54 ppm. Similar shifts were found upon titration of wild type HRas and KRas (d2*(T)= 
-3.6 and -3.51 ppm, respectively; Table 3.1 and [117]). The resonances of a- and b-
phosphates remain virtually unperturbed during the titration (Table 3.19). The molecular 
mass of the Ras-Raf complex is 1.5-fold higher than Ras alone. This increase of size is 
directly related with the increase of the spectral linewidths as it can be seen from the b-
phosphate, from Dn1/2= 67.5 Hz in Ras alone to Dn1/2 =102 Hz (1.5-fold) at a 1:1 ratio. This 
direct relationship is however not valid in the case of the a- and the g-phosphates because 
they are exchange broadened 
by the presence of the distinct 
conformational states 1(T) and 
2(T). The apparent dissociation 
constant can also be estimated 
from the 31P NMR spectra given 
the existence of the two distinct 
resonance lines in a slow 
exchange regime located at the 
b-phosphate (blue coloured line 
in Figure 3.49). Their integrals 
were considered to be 
proportional to the 
concentration of free Ras 
([Ras]free) and to the 
concentration of the Ras-Ras 
complex ([RR]) for a given 
molar ratio. The value of [RR] is 
given by the ratio of the areas 
multiplied by [Ras]free. From this 
assessment, an apparent KD of 
Figure 3.49. 31P NMR spectroscopy on the titration of 
HRasH27E•Mg2+•GppNHp with the effector Raf-RBD measured at 
278 K and pH 7.5. To an initial 1.5 mM solution of RasH27E dissolved 
in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with 
additionally 0.2 mM DSS, 150 mM NaCl and 5% D2O, increasing 
amounts of Raf-RBD from a highly concentrated 6.5 mM stock 
solution were added, up to a final ratio of 1:1. The evolution of state 
2(T) into 2*(T) upon Raf binding is indicated. The integrated areas of 
the fitted Lorentzian lines at the b-phosphate, coloured in blue, are 
assumed to be directly proportional to the concentration of free Ras 
(Rasfree) and Ras-Raf (RR) complex and were used to calculate the 
apparent KD of the interaction. An EM function with LB= 15Hz was 
applied to the FID during the processing of the data. The chemical 
shifts and linewidths are shown in Table 3.19. 
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ca. 100 µM was obtained which does not agree with the ITC measurements. It should be 
mentioned that this method is intrinsically inaccurate because relies on concentrations in 
the order of the mM range required in 31P NMR but typically considered too high for a 
realistic determination of µM or sub-µM binding affinities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.19. 31P NMR chemical shift values and linewidths for the protein-protein 
complex HRasH27E(1-166)•Mg2+•GppNHp•Raf-RBD. 
Protein 
complex 
Ras:
Raf 
a-phosphate b-phosphate g-phosphate 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T),2(T)
a
 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
       RasH27E -- -10.83 -11.67 -0.22 -2.52 -3.27 
       + Raf-RBD 1:0.6 -11.09 -11.72 -0.25 -2.55 -3.47 
 1:1 -- -11.65 -0.26 -- -3.54 
                 a-phosphate b-phosphate g-phosphate 
  Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T),2(T)a 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
                RasH27E -- 122 103.8 67.5 61.5 66.5 
        + Raf-RBD 1:0.6 194 112 74.6 86.5 106.1 
 1:1 -- 122.8 102 -- 60.5 
                All the values are fitted from the experimental spectra recorded at 278 K, pH 7.5. The 
maximum estimated errors from the fitting procedure are ± 0.02 ppm in chemical shift 
values and ± 0.12 Hz in linewidths for the g-phosphate. An LB= 15 Hz was applied to 
the FID and subtracted afterwards from the final fitted linewidths. 
a States 1(T) and 2(T) of the b-phosphate cannot be separated at the magnetic field 
used. 
KD =
[Ras] free.[Raf ] free
[RR]
[Ras]total = [Ras] free + [RR]
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3.4.4   Interaction Between HRasD33K•Mg2+•GppNHp and Raf-RBD 
Due to its intriguing properties, RasD33K was subjected to an additional series of biophysical 
studies, including the interaction with Raf-RBD. The results from the titration indicate that 
the residual population of state 1(T) (red coloured line in Figure 3.50) rapidly disappears 
upon addition of 0.5 molar equivalents of Raf. There is a direct response to the presence of 
effector as this population is converted into state 2(T). The typical upfield shift of state 2(T) 
is also observed as before upon titration of RasWT with the same protein (from d= -3.40 ppm 
to d= -3.63 ppm at 1:2 ratio, Table 3.20). This indicates that the changes in the chemical 
environment of the g-phosphate that accompany the process of binding are identical to the 
ones observed for RasWT. However, the situation is different for the a- and b-phosphates: 
the initial resonance observed at the a-phosphate in RasD33K alone (d= -11.46 ppm) seems 
to split into another component as soon as Raf is added and remains with the same 
configuration in all the subsequent steps of the titration (i.e. there is no additional change in 
chemical shifts or linewidths as the concentration of Raf is increased). This behaviour is 
markedly different from the titration of RasWT, where the a-phosphate is also converted into 
state 2*(T) shifting upfield by a Dd of -0.15 ppm (Figure 3.1 and [117]. The formation of state 
2*(T) is thus impaired in 
RasD33K for the a-phosphate, 
which might explain the low 
affinity of binding for the 
protein-protein complex (Table 
3.18). The response of the b-
phosphate is characterised by 
a severe increase of its line 
broadening and by the 
appearance of an additional 
component that protrudes from 
its right-side as a broad 
shoulder. This shoulder seems 
to be, in fact, formed by multiple 
resonances that cannot be 
resolved separately. An 
unknown peak at ca. 1.04 ppm 
can be found in all the spectra 
of the series and increases in 
Figure 3.50. 31P NMR spectroscopy on the titration of 
HRasD33K•Mg2+•GppNHp with the effector Raf-RBD measured at 
278 K and pH 7.5. To an initial 2.94 mM solution of RasD33K dissolved 
in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with 
additionally 0.2 mM DSS, 150 mM NaCl and 5% D2O, increasing 
amounts of Raf-RBD from a highly concentrated 6.5 mM stock 
solution were added, up to a final ratio of 1:2. An EM function with 
LB= 15 Hz was applied to the FID during the processing of the data. 
The chemical shifts and linewidths are shown in Table 3.20. 
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intensity as the concentration of Raf-RBD is increased (note that this peak is already 
present in the spectrum of Ras alone). Within the available data It is not possible to ascertain 
if this peak is just an impurity or a new feature characteristic of the mutant RasD33K. 
In the light of these results, the previous classification of RasD33K as a state 2(T)/3(T) fits its 
spectroscopic properties observed by 31P NMR but is not in line with the typical biochemical 
characteristics of state 2(T) (higher affinity towards effectors, faster intrinsic and/or GAP-
mediated hydrolysis, affinity towards GAP’s). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.20. 31P NMR chemical shift values and linewidths for the protein-protein 
complex HRasD33K(1-166)•Mg2+•GppNHp•Raf-RBD. 
Protein 
complex 
Ras:
Raf 
a-phosphate b-phosphate g-phosphate 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
       RasD33K -- -11.46 -0.31 -2.47 -3.40 
       + Raf-RBD 1:0.5 -- -11.42 -- -0.34 -- -3.64 
 1:1 -- -11.37 -- -0.32 -- -3.62 
 1:2 -- -11.41 -- -0.33 -- -3.63 
                 a-phosphate b-phosphate g-phosphate 
  Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
                RasD33K -- 77.31 41.92 73.40 55.48 
        + Raf-RBD 1:0.5 -- 106.37  63.65 -- 60.95 
 1:1 -- 106.45  81.00 -- 60.25 
 1:2 -- 120.31  84.15 -- 63.85 
                All the values are fitted from the experimental spectra recorded at 278 K, pH 7.5. The 
maximum estimated errors from the fitting procedure are ± 0.02 ppm in chemical shift 
values and ± 0.12 Hz in linewidths for the g-phosphate. An LB= 15 Hz was used in 
the processing of the FID and subtracted afterwards from the final fitted linewidth 
values. 
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3.4.5   Interaction Between HRasD33K•Mg2+•GppNHp and NF1 
The features of the RasD33K•NF1 complex were also investigated herein and revealed to be 
very distinct from the ones of its counterpart RasWT•NF1. The most obvious difference lies 
in the fact that a resonance that unequivocally corresponds to state 3(T) cannot be identified 
in the 31P NMR spectra. As seen in Figure 3.51, addition of NF1 leads to the appearance of 
an extremely broad line at the g-phosphate that consists of multiple unresolved resonances 
(the fitted component is shown in Figure 3.51 for the ratios 1:0.75 and 1:1 on the g-
phosphate). Even at a molar ratio of 1:2 its centre cannot be accurately located as in the 
case of RasWT•NF1 (Figure 3.39). Furthermore, its centre lies around d= -2.80 ppm (Table 
3.21), which differs by a Dd of 0.2 ppm from the typical state 3(T) located at d= -3.0 ppm in 
the RasWT•NF1 complex (Table 3.12). The relative area of state 2(T) on the g-phosphate 
(green line) does not decrease as the titration proceeds. In fact, its relative area in RasD33K 
alone and in the 1:1.75 Ras-NF1 complex is 1.73 ± 0.17 and 1.83 ± 0.32, respectively (the 
numbers have arbitrary units and were obtained as the integrals of the fitted lines). This 
constitutes an indication that state 2(T) remains unperturbed and cannot effectively be 
converted into state 3(T) by the presence of NF1. 
The b-phosphate is also markedly different from the one in the wild type complex: with 
addition of NF1 it moves upfield, from d= -0.35 ppm up to a maximum of d= -0.17 ppm (Dd= 
-0.18 ppm). More importantly, the saturation behaviour observed in RasWT•NF1 (section 
3.4.1.2) is not observed in the present case (even at a ratio of 1:2 its main component is 
the original line found in RasD33K alone). Similar findings can be found at the a-phosphate: 
at complex ratios of 1:1.75 and 1:2 its main component is still the one of RasD33K alone. The 
resonance arising from the protein complex is again extremely broad and not well-defined. 
As result, the chemical shift values given in Table 3.21 for the a3(T)-phosphate are only a 
rough estimation since a proper fitting of the line is not possible. This result agrees with the 
observations found for the g-phosphate and together they show that RasD33K cannot 
undergo the necessary conformational modifications to achieve state 3(T) which renders it 
incapable of binding NF1 either completely or partially. 
 
The overall results indicate so far that RasD33K has an impaired affinity towards both, Raf-
RBD and NF1. Based on these data, RasD33K does not follow the characteristics of a typical 
state 2(T) mutant, despite the apparent indications given by the shift of the equilibrium at 
the g-phosphate of at the GppNHp-bound spectra level. 
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Figure 3.51. Protein complex formation between RasD33K•Mg2+•GppNHp and NF1 followed 
by 31P NMR spectroscopy at 278 K. To an initial 1.3 mM of Ras dissolved in buffer F (40 mM 
Tris/HCl pH 7.5; 10 mM MgCl2; 2 mM DTE) with additionally 150 mM NaCl, 0.2 mM DSS in 
10% D2O, increasing amounts of the GAP protein NF1 (from a 0.74 mM stock solution) were 
added (the corresponding molar ratios for each step are presented). The concentration of Ras 
and NF1 in the final step (1:2 ratio) was 0.35 mM and 0.7 mM, respectively. An exponential 
filter with LB=15 Hz was applied to the processed FID. Each spectra was obtained by 
accumulation of approximately 10000 scans. The resonance lines corresponding to the a-, b- 
and g-phosphates are indicated as well as the states 1(T) and 2(T), represented by the red 
and green colours, respectively. The dashed vertical lines mark the chemical shift position of 
the initial phosphate resonances observed in RasD33K alone. The new spectral features 
observed from the addition of NF1 to Ras are coloured in blue. As an example, the 
deconvolution into separated Lorentzian lines is shown for two different titration steps (1:0.75 
and 1:1) on the g-phosphate. 
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These results constitute perhaps the first evidence that the common correlation between 
the different structural states 1(T) and 2(T) and their correspondingly different functional 
and biochemical properties should be used with caution, especially when investigating 
atypical mutants, as the correlations might be true for RasWT, partial loss-of-function or 
oncogenic variants but might not apply in other cases [123]. RasD33K can undergo a 
conformational change towards state 2(T)/2*(T) at the g-phosphate in the presence of 
effector. However, the impaired Raf binding observed from ITC can be in part explained by 
the inability of the b- and mostly the a-phosphate to undergo the necessary conformational 
modifications. The interaction with NF1 is also disrupted comparatively to RasWT as the 
binding seems to be severely impaired for all the three phosphate groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Table 3.21 31P NMR chemical shift values and linewidths for the protein-protein complex 
HRasWT(1-166)•Mg2+•GppNHp•NF1. 
         Protein 
complex 
Ras:NF1 
ratio 
a-phosphate b-phosphate g-phosphate 
d3(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T)2(T)
 
[ppm]b 
d3(T) 
[ppm] 
d1(T) 
[ppm] 
d3(T) 
[ppm] 
d2(T) 
[ppm] 
                           RasD33K -- -- -11.52 -0.35 -- -2.67 -- -3.45 
         +NF1 1:0.25 -11.17 -11.52 -0.31 0.46 -- -2.80 -3.43 
 1:0.5 -10.84 -11.49 -0.28 --a -- -2.78 -3.41 
 1:0.75 -10.92 -11.49 -0.27 --a -- -2.82 -3.41 
 1:1.0 -10.70 -11.46 -0.25 --a -- -2.76 -3.40 
 1:1.5 -10.79 -11.46 -0.21 --a -- -2.80 -3.39 
 1:1.75 -10.54 -11.45 -0.20 --a -- -2.82c -3.43c 
 1:2.0 -11.09 -11.51 -0.17 --a -- -2.80c -3.37c 
                    a-phosphate b-phosphate g-phosphate 
  Dn1/2 3(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 
[Hz] 
Dn1/2 3(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 3(T 
[Hz]) 
Dn1/2 2(T) 
[Hz] 
                  RasD33K -- -- 87.38 51.50 -- 397 -- 59.86 
      --   +NF1 1:0.25 202.4 99.16 61.08 559 -- 176.8 62.42 
 1:0.5 162.0 105.7 104.1 --a -- 183.4 67.29 
 1:0.75 184.6 118.6 136.9 --a -- 177.5 67.76 
 1:1.0 184.9 131.9 167.4 --a -- 187.2 77.03 
 1:1.5 187.6 135.9 256.6 --a -- 172.2 81.02 
 1:1.75 174.6 197.4 237.4 --a -- 194.5c 67.05c 
 1:2.0 164.8 159.5 268.9 --a -- 151.7c 113.3c 
         All the values are fitted from the experimental spectra recorded at 278 K, pH 7.5. The 
estimated errors from the fitting procedure are ± 0.02 ppm in chemical shift values and ± 
0.20 Hz in linewidths for the g-phosphate. An LB= 15 Hz was applied to the FID and 
subtracted afterwards to the final fitted linewidth values. 
a The resonance line could not be properly fitted 
b States 1(T) and 2(T) of the b-phosphate cannot be separated at the magnetic field used 
and were therefore fitted as a single Lorentzian line. 
c The given values are an approximation (error ±0.1 ppm and ±5.0 Hz) due to the very broad 
shape of the peaks. 
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3.4.6   31P Longitudinal Relaxation Times of RasWT, RasT35A and RasD33K 
The goal of this study was to evaluate the T1 spin-lattice relaxation for the GppNHp-bound 
RasD33K and to assess how the values compare with RasWT and RasT35A. The experiments 
were carried at 278 K in a spectrometer operating at a 31P frequency of 242.896 MHz (600 
MHz spectrometer). The magnitude of the recorded transverse magnetisation is dependent 
on the time given for the recovery after the initial 180º pulse. The plot of the relative signal 
areas as a function of the τ time is given in Figure 3.52 and the corresponding fitted T1 
values are shown in Table 3.22. Phosphorous relaxation times of nucleotides bound to 
proteins are rarely described in literature. Due to the fact that the 31P atoms are isolated by 
their shell of oxygen atoms from other spins of the lattice, rather long T1 times are to be 
expected. Indeed, the shortest T1 presently recorded is within the range of 3 seconds. The 
values show that for all the three proteins, the relaxation rate of the a-phosphate is in 
average 1.5 times faster than the b- and g-phosphates. If one compares the three proteins 
in terms of each phosphate group separately, the relaxation rates are very similar, i.e. the 
state 1(T) RasT35A and the state 2(T) RasD33K are similar to each other and also similar to 
RasWT whose 1(T)/2(T) T1 times were averaged. The only major difference is observed in 
terms of M0: the amount of longitudinal relaxation when the nuclear spins are fully relaxed 
is much lower in the case of RasD33K than in the other two proteins. The reason for this 
difference is simply related with the use of relative units for the calculation of the integrated 
areas and has no intrinsic biochemical meaning (in other words, all the plotted areas in the 
y axis should have been divided by the area of the signals obtained at M0, in order to 
normalise the y scale from -1 to +1). Comparable T1 measurements for RasWT and RasT35A 
are available from previous work performed at our department [116], where a magnetic field 
operating at a 31P frequency of 202.456 MHz (500 MHz spectrometer) was used. The rate 
of relaxation depends on the magnetic field strength and therefore the two measurements 
have different T1 times. Generally T1 tends to decrease as the field strength increases. 
However, the comparison between the published data with the present one shows an 
opposite effect: the 31P NMR T1 times of RasWT and RasT35A decrease as the magnetic field 
increases from 202.4 to 242.8 MHz. 
Normally T1 is the shortest when the correlation time τc is approximately equal to the Larmor 
frequency. Molecules tumbling faster or slower are less efficient at spin-lattice relaxation, 
having therefore longer T1 values. For atoms in highly mobile molecules (such as free 
water), changing field strength (and hence the Larmor frequency) will not appreciably alter 
the fraction of protons moving at this frequency. Thus, T1 is generally not much affected. 
For atoms in molecules with intermediate or low mobility, however, shifting the magnetic 
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field to a higher value may significantly decrease the fraction of these nuclei that are able 
to interact at the new (higher) Larmor frequency. 
 
 
 
 
Based on the multiple studies conducted so far on RasD33K, this mutant is considerably 
different from RasWT. The present analysis is relevant since T1 times affect directly signal 
sensitivity and integration accuracy in NMR experiments. However, they do not provide 
additional clues about the biochemical nature of the protein. Nevertheless, the titration 
experiments conducted in the above sections 3.4.4 and 3.4.5 for the interaction with Raf-
RBD and NF1 unequivocally elucidate important biochemical aspects. 
Since the primary goal for investigating RasD33K was to promote a state 2(T)-to-3(T) 
transition (section 3.4.2.3), one question remains: was the equilibrium shifted in the 
expected direction? From the 31P NMR titration measurements it does not seem to be the 
case. Nevertheless, a true binding affinity assay involving a GAP protein such as NF1 (not 
only for RasD33K but for all other mutants studied herein) remains to be done. Several 
attempts were made using ITC but in all the cases no obvious binding curves could be 
Table 3.22. Phosphorous T1 relaxation times in the HRas(1-166)•Mg2+•GppNHp proteins. 
          Protein T /K a-phosphate b-phosphate g-phosphate 
          RasWT 278 3.10 ± 0.05 4.35 ± 0.07 4.81 ± 0.11 
RasT35A 278 2.83 ± 0.07 4.32 ± 0.14 4.25 ± 0.10 
RasD33K 278 2.98 ± 0.1 4.02 ± 0.15 4.93 ± 0.31 
          T1 is given in seconds. The data was obtained from a proton-decoupled inversion recovery 
experiment at 242.896 MHz. 
Figure 3.52. T1 relaxation times in HRas(1-166)•Mg2+•GppNHp. The integrals of the resonance lines of the a-, 
b- and g-phosphates were plotted as a function of time, t, in an inversion recovery experiment (eqn. 10, 
experimental section 2.2.5.4). The lines corresponding to the two conformational states were averaged and the 
time allowed for the recovery of the magnetization was varied between 0.01 and 21.0 s. Measurements were 
performed for RasWT (-=-), RasT35A (--) and RasD33K (-¿-) at 278 K in a spectrometer operating at a frequency 
of 242.896 MHz. All the protein samples were used at the same concentration of 1.0 mM and dissolved in buffer 
F (40 mM Tris/HCl pH 7.5; 10 mM MgCl2; 2 mM DTE) with additionally 0.2 mM DSS in 10% D2O. The relaxation 
times obtained from the fitting routine are shown in table 3.22. 
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obtained due to severe artefacts in the heat signatures, supporting the idea that Ras-GAP 
complex formation does not obey to a single step and/or to steady-state conditions [255, 
256]. 
The assignment of RasD33K as being either predominantly shifted towards 1(T) or 2(T) is not 
straightforward: this mutant is biochemically similar to a typical state 1(T) (such as T35S or 
Y32R/W [123]) but its conformational equilibria is almost completely shifted towards state 
2(T) from an NMR point of view. More importantly, it gives the first evidence that the 
common correlation between the different structural states 1(T) and 2(T) and their 
correspondingly different functional and biochemical properties should be used with 
caution. 
Indeed, not all known state 1(T) mutants show a decreased affinity to effector or GAP 
proteins and/or a decreased GTPase activity (although being generally the case, there are 
exceptions [51, 123]). As result, and based in the 31P NMR spectra of the GppNHp-bound 
nucleotide (Figure 3.47), RasD33K is hereafter classified as a state 2(T) mutant. Additional 
preliminary results from [1H-15N]-HSQC NMR (see section 3.4.9) support this conclusion: 
just as the typical state 1(T) RasT35S shows additional cross-peaks (relative to wild type) that 
are representative of state 1(T), also RasD33K shows additional cross-peaks that seem to be 
representative of state 2(T) and that are not observable in RasT35S. A detailed investigation 
of peak volumes between the three proteins (WT, T35S, D33K) is detrimental to understand 
the exchange mechanisms between states 1(T) and 2(T). The analysis is being presently 
conducted at our department. The importance of residue 33 in the modulation of the 
dynamics of the equilibrium between the two states can also be further investigated in the 
future by exploring the effect of replacement to other amino acids. 
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3.4.7   31P HP NMR on HRas(1-166)D33K•Mg2+•GppNHp 
RasD33K opens the possibility for investigating the equilibria starting from the point of view 
of states 2(T) for the first time. In fact, to the best of the authors knowledge, this is the only 
known mutant whose equilibria at ambient pressure almost does not contemplate the 
contribution of state 1(T). Its conformational dynamics and unusual functionality constitutes 
one of the most surprising findings among the body of work performed within this thesis. 
A total of 21 steps were performed in the 31P HP NMR series of RasD33K, ranging from 0.1 
up to 200 MPa. Figure 3.53 shows the 31P HP NMR series of 11 of these steps with intervals 
of 20 MPa. The dependence of the chemical shifts as a function of pressure is shown 
graphically in Figure 3.54 and numerically in Table 3.23. 
The most obvious pressure-induced change is the repopulation of state 1(T) at the g-
phosphate given by the increase of its corresponding integrated area (red line Figure 3.53). 
At the same time its resonance line shifts downfield by a Dd of 0.054 ppm, (between 80 and 
200 MPa. Below 80 MPa this resonance could not be properly fitted due to its only residual 
population). The downfield shift is accentuated upon correction (Dd= 0.156 ppm, from d= -
2.406 to d= -2.250, Figure 3.54, and Table J appendix section) because the g-phosphate of 
free Mg2+•GppNHp moves in the opposite direction (i.e. upfield, Figure 3.26) than the g-
phosphate of the protein. The same behaviour is also observed for state 2(T). This signal 
(represented by the orange coloured lines in Figure 3.54) shows a very large downfield shift 
by a Dd= 0.47 ppm, from d= -3.40 ppm at 0.1 MPa to d= -2.93 MPa at 200 MPa. 
The pressure dependence of the a-phosphate indicates that the re-population of state 1(T) 
is not possible in this case. Between the first and the last pressure steps the signal broadens 
slightly (ca. 8%) and moves downfield by Dd= 0.460 ppm (Dd= 0.480 ppm upon correction); 
the signal seems to consist of at least two components at high pressures (180-220 MPa) 
and has an ill-defined centre and a non-Lorentzian shape, with the components being too 
close together to allow an independent fit. Regarding the b-phosphate, its pressure 
dependency is similar to the one observed for RasWT and RasT35S, shifting upfield (Dd= -0.09 
ppm) for the uncorrected shift values and downfield (Dd= 0.168 ppm) upon correction. 
The fitting of a Taylor polynomial (eqn. nº15, experimental section 2.2.5.4) yielded again 
small and mostly negative second order B2 coefficients which indicate a rather linear 
pressure dependence of the bound nucleotide. Although some exceptions occur such as 
the b-phosphate that shows a B2 value markedly higher than B1 (1.25 ppm GPa-2 vs -0.68 
ppm GPa-1, Table 3.23). In most curves, the fitting of the DG and DV parameters was only 
accomplished when fixing the initial and final chemical shift values, d1 and d2. 
 
3. Results 
 
172 
 
Figure 3.53. Conformational equilibria of HRasD33K(1-166)•Mg2+•GppNHp as a function of pressure 
determined by 31P NMR at 278 K. The 4.45 mM protein dissolved in buffer F (40 mM Tris/HCl pH 7.5, 
10 mM MgCl2, 2 mM DTE) with additionally 0.4 mM DSS and 20% D2O was subjected to increasing 
step-variations of pressure, up to a maximum of 200 MPa. Each spectrum was obtained by 
accumulation of 800 scans. The evolution of states 1(T) and 2(T) is represented by the red and green 
lines, respectively. The 31P resonances of the free nucleotide observed at higher pressures are also 
indicated. The last step corresponds to the reversibility test of the pressure-induced changes. The 
fitted chemical shift values for all the resonance lines are listed in Table J of the appendix section. 
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Figure 3.54. Corrected pressure dependence of 31P chemical shifts of HRasD33K(1-166)•Mg2+•GppNHp 
recorded at 278 K. The Ddfreenuc fit values were applied as correction factors upon addition or subtraction to 
the dRas uncorrected values, depending on the direction of the observed shifts, leading to the final dcorrected values, 
represented here for each plot as orange lozenges (-¿-). The uncorrected shift values are also plotted as 
black circles (-●-). The second order polynomial fit of a Taylor expansion was applied for the determination 
of B1 and B2 and the values are presented on Table 3.23. The calculated chemical shift differences, 
Dd=d200MPa-d0.1MPa, are shown near each curve. In the case of the g1(T)-phosphate Dd=d200MPa-d80MPa. Note 
that the vertical scaling is different for each plot to allow a better visualisation of the details from the different 
curves. 
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Within the limits of error the 
values obtained for the a-, b- 
and g2(T)-phosphates are very 
similar, leading to a similar 
pressure-dependent similar 
type of transition for the three 
phosphate groups. Their 
averaged DG and DV values are 
5.62 kJ mol-1 and 59.87 mL mol-
1, respectively for Ras 
uncorrected, and 5.93 kJ mol-1 
and 59.2 mL mol-1 for Ras 
corrected. The application of 
the correction does not change significantly the thermodynamics, contrary to the 
observations for RasWT, where the correction seems to exert a greater influence (Table 
3.23). In the case of the g1(T)-phosphate, considerably higher molar free energies and 
volumes were obtained when compared with the other three phosphate groups, and again 
within similar values between the corrected and uncorrected cases (DGcorrected= 14.3 ± 0.8 
kJ mol-1 and DVcorrected= -105 mL mol-1), which is indicative that state 1(T) is most likely 
related to a conformational modification that is different than the one sensed by the other 
phosphates. 
The fit of LnK12 as a function of pressure (Figure 3.55) leads to a DG12 of 3.40 kJ mol-1 and 
DV12 of -16.72 mL mol-1, respectively. An identical volume variation was found in the case 
of RasWT (DV= -18.63 mL mol-1, Figure 3.30), although the energy required for the 
conformational transition to take place is two-fold higher in RasD33K. In practical terms the 
mutant seems to be less pressure-responsive than the wild type (a higher energetic input 
is necessary to shift the equilibria in the same pressure interval). 
The conformational aspects that define the g-phosphate in RasD33K can be modulated by 
pressure, and the initial population defined by a K12= 11.3 at 0.1 MPa can be brought back 
to the original ratio observed for RasWT (K12= 1.7) around 150 MPa. One can envisage that 
given enough pressure, the equilibria could be shifted even further. On the other hand, the 
conformational aspects that define the a-phosphate are not as easily modulated and a 
direct shift from state 2(T) towards state 1(T) is not possible in this case. Indeed, RasD33K 
can be defined as being a state 2(T) mutant at the g-phosphate. There is no direct or obvious 
indication from the present HP data that state 3(T) can be significantly populated. 
Figure 3.55. Plot of LnK12 as a function of pressure in 
RasD33K•Mg2+•GppNHp (-¿-). The fit of the data gives a specific 
molar volume and Gibbs energy of DV= -16.72 ± 0.4 mL mol-1 and 
DG= 3.40 ± 0.01 kJ mol-1, respectively. The K12 values for each 
pressure point are shown in the table. The plot of RasWT (-●-). is also 
shown for comparison (DG= 1.53 kJ mol-1 and DV= -18.63 mL mol-
1, see also Figure 3.30. 
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3.4.8   Thermal Unfolding of HRas Proteins Investigated by nanoDSF  
Thermal and chemical unfolding experiments are highly appreciated methods to quantify 
protein stability. With the intent of further characterise different mutants, with especial 
emphasis in RasD33K, the thermal unfolding of wild type Ras, together with four different 
mutants was investigated by nanoDSF. The work presented here was part of a two-day 
workshop conducted at our department and therefore the study could not be extended to 
all the proteins involved in this doctoral project. 
The obtained results are presented graphically in Figure 3.56 and numerically in Table 3.24. 
They show that the thermal unfolding of RasWT is a biphasic process characterized by two 
melting temperatures, Tm1= 50.15 ºC and Tm2= 58.63 ºC. The same is observed for the 
mutants RasH27E and RasT35S, whose unfolding profiles and Tm values are almost identical. 
Contrary to RasT35S, the melting profile of the closely related mutant RasT35A proceeds in a 
Table 3.23.  Fitted pressure coefficients and thermodynamic molar free energies, DG, and 
volumes, DV, for HRasD33K(1-166)•Mg2+•GppNHp at 278 K and pH 7.5. 
            31P position d0a /ppm B1 /ppm GPa-1 B2 /ppm GPa-2 -- --             Uncorrected 
      a -11.51 2.31 ± 0.11 0.45 ± 0.51   
b -0.29 -0.68 ± 0.03 1.25 ± 0.11   
g1(T) -2.56 0.80 ± 0.20 -1.06 ± 0.70   
g2(T) -3.40 1.63 ± 0.04 -1.13 ± 0.20   
Pi 1.91 -1.25 ± 0.04 1.42 ± 0.18   
            Corrected 
            a -11.51 2.35 ± 0.11 0.94 ± 0.51   
b -0.29 0.70 ± 0.03 0.70 ± 0.11   
g1(T) -2.56 2.06 ± 0.20 -2.54 ± 0.70   
g2(T) -3.40 2.89 ± 0.04 -2.60 ± 0.20   
             d1b /ppm d2b /ppm DG /kJ mol-1 DV /mL mol-1 Transition 
       Uncorrected 
a -11.49c -11.01 6.39 ± 0.28 -58.69 ± 4.0 -- 
b -0.29c -0.37 4.76 ± 0.28 -62.40 ± 3.2 -- 
g1(T) -2.50 -2.44 12.95 ± 1.05 -98.66 ± 9.3 1-to-0 (?) 
g2(T) -3.40c -3.12 5.72 ± 0.24 -58.55 ± 2.23 2-to-3 (?) 
Pi 1.91 1.72 4.98 ± 0.21 -57.64 ± 2.10 -- 
            Corrected 
            a -11.50c -11.01c 6.61 ± 0.28 -63.03 ± 2.51 -- 
b -0.29 -0.12c 5.63 ± 0.25 -54.86 ± 2.27 -- 
g1(T) -2.41c -2.25 14.32 ± 0.83 -104.9 ± 5.97 1-to-0 (?) 
g2(T) -3.40a -2.93c 5.55 ± 0.25 -60.19 ± 2.45 2-to-3 (?) 
      ad0 is the chemical shift value obtained at ambient pressure at the corresponding pH. 
bd1 and d2 are the chemical shift values obtained for the first and last pressure steps, respectively. Due 
to the linear tendency of the fitted curves, the obtained values constitute a coarse approximation. 
c The value was fixed during the fitting routine. 
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single step with only one Tm of 59.11 ºC, numerically close to the Tm2 of the three proteins 
above mentioned. Biochemically, RasT35A exists predominantly in state 1(T), just like 
RasT35S. However, contrary to RasT35S that can still adopt a state 2(T) conformation in the 
presence of effectors, RasT35A remains locked in state 1(T) [156]. These structural 
differences might account for the strikingly different unfolding profiles. The case of RasD33K 
is also interesting since only one Tm was observed for a mutant that exists predominantly in 
the conformational state 2(T) (Tm2= 61.84 ºC, being 3.2 ºC higher than Tm2 of RasWT). 
It is worth mentioning the robustness of nanoDSF as a technique: despite Ras having no 
Trp amino acids in its sequence (there are only seven Tyr residues at positions 4, 32, 64, 
71, 96, 137, 141), the melting profile of the protein could be measured within seconds, with 
a good intensity fluorescent signal and with high degree of accuracy (StdDev ≤ 0.11, Table 
3.24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.24. Melting temperatures experimentally obtained for 
HRas(1-166)•Mg2+•GppNHp by nanoDSF. 
          Protein Tm1 /ºC StdDev (n=3) Tm2 /ºC StdDev (n=3) 
          WT 50.15 0.07 58.63 0.11 
H27E 50.23 0.06 59.25 0.13 
T35S 49.61 0.07 57.19 0.03 
T35A -- -- 58.11 0.04 
D33K -- -- 61.84 0.03 
     
Figure 3.56. nanoDSF performed for the wild type Ras•Mg2+•GppNHp protein and 
three selected mutants: D33K, T35A and T35S. All the proteins were dissolved in buffer 
F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2 and 2 mM DTE) in concentrations ranging 
between 1.0 and 1.3 mM and measured directly. The melting scan is shown in the 
upper panel as a fluorescence ratio plotted over the recorded temperature interval (20-
95 ºC). The vertical lines are placed at the transition point of each curve and 
correspond to their peak maxima. In the lower panel the first derivatives of the 
fluorescence traces are shown for each protein. This represents a more convenient 
way to directly discriminate between the obtained Tm values for the different proteins. 
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3.4.9   [1H-15N]-HSQC Spectra of HRasWT and HRasD33K Bound to Mg2+•GppNHp 
The differences in the conformational equilibrium detected at the a- and g-phosphates 
between the 31P NMR spectra of RasWT and RasD33K prompted a more detailed investigation 
of both proteins using high resolution 2D NMR techniques. 
The [1H-15N]-HSQC spectrum of RasWT bound to GppNHp was previously published and 
assigned at 303 K by Ito and co-workers [94]. From this and subsequent studies [171, 257] 
it was found that 22 non-proline residues give no detectable 1H-15N cross-peaks (10-13, 21, 
31-39, 57-64 and 71), contrary to the GDP-bound form, where all the residues can be 
assigned. These peaks belonging to the P-loop and both switch regions, become 
broadened beyond detection due to intermediate chemical exchange processes correlated 
with the existence of the conformational states 1(T) and 2(T) [122]. In contrast, the state 
1(T) mutant RasT35S•Mg2+•GppNHp is able to eradicate the exchange since state 2(T) is not 
present at ambient pressure. Its HSQC spectrum is therefore a fingerprint for state 1(T) 
(pdb: 2lcf) [95]. Likewise, RasD33K being the only known state 2(T) could be used to better 
understand the dynamics of this state. 
Based on these premises, the first concern was to obtain a correct and detailed assignment 
of the 1H-15N cross-peaks for both proteins. This was accomplished by performing a HSQC 
temperature series from 278 to 303 K. The overall spectra are shown in Figure 3.57. The 
published assignment at 303 K [94] was automatically transferred to the RasWT spectra at 
the same temperature and adjusted for the slight differences in pH and buffer. The 
assignment at 278 K (shown in Figure 3.57) was obtained by following the temperature 
dependence of the chemical shifts. The assignment for RasD33K was done based in the one 
of RasWT. 
It is important to note that the peak intensities and volumes of each protein are not directly 
comparable. The series on RasWT was recorded using the sofast methodology based on 
the Ernst angle [258], which allows for fast acquisition. The series on RasD33K were recorded 
using a standard Bruker HSQC pulse sequence. 
A preliminary analysis of the series shows a temperature-dependence for most cross peaks, 
although some of them remain mostly unperturbed (G138, A146 in RasWT and G138, G15 
in RasD33K). Several peaks are only visible at high temperatures (E99, Q153, H94) most 
likely because they are in slow exchange at low temperatures, remaining undetectable. It is 
worth mention that a few residues show double assignments in the spectra due to distinct 
conformational reorientation of their side chains (A11*, D47* in RasD33K). With the 
assignment obtained herein, the accurate comparison of the different peak intensities, 
volumes and chemical shifts between the two proteins is now presently being investigated 
3. Results 
 
178 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Results 
 
179 
at our department. The help of 
Dr. Markus Bech Erlach and 
Sebastian on the processing of 
the spectra presented here is 
gratefully acknowledged. 
 
Figure 3.57. [1H-15N]-HSQC NMR 
spectra of  HRas(1-
166)•Mg2+•GppNHp proteins.  
Left page: a temperature series was 
recorded between 278 and 303 K for 
the wild type protein (on the top) and 
the D33K mutant (on the bottom). Both 
proteins ranging between 1.0 and 1.3 
mM were dissolved in buffer F (40 mM 
Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM 
DTE) with additionally 10% D2O and 
0.1 mM DSS. Five HSQC spectra were 
recorded for each protein in a 
spectrometer operating at a proton 
frequency of  800 MHz. Both proteins 
were extensively dialyzed against the 
same buffer before acquisition. The 
assignment for RasWT at 303 K was 
directly transferred from the one 
published by Ito et al [94] and manually 
adjusted to the present conditions (pH, 
type of buffer). The assignment shown 
herein refers to 278 K and was 
obtained by analysing the 
temperature-dependent chemical shift 
changes of each peak. Note that the 
peak volumes or intensities between 
both proteins are not directly 
comparable: in the case of RasWT a 
sofast HMQC pulse sequence was 
used while RasD33K was measured using a standard HSQC method. 
Right page: detail of the central region where several cross-peaks overlap. Some of these residues show a 
marked difference in terms of peak volumes between the HP series of RasWT and RasD33K (currently under 
analysis at our department), portending their involvement in conformational transitions that are specific for each 
protein. 
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3.4.10   31P NMR investigations of HRas(1-166)G12P and HRas(1-166)T35S/G12V 
The reasons underlying the investigations on these two last mutants are not directly related 
with the mutational analysis of Ras derived from the HP investigations, described in the 
above sections. In fact, both mutants are already known by the scientific community and 
have been characterised over the past years. Particularly, the crystal structure of RasG12P 
was obtained under collaborative work pioneered by our department already in 1993 [259]. 
Both mutants are revisited within the framework of this thesis because their interesting 
properties: RasG12P was found to be the only mutant from G12 with non-transforming 
properties and RasG12V/T35S was found to be a partial gain-of-function mutant, capable of 
activating some signal transduction pathways by interacting with specific effectors such as 
Raf-RBD but not with others, such as Ral-GDF.  
Contrary to the mutational studies presented in section 3.4.2, the two mutants were not 
created de novo at our department, instead, the vectors containing the sequences were 
kindly provided by the research group of Prof. Dr. Alfred Wittinghofer from Max-Planck 
Institute for Molecular Physiology, Dortmund. Their conformational equilibria was never 
investigated in terms of 31P NMR spectroscopy rendering them an interesting case of study, 
especially RasG12V/T35S, which has a contribution of two opposing mutants (G12V, a gain-of-
function and T35S, a partial loss-of-function). 
 
3.4.10.1   31P NMR GppNHp and GTP Spectra. Raf Interaction and GTPase Activity 
The spectral features of RasG12P•Mg2+•GppNHp are very distinct from the wild type protein 
as one can infer from Figure 3.58A: with exception of a2(T)-phosphate that remains 
unaltered, all other resonances become upfield shifted by an average of d= -0.17 ppm, the 
highest deviation being observed for the g2(T)-phosphate with a Dd= -0.35 ppm. A 
concomitant overall line broadening is also observed, especially in the case of state 2(T), 
(Table 3.25). The 31P NMR spectra of RasG12V was also investigated for comparison (the 
mutation was created de novo by SDM. Note that this corresponds to the truncated variant 
(aa 1-166). Again, pronounced shift differences are observed between the two proteins: 
with exception of the g2(T)-phosphate, all the resonances in RasG12V become downfield 
shifted by an average of Dd= 0.22 ppm compared with RasG12P. In this respect, the biggest 
change is observed for the b-phosphate, with a Dd= 0.43 ppm. On the other hand, the g2(T)-
phosphate shifts upfield by a Dd of -0.41 ppm. Together, these differences constitute one of 
the largest spectral modifications observed so far between two any point mutants and wild 
type variant in the 31P NMR spectra of Ras proteins. Replacing Gly12 by a Pro leads to a 
modification of the equilibrium constant, K12, from 1.70 to 1.16, respectively. Substitution to 
3. Results 
 
181 
Val leads to a further decrease to K12= 0.84, as the population ratio is inverted and state 
1(T) surpasses the population of state 2(T) (Table 3.25). 
The 31P NMR spectra of the respective GTP-bound proteins is shown in Figure 3.58B. State 
1(T) at the g-phosphate of RasG12P cannot be unequivocally identified, although it seems to 
appear as a very broad shoulder very close to state 2(T) and slightly upfield shifted when 
compared with RasWT (Dd= -0.05 ppm, from d= -2.57 to d= -2.62 ppm). However, the most 
striking differences between RasG12P and RasWT are in terms of chemical shifts of the b- and 
g2(T)-phosphate groups, the former being upfield shifted and the latter being downfield 
shifted by Dd= -0.13 (from d= -0.25 ppm to d= -0.38 ppm) and a Dd= 0.12 ppm (from d= -
7.98 ppm to d= -7.86 ppm), respectively, Table 3.25. The GTP spectrum of RasG12V has 
also distinct features from those of RasG12P: a general line broadening is again observed for 
all resonance lines of the oncogenic mutant and all its three phosphate signals, a-, b- and 
g2(T) become downfield shifted by a Dd= 0.13, 0.3 and 0.28 ppm, respectively, when 
compared to RasG12P. This difference is particularly remarkable for the g2(T)-phosphate, 
assigned at d= -7.58 ppm in RasG12V and d= -7.86 ppm in RasG12P. In addition, both g2(T)-
phosphates are downfield shifted when compared with RasWT (d= -7.98 ppm). It is also worth 
mention that the yield of the nucleotide exchange reaction (calculated from the ratio of the 
areas between GTP-bound and GDP-bound Ras choosing either the a- or b-phosphates) 
is much higher in the case of RasG12V (ca. 92%) than in the case of RasG12P (ca. 65%), which 
asserts for the different nature of these mutants. It is indeed common for oncogenic variants 
such as G12V, G12D or G13R to undergo an almost complete (over 90%) exchange to 
GTP, contrary to non-oncogenic ones, whose degree of exchange is normally much lower 
(70-75%). This observation precludes the assessment that RasG12P, contrary to the other, 
has characteristics of a non-transforming mutation. 
To better characterise RasG12V/T35S, the point-mutant RasT35S was also investigated 
separately. As it can be directly observed from Figure 3.58A, the GppNHp spectrum of the 
double mutant resembles directly the one of RasT35S for whom state 2(T) is completely 
abolished, in contrast to RasG12V, where the equilibria between states is still maintained 
(K12= 0.84). Rather surprisingly, the chemical shift values of the double mutant are 
numerically closer to the ones of RasG12V than RasT35S. For example, the b-phosphate in 
RasG12V/T35S lies at d= 0.08 ppm. The same resonance is observed in RasG12V at d= 0.05 
ppm and in RasT35S at d= -0.33 ppm. This corresponds to a Dd of 0.05 ppm in the first case 
and -0.25 ppm in the second case. Based on the fitted values of Table 3.25 similar 
considerations can be done for the a- and g-phosphates (both are closer to RasG12V than 
RasT35S. 
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Figure 3.58. Conformational dynamics of RasG12P, RasG12V, RasT35S and 
RasG12V/T35S investigated by 31P NMR spectroscopy at 278 K. The proteins were 
dissolved in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with 
additionally 0.2 mM DSS and 10% D2O, at a final concentration ranging 
between 0.92 and 1.63 mM. The measurements were done for A. 
Ras•Mg2+•GppNHp and B. Ras•Mg2+•GTP. All the spectra except RasG12P 
were obtained in a magnetic field operating at a 31P resonance of 242.896 MHz 
(600 MHz spectrometer). RasG21P was measured at a 31P frequency of 202.456 
MHz (500 MHz spectrometer). An EM function with LB= 10 Hz was used during 
the processing of the FID’s. aGDP and bGDP represent the chemical shift of a- 
and b-phosphate groups of GDP-bound Ras, respectively. 
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For example, the g1(T)-phosphate is located at d= -2.56 ppm in the serine mutant, d= -2.38 
ppm in the oncogenic mutant and d= -2.40 ppm in G12V/T35S). The averaged linewidths in 
RasG12V/T35S are numerically more similar to RasT35S due to the lack of exchange broadening 
processes between states 1(T) and 2(T) in these two mutants, contrary to RasG12V (Table 
3.25). 
Similar results can be found when comparing the GTP-bound spectra (Figure 3.58B): 
RasG12V/T35S is state 1(T)-driven, just like RasT35S and in opposition to RasG12V, which exists 
predominantly in state 2(T). The respective equilibrium constants are 0.05, 0.13 and 9.38 
(Table 3.23). Again, the chemical shift values for the double mutant are closer to the ones 
of RasG12V than RasT35S. For example, the g1(T)-phosphate lies at d= -6.10 ppm in both, 
G12V/T35S and in G12V and at d= -6.57 ppm in T35S. An interesting feature can be 
observed in the spectrum of RasT35S located at d= -11.47 ppm as a shoulder on the a-
phosphate. The 31P NMR spectra of each protein in complex with Mg2+•GDP is shown in 
Figure D of the appendix section. Typical chemical shift differences between a- and b-
phosphates of different proteins are observed and are in line with the above results for the 
GppNHp and GTP-bound spectra. 
Although biochemical properties of different Ras mutants can be presumed at some extent 
from the spectral characteristics, general or unanimous correlations cannot be made since 
conformation is not necessarily linked to a particular function (as seen in the previous case 
of RasD33K, a state 2(T) mutant with impaired Raf affinity). In detriment of this idea, RasG12P 
and RasG12V/T35S were investigated in terms of their affinity to Raf-RBD by ITC and in terms 
of their ability to hydrolyse their natural ligand, GTP, by HPLC. 
The obtained results show that RasG12P has a slightly higher rate of hydrolysis relative to 
RasWT (kcat= 0.035 min-1 vs 0.026 min-1, respectively, Figure 3.59 and Table 3.26). Two 
somewhat higher values (kcat= 0.043 and 0.055 min-1) were previously reported in the 
literature [260, 261], although both values are in agreement within the limits of the error for 
the present measurement. Addition of effector Raf-RBD does not change significantly the 
obtained values (kcat= 0.039 min-1, τ= 17.78 min., data not shown). The intrinsic GTPase 
activity of RasG12P remains unchanged compared with the wild type protein and contrary to 
a typical oncogenic variant where the same reaction is severely impaired. The three 
dimensional structure of RasG12P was found to be very similar to that of wild type (pdb entry: 
1ago [259]), especially in the vicinity of the catalytic residue Gln61, which accounts for a 
possible explanation of their similar rate constants. The thermodynamics of binding to Raf 
shows that the association proceeds as usual with a greater entropic contribution (-TDS= -
21.2 kJ mol-1, DH= -14.4 ± 0.56 kJ mol-1, Table 3.26). The free energies of binding for RasWT 
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and RasG12P re respectively DG= -36.4 and  DG= -35.6 kJ mol-1 and the corresponding 
dissociation constants are 0.42 ± 0.12 and 0.59 ± 0.12 µM (Table 3.26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.25. 31P NMR chemical shift values and linewidths obtained for the 
different mutants of HRas(1-166). 
          
Protein 
a-phosphate b-phosphate g-phosphate 
K12b d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T),2(T)
a 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
               Mg2+•GDP 
       WT -10.50 -1.97 -- -- 
G12P -10.55 -1.95 -- -- 
G12V -10.61 -1.97 -- -- 
G12V/T35S -10.40 -1.82 -- -- 
T35S -10.53 -2.01 -- -- 
       Mg2+•GppNHp 
       WT -11.17 -11.68 -0.25 -2.57 -3.33 1.70 
G12P -11.31 -11.69 -0.38 -2.62 -3.68 1.16 
G12V -11.22 -11.57 0.05 -2.38 -4.09 0.84 
G12V/T35S -11.19 -- 0.08 -2.40 -- -- 
T35S -10.97 -- -0.33 -2.56 -- -- 
        Mg2+•GTP 
       WT -11.68 -14.87 -6.63 -7.98 11.3 
G12P -11.66 -15.00 -- -7.86 -- 
G12V -11.43 -14.70 -6.10 -7.58 9.38 
G12V/T35S -11.33 -15.00 -6.10 -7.48 0.05 
T35S -11.11 -15.14 -6.57 -8.0 0.13 
               a-phosphate b-phosphate g-phosphate  
 Dn1/2 1(T) [Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T)/2(T)
a 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz]  
               Mg2+•GDP 
       WT 46.89 30.02 --  
G12P 47.21 35.13 --  
G12V 58.08 32.73 --  
G12V/T35S 89.62 40.84 --  
T35S 69.52 43.70 --  
        Mg2+•GppNHp 
       WT 105.39 75.15 45.84 74.47 55.07  
G12P 71.44 88.43 35.66 62.54 91.96  
G12V 122.2 98.84 75.66 91.70 143.3  
G12V/T35S 81.94 -- 56.68 51.84 --  
T35S 66.72 -- 53.55 40.94 --  
        Mg2+•GTP 
       WT 54.74 45.66 20.33 35.44  
G12P 58.04 38.70 -- 46.32  
G12V 76.52 62.31 34.79 46.81  
G12V/T35S 78.83 62.02 65.00 58.01  
T35S 50.41 60.66 59.54 67.68  
              All the values are fitted from the experimental spectra recorded at 278 K and 
pH 7.5. The maximum estimated errors are ± 0.02 ppm in chemical shift values 
and ± 0.15 Hz in linewidths for the g-phosphate. An EM function with LB= 10 
Hz was used for processing the FID. 
a States 1(T) and 2(T) of the b-phosphate in cannot be separated at the 
magnetic field used and were therefore fitted as a single Lorentzian line. 
b The equilibrium constant, K12, was calculated using the population distribution 
on the g-phosphate. The associated error is ± 0.2. 
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From the obtained values it can be 
hypothesised that the Pro12 
mutation does not greatly affect the 
structural configuration of the 
effector loop region (aa 32-40) 
involved in the binding of Raf-RBD 
since the binding proceeds with the 
same energetics and affinity as the 
one observed for RasWT. 
The GTPase activity of the double 
mutant is extremely slow, proceeding 
with a kcat= 0.003 min-1 and a 
surprising slow half-life of 208.5 min. 
(ca. 3 hours). For a better 
characterisation, the same 
measurements were conducted in the single mutants RasG12V and RasT35S (Table 3.26). By 
comparison it becomes evident that RasG12V/T35S follows closely the properties of the 
oncogenic variant (kcat= 0.005 min-1, τ=136.1 min.), with RasT35S having a more than 2-fold 
faster hydrolysis rate (kcat= 0.011 min-1, τ= 61.64 min.). kcat and k12 values have been 
reported elsewhere in the literature for full length (1-188/189) RasG12V and RasT35S and are 
comparable to the ones presently obtained for the truncated (1-166) forms [67, 262]. 
The affinity of RasG12VT35S towards Raf-RBD is more than 15 times lower than RasWT (kD= 
13.52 ± 2.7 µM vs 0.42 ± 0.1 µM) and more than 2 times lower than RasT35S (KD= 6.45 ± 1.2 
µM, Table 3.26). Both point-mutants separately have a lower affinity than the wild type 
protein. However, their combination into the double mutant seems to have a synergistic 
effect that leads to a further decreased affinity for the effector. The enthalpy variation, DH, 
is -4.38 ± 0.2 kJ mol-1, a value three times lower than the one obtained for RasT35S and 
RasG12V separately. The binding proceeds with a similar free energy variation for all proteins, 
possibly due to an entropic compensation (the reader is advised for the fact that only DH is 
explicitly calculated form the experimental data, therefore, the global DG values might not 
reflect the energetic reality of the binding process; experimental section 2.2.4). 
 
 
 
 
Figure 3.59. Determination of the intrinsic GTPase activity of 
RasG12P, RasG12V, RasG12V/T35S and RasT35S by HPLC at 310 
K. Upon integration of the fluorescence signal, the 
percentage of Ras-GTP was plotted against time and the 
data fitted with a first order exponential decaying function. 
The fitted rate constants and half-life times are shown in 
Table 3.26 (see Figure 3.43 for details on the description of 
the method). 
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3.4.10.2   Interaction Between HRasG12P•Mg2+•GppNHp and Raf-RBD 
As already revealed by ITC, the thermodynamics of binding between RasG12P and Raf-RBD 
was found to be very similar to the wild type protein. The same interaction was investigated 
by 31P NMR. As usual, addition of increasing amounts of effector leads to the modification 
of the initial equilibria by promoting a conformational transition of the initial population 
defined by the state 1(T) (red coloured lines) into state 2(T) (green coloured lines) and 
subsequent formation of the Ras-Raf complex indicated by the typical upfield shift of state 
2(T) that culminates with the formation of state 2*(T) at the g-phosphate (Figure 3.60). The 
concomitant shift change is from d= -3.68 ppm (1:0 ratio) up to d= -3.90 ppm (Dd= -0.22 
ppm, Table 3.27). The same spectral features and evolution of chemical shifts were found 
during the titration of KRasWT and HRasH27E, (Figures 3.1 and 3.49) but not HRasD33K (Figure 
3.50), whose association with the effector is lower than wild type. The b-phosphate was 
fitted with a single Lorentzian line across the titration series although it would be probably 
best characterised by a two-line fitting, as previously performed for RasH27E (Figure 3.49, 
Table 3.19).  
The linewidth of the b-phosphate increases from n1/2= 36.51 Hz to n1/2= 81.68 Hz at a protein 
ratio of 1:1. This corresponds to a to a 2.25-fold increase, which is somewhat larger than 
expected, according to the molecular mass of the protein-protein complex (from 1:0 to 1:1 
ratio the increase of the molecular mass should be only 1.52-fold). Therefore, the b-
phosphate is further broadened by exchange processes which makes it difficult to 
distinguish between the free and the bound Ras protein. 
 
 
Table 3.26. Thermodynamics of interaction between HRas•Mg2+•GppNHp and Raf-RBD measured by ITC 
and intrinsic GTPase activities measured by HPLC for HRas•Mg2+•GTP. 
                      Protein T K 
[Ras] 
mM 
[Raf] 
mM 
DG 
kJ mol-1 
DH 
kJ mol-1] 
-TDS 
kJ mol-1 
KD 
µM 
T 
K 
kcat 
min-1 
τ 
min. 
                      HRasWT 298 60 778 -36.4 -8.10 ± 0.23 -28.3 0.424 ± 0.12 310 0.026 26.85 
HRasG12P 298 31 312 -35.6 -14.4 ± 0.56 -21.2 0.591 ± 0.12 310 0.035 20.01 
HRasG12V/T35S 298 107 1730 -27.8 -4.38 ± 0.24 -23.4 13.52 ± 2.69 310 0.003 208.5 
           HRasT35S 298 51 850 -29.7 -13.3 ± 0.66 -16.3 6.45 ± 1.20 310 0.011 61.64 
HRasG12V 298 85 836 -35.3 -13.5 ± 0.41 -21.9 0.66 ± 0.15 310 0.005 136.1 
           kcat represents the hydrolysis rate constant and is calculated as 1/t. τ represents the half-life for the GTP 
hydrolysis (τ=t*ln2). ITC experiments were done according to the experimental section 2.2.4. The 
experimentally obtained thermograms and signature plots are shown in Figure F of the appendix section. The 
N parameter (binding sites) was allowed to vary during the fitting procedure. The greatest deviation from a 1:1 
ratio was obtained for RasG12V/T35S with N= 1 ± 0.14. The error on all the other measurements was always 
smaller than ± 0.2. 
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Table 3.27. 31P NMR chemical shift values and linewidths for the protein-protein 
complex HRasG12P(1-166)•Mg2+•GppNHp•Raf-RBD. 
Protein 
Complex 
 
ratio 
a-phosphate b-phosphatea g-phosphate 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T)/2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
       RasG12P -- -11.31 -11.69 -0.37 -2.62 -3.68 
       + Raf-RBD 1:0.5 -11.45 -11.77 -0.43 -2.64 -3.90 
 1:1 -11.55 -11.77 -0.47 -- -3.90 
 1:1.5 -- -11.77 -0.47 -- -3.90 
                 a-phosphate b-phosphatea g-phosphate 
  Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/21(T),2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
                RasG12P -- 80.46 73.60 36.51 67.12 81.58 
        + Raf-RBD 1:0.5 141.0 70.97 68.19 96.70 76.54 
 1:1 96.35 77.04 81.68 -- 52.13 
 1:1.5 -- 87.45 88.24 -- 53.51 
                All the values are fitted from the experimental spectra recorded at 278 K, pH 7.5. The 
maximum estimated errors from the fitting procedure are ± 0.02 ppm in chemical shift 
values and ± 0.16 Hz in linewidths for the g-phosphate. An EM function with LB=15 
Hz was used in the processing of the FID and subtracted from the final linewidths. 
Figure 3.60. 31P NMR spectroscopy on the titration of 
HRasG12P•Mg2+•GppNHp with the effector Raf-RBD measured at 278 K. 
To an initial 0.74 mM solution of RasG12P dissolved in buffer F (40 mM 
Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with additionally 0.2 mM 
DSS, 150 mM NaCl and 5% D2O, increasing amounts of Raf-RBD were 
added. The molar ratio is indicated for each titration step. The final 
concentrations of Ras and Raf (1:1.5 ratio) are 0.58 mM and 0.92 mM, 
respectively. All 31P resonances were recorded at a frequency of 
202.456 MHz (500 MHz spectrometer). An EM function with LB= 15 Hz 
was applied during the processing of the FID. 
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3.4.10.3   Interaction Between HRasG12P•Mg2+•GppNHp and NF1 
The lack of oncogenicity of RasG12P is likely related to its normal GTPase activity. Kinetic 
parameters reported in literature are very similar to RasWT in terms of kon, koff nucleotide rate 
constants and effector and GAP association affinities [259]. The interaction of this mutant 
with NF1 was investigated here by 31P NMR. Due to the larger chemical shift separation 
between states 1(T) and 2(T) at the g-phosphate in RasG12P compared to RasWT (the 
distance between both states, Dd= d2(T)-d1(T), is 2.52 ppm and 1.63 ppm, respectively, Figure 
3.61 and Table 3.28), the characterization of state 3(T) by deconvolution of the partially 
superimposed 31P NMR lines was easier to perform. 
As expected, the overall titration series shown in Figure 3.61 is very similar to the one 
obtained for the wild type protein: the new resonance line of state 3(T) appears as soon as 
NF1 is added to the NMR tube and its integrated area increases as the Ras:NF1 ratio 
increases. Its chemical shift position is independent of the concentration of NF1 and is 
slightly upfield shifted (Dd= 0.22 ppm) when compared to the same state 3(T) in the titration 
series of RasWT (d3(T) /G12P= -3.22 ppm vs d3(T) /WT= -3.00 ppm, section 3.4.1.2, Figure 3.39), 
possibly due to the intrinsically different chemical environment of the g-phosphate prompted 
by the presence of the P12 mutation. Between RasG12P free and the last titration step at 1:1 
ratio, the increase of linewidth is only of 1.7-fold as measured at the g-phosphate (from a 
Dn1/2= 92.32 to 117.8 Hz), which is only half of the expected increase in linewidth since the 
molecular mass of the protein complex is 3-fold higher than Ras alone. Since the dynamics 
of the g-phosphate in RasG12P is different than RasWT (different K12 and Dn1/2 values), it is 
likely that state 3(T) in the RasG12P•NF1 is exchange broadened by states 1(T) and 2(T). It 
is also observed that the chemical shift value of these states remains unperturbed over the 
course of the titration (d1(T)≈ -2.62 ppm and d2(T)≈ -3.72 ppm, Table 3.28), indicating that the 
interaction still follows a slow exchange mechanism in the NMR time scale. 
The same dynamic features are observed in the case of the a-phosphate, although the 
deconvolution of the third state is more difficult due to the closer proximity of the NMR lines. 
Again, states 1(T) and 2(T) do not seem to shift significantly during the titration (Table 3.28, 
note that the error in the chemical shift determination of sates 1(T) and 2(T) for the a-
phosphate is much larger than the one obtained for the g-phosphate, ±0.08 ppm vs ±0.01 
ppm, respectively). The chemical shift position of state 3(T) could only be unequivocally 
determined at the molar ratio of 1:1 and was found to be d= -11.15 ppm. A similar value of 
d= -11.12 ppm was found in the titration of RasWT (Table 3.12). The binding of Ras to NF1 
originates a severe perturbation in the chemical environment of the b-phosphate: as the  
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main line (corresponding to [Ras]free) decreases, a new very broad line appears at the left 
side, whose area increases as the concentration of NF1 increases (Figure 3.61). This new 
line could be ascribed to the Ras-NF1 ([RNF1]) complex, although additional contributions 
might be lying underneath its broad shape. 
At a protein ratio of 1:1 almost completely saturation is achieved (Figure 3.61). This is 
marked by three single broad peaks at the a- , b- and g-phosphates, respectively, and by 
the disappearance of the former states 1(T) and 2(T). The very broad nature of the b-
Figure 3.61. Protein complex formation between RasG12P•Mg2+•GppNHp and NF1 
followed by 31P NMR spectroscopy at 278 K. To an initial 0.82 mM of Ras dissolved in 
buffer F (40 mM Tris/HCl pH 7.5; 10 mM MgCl2; 2 mM DTE) with additionally 150 mM 
NaCl, 0.2 mM DSS in 10% D2O, increasing amounts of the GAP protein NF1 (from a 
0.71 mM stock solution) were added (the corresponding molar ratios for each step are 
presented). The concentrations of Ras and NF1 in the final step (1:1 ratio) are 0.30 
mM and 0.29 mM, respectively. An EM filter with LB=15 Hz was applied to the 
processed FID. The number of scans was increased over the course of the titration, 
from 3000 in the first step, to 11000 in the last step. The resonance lines corresponding 
to the a-, b- and g-phosphates are indicated as well as the states 1(T) and 2(T), 
represented by the red and green coloured lines, respectively. The new spectral 
features observed from the addition of NF1 to Ras are coloured in blue. As an example, 
the deconvolution into separated Lorentzian lines is shown for two different titration 
steps (1:0.25 and 1:0.5) on the g-phosphate. 
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phosphate (Dn1/2= 196.7 Hz) indicates that at least two different conformations with distinct 
chemical environments in its vicinity might be present when the Ras-NF1 complex is 
formed, as already observed in the case of the RasWT-NF1 complex. 
 
 
 
3.4.10.4   Interaction Between HRasG12V/T35S•Mg2+•GppNHp and Raf-RBD 
The interaction between RasG12V/T35S and Raf-RBD was already surveyed by ITC within the 
framework of this thesis. The obtained KD value of 13.52 µM (Table 3.26) led to the 
conclusion that this mutant binds the effector with much lower affinity than the wild type 
protein. Due to its interesting nature, a 31P NMR titration using the same effector was 
envisaged. The spectral series are shown in Figure 3.62 and can be interpreted as follows: 
as Raf is added to Ras, the population of the initially predominant state 1(T) is converted 
into the effector recognizing state 2(T). The process can be identified by the decrease of 
the integrated area of state 1(T) and concomitant increase in the area of the new state 2(T), 
both being directly dependent of the concentration of Raf added at each step. An upfield 
shift of state 1(T) is observed from, d= -2.37 ppm to ca. d= -2.60 ppm (Dd= -0.23 ppm, note 
that in the final titration steps, its centre is not well defined due to its broad nature and the 
chemical shift values listed in Table 3.29 are just an approximation). A shift in the same 
Table 3.28. 31P NMR chemical shift values and linewidths for the protein-protein complex 
HRasG12P(1-166)•Mg2+•GppNHp•NF1. 
                    Protein 
complex 
Ras:NF1 
ratio 
a-phosphate b-phosphate g-phosphate 
d1(T) 
[ppm] 
d3(T) 
[ppm] 
d2(T) 
[ppm] 
da 
[ppm] 
d3(T) 
[ppm] 
d1(T) 
[ppm] 
d3(T) 
[ppm] 
d2(T) 
[ppm] 
                              HRasG12P -- -11.32 -- -11.73 -0.37 -- -2.60 -- -3.70 
          +NF1 1:0.25 -11.31 --b -11.73 -0.39 0.31 -2.62 -3.24 -3.73 
 1:0.5 -11.25 --b -11.71 -0.39 0.31 -2.64 -3.24 -3.72 
 1:1 -- -11.15 -- -0.40 0.31 -- -3.22  
                      a-phosphate b-phosphate g-phosphate 
  Dn1/2,1(T) 
[Hz] 
Dn1/2,3(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2
a
 
[Hz] 
Dn1/2,3(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2,3(T) 
[Hz] 
Dn1/2,2(T) 
[Hz] 
                    HRasG12P -- 76.80 -- 115.0 50.20 -- 76.22 -- 92.32 
          +NF1 1:0.25 101.3 --b 164.4 61.32 87.47 61.80 133.4 110.7 
 1:0.5 79.11 --b 183.1 65.64 186.1 74.81 109.8 131.0 
 1:1 -- 204.5 -- -- 196.7 -- 117.8 -- 
          All the values are fitted from the experimental spectra recorded at 278 K, pH 7.5. The maximum 
estimated errors from the fitting procedure are ± 0.02 ppm in chemical shift values and ± 0.11 Hz in 
linewidths for the g-phosphate. 31P data were recorded at a frequency of 242.896 MHz. An EM 
function with LB= 15 Hz was used in the processing of the FID and subtracted afterwards from the 
final fitted linewidth values. 
a States 1(T) and 2(T) of the b-phosphate cannot be separated at the magnetic field used and were 
therefore fitted as a single Lorentzian line. 
b State 3(T) of a-phosphate could not be fitted independently of states 1(T) and 2(T) at the indicated 
molar ratio. 
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direction is also observed for the a1(T) and b1(T)-phosphates, albeit less pronounced (Dd≈ -
0.05 ppm). The chemical shift of state 2(T) at the g-phosphate is d= -4.18 ppm and 
independent of the concentration of Raf added.The corresponding chemical shift values in 
the titration of RasWT and RasH27E are d= -3.60 ppm [117] and d= -3.54 ppm (Table 3.19), 
respectively. In the case of RasG12V/T35S the initial state 2(T) is not defined and therefore it is 
assumed that the observed state 2(T) represented by the green coloured line that rises 
along the titration in Figure 3.62 is in fact state 2*(T). Based on this assumption, both, the 
red and green coloured resonance lines at the g-phosphate represent respectively the Ras-
free and the Ras-bound complexes. From their integrated areas it is possible to obtain the 
dissociation constant for the complex at any given ratio. The calculations led to an averaged 
apparent KD of 0.1 mM, which is one order of magnitude higher than the value obtained 
from ITC (13.52 µM). The mismatch in the obtained values between both techniques is 
expected as the concentrations used in NMR are much higher than the typical KD interval 
for the interaction (low hundreds in the nM range). 
 
 
 
 
 
 
 
 
 
Table 3.29. 31P NMR chemical shift values and linewidths for the protein-protein 
complex HRasG12V/T35S(1-166)•Mg2+•GppNHp•Raf-RBD. 
Protein 
complex ratio 
a-phosphate b-phosphate g-phosphate 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
       RasG12V/T35S  -11.13 -- 0.12 -2.37 -- 
       + Raf-RBD 1:0.25 -11.12 -11.72 0.12a -2.36 -4.17 
 1:0.5 -11.12 -11.58 0.12 -0.20 -2.40 -4.17 
 1:1 -11.14 -11.57 0.07 -0.26 -2.50 -4.17 
 1:1.25 -11.16b -11.58 0.08 -0.23 -2.60b -4.17 
 1:1.5 -11.16b -11.58 0.08 -0.23 -2.66b -4.18 
                 a-phosphate b-phosphate g-phosphate 
  Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
                RasG12V/T35S  73.82 -- 53.44 47.49 -- 
        + Raf-RBD 1:0.25 90.46 111.5 67.23a 53.00 113.6 
 1:0.5 117.4 109.0 67.29 109.0 57.43 121.1 
 1:1 169.5 179.4 91.82 152.7 131.3 126.2 
 1:1.25 128.2 129.8 91.55 107.2 198.0 118.9 
 1:1.5 115.9 149.1 73.07 123.3 253.1 138.6 
                All the values are fitted from the experimental spectra recorded at 278 K, pH 7.5. The 
maximum estimated errors from the fitting procedure are ± 0.02 ppm in chemical shift 
values and ± 0.16 Hz in linewidths for the g-phosphate. An EM function with LB= 10 Hz 
was used in the processing of the FID. Data were recorded at 242.896 MHz. 
a States 1(T) and 2(T) of the b-phosphate cannot be separated at the magnetic field 
used and were therefore fitted as a single Lorentzian line. 
bThe centre of the peak is not well defined enough to allow an accurate fitting. The 
listed value is a very rough estimation. 
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Figure 3.62. 31P NMR spectroscopy on the titration of HRasG12V/T35S•Mg2+•GppNHp with the 
effector Raf-RBD measured at 278 K. To an initial 1.09 mM solution of RasG12V/T35S dissolved 
in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with additionally 0.2 mM DSS, 
150 mM NaCl and 10% D2O, increasing amounts of Raf-RBD were added. The molar ratio is 
indicated for each titration step. The final concentrations of Ras and Raf (1:1.5 ratio) are 0.75 
mM and 1.5 mM, respectively. All 31P resonances were recorded at a frequency of 242.896 
MHz (600 MHz spectrometer). The number of scans was increased from 2000 (first step) up 
to 16000 (last step). An EM window with LB= 10 Hz was applied during the processing of the 
FID. 
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3.5   High Pressure Macromolecular Crystallography (HPMX) 
The crystallographic work presented herein is a collaboration with Nathalie Colloc’h, Eric 
Girard, Anne-Claire Dhaussy and Thierry Prangé. The individual contribution from the 
author of the present thesis to the project relied in protein crystallisation and data 
acquisition. All structure refinements, b-factor calculations and compressibility curves that 
originated the final results were kindly provided and analysed according to the expertise of 
the team of crystallographers. 
 
3.5.1   Crystal Structure of RasWT(1-166)•Mg2+•GppNHp at Ambient Pressure 
There are many crystal structures of RasWT deposited on the pdb database solved at low (~ 
278 K) or at cryogenic temperatures (most of them at 100 K or bellow). However, since all 
the HPMX data were collected at RT, the structure of RasWT was firstly determined in the 
same conditions and sample environment (loading into the DAC, beam alignment, etc.). 
The final refined structure was obtained at a resolution of 1.8 Å and serves as a control 
experiment necessary to provide meaningful relationships and to minimise any instrumental 
discrepancies between conventional and HP crystallography. 
The ambient pressure (corresponding to 0.1 MPa, abbreviated as pamb), RT structure is 
shown in Figure 3.63 (coloured in cyan), and a comparison with the representative structure 
of GppNHp-bound Ras from Pai et al. is made (coloured in grey, pdb: 5p21, [12]). 5p21 was 
obtained at 277 K, whereas this one was obtained in the 293-298 K interval. Both crystallise 
under the same trigonal space group P3221 and are essentially identical, with a perfect 
superposition for all the helixes and b-sheets that are in a distal position relative to the 
nucleotide (a5, b1, b2, b3). Some residues shown at the surface and nearby the C-terminal 
region have slightly different rotation angles (Figure 3.63A, R128, R135 and H166). The 
only noticeable differences occur always in loops and at the helix a2 (aa 66-74). As can be 
seen from Figure 3.63B and C (left side), helix a2 from 5p21 is spatially closer to helix a3 
than the corresponding one in the structure obtained at RT. In the latter, the helix a2 is 
pushed upward (indicated by the arrow in Figure 3.63C) and becomes slightly displaced 
away from helix a3. The maximum separation between the two a2 helixes on the two 
structures measured at any two corresponding Ca’s is ca. 2.0 Å. 
The remaining residues that comprise switch 2 and switch 1 align very well respective to 
their counterparts, with only minor deviations that can be assigned to a different spatial 
orientation of specific residues resulting from their multiple rotational degrees of freedom. 
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Figure 3.63. Refined crystal structure of HRasWT(1-166)•Mg2+•GppNHp obtained at ambient pressure and room 
temperature (coloured in cyan) and comparison with one of the representative structures from Pai et al [12], 
pdb: 5p21, recorded at 277 K (coloured in grey). Both structures are superimposed. A. Surface representation 
evidencing some residues at the C-terminal that show different orientations due to rotational movement (R128, 
S136, Q165). B. Structural details around the nucleotide binding site. The residues that show a significantly 
different degree of rotation between both structures are represented as thin lines (D30, E31, Y32 in switch 1 
and Q61, E62, E63, Y64, M67 in switch 2). C. The small but significant upward movement of the helix a2 of 
switch 2 in the RT structure obtained in this work compared to 5p21 is evidenced (left side). At the right side, 
details of the catalytic waters are evidenced: the catalytic water (w175) and the nearby w189, from 5p21 are 
shown as small spheres. In comparison, no equivalent waters could be found in the electron density map of the 
RT structure. Instead, their role is replaced by the terminal extremity of Q61 that moves closer to the g-
phosphate. As consequence, the H-bonding network between both structures is slightly different. 
3. Results 
 
195 
This effect can be observed for D30 and E31 in switch 1 and for Q61, E62, E63, Y64 and 
M67 in switch 2. 
The two structures show also differences in terms of trapped waters at the catalytic centre: 
the catalytic water, known for initiating the nucleophilic attack to the g-phosphate during the 
GTPase reaction is named w175 in the 5p21 structure and is coordinated to the g-
phosphate, T35, G60 and to another nearby water named w189 in a tetragonal geometry 
(Figure 3.63C right side). None of them could be found in the RT structure. As result, the 
H-bond network is slightly different and leads to the movement of Q61 closer to the g-
phosphate, allowing the NH side chain of this residue to be at a distance of 3.0 Å from the 
g-phosphate (the corresponding residue is more than 8 Å away in 5p21), establishing 
therefore a direct contact with it. An identical orientation of Q61 is observed in both, the 
Ras-GAP (pdb: 1wq1 [83]) and the Ras-SOS (pdb: 1nvw, [45]) complexes, where none of 
the two crucial waters (w175 and w189) can be found. These differences in the number of 
waters can also be extended to the complete unit cell: the RT crystal has much less 
crystallographic waters than 5p21. A possible reason can be related with different degrees 
of hydration due to different contents of PEG in the crystals (32% in the present work. The 
PEG content of 5p21 is not expressly mentioned in the published paper). 
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3.5.2   Crystal Structure of RasWT(1-166)•Mg2+•GppNHp at High Pressure 
A total of four datasets were obtained: 
• 200 MPa, resolution of 1.9 Å 
• 270 MPa, resolution of 2.0 Å 
• 490 MPa, resolution of 1.85 Å 
• 650 MPa, resolution of 1.70 Å 
During the experimental elaboration of this work it was directly verified that an important 
factor regarding the pressure response of the crystals was the incubation time at certain 
pressure values. When a continuously ramping was performed from 0.1 MPa up to above 
270 MPa, with no waiting time for the accommodation of the crystal to high pressures, 
diffraction was completely lost. In fact, good Bragg reflections at the two last recorded points 
(490 MPa and 650 MPa) could only be gathered upon an overnight incubation around 200 
MPa. From these results, it was possible to conclude that a slow adaptation to high pressure 
was necessary, suggesting the existence of a slow conformational modification taking place 
in the range of 200-270 MPa. 
 
3.5.2.1   Analysis of the Compressibility Curve 
A transition to a new conformation was also verified by the analysis of the compressibility 
curve (the metric dependency of the crystal cell parameters with the applied thrust) [180] 
and indicated that the unit cell volume decreases linearly with pressure, down to 3.6%, 
measured at 270 MPa relative to ambient pressure (Figure 3.64). Above this point an 
unusual expansion of 0.6% was observed, from 270 MPa to 490 MPa. At the maximum 
pressure recorded of 650 MPa, for which a complete crystallographic dataset was obtained, 
the calculated increase in 
volume relative to 270 MPa 
was 0.75%. At even higher 
pressures, the volume of the 
cell was reduced again and 
diffraction degraded rapidly 
(resolution of 3.6 Å at 850 
MPa), rendering impossible the 
obtention of a full dataset. At 
low pressure (between 20 and 
150 MPa) it was decided to 
collect only a few reflections, 
Figure 3.64. Compressibility curve obtained for the HP series on 
HRasWT(1-166)•Mg2+•GppNHp at RT. The volume of the unit cell 
(shown in Å3) is plotted as a function of pressure. Only four complete 
data sets were recorded at 200, 270, 490 and 650 MPa. For the lower 
pressure points it was chosen to collect only a few frames. At 850 
MPa the crystal degraded very rapidly. 
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enough to characterise the unit cell, but not complete datasets due to user time limitations 
at the synchrotron beamlines. Data acquisition in this range was also avoided because the 
accurate measurement of the pressure in the DAC is difficult at low pressures (between a 
few tens of MPa, up to ca. 120 MPa). The pressure uncertainty of a crystal mounted at 100 
MPa is ± 20 MPa. Pressure increases in the DAC as the thickness of the metallic gasket (a 
thin foil) decreases. For an increase of 100 MPa, this reduction is typically less than 10 µm 
and difficult to measure precisely by the separation of the Fluoresceence emission lines of 
a Ruby chip [178, 240]. The movement of the piston located on the DAC through which 
thrust is transmitted is also non-linear due to mechanical constrains and aggravates further 
this uncertainty [178, 229]. The problem is alleviated at higher pressures, especially above 
200 MPa, where the thrust can be steadily maintained with minimal oscillations (after 
overnight incubation at 250 MPa, the oscillation was typically ±15 MPa). 
From Figure 3.64 it can be taken that the transition zone for the conformational modification 
occurs slightly above 270 MPa, probably around 300-400 MPa. This is also concluded by 
the increase in the quality of the diffraction, as revealed by the resolution limits which are 
1.75 Å at 0.1 MPa, 1.9 Å at 200 MPa, 2.0 Å at 270 MPa and increase afterwards to 1.85 Å 
and 1.70 Å at 490 and 650 MPa, respectively. The number of visible waters in the electron 
density maps follows the same trend, with 112, 85, 58, 108 and 167 molecules at 0.1, 200, 
270, 490 and 650 MPa, respectively. 
 
3.5.2.2   Analysis of rmsd and b-factor Values 
Global Differences 
The crystal structures refined at HP are shown in Figure 3.65. Additional details of the Mg2+ 
ion coordination environment are shown in Figure G of the appendix section. By doing a 
sequence alignment followed by a structural superposition using the Pymol® software, it was 
found that only minor changes are observed in terms of reorientation of the protein 
backbone at different pressures. The helixes a1, a3 and a4 are perfectly aligned. The most 
noticeable differences occur at the loops λ5 and λ7, at the switch regions, including the helix 
a2 and at the b2 and b3 strands for which the highest deviation (relative to the pamb 
structure, coloured in grey) is seen at 490 MPa (coloured in orange) and 650 MPa (coloured 
in blue, Figure 3.65A left). The residues of all five structural motifs are presented in Figure 
3.65B. It is noticeable that the switch 1 (aa 30-40) is less affected by pressure effects 
comparatively with switch 2 (aa 60-76), given by the higher disorder of the latter relative to 
the former (shown by different torsional and rotational orientation of almost all residues from 
the helix a2 at different pressures, compared with the more structured switch 1). The three 
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other motifs (P-loop, G4 and G5) remain almost unperturbed in the tested pressure range. 
This result is expected given that they are detrimental for the tight binding of the a- and b-
phosphate groups and confer specificity for the guanine nucleotide. The switch regions are 
shown in more detail in Figure 3.65C (switch 1) and D (switch 2). Again, with exception of 
some residues such as E31, D30 and E37, there are no pronounced modifications at switch 
1, contrary to switch 2. 
 
A more quantitative analysis of the data can be given by looking to the b-factors (determined 
at the alpha carbons to avoid the problem of multiple positions of the side chains), whose 
interpretation can provide an insight into the functional relevance of possible excited states 
existing at high pressure [179]. The averaged factors increase from 20.0 Å2 at 0.1 MPa to 
29.2 Å2 at 200 MPa and to 33.6 Å2 at 270 MPa. However, they decrease significantly to 17.0 
Å2 at 490 MPa and to 13.5 Å2 at 650 MPa, leading to the reasoning that that the two last 
structures are further stabilised comparatively to the 200 and 270 MPa ones. 
The rmsd values between the different HP structures were calculated and shown in Figures 
3.65-3.67. A rather small averaged deviation of 0.17 ± 0.12 Å was obtained between the 
0.1 and the 200 MPa structures. A similar value of 0.23 ± 0.15 Å was obtained for the pair 
pamb-p270 (Figure 3.66A). However, after the transition state, a deviation of 0.47 ± 0.23 Å 
was obtained for p270-p490 (Figure 3.67A). A smaller rmsd of 0.28 Å was obtained for the 
pair pamb-p650 (Figure 3.68A). Together these values indicate again the existence of a 
relevant structural rearrangement around 490 MPa. 
 
Specific Differences 
3.5.2.2.1   Structure at 270 MPa 
Since the 200 MPa structure is quite similar to the 270 MPa one (average rmsd of 0.13 Å, 
Figure 3.66A black line), only the comparison between pamb and p270 will be presented 
(Figure 3.66A yellow line). The two structures are very similar in the switch 1 region, with 
only slight differences in the orientation of E37, E31 and D30. The most pronounced ones 
are observed in the middle of the helix a2 for R68 and D69 (Figure 3.66C). The b-factors 
increase in average 13 Å2 and more than 20 Å2 around switch 2 (Q61-Q70, M72, R73) and 
in the loop λ7, comprised between the helix a3 and the sheet b5 (residues K105-D108, Figure 
3.66B). A similar averaged value of 10 Å2 was found between pamb-p200 and almost no 
isotropic displacement was found between p200 and p270. The latter structure seems to 
be less stable than the one at ambient pressure, given the observed increase of the b-
factors. Overall, the most noticeable pressure-induced modification between 270 and 0.1 
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MPa was the destabilisation of switch 2, especially the a2 helix that became slightly pushed 
towards the loop λ7. Since no considerable differences are observed between the p200 and 
the p270, they are assumed to represent the same high-energy sub-state. 
 
3.5.2.2.2   Structure at 490 MPa 
The collection of high completeness data at 490 MPa was only possible when the crystal 
as left at 250 MPa overnight and subsequently ramped up to 450 MPa prior to data 
acquisition. The mean rmsd between p490 and 0.1 MPa is 0.56 ± 0.40 Å, with several local 
values being higher than 0.7 Å (Figure 3.67A, orange line). The most pronounced effects 
were detected at the beginning of the N-terminal extremity (M1, T2), at the b2 and b3 strands, 
comprising the residues from Q43 to L52 and at the switch 2, especially in the S65-M72 
sequence (Figure 3.67C). A concerted shift is observed for the b2-b3 strands and the first N-
terminal residues, all moving towards the helix a5 comparatively to the 0.1 MPa structure. 
The switch 2 becomes also largely shifted towards the helix a3 and the loop λ7 located close 
to the C-terminal. Concomitantly, the segment that precedes switch 1 (T20-E31) becomes 
slightly shifted towards the nucleotide (Figure 3.67D). Remarkably, the average main chain 
b-factors from the structure at 490 MPa are 16 Å2 smaller than the corresponding ones at 
270 MPa (Figure 3.67B). They are also 3.5 Å2 lower than the obtained ones at 0.1 MPa. 
However, different areas on the protein are affected differently. For example, switch 2 
becomes destabilised by pressure (having higher b-factors than the corresponding region 
at ambient pressure). At the same time, the b2-b3 region becomes greatly stabilised, with all 
the local b-factors differing by more than -6 Å2 relative to pamb. 
 
3.5.2.2.3   Structure at 650 MPa 
The refined structure at 650 MPa closely resembles the one obtained at 490 MPa but it 
seems to be further stabilised (less disordered) by pressure as indicated by the temperature 
factors. The averaged rmsd between both is small and equal to 0.28 ± 0.39 Å (Figure 3.68A, 
blue line. A higher value of 0.61 ± 0.45 Å was obtained relative to 0.1 MPa, black line). The 
structural differences between p650 and pamb are similar to the ones already reported 
between p490 and pamb, with most of them involving the residues at the beginning of switch 
1 (I24-N26), the N-terminal (M1-Y4), and the Q43-D54 sequence, comprising the strands 
b2 and b3 (Figures. 3.67C and D). 
The comparison of p650 with p490 shows that all main chain b-factors are lower in the 
former structure relatively to the latter, with exception of the sequence E62-A66 (Figure 
3.68B). The beginning and the end of the switch 2 is further stabilised at 650 MPa, as 
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observed again by the large decrease of the b-factors (more than -5 Å2 relative to p490) for 
the T58-Q61 and R68-Y71 regions. A similar decrease is observed for some areas 
comprising switch 1 (F28-D33, D33, I36-S39), the helix a3 (E91, Q99-V103) and the loop 
λ10 that connects the b6 strand to the helix a5 (T148-G151). The calculated b-factors for the 
nucleotide and for the Mg2+ ion are also significantly decreased. 
Despite the structural similarity between the p650 and p490 structures, several local 
differences can be found (rmsd < 0.8 Å) comprising the residues Q61-A66, R68, Q70-M72. 
Their different reorientation comparatively to p490 leads to a simultaneous displacement of 
the helix a2 towards of the loop λ4 and towards the bulk (Figure 3.68E, bottom). One of the 
most dramatic displacements is observed for Gln61. This residue is normally positioned 
almost in-plane with the g-phosphate as it establishes an H-bond with it in all the refined 
structures except at 650 MPa, where it assumes a perpendicular position and points 
upwards and towards the bulk. In this new position, Gln61 becomes stabilised by an H-bond 
between its side chain and one of the oxygen atoms of the g-phosphate from the adjacent 
molecule in the unit cell. The b-factor of the nitrogen atom engaged in the H-bond shows a 
large decrease when compared with the other structures (37 Å2 at pamb, 46 Å2 at p490 and 
25 Å2 at p650), indicating that the new position for Gln61 at 650 MPa is a very stable one 
(Figure 3.68E, top). 
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Figure 3.65. HP series on HRasWT(1-166)•Mg2+•GppNHp at RT. A. General overview of the superimposed structures 
evidencing differences in the relative orientation of the a-helixes and b-sheets. B. An overview of the pressure-induced 
effects on the motifs of the G domain surrounding the catalytic centre is given (switch 1, aa 30-40; switch 2, aa 60-76; 
P-loop, aa 10-17; G4, aa 116-119; G5, aa 145-147). The Mg2+ ion is represented as a sphere located nearby the g-
phosphate C. Details at switch 1 evidencing the re-orientation of the side chains for some residues. D. Details at switch 
2. 
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Figure 3.66. Structural details of RasWT(1-166)•Mg2+•GppNHp obtained at 270 MPa (coloured in yellow) 
and comparison with pamb (coloured in grey) and the 200 MPa structure (coloured in green). A. Rmsd plot 
of p200 against pamb (green line), p270 against p200 (black line) and p260 against pamb (yellow line). B. 
Plot of the b-factors for pamb, p200 and p270. C. Local details evidencing the regions where the most 
pronounced structural differences between p270 and pamb were detected (around helix a2 and loop λ7). 
Figure 3.67. Structural details of RasWT(1-166)•Mg2+•GppNHp obtained at 490 MPa (coloured in orange) and 
comparison with pamb (coloured in grey) and the 270 MPa structure (coloured in yellow). A. rmsd plot of p490 against 
p270 (black line) and p490 against pamb (orange line). B. Plot of the b-factors for pamb, p270 and p490. C. Local 
details evidencing the regions where the most pronounced structural differences between p490 and pamb were 
detected (at helix a2, Y64-M72 and at the N-terminal, including M1-Y4 and b2-b3 strands, Q43-L52. Additional 
modifications were detected at the helix a5 (rmsd > 0.7 Å) involving F146, Y157, R161, E162 and Q165. D. General 
overview of the structural changes observed between pamb, p270 and p490 at the N-terminal (dashed circle) and at 
the switch 2 region, marked by the upward arrow and by the movement of a2 towards a3, located behind it. 
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Figure 3.68. Structural details of RasWT(1-166)•Mg2+•GppNHp obtained at 650 MPa (coloured in blue) and 
comparison with pamb (coloured in grey) and with the 490 MPa structure (coloured in orange). A. rmsd plot of 
p650 against p490 (blue line) and p650 against pamb (black line). B. Plot of the b-factors for p490 and p650. 
C. Plot of the b-factors for p650 and pamb. D. Local details evidencing the structural differences for which the 
rmsd values are higher than 1.0 Å, between p650 (blue) and pamb (grey). In the upper Figure the N-terminal 
region is highlighted (M1-Y4) together with the residues comprising the beginning of the helix 𝛼1 (I24-N26). The 
observed differences in the strands b2 and b3 are highlighted in the lower Figure for the residues Q43-D54. 
Other significant changes, not depicted here, were also found again at the helix 𝛼2 (Q62-D69, Y71, M72) and 
for E162 located at the helix helix 𝛼5. E. Details of the structural modifications (rmsd > 1.0 Å) between p490 
(blue and p650 (orange). The pamb structure is also shown (grey). In the upper Figure, the different orientation 
of Q61 in p650 is evidenced. The switch 1 is almost identical for all the three proteins but remarkable differences 
are observed again at the switch 2, namely at the helix 𝛼2, represented in the lower picture. 
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3.5.3   Crystal Structure of RasD33K(1-166)•Mg2+•GppNHp at Ambient Pressure 
RasD33K was solved with a resolution of 1.95 Å at RT and ambient pressure. The structure 
is very similar to RasWT, with the total averaged rmsd value between both being only 0.13 
Å. Their similarity can be inferred from the perfect superposition of their crystal structures, 
shown in Figure 3.69A (RasWT is coloured in grey and RasD33K is coloured in green). The 
refined electron density in the vicinity of Lys33 is shown in Figure 3.69B. The side chains of 
Lys33 and Asp33 point in the same outward direction, towards the surface of the proteins, 
and the switch 1 is almost identical for both. The only noticeable differences are the distinct 
rotational orientations of Asp30 and Glu37, together with the formation of an H-bond 
between Lys33 and Glu31. The switch 2 is only slightly different for residues Q61-Y64 and 
R68-Q70, with an rmsd > 0.3 Å. The obtained b-factors are also very similar in the two 
structures (20 Å2 for RasWT and 21 Å2 for RasD33K). 
 
Figure 3.68. Refined crystal structure of HRasD33K(1-166)•Mg2+•GppNHp obtained at ambient pressure and RT 
(coloured in green) and comparison with the wild type protein obtained in the same conditions (coloured in grey). 
A. Cartoon representation of the superimposed structures. The nucleotide from RasWT is coloured in dark orange 
and the nucleotide from RasD33K is coloured in light orange. B. View of the electron density map of RasD33K 
around the mutated residue. The neighboring amino acids are also shown. C. Comparison of the structural 
details between both proteins at the switch 1 region. D. Comparison at the switch 2 region. The residues showing 
different degrees of rotation are represented as thin lines. The small dark blue coloured spheres refer to the 
solvent waters of RasD33K and the light blue coloured ones refer to those of RasWT. 
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3.5.4   Crystal Structure of RasD33K(1-166)•Mg2+•GppNHp Under High Pressure 
3.5.4.1   Analysis of the Compressibility Curve 
Two complete HP datasets were collected for RasD33K under pressure 
• 200 MPa, resolution of 2.1 Å 
• 880 MPa, resolution of 1.65 Å 
In the first one, pressure was continuously ramped from 0.1 MPa with no waiting period for 
pressure accommodation. In the second one, again an overnight incubation at 550 MPa 
revealed to be necessary to achieve very high pressure, otherwise diffraction was 
completely lost. A third dataset was recorded at 500 MPa after previous incubation at 200 
MPa for ca. 2 hours. Although, perhaps due to the short incubation period, diffraction was 
quickly lost, rendering impossible the acquisition of a full-refined structure. Figure 3.70 
shows that the unit cell volume decreases 1.7% from 0.1 to 500 MPa and 4.6% from 0.1 to 
880 MPa. The decrease between 200 and 880 MPa is of 2.9%. These results indicate that 
the transition zone for RasD33K occurs at a higher pressure (ca. 500 MPa) comparatively to 
RasWT (300-400 MPa). 
The quality of the diffraction also improves with pressure, as observed from the obtained 
resolution limits (1.95 Å at 0.1 MPa, 2,1 Å at 200 MPa, 1,65 Å at 500 MPa and 1.8 Å at 880 
MPa). The same trend can be observed by the number of crystallographic waters which 
increases from 80 (pamb) to 82 (p200) and 237 (p880). The same assessment can be 
followed by considering the averaged values of the b-factors, which decrease from 21 Å2 at 
0.1 MPa to 16.8 Å2 at 880 MPa. The rmsd value between ambient pressure and 200 MPa 
is 0.17 Å and 0,64 Å between 200 and 880 MPa. Together these results suggest again a 
Figure 3.70. A. Compressibility curve obtained for the HP series on HRasD33K(1-
166)•Mg2+•GppNHp at RT. The volume of the unit cell (shown in Å3) is plotted as a function 
of pressure. B. Photography of a RasD33K crystal at 880 MPa. The crystal occupies the full 
length of the DAC (400 nm). Several cracks are noticeable at one of the edges due to the 
extreme pressure. The tiny circle in the bottom of the cavity is a ruby sphere used for an online 
measurement of the pressure. Due to its rather flat shape, the crystal needed to be reoriented 
using a diamond splinter (dark figure on the top). This process helps the acquisition of high 
completeness data. Surrounding the cavity is the metallic gasket that was carefully machined 
and positioned between the culets of the two diamond anvils. 
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structural rearrangement between 200 and 880 MPa and possibly the existence of a new 
conformation at very high pressure. 
 
3.5.4.2.   Analysis of rmsd and b-factor Values 
Global Differences 
A general overview of the RasD33K HP series is given in Figure 3.71. As already observed 
in the case of RasWT, there are no dramatic changes on the protein structure such as a 
complete unwinding of an helix or a broad displacement of a loop comparatively the 0.1 
MPa structure. The superimposed structures shown in Figure 3.71A indicate that the helixes 
a3, a4 and a5 remain unaltered, being the only affected regions switch 1, the helix a2 and 
the C-terminal of the protein. A closer look to the five fingerprint motifs of the G domain 
(Figure 3.71B) evidences again the greater mobility of switch 2 with pressure relative to 
switch 1 and an almost unperturbed behaviour for the P-loop, G4 and G5. 
 
Specific Differences 
3.5.4.2.1   Structure at 200 MPa 
The 200 MPa structure is quite similar to the one solved at ambient pressure, with an 
averaged rmsd of 0.17 ± 0.09 Å (Figure 3.72A). The switch 1 is virtually identical in both 
proteins and only significant changes are observed in switch 2, for which an rmsd > 0.5 Å 
was obtained at Glu63 and Arg68 (Figure 3.72A). The global behaviour of RasD33K between 
these two pressure points seems to be similar to the one of RasWT between ambient 
pressure and 270 MPa. However, there is almost no change in the b-factors in the case of 
the mutant (ca. 1.2 Å2, Figure 3.72B vs 13 Å2, Figure 3.66B, respectively). High local b-
factors (> 6 Å2) could only be found in the switch 2 (Q62, E63-D69, Y71) and for S39 in 
switch 1, G151 in the helix a5 along with the Mg2+ ion. Given these results it can be inferred 
that RasD33K seems to be less prone to pressure-induced conformational rearrangements 
comparatively to RasWT (both show a small difference in the rmsd values and almost no 
difference in the temperature factors). 
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3.5.4.2.2   Structure at 880 MPa 
The 880 MPa structure, however, is remarkably different from the other two. The obtained 
average rmsd values are 0.71 ± 0.5 Å and 0,64 ± 0.5 Å relatively to 0.1 MPa and 200 MPa 
(Figure 3.73A). Furthermore, the closest pressure point in the wild type series is 650 MPa. 
Comparing both, a relatively high rmsd is also obtained (0.32 Å). 
The main differences between RasD33K at 0.1 MPa and at 880 MPa (rmsd >1.0 Å) lie at the 
very beginning of the N terminal (M1, T2), at the helix a1 (I24-H27) at the beginning of switch 
1 (V29-Y32), the b2 and b3 strands (R41-D54), the switch 2 (Q61 – M67, Y71 – T74), and 
residues A122 ,R128 (helix a4), and E162 (helix a5). At 880 MPa, the segment I24-Y32 
becomes shifted by more than 1.0 Å towards the nucleotide and the residues E31, E37, 
S39 and R41 point in different directions. Furthermore, in the switch 2, the loop λ4 (Q61 – 
Y64) becomes shifted by more than 2.0 Å towards helix a5. Finally, the a2 helix (S65 – T74) 
becomes shifted by 1.0 Å towards the loop λ4, with all residues pointing in different 
directions (Figure 3.73C). Particularly, the crucial Gln61 becomes H-bonded to NH side 
chain of Tyr64, pointing away from the nucleotide g-phosphate, as already observed in 
RasWT at 650 MPa (Figure 3.73D, top). The b-factors decrease in average 4.5 Å between 
p880 and pamb (Figure 3.73B). However, a local increase is observed at the end of P-loop 
(K16-L19), switch 1 (Y32-I36), switch 2 (A59-M67, Y71), at the Mg2+ ion together with two 
H2O molecules coordinating it. 
 
3.5.4.2.3   RasD33K at 880 MPa vs RasWT at 650 MPa 
When comparing the p880 RasD33K with p650 RasWT significant differences can be found in 
switch 1 (V29-Y32) and the switch 2 (Q61-T74, Figure 3.72C). The obtained rmsd values 
in these regions are always higher than 0.7 Å. In RasD33K at 880 MPa switch 1 shifts more 
with pressure than the corresponding region in RasWT at 650 MPa (increased b-factors in 
the segment Y32-I36). It is not possible to conclude if this happens because of the presence 
of the mutation or because of a higher pressure (880 MPa instead of 650 MPa). 
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Figure 3.71. HPMX on HRasD33K(1-166)•Mg2+•GppNHp at RT. A. General overview of the superimposed structures 
evidencing differences in the relative orientation of the a-helixes and b-sheets. B. An overview of the pressure-induced 
effects on the residues surrounding the catalytic centre is given (switch 1, aa 30-40; switch 2, aa 60-76; P-loop, aa 10-
17; G4, aa 116-119; G5, aa 145-147). C. Details at the switch 1. D. Details at the switch 2. 
3. Results 
 
211 
 
Figure 3.72. HP X-ray crystallography on RasD33K(1-166)•Mg2+•GppNHp. A. Rmsd plot of p200 against 
pamb (orange line) and comparison with RasWT p200 against RasWT pamb (green line). B. Plot of the b-
factors for D33K pamb and D33K p200 C. Structural details evidencing the detected differences (rmsd > 1 
Å) at switch 1 (top) and switch 2 (bottom) between RasD33K at 880 MPa (blue coloured) and RasWT at 650 
MPa (pink coloured). 
Figure 3.73. HP X-ray crystallography on RasD33K(1-166)•Mg2+•GppNHp. A. rmsd plot of p200 against pamb 
(orange line), p880 against p200 (black line) and p880 against pamb (blue line). B. Plot of the b-factors for 
pamb and p880. C. Structural details evidencing the observed small deviations (rmsd > 0.5 Å) at switch 2 
between RasD33K at pamb and at 200 MPa. D. Similar comparison between pamb and p880. Significant 
differences were found at the beginning of switch 1 (top) and especially at the N-terminal region (rmsd > 1.0 
Å), involving the residues from the b2 and b3 sheets (bottom). 
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3.5.5   Crystal Structure of HRasWT(1-166)•Mg2+•GppNHp Soaked with Zn2+-cyclen 
3.5.5.1   Analysis of the Compressibility Curve 
For the purpose of these investigations, the previously grown Ras crystals were soaked 
with 10-12 mM of Zn2+-cyclen from a highly concentrated stock solution (> 20 mM) at least 
10 hours before data acquisition. Four complete datasets were obtained, all within the same 
trigonal P3221 space group: 
• 0.1 MPa, resolution 1.8 Å 
• 180 MPa, resolution 2.05 Å 
• 240 MPa, resolution 2.80 Å 
• 520 MPa, resolution 2.70 Å 
The analysis of the compressibility curve shows that the unit cell volume decreases linearly 
with pressure, down to 5% at 520 MPa (Figure 3.74, orange line; only a few frames were 
collected at 100 MPa). The decreasing is continuous, contrary to the behaviour of the Apo 
structure (black line), whose volume increases between 270 and 490 MPa. It can be 
observed that at any given pressure the cell volume of the protein soaked with the drug is 
always smaller than the Apo structure, indicating that the inhibitor is diffusing and interacting 
with Ras in the crystal (either specifically or unspecifically). In this series, incubation was 
only performed for the last point at 200 MPa overnight. Afterwards, thrust was continuously 
applied up to 520 MPa followed by data acquisition. Contrary to the observations for the 
Apo structure, the quality of the diffraction does not improve with the increase of pressure. 
The resolution limits are around 2.0 Å at low pressures and 2.8 Å at high pressures. The 
number of visible waters also decreases with pressure, again as opposed to the Apo 
protein, from 95 at pamb to 62, 69, 10 and 34 at p100, p180, p240 and p520 MPa, 
respectively. 
 
 
 
 
 
 
 
 
 
 
Figure 3.74. Compressibility curve obtained for the HP series on 
HRasWT(1-166)•Mg2+•GppNHp crystals soaked with 10-12 mM Zn2+-
cyclen at RT (orange coloured line). The compressibility of RasWT 
alone, named here as Apo, is also shown for comparison (black 
coloured line). 
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3.5.5.2.   Analysis of rmsd and b-factor Values 
The averaged main chain b-factors increased with pressure, from 22 Å2 at ambient pressure 
to 31 Å2 at 100 MPa, 29 Å2 at 180 MPa, 43 Å2 at 240 MPa, decreasing subsequently to 30 
Å2 at 520 MPa. It is worth mention that the structure at 240 MPa was collected on the same 
crystal used at 100 MPa. This can partially explain the degradation of the diffraction at 240 
MPa (very small number of crystallographic waters, high b-factors). The averaged rmsd 
values between RasWT•Zn2+-cyclen at ambient pressure and p100, p180, p240 and p520 
MPa are 0.17, 0.19, 0.36 and 0.87 Å, respectively. 
Rather surprisingly, no Zn2+-cyclen molecules are visible in the electron density maps of the 
crystal structures at 100, 180 and 240 MPa. 
 
3.5.5.2.1   Ras Apo vs Ras•Zn2+-cyclen at Ambient Pressure 
No significant differences were observed between RasWT Apo and in complex with Zn2+-
cyclen at 0.1 MPa. The average rmsd between both is 0.13 Å. The highest local deviations 
(rmsd > 0.3 Å) were found for D110 and V111 at the loop λ7. No differences were detected 
near the C-terminal H166 or at Q61. Both the Mg2+ ion and GppNHp lie at the exact same 
position. Similar results were found when comparing Ras•Zn2+-cyclen at ambient pressure 
with the structures resolved at 100 and 180 MPa. 
 
3.5.5.2.2   Structure at 240 MPa 
The structure obtained at 240 MPa is not drastically different from the one at 0.1 MPa, 
however high local main-chain rmsd values were found between both involving the helix a1 
and the remaining switch 1 region (rmsd > 0.5 Å for L23, N26, H27, D30-T35 and D38). 
Particularly, T35, D33 and G48 showed an rmsd > 1.0 Å. These overall modifications led to 
the shift of switch 1 away from the nucleotide and from the Mg2+ ion comparatively with its 
corresponding position at 0.1 MPa. Additional differences were found in switch 2 that also 
shifts away from the nucleotide: L56, D57-E63, R68, D69 were all found to have a rmsd > 
0.5 Å relative to 0.1 MPa. For Q61-Q63 the deviation is greater than 1.0 Å. The Mg2+ ion is 
itself shifted by 0.71 Å towards the bulk relative to the ambient pressure structure. More 
importantly, Zn2+ is observed in the electron density map between the O1 of the g-phosphate 
(distance of 2.5 Å), the side chain of Y32 (distance of 2.6 Å) and the side chain of P34 from 
the adjacent molecule in the unit cell (distance of 2.9 Å). However, the cyclen moiety that 
should surround the metal is not visible. Given these results alone, it is difficult to conclude 
whether if cyclen is too disordered to be localized or not present at all. 
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3.5.5.2.3   Structure at 520 MPa 
The 520 MPa structure is considerably different from the one at ambient pressure. Both are 
superimposed in Figure 3.75. The average rmsd value is 0.8 Å with localised differences 
accounting for a rmsd > 1.5 Å (Figure 3.76A). These occur mainly in switch 1 and in the 
loop λ7 that connects the strands b2 and b3 (rmsd of 1.6 Å for V44-C51). This last region 
shifts towards the bulk relative to the ambient pressure structure (Figure 3.75B). 
Structural differences were also found at switch 2, particularly for Q61, E63 and the segment 
S65-Y71, all with an rmsd > 1.0 Å relative to the 0.1 MPa structure (Figure 3.75C). It is also 
worth mention that switch 2 in the Ras•Zn2+-cyclen at 520 MPa is structurally more similar 
to Ras Apo at p490 than Ras Apo at p650. With the exception of switch 1, both structures 
(Ras•Zn2+-cyclen p520 and Apo p490) can be considered identical. The analysis of the 
temperature factors shows that these are increased by pressure in average 8.0 Å2 and more 
than 20 Å2 in both switch regions (D33-D38, E62-Y64, D69-Y71, Figure 3.76B) at 520 MPa. 
Similarly to the p280 structure, a Zn2+ ion has been visualized in the electron density map 
of p520, located close to the nucleotide and at a distance of 2.0 Å from O1 of the g-
phosphate. This ion lies very close to its symmetrical counterpart, with the distance between 
them being 4.2 Å (Figure 3.76D); it shows a full occupancy, a high temperature factor (ca. 
70 Å2) and is further coordinated by three H2O molecules (at a distance of 2.01, 2.56 and 
2.78 Å). However, as for p280, no cyclen was detected around it. 
The most important difference between the structure solved at 520 MPa and the one at 
ambient pressure lies in the switch 1 (Figures 3.75B and 3.76C): at 520 MPa the segment 
comprising S17-S39 shows a rmsd > 0.5 Å, with I24-H27 having a deviation higher than 1.0 
Å. At the same time, D30-D38 became shifted towards the bulk by almost 5.0 Å. Due to 
such a large movement, the side chain of T35, that normally coordinates the Mg2+ ion, is 
now more than 4.0 Å away from it, as shown in Figure 3.76C. At the otherwise normal 
position of the side chain OH group from T35 lies now a water molecule coordinating the 
Mg2+ ion. 
The 520 MPa structure is considerably different than he one at 240 MPa. The average rmsd 
between both is 0.79 Å, with the residues E31-E37 showing a deviation higher than 5.0 Å. 
Marked differences are also found at the segment b2-b3 (V44-T50, rmsd > 1.0 Å) and at 
switch 2 (Q61-Q63, S65-M67, Q70, Y71, rmsd > 1.0 Å). Other major differences involve the 
position of both metal ions, with Mg2+ and Zn2+ being displaced towards switch 2 in p520 by 
1.69 and 2.26 Å, respectively. 
 
3. Results 
 
216 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.75. HPMX on HRasWT(1-166)•Mg2+•GppNHp at RT complexed with the small 
inhibitor Zn2+-cyclen. The refined structure at 520 MPa (coloured in green with the 
nucleotide in dark grey) is shown superimposed with the one at ambient pressure 
(coloured in violet with the nucleotide in orange). Both crystals were soaked for at least 
10 hours with 12 mM Zn2+-cyclen A. General overview evidencing the overall 
differences between both. B. Structural details of switch 1 (aa 30-40). C. Structural 
details of switch 2 (aa 60-70). For both structures, no Zn2+-cyclen was detected in the 
electron density maps. However, Zn2+ alone (coloured in blue) was detected in the 520 
MPa structure close to the g-phosphate. The cyclen group could not be found, although 
due to the large movement of switch 1 there is enough space to accommodate it. 
3. Results 
 
217 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.76. HP X-ray crystallography on RasWT(1-166)•Mg2+•GppNHp complexed with Zn2+-cyclen. 
A. rmsd plot of p520 against pamb (violet line) and RasWT Apo p490 against Ras•Zn2+-cyclen p520. 
B. Plot of the b-factors for Ras•Zn2+-cyclen at pamb (violet line) and p520 (green line). C. Details 
around the Zn2+ coordination site. This ion is stabilised by contacting the g-phosphate and the side 
chain of Q61. The movement of switch 2 relative to the original position at pamb (violet ribbon) leads 
to the displacement of T35 and Y32 outwards. At 520 MPa these residues can no longer establish 
polar contacts with the nucleotide. D. Details evidencing the spatial symmetry of the Zn2+ ion. The 
distance between its symmetric counterpart is 4.2 Å. 
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4. Discussion 
 
“If you’re not part of the solution, you’re part of the precipitate” 
Henry J. Tillman
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4.1   Full-Length H and KRas. Conformational Equilibria and Inhibition by Zn2+-cyclen 
Due to the renovated interest in KRas it was presently investigated if the body of work 
previously conducted in HRas in terms of 31P NMR could be transferred to KRas [67, 116, 
155]. 
 
4.1.1   Interaction of KRasWT(1-188)•Mg2+•GppNHp with Raf-RBD 
The results showed that the equilibrium population distribution is almost identical in HRasWT 
and KRas4bWT: two conformational states dominate the GppNHp spectrum with a K12= 2.0 
in both proteins (section 3.1.1, Figure 3.1). The interaction of KRasWT with the effector Raf-
RBD was tested by 31P NMR and showed that complex formation is characterised by a 
significant upfield shift of state 2(T) (Dd= -0.21 ppm, from d= -3.30 ppm to d= -3.51 ppm, 
Table 3.1). The difference indicates the state 2(T) is modified in the Ras-Raf complex by 
small conformational changes that are generally termed as an induced fit model of binding 
[263]. In order to distinguish these small but significant differences the notion of state 2*(T) 
was presently introduced. Additional studies reported by our department, involving the 
partial-loss-of-function mutants RasT35A and RasT35S led to the same conclusion regarding 
the weak-effector bound state 1(T): also in this case, state 1(T) isomerises into state 1*(T) 
upon effector binding [156] The upfield shift resulting from the general isomerisation process 
observed in the 31P NMR spectra can be used in other studies as a fingerprint to discriminate 
between Ras mutants that can bind to Raf from non-binding ones. 
The affinity of full length HRasWT and KRasWT towards Raf was also tested by ITC. The 
obtained KD values of 0.24 µM and 0.72 µM, respectively, indicate that the former binds with 
a 3-fold greater affinity to the effector than the latter (Figure 3.2). Previous measurements 
reported in the literature indicate a KD= 0.084 µM for the HRasWT-Raf complex (measured 
at the same temperature and in 50 mM Tris/HCl pH 7.4, 5 mM MgCl2 with 100 mM NaCl) 
[33, 244, 264], which corresponds to a 3-fold higher affinity compared with the presently 
obtained value. This difference can be due to the differences in buffer composition. No 
affinity data measured by ITC was found in the literature for the KRas•Raf complex.  
The experimental DH, DG and -TDS values obtained here for HRasWT•Raf are -13.1, -37.7 
and -24.6 kJ mol-1, respectively, and the corresponding published ones from the same study 
are -21.7, -40.6 and -18.8 kJ mol-1, respectively [33]. The interaction has a very similar 
associated Gibbs free energy in both cases. The main difference lies on the different 
contributions: the published data has a greater enthalpic contribution and the present 
measurements show a greater entropic contribution. 
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In the case of the four Ras isoforms, all known effectors contact the protein surface in a 
similar way by establishing an intermolecular b-strand comprised of Ras-b2 and b3, and 
RBD-b1 and b2 elements [243]. Based on these structural similarities the 3-fold difference 
in the measured affinity might be due to the simple uncertainty of the measurements but 
can also be due to the influence of the hypervariable region (HVR) which is structurally 
different in both, H- and KRas isoforms. 
 
4.1.2   Stabilization of State 1(T) by Zn2+-cyclen Studied by 31P NMR 
The direct modulation of the conformational equilibrium by stabilising state 1(T) upon 
interaction with Zn2+-cyclen was also addressed in this work in section 3.1.2. The obtained 
titration curves (Figure 3.3) show that this small compound binds to both isoforms in a 
cooperative manner (n=2) and their sigmoidal behaviour is indicative of at least two binding 
sites. The same conclusion was obtained when previous 31P NMR spectroscopic studies 
conducted by our group revealed that HRasWT•Mg2+•GppNHp shifts towards the weak 
binding state 1(T) upon binding of Zn2+ or Cu2+-cyclens [157, 254]. This result also 
corroborates the finding of two different binding sites for Zn2+-cyclen on the surface of the 
protein [157]. 
By fitting the plot of the chemical shift difference (Dd) of state 1(T) over the course of the 
titration as a function of Zn2+-cyclen concentration to the Hill equation, a numerical value for 
the dissociation constant was found to be equal to 9.9 ± 0.2 mM (Figure 3.3), for both Ras 
isoforms. In parallel with this data, additional experiments reported by our group involving 
the titration of RasT35S led to the calculation of an IC50 =18 mM for this drug [156].Taken 
together, these values clearly show that the affinity of Zn2+-cyclen for Ras is too low for in 
vivo investigations. However, its mode of action on Ras, and possibly on other GTPases 
renders it a lead compound for the 
allosteric inhibition of effector 
interaction. Its direct localization 
at the active centre of Ras can be 
exploited to derive more selective 
compounds, especially for 
oncogenic variants. Despite its 
low affinity, studies performed by 
stopped-flow kinetics were able to 
show that it has a clear inhibitory 
effect on the Ras-Raf interaction. 
Figure 4.1. Typical mode of action of Zn2+-cyclen and other state 
1(T) inhibitors. Upon interaction with Raf, state 2(T) of Ras 
isomerises into state 2*(T). Zn2+ cyclen perturbs this process by 
stabilising state 1(T), decreasing the population of state 2(T) and 
preventing the transition into state 2*(T). Taken from [156]. 
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The reported association rate constant, kon, for the complex formation in its absence and in 
its presence is 19.0 µM-1 s-1 and 2.2 µM-1 s-1, respectively [156]. Figure 4.1 shows 
schematically its mode of action. 
The studies on the inhibition of Ras by Zn2+-cyclen were further complemented by 
investigating the displacement of this drug from full-length HRasWT and KRasG12D upon 
addition of increasing amounts of Raf-RBD (Figures 3.4 and 3.6, respectively). It was 
demonstrated that both, Raf and Zn2+-cyclen compete for binding to Ras and that the 
original equilibrium observed at the g-phosphate for the Ras-Raf complex can be fully 
restored when a 2-fold excess of effector is added to the original Ras•Zn2+-cyclen complex. 
These results were further complemented by fluorescence titration experiments reported in 
the published paper [156]. They further indicated that the interaction between the 
conformational state 1(T) and Zn2+-cyclen prevents the formation of a trimeric complex 
Ras•Zn2+-cyclen•Raf in significant concentrations. 
 
4.1.3   Conformational Equilibria of KRasG12D•GTP and KRasG12V•GTP 
The conformational equilibria for the full-length oncogenic variants KRasG12D and KRasG12V 
bound to Mg2+•GTP was also investigated by 31P NMR (section 3.1.4, Figure 3.5 and Table 
3.6). From the obtained spectra, state 1(T) at the g-phosphate can be directly observed for 
G12V but not for G12D or the wild type proteins. This indicates that the P-loop mutation 
form Gly12 to Val12 leads to a significant perturbation of the chemical environment on the 
g-phosphate. However, the mutation to Asp has virtually no significant influence based on 
the spectra of KRasWT. Structural relationships that might explain these differences are 
difficult to assess, especially because there are no crystal structures of the GTP-bound 
mutants. The observation of the corresponding crystal structures of HRasG12D(1-
166)•Mg2+•GppNHp (pdb: 1agp) and HRasG12V(1-166)•Mg2+•GppNHp (pdb: 4efm) shows 
that the arrangement of Gln61, Tyr32 and Pro34 differs markedly between the two mutants. 
In the case of HRasG12D the Asp12 side chain establishes an H-bond to the side chains of 
Gln61 and Tyr32, that becomes very close (2.65 Å) to the g-phosphate and pulled towards 
the interior of the molecule. Gln61 is also pulled towards the g-phosphate and Pro34 is fully 
exposed at the surface. In the case of HRasG12V Tyr32 points away from the molecular 
surface, being more than 4 Å distant the g-phosphate [265]. These differences account for 
the different 31P NMR spectral features of the GTP-bound proteins, especially the different 
movement of Tyr32, and for their different GTPase activity (G12D being 70% faster than 
G12V) [266, 267]. 
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4.2   Modulation of the Conformational Equilibrium of KRasG12D(1-188)•Mg2+•GppNHp 
        by Small Compounds 
4.2.1   General Considerations 
The effect of different 15 small compounds in the conformational equilibrium of KRasG12D 
bound to Mg2+•GppNHp was investigated by 31P NMR (section 3.2). Six of them (#643, 
#098, #703, #449, #071, #109) have no pronounced effects, contrary to the remaining nine 
(#727, #755, #757, #612, #613, #624, #307, #308, #616) that lead to a decrease of the K12 
values relative to Ras alone. The highest effects are observed for the Fesik compounds 
#755 and #757 [145] as well as (but at a smaller extent) the Sulindac analogues #307 and 
#308 [147, 148]. A global overview is given in Figure 4.2 were the equilibrium constants are 
plotted for the tested concentrations of 1.5 mM (grey) and 3.0 mM (orange). Under the 
present conditions, the equilibrium could not be shifted completely. This may be due to an 
inherent property of these inhibitors or simply because the 3.0 mM maximum concentration 
is not sufficient. 
Most of the compounds are intrinsic allosteric inhibitors of Ras that act by stabilising state 
1(T) leading to a decreased SOS-mediated exchange activity; although their main function 
is assumed to focus on the GDP-bound state (as state 1(D) stabilisers), their action can be 
extended to GppNHp-bound Ras as proven here, and most certainly also to GTP-bound 
Figure 4.2. Comparative plot of the obtained equilibrium constants, K12=Astate2(T)/Astate1(T), for the 
g-phosphate of KRasG12D•Mg2+•GppNHp in the presence of the tested compounds at 1.5 mM 
(grey colour) and 3.0 mM (orange colour). The first bar, noted as, ‘KRasG12D’, refers to the control 
experiment were the influence on K12 was measured in the absence (grey) and in the presence 
(orange) of 6% DMSO. The six compounds published by the Fesik group and their structural 
differences are indicated together with DCAI from Genentech. 
4. Discussion 
 
226 
Ras. This series of experiments also shows that 31P NMR spectroscopy can be used to 
quickly select and score potential drug candidates from large libraries. This is extremely 
useful in the field of Ras inhibition and can be potentially extended to any other GNBP from 
the Ras superfamily.  
The inhibitory effect of the two Fesik compounds and DCAI is discussed in more detail in 
the following sections. 
 
4.2.2   Inhibition of Ras-Raf Interaction by #755 and #757 Followed by ITC 
Both compounds impair the protein complex formation, with #757 having the highest 
inhibitory effect (sections 3.2.9 and 3.2.10). The measured KD for the Ras-Raf binding 
increases from 0.37 µM to 0.62 µM in the presence of 300 µM of #755 and from 0.37 µM to 
3.54 µM in the presence of an equal concentration of #757. Both differ only in the 
substituents at their benzimidazole group, with #755 having an methylbuthanamide moiety 
and #757 having a bulkier, proline-like, moiety (Figures 3.15 and 3.17) [133, 145]. The 
bigger size of the proline substituent of #757 allows the molecule to expand further into the 
binding cleft (Figure 3.17) and accounts for the enhanced disruption of Ras-Raf mediated 
interaction [145]. As #757 is bulkier, its binding on the Ras surface leads to a more 
pronounced rigidity of the protein around the binding site compared to #755, which implies 
a greater effort in performing a conformational modification to achieve Raf binding. This 
interpretation explains the negative entropic contribution (positive -TDS, Figure 3.18) of the 
process in the presence of #757, contrary to #755, where the more hydrophilic 
methylbuthanamide would favour an extended water network in the vicinity of the binding 
cleft, responsible for the positive enthalpic and entropic contributions (Figure 3.16). 
The positive increase in entropy from the Ras-Raf complex alone comparatively with the 
same complex in the presence of #755 (-TDS= -13.3 kJ mol-1 vs -25 kJ mol-1, Figure 3.16) 
could be unrelated with the characteristics of complex formation but instead due only to 
unspecific effects (such as decreased solubility of the ligand in solution). A direct 
contribution for the increase in entropy can be related with the binding of #755 to Ras and 
the associated release of hydration waters from the contact surface of the protein [268]. 
The true contributions, however, are difficult to rationalize due to the likely existence of 
enthalpy-entropy compensation mechanisms  where a ligand modification that results in a 
change in the enthalpic contribution to binding DDH≡DHRas/drug-Raf−DHRas-Raf can be partially 
or fully offset by a similar change in the entropic component of binding, DDTS≡DTSRas/drug-
Raf−DTSRas-Raf [244, 269]. When enthalpy-entropy compensation occurs, normally DDH and 
DDTS share the same and that DDG≈0. This is presently the case for #757: comparing the 
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titration in the presence of 150 µM of #757 (Figure 3.18B) with the Ras-Raf interaction alone 
(Figure 3.18A) it follows that DDH= -28 kJ mol-1 and DDTS= -32 kJ mol-1. The changes in 
the Gibbs energy, DDG, are only 4 kJ mol-1. Similar values are obtained for the binding of 
the two proteins measured in the presence of 300 µM of the drug [270, 271]. 
 
4.2.3   Inhibition of Ras-Raf Interaction by #616 (DCAI) Followed by ITC 
DCAI from Genentech [18] represents an interesting case since it inhibits Raf binding by a 
factor of 10 (KD= 3.53 µM at 300 µM of #616 vs 0.37 µM in Ras alone) but shifts the 
equilibrium in the opposite direction, favouring state 2(T) (K12 increases from 0.7 in Ras in 
6% DMSO to 1.02 at 3.0 mM, section 3.2.16, Table 3.3). In vivo Ras-Raf inhibition in its 
presence was also reported and further supports the present ITC data [18]. How can a 
compound stabilise the effector recognising state and at the same time inhibit the interaction 
with Raf? Within the conformational model of Ras it can be speculated that #616 stabilises 
state 3(T) that is adjacent to state 2(T) in the 31P NMR spectrum (see [171] and section 
3.4.1.2). The chemical shift of state 2(T) shifts downfield, from d= -3.49 ppm in Ras in 6% 
DMSO to d= -3.40 ppm at 3.0 mM of the drug (Table 3.2) and the chemical shift of state 
3(T) in the Ras-NF1 complex is d= -3.0 ppm. A Dd of 0.4 ppm is observed. It is not possible 
to unequivocally ascertain if the drug stabilises indeed state 3(T) despite leading to the 
same downfield shift of state 2(T) and to an increase of its relative area. If this is the case, 
DCAI would have a double effect as an inhibitory drug, since it could also stimulate the 
GTPase reaction. A straightforward way to prove this hypothesis would rely in the 
comparison of the intrinsic and GAP stimulated GTPase reaction in its absence and in its 
presence. 
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4.3   High Pressure 31P NMR Spectroscopy 
4.3.1   High Pressure 31P NMR on GppNHp 
Reported studies have shown that pressure coefficients of model peptides are significantly 
influenced by pH when the side chain pKa value is close to the pH value at which the 
experiment is being performed [272]. Assuming that this finding is applicable to other 
molecules, including nucleotides, the pH-dependent chemical shift changes of GppNHp 
were presently avoided by working at a pH value of 2-3 units above the pKa for the 
deprotonation of the third phosphate group [116]. This corresponds to a pH of 9.0 and 11.5 
in the presence and in the absence of Mg2+, respectively. 
Following the pressure-dependent resonance lines in Figure 3.26, section 3.3.1, it is 
possible to observe that all the chemical shifts decrease with pressure (they become more 
negative, corresponding to an upfield shift in the spectra, see also Figure A, appendix). If 
this would be due to a pressure induced pH-change (and not to a pressure effect), then the 
pH of the sample would drop by more than 2 units (or the intrinsic pKa should increase). 
This possible variation in pH was followed by measuring any shift changes of the 1H 
resonance spectra from the Tris buffer, which works as a pH sensor. A maximum shift of -
0.006 ppm at pH 9.0 (in the presence of Mg2+) and -0.0012 ppm (in the absence of Mg2+) 
was found [226]. This corresponds to a slight increase in the pH smaller than 0.2 units 
(which is on itself difficult to detect by NMR) and would lead to a small downfield shift of the 
phosphate resonances, partially compensating the pressure-induced upfield shifts. The pKa 
value of the nucleotide should decrease since pressure usually leads to a dissociation of 
protons. Therefore, the obtained pressure shifts cannot be explained by a pH or a pKa effect 
and are therefore a true consequence of intrinsic pressure-induced structural modifications 
on GppNHp [226, 249]. 
 
4.3.1.1   Pressure Effects in the Presence and in the Absence of Mg2+ 
All calculated second order coefficients are higher for GppNHp than Mg2+•GppNHp (Table 
3.5), indicating that Mg2+ has the effect of stabilising the ground-state conformation(s) of the 
nucleotide, rendering it more insensitive modulation by pressure. 
In the presence of this ion (Figure 3.26A), the a-phosphate shows the smallest pressure 
dependence, with a Dd of -0.028 ppm between 0.1 and 200 MPa. The b- and g-phosphates 
are prone to considerably larger effects, with Dd values of -0.25 and -0.2 ppm, respectively. 
The same behaviour is also observed in the absence of Mg2+ (Figure 3.26B): the a-
phosphate is always the least pressure dependent. Comparing the intensity of the shift 
changes with and without Mg2+, it becomes clear that the Dd values are considerably higher 
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in the latter case. Considering g-phosphate as an example, Dd= -0.2 ppm in the presence 
and Dd=-0.40 in the absence of Mg2+. 
All phosphorous resonances, including inorganic phosphate (Pi), are characterized by 
negative B1 values. This is indicative of an initial upfield shift of the resonance lines, as the 
pressure is increased. The conclusion is valid for both, with and without Mg2+. 
Analysing now the differences between the two separately, in the absence of Mg2+ all 
phosphate resonances are characterized by positive B2 coefficients, indicating a 
“saturation” like behaviour at high pressures (i.e. the pressure induced chemical shift 
changes become smaller at higher pressures, which is noticeable by the plateau-like shape 
of the curves in Figure 3.27, and this can be associated with B2 > 0). The same is observed, 
in fact, in the presence of Mg2+, except for the a-phosphate that has a negative B2. 
Published results by our group have shown that at higher pressures there is a general 
tendency for the adenine and guanine nucleotides to dissociate from the metal ion. This is 
generally accompanied by a downfield shift of the resonance lines [226, 249]. Although, no 
downfield shift is presently observed for any of the Mg2+•GppNHp phosphates. The same 
effect could also be used in a tentative way to explain the “saturation”-like behaviour of the 
curves. However, the same behaviour is observed for GppNHp in the absence of Mg2+ 
(Figure 3.26) which leads to the conclusion that the small chemical shift changes at higher 
pressure are not a specific effect arising from the release of Mg2+ but due to a true pressure-
dependent mechanism that is correlated with the structural dynamics of GppNHp in solution 
[226, 249]. 
Although HP NMR in nucleotide binding proteins is not a widely pursued topic by the 
scientific community, the knowledge gathered about the behaviour of isolated GppNHp and 
other nucleotides under pressure is detrimental to understand the true mechanistic pressure 
effects on the conformation and equilibrium of Ras and other nucleotide binding proteins 
[273]. 
The 31P NMR chemical shifts of nucleotides can be mainly ascribed to two factors: 
conformational strain of bonds and electric field effects that lead to the polarization of the 
oxygens in the phosphate groups. Bond polarization by hydrogen bonding or nearby electric 
charges that can cause small shifts in the protonation/deprotonation equilibrium may be the 
dominant factors [274]. Additional effects might be caused by magnetic anisotropy of the 
guanine ring that assumes different averaged positions relative to the phosphate groups in 
a syn/anti equilibrium [275]. The average position and average orientation of the ring is 
influenced by pressure, which leads to the observed chemical shift dependencies at the 
phosphate groups. 
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4.3.2   High Pressure 31P NMR on Ras Proteins 
4.3.2.1   HP 31P NMR on HRasWT(1-166)•Mg2+•GppNHp 
Measurements at 278 K 
For all proteins investigated, the processing of the experimental data with an appropriate 
Gaussian function revealed to be better than a Lorentzian function in retrieving accurate 
chemical shift values (section 3.3.2.1, Figure 3.28). 
As the pressure increases, the integrals corresponding to state 2(T) decrease, 
concomitantly with the increase of the integrals corresponding to state 1(T) (Figure 3.27, 
green line). At 250 MPa, state 1(T) dominates over 2(T), given by the decrease in the 
equilibrium constant from 1.7 at 0.1 MPa to 0.24 at 250 MPa. This entails a direct evidence 
for the pressure-induced 2(T)-to-1(T) transition. The calculated difference of the free 
energy, DG12 and partial molar volume, DV12, is 1.53 kJ mol-1 and -18.60 mL mol-1, 
respectively (Figure 3.30). Similar values were found in previous studies on the full-length 
variant [125]. it is thus possible to conclude that the dependence of LnK12 with pressure is 
not linear. A closer look to the distribution plot indicates a slight but continuous deviation 
from linearity over the tested pressure interval. This is a direct evidence for the fact that 1(T) 
and 2(T) do not represent pure states but have additional (or ‘hidden’) contributions from 
states 3(T) and 1(0) [171, 276]. 
Since in state 1(0) the affinity of Ras towards the nucleotide is much lower comparatively 
with state 1(T), the release of nucleotide from the protein should be observed at high 
pressures [67]. This is indeed detected, especially at 220 and 240 MPa by the presence of 
the small additional peaks at d= -1.33, -6.0 and -10.15 ppm, corresponding to the free a, b 
and g-phosphates, respectively (Figure 3.27). This finding, together with previous 
denaturing studies involving GdmCl [125] leads to the conclusion that state 1(0) is coupled 
with state 1(T) and by application of pressure, the equilibrium can be shifted in the 1(T)-to-
1(0) direction. It is expected that such a conformational transition involves a great 
readjustment of the Ras surface and should be therefore governed by a slow exchange 
mechanism, which is marked by a change in the 31P NMR peak areas of the g1(T)-phosphate 
but not in chemical shifts. This is verified when considering the uncorrected values for the 
g1(T)-phosphate: the variation of the pressure-induced shift, Dd, is only 0.015 ppm (Figure 
3.29 and Table F, appendix section) corresponding to a very small change that lies in the 
limits of the error of the measurement. However, the corrected value shifts downfield by a 
Dd of 0.241 ppm (blue line in Figure 3.29). In this case the transition 1(T)-to-1(0) becomes 
governed by a fast exchange process. 
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If the transition to the nucleotide free state 1(0) is coupled with state 1(T), then by exclusion, 
the transition towards the GAP recognition state is coupled with state 2(T). This is directly 
observed from the Ras-GAP titration experiments (Figure 3.39 and [117]). Following the 31P 
pressure dependence of the g2(T)-phosphate (Figure 3.27 and Table F appendix section) 
one can observe that this signal shifts from d= -3.33 ppm at 0.1 MPa, to d= -3.00 ppm at 
110 MPa, down to d= -2.68 ppm at 250 MPa (these refer to the corrected pressure values). 
Such continuous downfield shift is indicative that this state is in fast exchange with another 
state, namely 3(T), that becomes prominent at high pressures. Previous HP [1H-15N]-HSQC 
NMR investigations have shown that 3(T) is most populated around 110-130 MPa (Figure 
1.13, section 1.3.2 [171]) and the presently obtained HP 31P chemical shifts nicely agree 
with this result (the corrected d values obtained at 110 and 130 MPa are -3.0 and -2.96 
ppm, respectively). 
 
4.3.2.1.1   Analysis of Pressure Coefficients, Energy and Volume Changes 
The necessity for subtracting the pressure-dependent chemical shifts of free Mg2+•GppNHp 
from the chemical shifts of the protein is supported by the observation that the 31P NMR 
signals of the free nucleotide and the nucleotide-bound protein shift in opposite directions 
(the a- and g-phosphates shift upfield in the former and downfield in the latter. The b-
phosphate shifts in the same direction, Figures 3.26 and 3.29). Upon correction, all 
phosphate groups of the nucleotide-bound protein shift further downfield relative to the 
uncorrected case, as indicated by the absolute increase of the B1 values. The most linear 
pressure-dependence was found for the g1(T)-phosphate, whose B2 decreases from 1.90 to 
0.4 ppm GPa-1 upon correction and the most non-linear dependence was found for a1(T) and 
a2(T)-phosphates, with a B2(corrected)= -2.40 and -1.46 ppm GPa-1, respectively (Table 3.6). 
The obtained DG and DV values are largely dependent of the initial values given as input 
for the iteration process (experimental section 2.2.5.4, eqn. nº17). Nevertheless, the fitting 
led to some interesting results: It is valid to assume in a first approach that state 2(T) on 
both, the a- and g-phosphates is prone to the same type of transition. However, the obtained 
DG and DV values are considerable different (Table 3.6). For example, DGa2(T)corrected= 8.17 
kJ mol-1 and DGg2(T)corrected= 3.44 kJ mol-1. The corresponding DV values are -85.19 and -
37.31 mL mol-1. The difference can be due to the intrinsic difficulty of the fitting routine or 
due to a more complex profile of the conformational equilibria, with the a2(T)- and g2(T)-
phosphates effectively sensing different transitions. The same kind of assessment can be 
made regarding state 1(T). The averaged DGcorrected value for the 2(T)-to-3(T) transition is 
5.81 kJ mol-1 which is in good agreement with the reported value of 5.2 kJ mol-1 from 
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previous experiments [171]. A slightly greater difference is found in terms of DV values (-
61.25 vs -81.0 mL mol-1, respectively). Regarding the 1(T)-to-1(0) transition greater 
discrepancies between both measurements were found with the averaged DGcorrected.= 3.68 
kJ mol-1 obtained from the present 31P HP data and the reported one being 12.4 kJ mol-1. 
 
Measurements at 303 K 
When the temperature is increased from 278 to 303 K (Figures 3.31 and 3.32), the two 
conformational states coalesce into a single resonance line. The 31P NMR series becomes 
represented by the chemical shift evolution of the three phosphate groups, with their 
populations being a weighted average of the ones detected at 278 K. The obtained DG and 
DV values for the a-, b- and g-phosphates are numerically very similar to each other (DG= 
6.39, 5.50 and 5.65 kJ mol-1, respectively and DV= -43.92, -43.17 -54.78 mL mol-1, 
respectively, Table 3.7), Their similarity is a direct indication that the three phosphate 
groups are experiencing the same type of transition at this temperature. 
In summary, the 31P HP NMR series presently investigated provide a much more 
comprehensive survey for the dynamics of the protein at the nucleotide bound level than 
the previously published HP series (Figure 1.12A, [125]). 
 
4.3.2.2   HP 31P NMR on RasT35S(1-166)•Mg2+•GppNHp 
From the series shown in Figure 3.33 (section 3.3.3), increasing the pressure has no effect 
on the dynamics of state 2(T). This means that this state cannot be repopulated, even at 
high pressures. For such reason, the only possible conformational transition that can be 
assigned to the system is the 1(T)-to-1(0). 
The response of RasT35S to pressure is generally smaller and more linear than RasWT (Figure 
3.33). One exception is the a-phosphate of the mutant that shows a large second order 
coefficient (B2(corrected)= -2.27 ppm GPa-2, Table 3.8). 
The obtained thermodynamic values for each phosphate group are numerically similar, 
indicating that all are involved in the same transition even at 278 K (DG= 3.49, 4.55, and 
5.15 kJ mol-1 and DV= -70.7, -51.0 and -57.0 mL mol-1 for the a-, b- and g-phosphates, 
respectively, Table 3.8). One would expect that at high pressure a large amount of bound 
nucleotide would be released by the protein, as state 1(0) becomes populated. However, 
no free Mg2+•GppNHp can be observed in this series (Figure 3.33), contrary to RasWT 
(Figure 3.27). This apparent contradiction has no straightforward explanation. One can 
argue that most likely the ‘true’ nucleotide-releasing state occurs at much higher pressures 
than 200 MPa and that the population distribution of state 1(0) obtained from a 
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thermodynamic model previously reported in other studies is greatly overestimated (i.e. at 
ca. 200 MPa, the population of state 1(0) is probably much lower than predicted) [171]). 
Another explanation can be related with the existence of residual amounts of alkaline 
phosphatase (AP) inside the NMR tube. The presence of this enzyme would exert a 
sequential hydrolytic activity in the nucleotide that would be released, and given enough 
time, all of it would be converted to Pi. Indeed the Pi resonance line, located at d= 3.37 ppm 
(Figure 3.33) increases in its relative area over time. Nucleotide exchange using an 
immobilised AP column procedure instead of the ‘classical’ approach (experimental section 
2.2.2.4) was precisely devised and performed for all Ras samples used in HP experiments 
in order to alleviate this problem. 
Two obtained crystal isoforms of RasT35S•Mg2+•GppNHp (pdb: 3kkn, form 1 and 3kkm form 
2) constituted the first evidence for the occurrence of regional polysterism on state 1(T): 
both forms are a structural manifestation of this state [242]. From an NMR point-of-view, 
this type of polysterism would be characterised by the existence of more than one signal for 
a specific phosphate group(s), just like in the wild type case. However, no additional signals 
are detectable during the pressure series close to state 1(T), probably due to the too small 
modifications of the chemical environment around the nucleotide and to an intermediate or 
fast exchange regime for the interconversion between such conformations. 
 
4.3.2.3   HP 31P NMR on KRasG12V(1-188)•Mg2+•GTP 
There are two remarkable features that deserve to be addressed: the first one is the direct 
observation of two distinct conformational states, 1(T) and 2(T), on the b-phosphate and 
their interplay as the pressure is increased from 0.1 up to 195 MPa (section 3.3.4, Figure 
3.35. These states cannot be separated at the corresponding b-phosphate on the HP series 
of RasWT bound to GppNHp as they lie very close to each other (Figure 3.27 and [125]). 
The second feature is related with the different response to pressure of GTP and GppNHp-
bound Ras. From the higher B2 values and the more pronounced curvature of the chemical 
shift dependencies (Figure 3.36 and Table 3.9) it can be concluded that GTP-bound Ras is 
more sensitive to pressure than GppNHp-bound Ras. This is a reasonable finding since one 
can envisage that the additional imido group from GppNHp is capable of establishing 
additional polar contacts with the protein backbone (Figure 1.2), leading to a more 
conformational stiffing in its vicinity [124]. The considerations for the specific transitions 
made for RasWT and RasT35S are the same in the case of RasG12V, with state 2(T) being 
directly coupled to state 3(T) and state 1(T) being coupled with 1(0). The obtained DG and 
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DV values are in this case is particularly inaccurate due to the small number of pressure 
points collected and the high signal-to-noise ratio of the experimental data. 
 
4.3.2.4   HP 31P NMR on HRasD33K(1-166)•Mg2+•GppNHp 
The 31P pressure-dependence of a novel mutant RasD33K•Mg2+•GppNHp was also 
investigated in this thesis in section 3.4.7. Contrary to RasT35S that exists in state 1(T), 
RasD33K is almost completely shifted towards state 2(T) and shows only a residual 
population of state 1(T) at 0.1 MPa (Figure 3.53). Pressure leads to the direct effect of 
repopulating state 1(T) at the g-phosphate but not at the a-phosphate which remains locked 
in the initial conformation and shifts only by a Dd of 0.054 ppm (Figure 3.54, Table 3.23). 
Although the characteristic downfield shift of the chemical shift values is observed for all the 
phosphate groups, the calculated thermodynamic parameters are rather different from 
RasWT. For example, DGg1(T)corrected is equal to 14.32 kJ mol-1 and 5.54 kJ mol-1 in RasD33K 
and RasWT, respectively. This envisages the conclusion that the conformational transitions 
induced by pressure on RasD33K are not identical to the ones observed for RasWT. 
 
4.3.2.5   General Considerations 
The HP investigations on the different Ras proteins revealed that the observed 
conformational transitions have a more complex thermodynamics than the initial model 
proposed by us [125, 171]. The experiments prove unequivocally the existence of several 
discrete conformations that can be assessed by pressure perturbation [159, 165], with 
almost all phosphate groups showing indeed a non-linear response. Nevertheless, the 
accurate characterization of high energy states revealed to be difficult because the 
conformational readjustments can be 
easily missed when the associated 
chemical shift changes are not very 
strong as in the case of 31P NMR. The 
fitting of the broad Lorentzian lines with 
very often ill-defined centres is difficult 
and subtle but important aspects are 
impossible to detect, accounting for the 
also rather linear pressure dependency 
of most phosphate groups. Additional 
pH-dependent shift changes can 
obscure the true effects of pressure 
Figure 4.3. 31P chemical shift variation of Pi plotted as a 
function of pressure for Mg2+•GppNHp (black), RasWT 
(blue) and RasT35S (green). The dashed line indicates the 
pressure point of 70 MPa, for which the direction of the 
chemical shifts are reversed (from upfield to downfield). 
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[226]. To test if this is the case the 
analysis of the shift changes of free 
inorganic phosphate (Pi) was 
performed. Its resonance moves 
initially downfield by a Dd of 0.023 ppm 
(between 0.1 and 80 MPa) in RasWT 
and RasT35S (Figure 4.3) and then 
upfield, with a Dd of -0.054 ppm 
between 80 and 250 MPa. The total 
variation in the complete interval is 
only -0.033 ppm to which corresponds 
an insignificant change in pH over the 
course of the pressure series. Similar 
results were obtained by the analysis 
of the Tris signal in the 1H NMR spectra 
(data not shown) [116, 249, 273], 
proving that the pH does not change 
considerably. 
The 31P chemical shift changes of 
RasWT, RasT35S and RasD33K are plotted 
together in Figure 4.4, allowing a 
general overview of the results: at the 
a-phosphate (top graph), the highest 
variation is observed for RasD33K, 
where the range of the Dd values (from 
-11.49 to -11.0 ppm) occurs 
somewhere in between the values 
determined for states 1(T) and 2(T) of 
RasWT. The a-phosphate of RasT35S 
shows the less pronounced pressure 
dependence, with a Dd of 0.090 ppm 
between 0.1 and 190 MPa. In all 
cases, the corrected and uncorrected 
shifts are close related and follow the same downfield direction. 
The chemical shift of the b-phosphate on RasD33K at 0.1 MPa lies  somewhere in between 
Figure 4.4. 31P pressure-dependent chemical shift 
changes of RasWT and RasT35S and RasD33K in complex 
with Mg2+•GppNHp recorded at 278 K, pH 7.5. Each plot 
shows the uncorrected and corrected changes for the a- 
(top), b- (middle) and g-phosphates (bottom). Another 
version of this plot is shown in Figure E of the appendix 
where, instead the absolute chemical shifts, d, shown 
here, the Dd’s= dlast pressure point-d0.1MPa are plotted as a 
function of pressure. 
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the one of RasWT and RasT35S. The magnitude of its pressure-induced shift is more or less 
identical for the three proteins (middle graph). In the case of g-phosphate (bottom graph), 
the chemical shifts can be separated into two groups corresponding to state 1(T) and state 
2(T), with the magnitude the former being smaller than the latter. 
 
 
4.4   31P NMR Spectra of H, K and NRasWT(1-166)•Mg2+•GppNHp 
It was shown herein that NRas, is the isoform with the highest K12 value (2.57 vs 1,57 for 
HRas and 1.83 for KRas) and with the lowest apparent KD for Raf binding (0.18 µM vs 0.60 
µM for KRas and 0.42 µM for HRas, section 3.4.1.1, Figure 3.38, Table 3.11). These results 
are in good agreement with each other as NRas is the variant with a higher state 2(T) 
population and concomitantly higher Raf-affinity.In this respect, contradictory results are 
published in a recent study reporting the first crystal structure of NRasWT, where it is shown 
that the affinity of NRas to Raf is lower than the two other isoforms (the measured KD values 
at 308 K for H, K and NRas are 0.094, 0.098 and 0.206 µM, respectively) [277]. 
 
 
4.5   Interaction of RasWT, RasG12P and RasD33K with NF1 Followed by 31P NMR 
4.5.1   RasWT(1-166)•Mg2+•GppNHp•NF1 
The titration allowed the unequivocal assignment of state 3(T) for the a-, b- and g-
phosphates at -11.12, 0.07 and -3.00 ppm, respectively (Section 3.4.1.2, Table 3.12). A 
similar value was found in previous studies published by our group for the Ras-GAP333 
complex [117]. In saturating amounts of NF1 (ratio 1:2, Figure 3.39), the a- and g-
phosphates are defined by a single resonance whose linewidth at half-height increases by 
a 3-fold factor (from 64 to 205 Hz), nicely reflecting 3-fold increase in size on the molecular 
mass of the complex (from 18 to 54 kDa). 
The ill-defined, asymmetric centre of the b-phosphate above a 1:1 ratio is indicative of the 
existence of at least two different local conformational states. Keeping in mind the functional 
cycle of Ras, they can be explained on the basis that the GAP mechanism involves not only 
the isomerisation process, where Ras changes conformation to bind GAP, but also a 
transition state conformation that becomes stabilised by the arginine finger provided from 
GAP and is spatially oriented close to the b-phosphate (Figure 1.4) [23, 83]. The existence 
of different conformations at the nucleotide level in the Ras-GAP complex was also proved 
in recent studies involving FTIR spectroscopy and QM simulations [84]. The authors have 
shown that the geometry of Mg2+•GTP changes from a staggered position of the non-
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bridging oxygen atoms of the b- and g-phosphates to an eclipsed conformation, defined by 
different torsional and dihedral angles. This is caused by a change in the coordination to 
the Mg2+ ion from tridentate to bidentate forced by Ras and helped by the Arg finger from 
the GAP protein. These observations are in agreement with the profile of the present 31P 
NMR titration. 
 
4.5.2   RasG12P(1-166)•Mg2+•GppNHp•NF1 
Due to the greater separation between states 1(T) and 2(T) (Dd= 2.52 ppm, section 3.4.10.3, 
Figure 3.61 vs Dd= 1.63 ppm in RasWT) at the g-phosphate, state 3(T) is better defined in 
this complex. Its resonance becomes upfield shifted by a Dd of 0.22 ppm relative to its 
counterpart in the wild type protein (section 3.4.1.2, Figure 3.39 and [259]). Similar features 
are observed at the b-phosphate (at a 1:1 ratio, d3(T)= 0.31 ppm and d2(T),1(T)= 0.40 ppm, 
Table 3.28). Due to the identical profile of the titration relative to RasWT, the binding affinity 
of both proteins can be assumed as identical. Previous studies showed that this is indeed 
the case by using RasG12P to inhibit the GAP-mediated GTPase reaction of RasY32W, whose 
GAP affinity is equal to RasWT but shows a large fluorescent change upon GTP hydrolysis 
that can be easily quantified [259]. The measurements have shown that the affinity of 
RasG12P to p120-GAP is slightly decreased (ca. 2.8-fold lower) compared to RasWT. A similar 
decrease was found in the case of RasG12V but not for RasG12D, which still retains the affinity 
to GAP [265, 278]. 
 
4.5.3   RasD33K(1-166)•Mg2+•GppNHp•NF1 
RasD33K has a lower affinity towards NF1 (section 3.4.5, Figure 3.51 and Table 3.21). Even 
at a Ras:NF1 ratio of 1:2, the line corresponding to state 3(T) could not be detected, 
indicating that complex formation is impaired, although a quantitative measurement for the 
interaction is not possible to obtain directly from the 31P NMR titration. 
The structural basis for the loss of affinity is so not clear since the contact surface with GAP 
is much more extensive than Raf and not only subjected to the effector-loop region [31, 38]. 
From the published Ras-GAP complex (pdb: 1wq1 [83]), D33 interacts with the positively 
charged N942 and K949 residues. Since both are also present in the structure of NF1, the 
lower affinity of RasD33K to NF1 can be explained by the same reasoning used for the 
RasD33K-Raf complex, based on the steric and electrostatic clashes between the two Lys 
residues (K33 and K949, see discussion section 4.7). 
The measurement of the affinity between Ras and NF1 was attempted by ITC but in all 
cases no obvious binding curves could be obtained due to severe artefacts in the heat 
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signatures, corroborating the idea that the Ras-GAP complex formation does not obey to a 
single step and/or to steady-state conditions [255, 256]. Other methods such as 
fluorescence spectroscopy and thermophoresis could be used in the future to measure the 
affinity, complementing the present 31P NMR data [77, 108, 255]. 
 
 
4.6   Mutational Studies on HRasWT(1-166) 
4.6.4   General Considerations 
Figure 4.5 summarises the 
features of the GppNHp-bound 31P 
NMR spectra obtained upon site-
directed mutagenesis on Ras. 
From the seven investigated 
mutants, four of them (H27E, 
S39L, E3V and D33K) show novel 
structural properties, with RasE3V 
and RasD33K, being the most 
notable ones by dramatically 
affecting the dynamics of the 
bound nucleotide (D33K) and by 
exerting a clear allosteric 
interference that can be 
propagated from a distant 
localisation in the surface of the 
protein (E3V) and still affect the 
catalytic centre. This mutational 
investigation was performed with 
the expectation of shifting the 
conformational equilibrium at the 
nucleotide-bound level in the 
same direction previously 
predicted by HP NMR [125, 171]. 
The overall results show that in the 
light of the proposed 4-state 
model, the absence of a direct 
Figure 4.5. 31P NMR spectra of the different Ras mutants bound 
to Mg2+•GppNHp, created by SDM for the study of the 
conformational dynamics of Ras. The respective mutation, 
together with the calculated equilibrium constant, 
K12=Area2(T)/Area1(T) at the g-phosphate is indicated. All the 
spectra were recorded at 278 K, pH 7.5 in a magnetic field 
operating at a 31P frequency of 202.456 MHz (500 MHz 
spectrometer). 
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modification in the chemical shifts or integrated areas on the phosphate resonances of 
states 1(T) and 2(T) does not necessarily mean that the global equilibria is not affected. 
Any mutation can change both parameters for the conformational states 1(0) and/or 3(T) 
that are intrinsically hidden in the 31P NMR spectra since they are low populated at ambient 
pressure (0.4 and 7.7%, respectively [166, 171]). To this respect, the directly observable 
31P NMR spectral lines can remain inalterable relative to RasWT but the equilibria can still 
be shifted by the mutation. For example, if state 1(T) increases at expense of state 2(T) but 
if this is compensated by an increase of state 3(T) at expense of state 1(0), the equilibrium 
would still be shifted towards state 1(T) and there would be no noticeably modification 
relative to RasWT (K12= 1.7). This could be the case of RasN26K, RasH94D and RasA66T, all with 
a K12 value close to 1.7. 
Figure 4.6 is a schematic representation of how the equilibrium can be modulated by the 
interplay of the four conformational states. RasWT, RasT35S, RasH27E and RasD33K are given 
as examples. For each one, the four states are indicated and arranged by their increasing 
order of energy. Possible conformational transitions from the most populated, lowest energy 
states 1(T) and 2(T) are indicated by the dashed arrows. Note that additional transitions 
exist and that different arrangements of the four states for the same protein are also 
possible. For example, state 1(T) on RasT35S can become populated by decreasing the 
energy for this state and/or by increasing the energy of state 2(T). State 1(T) in RasH27E can 
become populated by decreasing the energy of state 1(0) and state 2(T) in RasD33K can 
become populated by decreasing the energy of state 3(T) or increasing the energy of state 
Figure 4.6. Interplay between the four different conformational states of Ras proteins. 
States 1(T) to 4(T) are coloured in red, green, blue and black, respectively and shown 
by their increasing order of energy Ras wild type, T35S, H27E and D33K are given as 
examples. The respective 31P NMR resonance at the g-phosphate is also shown. The 
dashed lines represent conformational transitions starting from states 1(T) and 2(T). 
Note that other possibilities exist. 
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1(T)/1(0). The energy difference between them can be modulated by pressure, as 
discussed in section 4.3.2 [123, 125, 171]. 
In summary, the study of the different Ras mutants shows the complex dynamics of this 
protein but also the limitations of 31P NMR in uncovering all of its conformational states [16, 
123, 125, 163]. A discussion of the spectroscopic and biochemical properties of each 
mutant is given in the following sections. 
 
4.6.2   2(T)-to-1(T) Transition: N26K, A66T and H94D 
In the light of the results obtained none of the three individual mutants led to a directly 
observable shift of the conformational equilibria in the direction of state 1(T). Their 
investigated properties are not different from the wild type protein. No chemical shift or 
linewidth differences were detected between them and RasWT (section 3.4.2.1, Figures 3.41 
and 3.42, Table 3.13) despite N26K and A66T being located in the vicinity of the nucleotide 
at the beginning of switch 1 and middle of switch 2, respectively (Figure 3.40, [16]). A 1.7-
fold increase in of the intrinsic hydrolysis rate for RasH94D in presence of Raf-RBD was 
however detected (kcat= 0.035 min-1 vs 0.021 min-1 in RasH94D alone, Figure 3.43B and Table 
3.14). The dissociation constant for the Raf binding obtained for the three mutants is also 
similar to RasWT. An averaged increase of -8 kJ mol-1 in the enthalpy of binding was however 
found for all of them relatively to RasWT. With exception of D94, the other two mutants are 
involved in polar contacts with the surface of Raf [33]. 
 
4.6.3   2(T)-to-1(0) Transition: E3V and S39L 
Larger effects were found in the case of RasE3V and RasS39L. Both mutations led to a 
meaningful modification of the conformational dynamics, independent of the expected 
direction of the underlying transition (section 3.4.2.2). 
RasS39L shows a significant perturbation of state 1(T) at the a- and g-phosphates, both 
becoming downfield shifted by 0.1 ppm relative to RasWT (d= -11.08 and -2.50 ppm, 
respectively vs d= -11.17 and -2.57 ppm in RasWT, Table 3.15), and with a decrease in the 
equilibrium constant from 1.7 to 1.5 favouring state 1(T). The rates of exchange for this 
state are also slightly faster comparatively to RasWT as given the average 1.4-fold decrease 
of their line broadening. Rather interestingly, the affinity of RasS39L to Raf increases by more 
than 5-fold, despite the shift towards the weak effector interacting state (KD= 0.0074 vs 
0.424 µM, Table 3.16). 
RasE3V, on the other hand, shifts in the opposite direction, showing a 20% increase in the 
integrated area of state 2(T) at the g-phosphate (Figure 3.45). The equilibrium constant 
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increases from 1.7 to 2.0. However, the affinity to Raf remains unperturbed (KD= 0.603 µM), 
as well as the GTPase activity (kcat= 0.027 min-1, τ= 27.12 min.). The effects of the mutation 
are remarkable considering that it lies at the beginning of the N-terminal, more than 20 Å 
away from the g-phosphate. The modulation of the dynamics of the nucleotide happens by 
a true allosteric mechanism in this case. It is possible that the same mechanism is 
responsible by the action of the state 1(T) inhibitor Zn2+-BPA whose binding site is located 
in the same region [158]. 
The two mutants investigated herein show antagonistic effects as both shift the equilibrium 
in different directions, with S39L affecting state 1(T) and E3V affecting state 2(T), but both 
residues were found to be involved in the same type of transition, towards state 1(0). In this 
respect it is worth mention that effect of a specific mutation on the dynamics of a protein 
depends on many factors including the amino acid that is chosen for replacement and it is 
only predictable at some extent by computational  methods [279]. Furthermore, as 
discussed above in section 4.6.1, the 31P NMR chemical shifts and peak areas are only 
surrogate markers for changes in the dynamics of the protein because states 3(T) and 1(0) 
are not immediately accessible for scrutiny. For example, the mutation E3V can still promote 
an increase on the population of state 1(0) at expense of state 1(T). In this case, the 
equilibrium would still be shifted towards state 2(T) as observed in Figure 3.45. 
 
4.6.4   2(T)-to-3(T) Transition: H27E and D33K 
Only D33K is located in the effector-loop region of the protein (aa 30-40), although both 
mutations affect pronouncedly the dynamics of the GppNHp-bound nucleotide (section 
3.4.2.3). 
Replacement of His27 to Glu changed the population towards state 1(T), leading to a 
decrease of the equilibrium constant from 1.7 to 1.0. The three phosphate groups become 
downfield shifted by an average Dd of 0.07 ppm for the b- and g-phosphates and more than 
0.3 ppm for the a-phosphate (Figure 3.47, Table 3.17). His27 is located at the beginning of 
switch 1 and more than 14 Å away from the g-phosphate, indicating that the interference 
detected at the phosphate groups has an allosteric basis. It is likely that its substitution to a 
negatively charged Glu causes a reorientation of the neighbouring Phe28 that lies 
perpendicular to the centre of the nitrogen base in the wild type structure [14, 117, 242]. 
The reorientation of the aromatic ring due to the presence of the negative charge would 
alter the magnetic anisotropy at the guanine base (for example, if the Phe ring moves from 
a perpendicular to a more parallel position relative to guanine, the nuclei from the guanine 
base would become more shielded to the external field B0), which would be transmitted 
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through the nucleotide system and lead ultimately to a modification of the magnetic 
susceptibility at the phosphate groups [116, 275]. Biochemically it was verified that the 
intrinsic GTPase reaction of RasH27E is no different than RasWT (kcat= 0.025 min-1, τ= 27.39 
min. vs kcat= 0.026 min-1, τ= 26.85 min., Figure 3.48) and that its affinity towards Raf-RBD 
is increased by a 2-fold factor (KD= 0.23 for RasH27E and KD= 0.42 for RasWT), leading to the 
idea that the mutation could have endorsed not only a conformational shift towards state 
1(T) but also a functional modification on the remaining state 2(T) population by slightly 
increasing their affinity towards effectors. The energetics of the binding proceeds with a 
greater enthalpic contribution in the case of RasH27E comparatively to the wild type protein 
(DH= -16.9 vs -8.10 kJ mol-1, respectively, Table 3.18), meaning that the mechanism of the 
interaction is essentially different in terms of network of H-bonding at the binding interface 
of the two proteins. 
Mutation of the negatively charged Asp33 to a positively charged Lys in RasD33K led to a 
drastic increase in the equilibrium constant, from 1.7 to 11.3, with state 2(T) being the most 
preponderant and state 1(T) collapsing to the level of the baseline noise (Figure 3.47 and 
Table 3.17). An upfield shift of -0.07 ppm was observed for state 2(T), with the new 
resonance line located at d= -3.40 ppm (vs d= -3.33 in RasWT). The resonance of state 2*(T) 
in the Ras-Raf complex is located at d= -3.51 ppm for full-length KRasWT (Table 3.1), d= -
3.60 ppm for the truncated variant [117] and at d= -3.54 ppm for RasH27E (Table 3.17), all 
values being slightly upfield shifted relatively to g2(T) in RasD33K alone, excluding the 
assignment of the g2(T)-phosphate as a 2*(T) state. It was in fact verified that the g2(T)-
phosphate of RasD33K can still undergo a further upfield shift, towards state 2*(T), in the 
presence of Raf-RBD (d2*(T)= -3.63 ppm, Figure 3.50, Table 3.20), leading to the conclusion 
that this mutant can still isomerise into the Raf-recognition state as in the case of RasWT 
(Figure 3.1), although with a much lower affinity (see section 4.7). 
To the best of our knowledge, RasD33K is the only known Ras mutant that is almost 
completely shifted towards state 2(T). This finding is particularly interesting if one considers 
that other known mutants from the switch 1 region such as T35A, T35S, Y40C, Y32W, 
Y40C, among others, are all typically state 1(T)-driven, whose state 2(T) is either residual 
or completely undetectable as in the case of T35S (Figure 3.47A) or T35A [123]. Direct 
experimental evidence also indicates that typically all switch 1 mutants have impaired 
affinity to Raf-RBD and impaired intrinsic GTPase activity [67, 123]. These biochemical 
properties correlate well with RasD33K, which also shows impaired affinity to Raf (KD= 10.4 
µM vs 0.42 µM relative to RasWT) and a slightly lowered GTPase activity (kcat= 0.016 min-1 
vs 0.026 min-1, Table 3.18). 
4. Discussion 
 
244 
- This page was deliberately left blank - 
4. Discussion 
 
245 
4.7   Interaction Between RasD33K and Raf-RBD Followed by 31P NMR. Structural Basis 
       for the Loss of Affinity 
The binding of RasD33K to Raf was investigated by ITC and 31P NMR in section 3.4.4 (Figure 
3.50, Tables 3.18 and 3.20). The apparent KD of 10.4 µM taken from the ITC measurements 
shows that this point mutation located in the middle of the effector-loop region drastically 
reduces the affinity towards Raf. A lower affinity was previously reported in the only 
available study, where it was shown that the binding of Raf to RasD33A was greatly reduced 
and completely abolished in the case of  RasD33K [63]. it is possible that the presently 
obtained KD of 10.4 µM might be slightly underestimated. From the data retrieved by ITC, it 
is clear that the binding to Raf still proceeds with favourable enthalpic and entropic 
contributions but the enthalpy variation is much lower comparatively to RasWT (DH= -4.24 ± 
0.25 kJ mol-1 for RasD33K vs -8.10 ± 0.23 kJ mol-1 for RasWT). This enthalpy decrease 
correlates very well with the disruption of an important H-bonding network that can be found 
in the RasWT-Raf complex but that is most likely abolished in the case of the RasD33K-Raf 
complex. 
The crystal structure of the RasWT•Mg2+•GppNHp•Raf-RBD complex is shown in Figure 4.7, 
with RasWT coloured in light brown and Raf coloured in light purple (pdb: 1g0n [64]). The 
contact interface between the two proteins involves mainly the antiparallel arrangement 
between a b-sheet from Raf and b3 from Ras and the effector-loop region comprising mainly 
switch 1 and an a-helix from Raf (Figure 4.7B). The negatively charged residues E31 and 
D33 from RasWT are crucial for establishing polar contacts with the positive ones, K84 and 
R73, from Raf, each pair acting like a clamp, holding the proteins together. The disruption 
of this clamping effect can be seen when the crystal structure of RasD33K obtained in the 
present work (section 3.5.3) is superimposed (coloured in light green in Figure 4.7): there 
is an obvious clash between K33 from RasD33K and K84 from Raf, which in fact is not only 
a steric clash but also an electrostatic one, as both residues have the same charge and 
repel each other. 
This local hindrance has more profound consequences evidenced in Figure 4.7C: as K84 
is held tightly by D33 and E81 in RasWT, its side chain -NH group becomes perfectly aligned 
to initiate a series of long-range H-bonding networks, that culminate with the establishment 
of polar contacts between crystallographic waters (represented as light purple spheres in 
Figure 4.7C) and the a-phosphate of the bound GppNHp. The same effect cannot happen 
in the case of RasD33K because K84 cannot approach the effector-loop region and initiate 
the process. It is likely that disruption of the water network leads to a more profound effect 
in the modification of the chemical environment in the vicinity of the nucleotide (by changing 
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Figure 4.7. Structural basis for the interaction of RasWT and RasD33K with Raf-RBD. A. 
The surface of the crystal structure of the protein-protein complex HRasWT(1-
166)•Mg2+•GppNHp•Raf-RBD is shown (pdb: 4g0n). RasWT is coloured in light brown and 
the RBD domain of Raf is coloured in light purple. Into this structure, the presently 
obtained x-ray structure of HRasD33K•Mg2+•GppNHp at pamb was superimposed 
(coloured in light green). The Ras-Raf interface region marked by the dashed rectangle 
is shown in detail in B. Important residues at the interface are represented as sticks and 
polar contacts between RasWT and Raf are represented by the dashed lines. Note how 
K33 from the superimposed RasD33K structure clashes in space with K84 from Raf and 
also in terms of electronic charge (both being positive). The disruption of the interface in 
RasD33K has more profound consequences evidenced in C. In the wild type complex, K84 
from Raf is held in place by E31 and D33 (both light brown coloured) and establishes long 
range polar contacts mediated by crystallographic waters (represented by the small light 
purple spheres) that culminate with the direct stabilisation of the a-phosphate. In the case 
of RasD33K, K84 is unable to take part in these interactions. Note that the GppNHp 
nucleotide from both structures is superimposed. Additional important polar contacts 
between RasWT and Raf are evidenced in the background. 
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the polarisation of the P-O bonds, for example) than the point mutation on itself. In fact, 
RasD33K shows a lower content of crystallographic waters at the nucleotide binding site 
compared to RasWT (pdb: 5p21), with Gln61 assuming the same position as in the Ras-GAP 
complex (pdb: 1wq1, [83]) by binding directly to the g-phosphate (see section 4.10.2). 
 
 
4.8   Thermal Unfolding of Ras Followed by nanoDSF 
A series of interesting conclusions can be taken directly from the thermal unfolding studies 
(section 3.4.8). From the obtained values (Figure 3.56, Table 3.24) It can be concluded that 
Ras has two sequential melting temperatures (Tm), the first one around 50 ºC, that 
corresponds to the melting of state 1(T), and the second one around 58 ºC, that corresponds 
to the melting of state 2(T). The latter being slightly more energetically stable than the 
former is the last to unfold. This was observed for RasWT and RasH27E, for whom K12= 1.7 
and 1.0, respectively. Rather surprisingly, two Tm values were also found for the state 1(T) 
mutant RasT35S, but only one for RasT35A (Tm= 58.11 ºC). This apparent contradiction can be 
explained considering that although being both state 1(T)-driven, the former, contrary to the 
latter, can readily isomerise into state 2(T) in the presence of effectors [156]. As the thermal 
unfolding is a sequential process, RasT35S can undergo the two thermal transitions, but not 
RasT35A for which a direct conversion from state 1(T) to 2(T) is not possible. A different 
unfolding pathway needs to occur in this case. This result is in good agreement with 
previous experiments where GdmCl was used to induce the chemical denaturation of RasWT 
and RasT35S, followed by 31P NMR [125]. 
RasD33K shows a single Tm of 61.84 ºC (Table 3.24). In this case, state 2(T) has a higher 
population than its counterpart in RasWT (K12= 11.3 vs 1.7), being more energetically stable, 
which accounts for the 3ºC higher Tm than the averaged Tm2 values. As state 1(T) is not 
significantly populated, its thermal unfolding remains undetected. 
 
 
4.9   Conformational Dynamics of RasG12P and RasG12V/T35S Followed by 31P NMR 
4.9.1   Considerations About RasG12P 
RasG12P was previously found to be the only mutant of Gly12 that has non-transforming 
properties in cells and leads to a normal phenotype [280], although there are no relevant 
structural and/or thermodynamic studies available in the literature and the exact mechanism 
that renders it non-transforming is still unknown. In terms of equilibrium populations, the 31P 
NMR spectrum of RasG12P•Mg2+•GppNHp is more similar to RasG12V than to RasWT (Figure 
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3.58A). However, the biochemical properties of the former are in fact more similar to the 
ones of RasWT: both show similar rates of GTP hydrolysis (kcat= 0.035 min-1 and kcat= 0.026 
min-1, respectively) and similar affinities towards Raf-RBD (KD= 0.59 µM vs KD= 0.42 µM, 
respectively, Table 3.26). Such findings further support the classification of RasG12P as non-
transforming [259, 261]. On the other hand, the typical oncogene RasG12V has a normal 
affinity to Raf but an extremely slow hydrolysis rate (kcat= 0.005 min-1, Table 3.26). The wild 
type-like affinity of RasG12P to effectors was further confirmed by following its titration with 
Raf-RBD by 31P NMR (section 3.4.10.2). The structural basis for the non-transforming 
properties of RasG12P is most likely related with differences in the orientation of Gln61 
located in switch 2: in the case of RasWT and RasG12P, this residue is positioned in its catalytic 
conformation by making an H-bond with the catalytic water, ready to initiate the nucleophilic 
attack. In the case of RasG12V the corresponding water molecule is not present in the crystal 
structure and Gln61 points towards the helix a3, in the opposite direction of the g-phosphate, 
due to the steric hindrance promoted by the presence of Val12 [259, 281]. In other cases 
as in RasG12D, Gln61 is oriented in the right direction but involved in a H-bond with D12 and 
unable to coordinate the catalytic water. 
 
4.9.2   Considerations About RasG12V/T35S 
The mutant has been used extensively in a wide range of cellular-based assays after it was 
found that it could retain the interaction with the effectors Raf and CDC25, among others 
but not with PiK3 or Ral-GDS, leading to the activation of only specific signalling cascades 
such as Ras/Raf/MEK/ERK but not EGF/EGFR or the Pi3K/AKT/mTOR pathways [110]. 
Although there is substantial evidence that it can activate the ERK pathway through Raf 
recognition and binding, the exact mechanism is also not known. Furthermore, the extent 
and duration of the activation seems to be largely dependent on the type of cell line [282]. 
 
In the scope of the work presented herein, the main question was if the nature of the double-
mutant could be governed by one of the mutants alone, and if so, what would be the 
preponderant contribution. From the 31P NMR investigations it was demonstrated that 
RasG12V/T35S has a greater contribution from RasT35S, whose properties dominate the 
GppNHp and the GTP spectra, with both being a state 1(T) mutant, contrary to RasG12V for 
which a K12= 1.16 (at the g-phosphate of bound-GppNHp) was obtained (section 3.4.10, 
Table 3.25). Although spectroscopically similar to RasT35S, the intrinsic GTPase and the 
affinity to Raf-RBD of RasG12V/T35S is much lower than the corresponding values obtained for 
the isolated mutants (RasG12V and RasT35S, Figure 3.62). Thus, the apparent KD for 
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dissociation from Raf was found to be 13.52 µM against 0.66 µM and 6.45 µM, respectively. 
In summary, the low affinity measured between RasG12V/T35S and Raf-RBD is in slight 
disagreement with the idea that the mutant can readily activate the Ras/Raf/MEK/ERK 
pathway upon association with Raf-RBD in living cells. It is plausible that the pathway can 
still be activated but the extent of and the potency of the downstream relayed signals is 
certainly much lower than the one observed in the case of RasWT or RasG12V alone. The 
experimental evidence for such difference reported in the literature is not unanimous: some 
investigations suggest that RasG12V/T35S retains a full-fledged binding activity, just like 
RasG12V [61, 111] while others suggest, in line with the presently obtained data, that the 
activation occurs but is greatly decreased [110]. One can envisage the activation of Raf-
dependent pathways taking place through a bypass mechanism that does not necessarily 
require Raf as initiator. Nevertheless, in the light of the present data that the double mutant 
does not have the same degree of affinity to the effector as the oncogene RasG12V. This fact 
should be taken into consideration when devising cell-based assays. 
 
 
4.10   High Pressure Macromolecular Crystallography (HPMX) 
4.10.1   HRasWT(1-166)•Mg2+•GppNHp  
Crystal structure at Ambient Pressure 
The presently obtained RT crystal structure of RasWT is similar to the representative 5p21 
one, obtained at 277 K (section 3.5.1, Figure 3.63). There are however several local 
distinctions comprising the switch 2, all marked by the different re-orientation of the side 
chains of specific residues relative to the protein backbone. These differences are more 
related with the commonly known intrinsic disorder of switch 2 than with the actual 
difference in temperature of the two structures [28, 94, 95]. The absence of the nucleophilic 
waters at RT is responsible for the different orientation of Gln61 relative to the same residue 
in 5p21 [12], envisaging the delicate balance between the spatial arrangement of these 
highly mobile regions and the nature of the macromolecular crystal (type of symmetry, 
degree of hydration, type of buffer, etc.). 
 
Crystal Structures at High Pressure 
The compressibility of the unit cell shows unequivocally the existence of a transition sate 
around 300 MPa (section 3.5.2.1, Figure 3.64). Two high energy conformers were solved 
above this point, the first at 490 and the second one at 650 MPa. Both differ from the 
structure at 0.1 MPa by an averaged rmsd value of 0.47 and 0.28 Å, respectively. 
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The overall observed structural changes indicate that a new conformation of the protein was 
trapped at 490 MPa given by the direct increase in resolution from 2.0 Å before the transition 
zone to 1.8 Å at 490 MPa and 1.7 Å at 650 MPa (Figure 3.67). The regions where the 
highest rmsd values between p650 and p490 are obtained correspond simultaneously to 
the regions in the p650 structure with the lowest thermal b-factors (Figure 3.68A and B). 
This interesting correlation indicates that the conformational state trapped at 650 MPa could 
either correspond to a further stabilization of the same excited state observed at 490 MPa 
or could correspond to a new state. In one hand, their very similar structures might indicate 
that the conformer is only further stabilised at 650 MPa. On the other hand, the observed 
differences at switch 2, especially at Q61 (Figure 3.68E), could indicate a glimpse of a new 
high energy conformer, whose structural features cannot be completely uncovered at his 
pressure and therefore would require a jump to higher pressures. The results obtained from 
RasD33K at 880 MPa (section 3.5.4.2) indicate that this structure represents a new conformer 
relative to the 650 MPa one of RasWT (Figure 3.72C), supporting the first assumption. 
Attempting to correlate the HPMX features with the HP NMR data is difficult. At 250 MPa in 
solution, states 1(T)/1(0) prevail. and are marked by an open conformation in which the 
entire switch 1 moves away from the nucleotide assuming a position similar to the one found 
in the nucleotide-free Ras•SOS complex (Figure 1.5) [44, 95, 242]. However, such large 
rearrangement could not be found in any of the presently solved structures, not even at 650 
MPa. The overall changes in the crystal are therefore less pronounced. 
It is known from NMR and X-ray studies that not only switch 2 but also switch 1 is highly 
mobile due to the transient binding of Tyr32 to the g-phosphate [51, 123]. However, many 
crystal structures of RasWT•Mg2+•GppNHp show a very well defined electron density for 
switch 1, with Tyr32 always contacting the g-phosphate. When this residue is found to be 
distant from it (especially in structures crystallised under the P3221 space group, as 5p21), 
it seems to be only because of the crystal packing constrains that force it to interact with 
the g-phosphate of a symmetry-related molecule (Figure G, appendix). The same constrains 
are probably also responsible for the well defined electron density of the whole switch 1, 
that has therefore no spatial freedom to fluctuate. The analysis of all the refined HP 
structures obtained in the present work either for RasWT and RasD33K also show the 
existence of these forces between the molecules that constitute the unit cell of the crystal 
(Figure G). Since hydrostatic pressure is transmitted homogeneously to the whole, infinite 
and three-dimensional, crystalline system [175, 183], even a pressure as high as 650 MPa 
is not enough to overcome them. The only possibility to alleviate their influence would be 
the transition of the P3221 symmetry into another space group. This can indeed occur given 
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that the crystal is kept under pressure during a long enough time. This relationship is an 
interesting topic worth pursuing on its own in the future. Another, and perhaps easier, 
possibility of approaching the problem is to attempt the direct crystallisation of Ras into a 
space group different than P3221. As example, several structures were reported to 
crystallise under the R32 space group, for which the movement of Tyr32 is not hindered by 
the crystal packing (neither the rest of the switch regions) [60, 283]. In one of these studies 
[241] the obtained crystals, still representative of a typical state 2(T) (pdb: 5b2z), were 
subsequently subjected to the Humid Air and Glue-coating (HAG) crystallisation method 
[284] which induced a direct transition of the lattice from state 2(T) to state 1(T) (pdb: 5b30). 
In 5b30, the loss of the Thr35 and Tyr32 interaction with the g-phosphate caused a marked 
deviation of switch 1 away from GppNHp which resulted in the expansion of the accessible 
surface area comparatively with 5b2z. Neither the 490 nor the 650 MPa structures presently 
obtained show such large movement for their switch regions. 
It is important to clarify that, independent of the possible hindrances caused by crystal 
packing, only subtle pressure-induced conformational changes are indeed expected in the 
crystal or at least they are considered to be within our model, the true representation for 
behaviour of the protein in solution. This observation is in agreement with previous studies 
where a slight change in the O-P-O dihedral and torsional angles of the bound nucleotide 
is sufficient to promote a conformational shift of the equilibrium given by the transient 
binding of Y32 and T35 to the g-phosphate [84, 117]. To this respect, the 5b2z and 5b30 
structures are very likely an extreme example for the conformational transition between 
states 1(T) and 2(T) represented by a dramatic movement of the switch regions. In solution, 
the protein needs to rapidly discriminate between the different partners (GEF’s, GAP’s, 
effectors) and therefore both states need to be closer to each other in the conformational 
landscape. In the light of this model and given the present HPMX results, the structures 
refined at 490 and 650 MPa are considered to be a representation of state 1(T), contrary to 
the ambient and low pressure (< 200 MPa) ones. This conclusion is obviously not definitive 
and needs further evidence by solving structures at even higher pressures or by using 
complementary techniques such as cryo-EM that allow the possibility of trapping the 
multiple conformational states of Ras. 
 
it is worth mention the inherent difficulties of retrieving meaningful real space refined 
diffraction data of low populated conformational states. Almost all crystal structures are built 
by interpreting density maps at 1σ greater than the mean electron density of the unit cell, 
which is the approximate boundary between the signal from the molecule and the noise 
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from the density map. The temperature factors represent a Gaussian decay of the electron 
density of the modelled atoms and because they combine contributions from motions, static 
disorder and model errors, their interpretation can disguise discretely disordered alternative 
side-chain and main-chain conformations [285, 286]. This is especially pertinent for systems 
like Ras, where rare conformational states can be easily missed. Several recently 
developed methods seem to be able to tackle the problem by building many structural 
models simultaneously into the electron density [99, 287, 288]. They are certainly worth to 
explore in future investigations coupled to HPMX on Ras. 
 
 
4.10.2   HRasD33K (1-166)•Mg2+•GppNHp  
Crystal structure at Ambient Pressure 
The crystal structure of RasD33K at 0.1 MPa and RT is almost identical to RasWT (section 
3.5.3, Figure 3.69). The result is not altogether surprising given that the 2-state equilibria 
observed in solution for RasWT is abolished in the crystal, being the typical X-ray structure 
also exclusively representative of state 2(T) [28, 241, 281]. The substitution of Asp33 to Lys 
did not led to drastic modifications of switch 1, which still overlays perfectly with its 
counterpart in RasWT. As expected, the only significant differences lie at the intrinsically 
disordered switch 2 moiety, for which the calculated b-factors are around 20 Å2 in both 
proteins. 
 
Crystal structures at High Pressure 
The major features discussed in the above section 4.10.1 for RasWT are also representative 
of the series on RasD33K. Unequivocal structural modifications were observed at high 
pressure, especially above 500 MPa, for which a transition state of RasD33K takes place 
(section 3.5.4.1). The decrease in temperature factors at 880 MPa relative to 200 and 0.1 
MPa supports the conclusion that the obtained structure is indeed a higher energy 
conformational and functional state of Ras (Figure 3.71). This structure could represent Ras 
in state 1(T) or a transition structure through a conformational pathway that culminates with 
the stabilisation of this state. 
There is no direct evidence for a strict correlation between the crystal and the solution 
structures [119, 120, 183]. Therefore, the 880 MPa structure could represent state 1(T) on 
its own right. Additional experiments at higher pressures and the careful investigation of the 
compressibility of the unit cell using short pressure intervals around the 880 MPa value 
would provide an unequivocal answer about the nature of this state. 
4. Discussion 
 
253 
The fact that the transition point for RasD33K occurs at higher pressures (around 500 MPa) 
than RasWT (around 350 MPa) indicates that the mutant is more resistant to pressure-
modulation than the wild type variant (Figure 3.70). Indeed, the nucleotide binding pocket 
of RasD33K seems to be more closed than the wild type counterpart, which might account for 
the difference. 
The 880 MPa structure of RasD33K also helps to further understand the functional aspects 
of the conformation detected at 650 MPa for RasWT: both represent most likely the same 
high energy conformer that is structurally different than the one detected at 490 MPa for the 
wild type protein (Figure 3.72C). Although possible, it is very unlikely that the difference 
between RasWT at p650 and RasD33K at p880 is due to the presence of the K33 mutation, 
but instead due to the 230 MPa difference in pressure between both (if the mutation alone 
would account for the different structural changes, these would have been also observed at 
intermediate and low pressures, which is not the case). 
In summary, the use of a novel Ras mutant coupled to state-of-the-art HPMX technologies 
represents an unprecedented approach to tackle the rather complex dynamics of a protein 
that is of capital importance to both, normal and the aberrant cellular functions. Its unique 
biochemical properties and structural topography were glimpsed herein and will hopefully 
help the scientific community to derive meaningful relationships and to better understand 
its role as a master switch of the cell. 
 
 
4.10.3   HRasWT(1-166)•Mg2+•GppNHp in Complex with Zn2+-cyclen 
The volume of the unit cell at 0.1 MPa of RasWT soaked with 10 mM Zn2+-cyclen is similar 
to the Apo protein at ~200-300 MPa (section 3.5.5.1, Figure 3.74). A similar relationship 
can be inferred from 31P NMR since Zn2+-cyclen leads to the stabilisation of state 1(T) 
(Figure 3.3) at expense of state 2(T). A shift in the same direction is obtained by 31P HP 
NMR, with an associated decrease in the partial molar volume of the protein in solution 
(DV= -18.60 mL mol-1, section 3.3.2.1, Figure 3.27). These relationships are only qualitative 
but they are nevertheless in line with the mode of action of this drug. 
Furthermore, the HP studies performed for RasWT in the presence of Zn2+-cyclen are able 
to corroborate the results gathered from the HP series on the Apo protein. They show that 
pressure leads unequivocally to a modification of switch 2 and the segment b2-b3 comprising 
loop λ7, both being independent of the presence of Zn2+-cyclen (Figure 3.75). On the other 
hand, the effect of pressure alone is not capable of inducing relevant modifications on switch 
1. The same is true for Zn2+-cyclen alone, since the structures at ambient pressure in both 
4. Discussion 
 
254 
series are almost identical. However, a synergistic effect seems to be achieved when both 
are used at the same time: at 520 MPa a large shift of switch 1 is indeed observed and 
despite cyclen not being detected, there is enough space for it around the Zn2+ ion in the 
electron density map (Figure 3.76). In the light of these data, it can be assumed that the 
Ras•Zn2+-cyclen complex at 520 MPa is indeed a representative structure of the 
conformational state 1(T) observed in solution [125, 171]. 
The absence of assignable electron density for the cyclen moiety can be due to different 
reasons: it can be highly mobile and therefore disordered, it can be partially obscured by 
the intense scattering of the metal ion or, under very high pressures, it can dissociate from 
it. In principle, the coordination to Zn2+ is very stable at ambient pressure [289]. The stability 
under pressure was also confirmed by HP 31P NMR up to 200 MPa (unpublished results), 
although no studies are available in the 500 MPa pressure range. 
It is worth mention that no Zn2+-cyclen was observed at the second binding site coordinated 
to H166 near the C-terminal region, contrary to the previous structure reported by us at 
ambient pressure (pdb: 3l8y, Figure 1.10 [157]). This 2.05 Å structure was crystallised in 
the H32 space group and contained 142 water molecules. The different space group (P3221 
in the present case) can account for an additional difficulty for the drug to diffuse through 
the crystal and bind specifically to Ras. The lower number of waters has also a direct 
influence in the degree of hydration and thus in the number of solvent-accessible channels, 
essential for the communication with the surrounding environment in which the crystal is 
grown and through which pressure is transmitted. 
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obtain new facts as to discover new ways of thinking about them” 
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5.1   Figures 
 
 
 
 
 
 
 
 
 
 
 
Figure A. Pressure dependence of GppNHp followed by 31P NMR spectroscopy. All measurements were 
done at 278 K, using a Bruker Avance 600 MHz spectrometer operating at a magnetic field of 242.9 
MHz. The pressure-induced chemical shift changes for a-, b- and g-phosphates, together with inorganic 
phosphate (Pi) were plotted as a function of pressure. In each plot the dependence for the same 
phosphate signal in the presence (squares) and in the absence (triangles) of Mg2+ is shown. A general 
trend arises from the comparison of the two situations: the magnitude of the chemical shift changes, i.e. 
the Dd, is always larger for the experiments done in the absence of the metal ion (see Figure 3.26 and 
Tables D and E). Samples were prepared by dissolving 5 mM of GppNHp in 40 mM Tris/HCl, 0.1 mM 
DSS, 10% D2O, with pH 9.0 and 15 mM MgCl2 (in the presence of Mg2+) or pH 11.5 and 0.5 mM EDTA 
(in the absence). The data points were fitted with a second order Taylor expansion. 
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Figure B. Conformational equilibria of the Ras(1-166)•Mg2+•GDP selected mutants detected 
by 31P NMR. The mutants were created by SDM upon choosing specific residues associated 
with the conformational transitions derived from HP investigations. All the measurements were 
done at 278 K in a 202.4 MHz magnetic field (500 MHz spectrometer). The proteins were 
dissolved in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with additionally 0.2 
mM DSS and 5% D2O at concentrations ranging between 0.6 and 1.5 mM. 
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Figure C. Impact of Cu2+-cyclen binding to HRas(1-166)•Mg2+•GppNHp followed by 
31P NMR spectroscopy. Two mutants, A. RasS39L and B. RasE3V were titrated with 
increasing amounts of the drug. The measurements were performed at 278 K in a 
202.456 MHz magnetic field (500 MHz spectrometer) and in buffer F at pH 7.5. The 
initial concentrations of RasS39L and RasE3V were 1.0 and 1.86 mM, respectively. To 
each protein Cu2+-cyclen was added from a highly concentrated stock solution. The 
concentration of the drug for each step is indicated. 
Cu2+-cyclen binds near the g-phosphate when Ras exists only in the conformational 
state 1(T) and can be used as a probe to recognize this specific state, being especially 
useful in novel mutants where the assignment of specific states from the chemical 
shifts can be difficult. The state 1(T) resonance on g-phosphate becomes broadened 
beyond detection upon addition of low milimolar concentrations (1-4 mM), which 
proves its unequivocally assignment. This method is independent of mutations or the 
nature of the GTP analogue used. The fitted chemical shift values and linewidths are 
given in Table I. 
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Figure D. Conformational equilibria of HRas(1-166)•Mg2+•GDP detected by 31P NMR at 278 K. All 
protein complexes were dissolved in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) 
with additionally 0.2 mM DSS and 5-10% D2O. The final concentrations were in the range of 0.4 and 
1.9 mM. 31P resonances were recorded in a magnetic field operating at a frequency of 242.896 MHz 
(600 MHz spectrometer) except for RasG12P, where a 202.456 MHz (500 MHz spectrometer) was 
used. The chemical shifts corresponding to the a- and b-phosphates of bound GDP are indicated, as 
well as the unbound or free (afree , bfree) nucleotide. The presence of free nucleotide results from 
practical aspects of the purification process, were free GDP is added to buffer D, used during last 
step of the purification. The presence of Pi and GMP is observed in some cases and results most 
likely from the time-dependent degradation of free GDP. An exponential lorentizan line broadening 
of 15 Hz was applied to the FID during data processing. The obtained shift values and linewidths are 
shown in Table 3.25, section 3.4.10.1. 
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Figure E. Plot of the variation of the pressure-dependent chemical shift changes, Dd=dlast pressure 
point-d0.1MPa of RasWT, RasT35S and RasD33K in complex with Mg2+•GppNHp at 278 K and pH 7.5. 
Each plot shows the uncorrected and corrected changes for the a- (top), b- (middle) and g-
phosphates (bottom). 
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Figure F. Thermodynamics of the interaction between different mutants of HRas(1-166)•Mg2+•GppNHp and the 
Ras binding domain of the effector protein Raf measured by ITC. All experiments were performed at 298 K in 
buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) with additionally 150 mM NaCl. All proteins were 
extensively dialyzed against this buffer. Ras was always placed in the cell of the calorimeter and Raf was always 
placed in the syringe. All the experiments were performed according to the default setting of the device used 
with a referential power of 10 µcal s-1 and a spacing between injections of 150 s or longer with a injection time 
of 2 s and stirring speed of 750 rpm. A total of either 19 or 31 injections of 2 µl each were applied in the 
determination of KD values. For each mutant tested, the raw heat of the reaction is plotted in the upper graph 
and the integrated heat per Ras:Raf ratio is shown in the lower graph. The signature plot is also shown with the 
following colour code: blue: DG, green: DH, red: -TDS. The thermograms shown here correspond to the best 
fitted data from a duplicate or sometimes a triplicate series of experiments, conducted for each mutant. All the 
data was corrected for the intrinsic heat of mixing given by buffer-in-buffer and buffer-in-protein injections (in 
the case of the different Ras mutants, the calibration used was relative to the heat of buffer-in-RasWT). For 
details see 2.2.4 
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Figure F - Continuation from the previous page. Thermodynamics of the interaction between different 
mutants of HRas(1-166)•Mg2+•GppNHp and the Ras binding domain of the effector protein Raf measured by 
ITC. All experiments were performed at 298 K in buffer F (40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 2 mM DTE) 
with additionally 150 mM NaCl. All proteins were extensively dialyzed against this buffer. Ras was always placed 
in the cell of the calorimeter and Raf was always placed in the syringe. All the experiments were performed 
according to the default setting of the device used with a referential power of 10 µcal s-1 and a spacing between 
injections of 150 s or longer with a injection time of 2 s and stirring speed of 750 rpm. A total of either 19 or 31 
injections of 2 µl each were applied in the determination of KD values. For each mutant tested, the raw heat of 
the reaction is plotted in the upper graph and the integrated heat per Ras:Raf ratio is shown in the lower graph. 
The signature plot is also shown with the following colour code: blue: DG, green: DH, red: -TDS. The 
thermograms shown here correspond to the best fitted data from a duplicate or sometimes a triplicate series of 
experiments, conducted for each mutant. All the data was corrected for the intrinsic heat of mixing given by 
buffer-in-buffer and buffer-in-protein injections (in the case of the different Ras mutants, the calibration used 
was relative to the heat of buffer-in-RasWT). For details see experimental section 2.2.4. 
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Figure G. High pressure macromolecular crystallography on HRasWT(1-166)•Mg2+•GppNHp. A. Details 
evidencing the coordination to the Mg2+ ion. The structures refined at pamb, 270, 490 and 650 MPa are 
superimposed and coloured in grey, yellow, orange and blue, respectively. The Mg2+ ion is coordinated by 
six atoms: S17, O1g, T35, O1b, w200 and w201. The coordination profile is virtually identical for all the 
recorded pressure points. The same coordination is also found in the case of the HPMX series of RasD33K. 
w200 is surrounded by six atoms: Mg2+, S17-OH, Og, T35-OH, D33-OH, Oa and w201 is surrounded by five 
atoms: Mg2+, D33-NH, Y32-OH, Ob and Og. Note that Y32, shown in the background, is establishing a polar 
contact with one oxygen atom from the g-phosphate of an adjacent nucleotide molecule. B. In fact, not only 
Y32 but most residues from the switch regions (particularly switch 1) are packed in the asymmetric unit 
against the neighbouring molecules. This tight packing seems to be a fundamental property of the 
crystallisation under the P3221 space group and is observed at all investigated pressure points. Within the 
obtained data, it is considered that the tight packing hinders the pressure-induced movement of the switch 
regions, preventing the observation of a ‘true’ open conformation, even at 650 MPa. 
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Figure H. Structural comparison between crystal forms of HRasWT(1-166)•Mg2+•GppNHp 
obtained by conventional X-ray at 77 K obtained for states 2(T) (coloured in grey, pdb: 5b2z) 
and 1(T) (coloured in teal, pdb: 5b30) seemingly obtained by Shima et al. [238] with the 
presently refined structures at 490 MPa (red coloured) and 650 MPa )light purple). All the 
proteins are aligned and superimposed A. Details of the switch 1 region. Note how both HP 
structures are better related to 5b2z than 5b30. The specific orientation in space of important 
residues is evidenced (F28,Y32, D33, P34, T35, I36). B. Details of the intrinsically disordered 
switch 2 region, showing the different orientation of Q61 and Y64 (top). A global overview is 
given in the bottom (aa 60-70). 
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Figure I. Structural comparison between the refined crystal structure of RasWT in the Apo form, 
obtained at pamb and RT (grey colour) with the one obtained from the crystals soaked with 12 mM 
Zn2+-cyclen (violet colour). No Zn2+ ions or the Zn2+-cyclen were observed in the electron density map 
of the latter structure. Details regarding the orientation of the residues comprising switch 1 and switch 
2 are given in A. and B., respectively. Note how the two structures superimpose perfectly, even at 
the highly mobile switch 2 region. C. Structural details of Q61 and the surrounding trapped waters. In 
both cases Q61 binds directly to the nucleotide and no equivalent nucleophilic waters, with respect 
to 5p21 (w175 and w189), could be found in the density maps. 
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5.2   Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A. 31P NMR chemical shift values for HRas and KRas4b•Mg2+•GppNHp proteins and their titration with the 
state 1(T) inhibitor Zn2+-cyclena 
Protein 
complex p:l 
a-phosphate b-phosphate g-phosphate 
K12c d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
FLHRasWTd -- -11.25 -11.71 -0.26 -0.16 -2.54 -3.24 1.90 
+ Zn2+-cyc 1:1.7 -11.18 -11.68 -0.23b -2.55 -3.30 2.23 
 1:3.4 -11.17 -11.67 -0.25b -2.47 -3.35 2.02 
 1:7 -11.18 -11.65 -0.46 -0.22 -2.18 -3.38 1.42 
 1:11 -11.08 -11.63 -0.64 -0.23 -2.00 -3.48 1.17 
 1:15 -10.96 -11.49 -0.77 -0.22 -1.88 -3.52 0.74 
 1:23 -10.92 -11.58 -0.94 -0.19 -1.71 -3.56 0.42 
 1:30 -10.81 -11.51 -1.04 -0.05 -1.64 -3.58 0.17 
FLKRasWT -- -11.27 -11.73 -0.32 -0.21 -2.58 -3.30 2.01 
+ Zn2+-cyc 1:1.7 -11.21 -11.72 -0.21b -2.53 -3.29 2.28 
 1:3.4 -11.17 -11.67 -0.25b -2.44 -3.30 1.55 
 1:7 -11.08 -11.63 -0.32b -2.18 -3.35 1.09 
 1:11 -11.00 -11.64 -0.66 -0.22 -1.98 -3.39 0.78 
 1:15 -10.93 -11.59 -0.79 -0.21 -1.83 -3.43 0.57 
 1:23 -10.84 -11.56 -0.97 -0.23 -1.69 -3.47 0.25 
 1:30 -10.74 -11.46 -1.06 -0.29 -1.61 -3.51 0.21 
aAll the values are presented in ppm and fitted from the experimental spectra recorded at 278 K, pH 7.5 with 10 
mM MgCl2 and 2 mM DTE. The protein:ligand (p:l) equivalents from the titration steps are shown. The estimated 
errors from the fitting procedure are less than ± 0.05 ppm in chemical shift values. An LB= 15 Hz was applied to 
the FID and subtracted afterwards to the calculated linewidth values. 
bThe b-phosphate was fitted as a single Lorentzian line because states 1 and 2 cannot be separated.  
cThe equilibrium constant, K12, calculated using the population distribution on the g-phosphate, is defined as the 
ratio between the relative areas of state 2 and state 1: K12=[Astate 2]/[Astate 1]. The error associated with this calculation 
is ± 0.2 due to the partial overlapping of the resonance lines. 
Table B. 31P NMR chemical shift values and linewidths  for the protein-drug complex 
HRasWT(1-189)•Mg2+•GppNHp•Zn2+-cyclen and the displacement upon Raf-RBD 
titration. 
Protein 
complex 
    p:l a-phosphate b-phosphate g-phosphate 
d1(T) d2(T) d1(T) d2(T) d1(T) d2(T) 
                HRasWT  -11.27 -11.73 -0.26 -0.16 -2.60 -3.30 
        + Zn2+-cyc 1:32 -10.92 -11.56 -1.01 -0.03 -1.64 -3.59 
        + Raf-RBD 1:0.4 -10.92 -11.60 -0.86 -0.16 -1.79 -3.54 
 1:0.8 -10.93 -11.61 -0.89 -0.19 -1.80 -3.57 
 1:1.2 -10.96 -11.62 -0.89 -0.17 -1.76 -3.56 
 1:1.5 -- -11.61 -- -0.19 -- -3.56 
                  a-phosphate b-phosphate g-phosphate 
  Dn1/2 (1) Dn1/2 (2) Dn1/2 (1) Dn1/2 (2) Dn1/2 (1) Dn1/2 (2) 
                HRasWT  136.4 80.5 40.9 56.2 94.6 58.5 
        + Zn2+-cyc 1:32 107.1 105.2 71.4 75.3 54.5 73.3 
        + Raf-RBD 1:0.4 105.4 81.6 72.4 83.7 56.4 65.5 
 1:0.8 121.0 114.3 69.3 79.8 57.2 64.2 
 1:1.2 112.4 110.0 78.0 89.3 51.8 60.8 
 1:1.5 -- 127.3 -- 62.5 -- 43.4 
        All values are determined from the spectra recorded at 278 K and pH 7.5 upon proper 
deconvolution of the spectral lines. The estimated error for the chemical shifts and linewidths is 
is ± 0.015 ppm and 0.18 Hz, respectively. 
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Table C. 31P NMR chemical shift values and linewidths for the protein-drug complex 
KRasG12D•Mg2+•GppNHp•Zn2+-cyclen and the displacement upon Raf-RBD titration. 
            Protein 
Complex p:l 
a-phosphate b-phosphate g-phosphate 
K12 d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
                  KRasG12D  -11.41 -11.71 -0.38 -2.48 -3.54 0.70 
        + Zn2+-cyc 1:0.5 -11.37 -11.65 -0.39 -2.45 -3.53 0.71 
 1:1.5 -11.37 -11.68 -0.37 -2.40 -3.51 0.69 
 1:5.0 -11.22 -11.50 -0.44 -2.12 -3.60 0.51 
 1:9.0 -11.24 -11.62 -0.45 -1.70 -3.62 0.36 
                    a-phosphate b-phosphate g-phosphate  
  Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
 
                  KRasG12D  82.6 87.1 72.6 160.3 78.0  
        + Zn2+-cyc 1:0.5 92.2 89.7 67.8 145.9 68.6  
 1:1.5 72.8 86.8 74.8 158.5 77.1  
 1:5.0 60.5 127.6 66.4 196.0 88.7  
 1:9.0 86.4 80.0 82.6 190.2 79.0  
         All values are determined from the spectra recorded at 278 K and pH 7.5 upon proper deconvolution 
of the spectral lines. The estimated error for the chemical shifts and linewidths is is ± 0.015 ppm and 
0.18 Hz, respectively.  An LB= 15 Hz was applied to the FID and subtracted afterwards to the calculated 
linewidth values. 
 
Table D. 31P pressure-dependent chemical shift values and linewidths of the 
Mg2+•GppNHp nucleotide. 
          Pressure 
[MPa] 
a-phosphate b-phosphate g-phosphate Pi 
d 
[ppm] 
Dn1/2 
[Hz]  
d 
[ppm] 
Dn1/2  
[Hz] 
d 
[ppm] 
Dn1/2  
[Hz] 
d 
[ppm] 
Dn1/2 
[Hz]  
                  0.1 -10.091 29.63 -5.602 54.25 -1.082 24.56 2.554 6.16 
10 -10.096 29.97 -5.617 53.52 -1.093 24.87 2.551 9.35 
20 -10.096 29.98 -5.631 53.05 -1.105 24.94 2.546 6.98 
30 -10.096 29.78 -5.638 55.19 -1.114 25.10 2.540 4.60 
40 -10.092 30.06 -5.648 54.11 -1.125 24.78 2.539 4.83 
50 -10.096 30.11 -5.665 55.36 -1.138 24.82 2.535 5.25 
60 -10.096 30.47 -5.678 55.25 -1.149 24.57 2.531 4.46 
70 -10.098 30.31 -5.688 54.48 -1.157 23.83 2.527 5.95 
80 -10.097 30.39 -5.703 57.59 -1.170 24.58 2.521 6.55 
90 -10.099 30.55 -5.713 54.15 -1.179 24.14 2.520 4.48 
100 -10.100 30.64 -5.732 55.57 -1.189 24.17 2.517 6.09 
110 -10.104 30.71 -5.748 54.53 -1.202 23.36 2.512 4.57 
120 -10.099 30.68 -5.753 55.81 -1.208 22.93 2.509 3.42 
130 -10.107 30.86 -5.774 56.08 -1.218 22.90 2.506 3.59 
140 -10.116 30.85 -5.793 53.89 -1.230 22.84 2.504 4.19 
150 -10.106 30.85 -5.795 54.71 -1.236 22.92 2.502 3.74 
160 -10.109 30.61 -5.811 56.57 -1.246 22.37 2.500 4.95 
170 -10.114 31.02 -5.826 54.66 -1.255 22.32 2.499 3.46 
180 -10.111 31.50 -5.829 56.60 -1.260 22.30 2.499 4.33 
190 -10.116 31.22 -5.834 56.86 -1.260 22.04 2.500 3.95 
200 -10.119 31.50 -5.848 56.86 -1.268 21.91 2.496 3.38 
0.1 -10.090 29.52 -5.600 54.28 -1.081 25.79 2.551 7.97 
         All values are determined from the spectra recorded at 278 K and pH 9.0. The artificial 
Lorentzian broadening of 4 Hz applied to the FID was subtracted from the final linewidth 
values presented here.  An LB= 4 Hz was applied to the FID and subtracted afterwards to 
the calculated linewidth values. 
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Table E. 31P pressure-dependent chemical shift values of the 
GppNHp nucleotide in the absence of Mg2+. 
          Pressure a-phosphate b-phosphate g-phosphate Pi 
[MPa] d /ppm d /ppm d /ppm d 
          0.1 -10.44 -7.56 -0.68 4.28 
10 -10.45 -7.59 -0.71 4.27 
20 -10.46 -7.61 -0.74 4.27 
30 -10.47 -7.63 -0.77 4.26 
40 -10.47 -7.65 -0.80 4.26 
50 -10.48 -7.67 -0.82 4.25 
60 -10.49 -7.69 -0.84 4.25 
70 -10.49 -7.71 -0.87 4.24 
80 -10.50 -7.72 -0.89 4.24 
90 -10.50 -7.73 -0.91 4.24 
100 -10.50 -7.75 -0.93 4.24 
110 -10.51 -7.76 -0.95 4.24 
120 -10.51 -7.77 -0.96 4.24 
130 -10.51 -7.78 -0.98 4.23 
140 -10.51 -7.79 -0.99 4.23 
150 -10.52 -7.79 -1.01 4.23 
160 -10.52 -7.80 -1.02 4.23 
170 -10.52 -7.81 -1.03 4.23 
180 -10.52 -7.81 -1.05 4.23 
190 -10.52 -7.82 -1.06 4.23 
200 -10.52 -7.82 -1.07 4.23 
210 -10.52 -7.83 -1.08 4.23 
0.1	 -10.44	 -7.56	 -0.68	 4.28	
	 	 	 	 		 	 	 	 	All values are determined from the spectra recorded at 278 K and pH 11.5.	
Table G. Uncorrected and corrected 31P NMR pressure-dependent chemical shift values of HRasT35S(1-
166)•Mg2+•GppNHp recorded at 278 K and pH 7.5. 
                
Pressure 
[MPa] 
a-phosphate b-phosphate g-phosphate Pi 
d [ppm] 
uncorrected 
d [ppm] 
corrected 
d [ppm]  
uncorrected 
d [ppm] 
corrected 
d [ppm] 
uncorrected 
d [ppm] 
corrected 
d 
[ppm] 
                0.1 -10,971 -10,971	 -0,324 -0,324	 -2,540 -2,540	 2,388 
10 -10,960 -10,960	 -0,330 -0,316	 -2,542 -2,530	 2,392 
25 -10,952 -10,951	 -0,332 -0,298	 -2,545 -2,515	 -- 
40 -10,944 -10,942	 -0,337 -0,283	 -2,550 -2,502	 2,397 
50 -10,936 -10,933	 -0,340 -0,273	 -2,554 -2,495	 2,397 
60 -10,927 -10,923	 -0,345 -0,264	 -2,557 -2,487	 2,397 
70 -10,923 -10,918	 -0,347 -0,254	 -2,559 -2,478	 2,395 
80 -10,919 -10,913	 -0,349 -0,242	 -2,560 -2,469	 2,395 
90 -10,914 -10,907	 -0,353 -0,233	 -2,561 -2,459	 2,392 
100 -10,912 -10,904	 -0,355 -0,223	 -2,561 -2,450	 2,388 
110 -10,909 -10,900	 -0,360 -0,215	 -2,560 -2,440	 2,386 
120 -10,907 -10,896	 -0,362 -0,204	 -2,560 -2,430	 2,382 
130 -10,906 -10,893	 -0,365 -0,195	 -2,559 -2,420	 2,379 
140 -10,905 -10,891	 -0,368 -0,186	 -2,558 -2,410	 2,376 
150 -10,904 -10,889	 -0,371 -0,177	 -2,558 -2,402	 2,371 
160 -10,906 -10,888	 -0,373 -0,167	 -2,557 -2,393	 2,368 
170 -10,906 -10,886	 -0,377 -0,159	 -2,556 -2,384	 2,364 
180 -10,905 -10,883	 -0,383 -0,152	 -2,554 -2,375	 2,360 
190 -10,905 -10,881	 -0,387 -0,145	 -2,552 -2,366	 2,356 
0.1 -10.969 -10.969 -0.317 -0.3224 -2.536 -2.540 2.305 
                All the uncorrected values were determined by processing the FID with a proper Gaussian function. The corrected values 
were obtained by simple addition or subtraction of Ddfreenuc fit to the duncorrected from the protein. 
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Table F. Uncorrected and corrected 31P NMR pressure-dependent chemical 
shift values of HRasWT(1-166)•Mg2+•GppNHp recorded at 278 K and pH 7.5. 
          
Pressure 
[MPa] 
a-phosphate b-phosphate g-phosphate 
Pi 
[ppm] d1(T) 
[ppm] 
d2(T) 
[ppm] 
d 
[ppm] 
d1(T) 
[ppm] 
d2(T 
[ppm]) 
              Uncorrected 
       0.1 -11.195 -11.641 -0.238 -2.517 -3.326 2.359 
10 -11.157 -11.646 -0.247 -2.520 -3.309 2.370 
20 -11.120 -11.652 -0.254 -2.525 -3.292 2.363 
30 -11.109 -11.648 -0.257 -2.530 -3.272 2.370 
40 -11.085 -11.640 -0.262 -2.538 -3.252 2.374 
50 -11.072 -11.628 -0.272 -2.540 -3.238 2.376 
60 -11.057 -11.625 -0.277 -2.541 -3.219 2.380 
70 -11.028 -11.619 -0.286 -2.540 -3.197 2.380 
80 -11.010 -11.612 -0.290 -2.541 -3.183 2.380 
90 -11.005 -11.599 -0.291 -2.540 -3.167 2.382 
100 -10.986 -11.592 -0.296 -2.539 -3.146 2.380 
110 -10.984 -11.583 -0.306 -2.539 -3.130 2.379 
120 -10.971 -11.589 -0.315 -2.539 -3.105 2.380 
130 -10.954 -11.584 -0.321 -2.538 -3.099 2.376 
140 -10.942 -11.581 -0.327 -2.536 -3.074 2.372 
150 -10.927 -11.576 -0.335 -2.535 -3.061 2.370 
160 -10.927 -11.571 -0.345 -2.532 -3.052 2.365 
170 -10.904 -11.573 -0.349 -2.528 -3.035 2.363 
180 -10.904 -11.579 -0.359 -2.525 -3.009 2.358 
190 -10.891 -11.578 -0.363 -2.522 -2.998 2.355 
200 -10.886 -11.576 -0.372 -2.519 -2.981 2.350 
210 -10.877 -11.580 -0.379 -2.516 -2.957 2.345 
220 -10.860 -- -0.388 -2.512 -2.961 2.342 
230 -10.854 -- -0.392 -2.509 -2.942 2.336 
240 -10.844 -- -0.403 -2.505 -2.931 2.330 
250 -10.845 -- -0.420 -2.502 -2.908 2.326 
0.1 -11.142 -11.638 -0.248 -2.514 -3.325 2.322 
       
       Pressure a-phosphate b-phosphate g-phosphate  
MPa d1(T) 
[ppm] 
d2(T) 
[ppm] 
d 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] -- 
              Corrected 
       0.1 -11,195 -11,641 -0,238 -2,517 -3,326  
10 -11,156 -11,645 -0,233 -2,508 -3,297  
20 -11,119 -11,651 -0,226 -2,500 -3,268  
30 -11,108 -11,647 -0,216 -2,494 -3,236  
40 -11,083 -11,638 -0,207 -2,490 -3,204  
50 -11,069 -11,626 -0,204 -2,481 -3,179  
60 -11,053 -11,621 -0,197 -2,471 -3,149  
70 -11,024 -11,614 -0,192 -2,459 -3,116  
80 -11,004 -11,607 -0,183 -2,450 -3,091  
90 -10,998 -11,592 -0,172 -2,439 -3,065  
100 -10,977 -11,584 -0,163 -2,427 -3,034  
110 -10,974 -11,573 -0,161 -2,418 -3,010  
120 -10,961 -11,578 -0,157 -2,409 -2,975  
130 -10,941 -11,572 -0,151 -2,399 -2,960  
140 -10,928 -11,567 -0,145 -2,389 -2,926  
150 -10,911 -11,561 -0,140 -2,380 -2,906  
160 -10,909 -11,553 -0,138 -2,368 -2,888  
170 -10,885 -11,554 -0,130 -2,357 -2,863  
180 -10,882 -11,557 -0,128 -2,346 -2,830  
190 -10,868 -11,554 -0,121 -2,336 -2,812  
200 -10,860 -11,550 -0,119 -2,326 -2,787  
210 -10,849 -11,551 -0,113 -2,316 -2,757  
220 -10,829  -0,111 -2,306 -2,755  
230 -10,821  -0,104 -2,297 -2,730  
240 -10,808  -0,104 -2,287 -2,713  
250 -10,806  -0,110 -2,279 -2,684  
0.1 -11,195  -0,238 -2,517 -3,326  
All the uncorrected values were determined by processing the FID with a 
proper Gaussian function. The corrected values were obtained by simple 
addition or subtraction of Ddfreenuc fit to the duncorrected from the protein. 
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Table H. Uncorrected and corrected 31P NMR pressure-dependent chemical shift values of KRasG12V(1-
189)•Mg2+•GTP recorded at 278 K and pH 7.5. 
                Pressure 
[MPa] 
a-phosphate b-phosphate g-phosphate Pi 
[ppm] d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
                Uncorrected 
        1.0 -- -11,532 -- -14,699 -6,004 -7,471 -- 
50 -- -11,513 -15,102 -14,739 -6,100 -7,453 2,365 
70 -- -11,498 -15,152 -14,754 -6,130 -7,426 2,374 
100 -- -11,466 -15,191 -14,779 -6,199 -7,384 2,354 
125 -- -11,457 -15,251 -14,786 -6,248 -7,358 2,350 
132 -11,150 -11,443 -15,256 -14,793 -6,260 -7,341 2,355 
150 -11,142 -11,449 -15,301 -14,807 -6,280 -7,321 2,347 
160 -11,101 -11,443 -15,310 -14,819 -6,309 -7,299 2,347 
172 -11,116 -11,425 -15,307 -14,823 -6,330 -7,257 2,337 
185 -11,101 -11,433 -15,311 -14,842 -6,347 -7,220 2,325 
195 -11,047 -11,416 -15,318 -14,850 -6,371 -7,176 -- 
1.0 -- -11.539 -- -14.712 -5.989 -7.422 -- 
                 a-phosphate b-phosphate g-phosphate  
 d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
-- 
                Corrected 
        1.0 -- -11,532 -- -14,695 -6,002 -7,473  
50 -- -11,488 -14,880 -14,517 -5,999 -7,554  
70 -- -11,464 -14,851 -14,454 -5,993 -7,562  
100 -- -11,418 -14,782 -14,370 -6,013 -7,570  
125 -- -11,399 -14,762 -14,297 -6,026 -7,581  
132 -11,089 -11,382 -14,746 -14,284 -6,028 -7,573  
150 -11,074 -11,380 -14,741 -14,247 -6,025 -7,576  
160 -11,029 -11,371 -14,724 -14,233 -6,043 -7,566  
172 -11,040 -11,348 -14,692 -14,208 -6,050 -7,537  
185 -11,020 -11,353 -14,666 -14,198 -6,053 -7,514  
195 -10,963 -11,331 -14,652 -14,184 -6,068 -7,480  
1.0 -- -11.532 -- -14.695 -6.068 -7.480  
                All the uncorrected values were determined by processing the FID with a proper Gaussian function. The corrected values 
were obtained by simple addition or subtraction of Ddfreenuc fit to the duncorrected from the protein. 
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Table I. 31P NMR chemical shift values and linewidths for the protein-drug interaction HRasS39L•Mg2+•GppNHp and 
HRasE3V•Mg2+•GppNHp with Cu2+-cyclena. 
Protein 
complex p:l 
a-phosphate b-phosphate g-phosphate 
K12c d1(T) 
[ppm] 
d2(T) 
[ppm] 
d1(T),2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
        HRasS39L -- -11.08 -11.67 -0.25 -2.50 -3.35 1.5 
+ Cu2+-cyc 1:2 -11.01 -11.66 -0.27 -2.94 -3.36 1.9 
 1:4 -11.07 -11.67 -0.28 -- -3.35 -- 
        
HRasE3V -- -11.23 -11.68 -0.27 -2.59 -3.33 2.0 
+ Cu2+-cyc 1:0.5 -11.18 -11.66 -0.28 -3.01 -3.33 -- 
 1:1 -11.18 -11.67 -0.29 -- -3.36 -- 
 1.2 -11.17 -11.67 -0.29 -- -3.37 -- 
                  a-phosphate b-phosphate g-phosphate  
  Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
Dn1/2 1(T),2(T) 
[Hz] 
Dn1/2 1(T) 
[Hz] 
Dn1/2 2(T) 
[Hz] 
-- 
                HRasS39L -- 98.05 62.88 42.55 48.95 50.82  
+ Cu2+-cyc 1:2 87.36 61.37 48.47 163.72 47.21  
 1:4 122.88 45.45 58.38 -- 78.83  
        
HRasE3V -- 122.22 67.33 54.39 78.74 53.00  
+ Cu2+-cyc 1:0.5 122.82 60.23 56.97 250 44.95  
 1:1 118.73 67.05 61.55 -- 61.55  
 1:2 117.31 74.55 70.00 -- 62.18  
        aAll the values fitted from the experimental spectra recorded at 278 K, with 40 mM Tris/HCl pH 7.5, 10 mM MgCl2, 
2 mM DTE, 0.2 mM DSS and 5% D2O. The protein:ligand (p:l) equivalents from the titration steps are shown. The 
estimated errors from the fitting procedure are less than ± 0.02 ppm in chemical shift values for the g-phosphate. 
bThe b-phosphate was fitted as a single Lorentzian line because states 1 and 2 cannot be separated.  An LB= 15 Hz 
was applied to the FID and subtracted afterwards from the final fitted linewidth values. 
cThe equilibrium constant, K12, calculated using the population distribution on the g-phosphate, is defined as the 
ratio between the relative areas of state 2 and state 1: K12=[Astate 2]/[Astate 1]. The error associated with this calculation 
is ± 0.2 due to the partial overlapping of the resonance lines. 
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Table J. Uncorrected and corrected 31P NMR pressure-dependent chemical 
shift values (in ppm) of HRasD33K(1-166)•Mg2+•GppNHp recorded at 278 K and 
pH 7.5. 
          Pressure 
[MPa] 
a-phosphate b-phosphate g-phosphate Pi 
[ppm] d1(T)/2(T) 
[ppm] 
d1(T),2(T) 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
              Uncorrected 
       0.1 -11.496 -0.285 -- -3.397 -- 
10 -11.490 -0.291 -- -3.386 -- 
20 -11.460 -0.301 -- -3.369 1.884 
30 -11.444 -0.308 -- -3.356 1.870 
40 -11.435 -0.312 -- -3.345 1.859 
50 -11.401 -0.318 -- -3.331 1.844 
60 -11.367 -0.321 -- -3.310 1.838 
70 -11.352 -0.325 -- -3.295 1.826 
80 -11.324 -0.331 -2.497 -3.277 1.818 
90 -11.308 -0.336 -2.498 -3.265 1.809 
100 -11.270 -0.343 -2.494 -3.252 1.797 
110 -11.246 -0.347 -2.484 -3.237 1.785 
120 -11.221 -0.347 -2.480 -3.221 1.779 
130 -11.200 -0.351 -2.477 -3.211 1.771 
140 -11.171 -0.356 -2.468 -3.193 1.759 
150 -11.148 -0.360 -2.459 -3.180 1.750 
160 -11.130 -0.364 -2.455 -3.171 1.741 
170 -11.104 -0.367 -2.454 -3.161 1.734 
180 -11.074 -0.366 -2.450 -3.147 1.725 
190 -11.064 -0.368 -2.448 -3.137 1.724 
200 -11.036 -0.371 -2.443 -3.123 1.716 
0.1 -11.498 -0.285 -- -3.396 -- 
              Pressure 
[MPa] 
a-phosphate b-phosphate g-phosphate  
d1(T) 
[ppm] 
d2(T) 
[ppm] 
d 
[ppm] 
d1(T) 
[ppm] 
d2(T) 
[ppm] 
-- 
              Corrected 
       0.1 -11.496 -0.285 -- -3.397  
10 -11.490 -0.278 -- -3.373  
20 -11.460 -0.274 -- -3.345  
30 -11.443 -0.267 -- -3.319  
40 -11.433 -0.258 -- -3.297  
50 -11.398 -0.250 -- -3.271  
60 -11.364 -0.240 -- -3.240  
70 -11.348 -0.231 -- -3.214  
80 -11.319 -0.224 -2.406 -3.186  
90 -11.301 -0.216 -2.396 -3.164  
100 -11.262 -0.211 -2.383 -3.141  
110 -11.237 -0.202 -2.363 -3.116  
120 -11.210 -0.189 -2.350 -3.091  
130 -11.188 -0.181 -2.338 -3.072  
140 -11.156 -0.174 -2.321 -3.045  
150 -11.132 -0.165 -2.303 -3.025  
160 -11.112 -0.158 -2.291 -3.007  
170 -11.085 -0.149 -2.283 -2.989  
180 -11.052 -0.136 -2.271 -2.968  
190 -11.040 -0.126 -2.262 -2.951  
200 -11.010 -0.117 -2.250 -2.930  
0.1 -11.496 -0.285 -- -3.397  
All the uncorrected values were determined by processing the FID with a 
proper Gaussian function. The corrected values were obtained by simple 
addition or subtraction of Ddfreenuc fit to the duncorrected from the protein. 
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5.5   List of Abbreviations 
AP alkaline phosphatase 
APS ammonium persulfate 
Arf ADP ribosilation factor 
bp base pair 
BSA bovine serum albumin 
c truncated 
ca. circa 
CCD charge coupled device 
Cdc25 cell division cycle 25 
CFC cardio-facio-cutaneous 
CM carboxymethyl 
CS costello syndrome 
Cu2+-cyclen copper cyclen 
CV column volume 
DAC diamond anvil cell 
DEAE diethylaminoethanol 
DACH diacylglycerol  
DFT density Functional Theory 
DMSO dimethyl Sulfoxide 
DNA desoxyribonucleic acid 
DTE dithioerithrol 
DSS 4,4-dimethyl-4-silapentane-1-sulfonic acid 
E. coli. Escherichia coli 
EDTA ethylenediaminetetracetic acid 
e.g. exempli gratia 
EM exponential Multiplication 
ERK extracellular signal-regulated kinase 
ESRF European Synchrotron Radiation Facility 
EtBr ethidium bromide 
EtOH ethanol 
eV electron volt 
FID free induction decay 
FL full length 
FPLC fast protein liquid chromatography 
FTI farnesyl transferase inhibitor 
G Gibbs free Energy (the variation is denoted DG) 
GAP GTPase Activating Protein 
GB Gaussian broadening 
GDP guanosine diphosphate 
GdmCl guanidinium hydrochloride 
GEF guanine Exchange Factor 
GM Gaussian multiplication 
GNBP guanine nucleotide binding protein 
GPa giga pascal 
GppNHp  5'-Guanylyl imidodiphosphate 
Grb2 growth factor receptor-bound protein 2 
GSK3b glycogen synthase kinase 3b 
GSH reduced glutathione 
GST glutathione S-transferase 
GTP guanosine triphosphate 
H enthalpy (the variation is denoted DH) 
HP high pressure 
HPLC high performance liquid chromatography 
HPMX high pressure macromolecular crystallography 
HSQC heteronuclear single quantum coherence 
HVR hypervariable region 
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IC inhibitory concentration 
ie. id est 
IEX ion exchange chromatography 
IPTG isopropyl b-d-1-thiogalactopyranoside 
ITC isothermal titration calorimetry 
J joule 
K kelvin 
kcal kilocalorie 
kDa kilo Dalton 
kJ kilo joule 
L litre 
LB lysogeny Broth 
LCMS liquid chromatography Mass spectrometry 
M molar 
MAPK mitogen activated protein kinase 
MD molecular dynamics 
MeOH methanol 
MHz mega Hertz 
min minute 
MLV murine leukemia virus 
mM milimolar 
MM minimal medium 
MPa mega pascal 
MR molecular replacement 
MST microscale thermophoresis 
NAG N-acetyl glucosamine 
NAM N-acetyl muramic acid 
NF1 neurofibromatin 1 
ng nanogram 
NMM new minimal medium 
NMR nuclear Magnetic Resonance 
NTA nitrilotriacetic acid 
OD optical density 
Pa pascal 
pamb ambient pressure 
PCR polymerase chain reaction 
Pdb protein data bank 
PEG polyethylene glycol 
PET  polyethylene terephthalate 
Pi inorganic phosphate 
PI3K phosphoinositide 3 kinase 
pM picomolar 
PMSF phenylmethanesulphonylfluoride 
ppm parts per million 
QCM quartz crystal microbalance 
QM quantum mechanics 
Rab ras in the brain 
Raf-RBD rapidly accelerated fibrosarcoma Ras binding domain 
RalGDF ras-like protein 
Ran ras in the nucleus 
Rap receptor associated protein 
Rho ras homologous  
Rmsd root mean square deviation 
RPLC reversed phase liquid chromatography 
rpm rotations per minute 
RT room temperature 
RTK receptor tyrosine kinase 
S entropy (the variation is denoted DS) 
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s second 
SAM S-adenosyl methionine 
SDM site directed mutagenesis 
SDS-PAGE sodium dodecyl sulphate Polyacrylamide Gel Electrophoresis 
SEC size exclusion chromatography 
Shc src homology 
SOC super optimal broth with catabolite repression 
SOS Son of Sevenless 
SP sulphopropyl 
SPR surface Plasmon Resonance 
sw1 switch 1 
sw2 switch 2 
T temperature (the variation is denoted DT) 
T1  longitudinal relaxation 
TAE tris-acetate-EDTA 
TB terrific broth 
TBE tris-borate-EDTA 
TEMED tetramethylethylinediamine 
TFB transformation buffer 
Tris tris(hydroxymethil)aminomethane 
TROSY transverse relaxation optimized spectroscopy 
µM micromolar 
WT wild type 
Zn2+-BPA zinc-bisphenol acid 
Zn2+-cyclen zinc-cyclen 
 
 
 
 
Conventions: 
throughout this thesis, all the amino acid names are abbreviated either by their three letter code (e.g. Asp33) 
or by their single letter (D33). Both are often used interchangeably. The commonly used abbreviation for the 
switch 1 and switch 2 regions is switch 1 and switch 2, respectively. However, the equivalent abbreviations 
SW I and SW II were sometimes used in the captions of several Figures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Appendix 
 
286 
5.6   List of Publications 
 
M Spoerner, M Karl, P Lopes, M Hoering, K Loeffel, A Nuehs, J Adelsberger, W Kremer 
and H Kalbitzer. High pressure 31P NMR spectroscopy on guanine nucleotides. J Biomol 
NMR. 2017 61(1), pp 1-13. 
 
M Marques, D Gianolio, G Cibin, J Tomkinson, S Parker, R. Valero, P Lopes and L. 
Carvalho. A molecular view of cisplatin's mode of action: interplay with DNA bases and 
acquired resistance. Phys Chem Chem Phys. 2015 17(14), pp 5155-5171. 
 
I Rosnizeck, D Filchtinski, P Lopes, B Kieninger, C Herrmann, H Kalbitzer and M Spoerner. 
Elucidating the Mode of Action of a Typical Ras State 1(T) Inhibitor. Biochem. 2014 53(24), 
pp 3867-3878. 
 
P Lopes, M Marques, R Valero, J Tomkinson and L. Carvalho. Guanine: A Combined Study 
Using Vibrational Spectroscopy and Theoretical Methods. Spectrosc-INT J. 2012 5(27), pp 
273-292. 
 
C. Matos, L. Carvalho, P. Lopes and M Marques. New Strategies Against Prostate Cancer 
– Pt(II)-Based Chemotherapy. Curr Med Chem. 2012 19(27), pp 4678-4687. 
  
P Lopes, R Valero, J Tomkinson, M Marques and L Batista de Carvalho. Applying 
vibrational spectroscopy to the study of nucleobases – adenine as a case study. New J 
Chem. 2013 37(9), pp 2691-2699. 
 
 
 
 
  
6.  References 
 
 “It takes a long time to understand nothiing” 
Edward Dahlberg 
  
 
 
 
 
 
 
 
 
 
 
6. References 
 
289 
1. Harvey, J.J., An Unidentified Virus which causes the Rapid Production of Tumours 
in Mice. Nature, 1964. 204(4963): p. 1104-1105. 
2. Kirsten, W.H. and L.A. Mayer, Morphologic Responses to a Murine Erythroblastosis 
Virus2. JNCI: Journal of the National Cancer Institute, 1967. 39(2): p. 311-335. 
3. Shimizu, K., et al., Isolation and Preliminary Characterization of the Transforming 
Gene of a Human Neuroblastoma Cell Line. Proceedings of the National Academy 
of Sciences of the United States of America, 1983. 80(2): p. 383-387. 
4. Milroy, L.-G. and C. Ottmann, The Renaissance of Ras. ACS Chemical Biology, 
2014. 9(11): p. 2447-2458. 
5. Wittinghofer, A., Ras Superfamily Small G Proteins: Biology and Mechanisms 1: 
General Features, Signaling. 2014: Springer Vienna. 
6. Willumsen, B.M., et al., The p21 ras C-terminus is required for transformation and 
membrane association. Nature, 1984. 310(5978): p. 583-586. 
7. Ahearn, I.M., et al., Regulating the regulator: post-translational modification of RAS. 
Nat Rev Mol Cell Biol, 2012. 13(1): p. 39-51. 
8. Wang, M. and P.J. Casey, Protein prenylation: unique fats make their mark on 
biology. Nat Rev Mol Cell Biol, 2016. 17(2): p. 110-122. 
9. Shen, M., et al., Farnesyltransferase and geranylgeranyltransferase I: structures, 
mechanism, inhibitors and molecular modeling. Drug Discovery Today, 2015. 20(2): 
p. 267-276. 
10. de Vos, A.M., et al., Three-dimensional structure of an oncogene protein: catalytic 
domain of human c-H-ras p21. Science, 1988. 239(4842): p. 888. 
11. Pai, E.F., et al., Structure of the guanine-nucleotide-binding domain of the Ha-ras 
oncogene product p21 in the triphosphate conformation. Nature, 1989. 341(6239): 
p. 209-214. 
12. Pai, E., et al., Refined crystal structure of the triphosphate conformation of H-ras 
p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. Vol. 8. 
1990. 
13. Saraste, M., P.R. Sibbald, and A. Wittinghofer, The P-loop: a common motif in ATP- 
and GTP-binding proteins. Trends in Biochemical Sciences, 1990. 15(11): p. 430-
434. 
14. Vetter, I.R. and A. Wittinghofer, The Guanine Nucleotide-Binding Switch in Three 
Dimensions. Science, 2001. 294(5545): p. 1299. 
15. Wittinghofer, A. and H. Waldmann, Ras—A Molecular Switch Involved in Tumor 
Formation. Angewandte Chemie International Edition, 2000. 39(23): p. 4192-4214. 
16. Wittinghofer, A. and I.R. Vetter, Structure-Function Relationships of the G Domain, 
a Canonical Switch Motif. Annual Review of Biochemistry, 2011. 80(1): p. 943-971. 
6. References 
 
290 
17. Lu, S., et al., Drugging Ras GTPase: a comprehensive mechanistic and signaling 
structural view. Chemical Society Reviews, 2016. 45(18): p. 4929-4952. 
18. Maurer, T., et al., Small-molecule ligands bind to a distinct pocket in Ras and inhibit 
SOS-mediated nucleotide exchange activity. Proceedings of the National Academy 
of Sciences, 2012. 109(14): p. 5299-5304. 
19. Banerjee, A., et al., The disordered hypervariable region and the folded catalytic 
domain of oncogenic K-Ras4B partner in phospholipid binding. Current Opinion in 
Structural Biology, 2016. 36(Supplement C): p. 10-17. 
20. Chavan, Tanmay S., et al., High-Affinity Interaction of the K-Ras4B Hypervariable 
Region with the Ras Active Site. Biophysical Journal. 109(12): p. 2602-2613. 
21. Castellano, E. and E. Santos, Functional Specificity of Ras Isoforms: So Similar but 
So Different. Genes & Cancer, 2011. 2(3): p. 216-231. 
22. Hu, J.-S. and A.G. Redfield, Conformational and Dynamic Differences between N-
ras P21 Bound to GTPγS and to GMPPNP as Studied by NMR. Biochemistry, 1997. 
36(16): p. 5045-5052. 
23. Scheidig, A.J., C. Burmester, and R.S. Goody, The pre-hydrolysis state of p21ras in 
complex with GTP: new insights into the role of water molecules in the GTP 
hydrolysis reaction of ras-like proteins. Structure, 1999. 7(11): p. 1311-S2. 
24. Farnsworth, C.L. and L.A. Feig, Dominant inhibitory mutations in the Mg(2+)-binding 
site of RasH prevent its activation by GTP. Molecular and Cellular Biology, 1991. 
11(10): p. 4822-4829. 
25. Farrar, C.T., C.J. Halkides, and D.J. Singel, The frozen solution structure of p21 ras 
determined by ESEEM spectroscopy reveals weak coordination of Thr35 to the 
active site metal ion. Structure, 1997. 5(8): p. 1055-1066. 
26. Schweins, T., et al., The role of the metal ion in the p21ras catalysed GTP-
hydrolysis: Mn2+ versus Mg2+11Edited by K. Nagai. Journal of Molecular Biology, 
1997. 266(4): p. 847-856. 
27. Rudack, T., et al., The Role of Magnesium for Geometry and Charge in GTP 
Hydrolysis, Revealed by Quantum Mechanics/Molecular Mechanics Simulations. 
Biophysical Journal, 2011. 103(2): p. 293-302. 
28. Lu, S., et al., Ras Conformational Ensembles, Allostery, and Signaling. Chemical 
Reviews, 2016. 116(11): p. 6607-6665. 
29. Wittinghofer, A. and E.F. Pal, The structure of Ras protein: a model for a universal 
molecular switch. Trends in Biochemical Sciences, 1991. 16(Supplement C): p. 382-
387. 
30. Milburn, M.V., et al., Molecular switch for signal transduction: structural differences 
between active and inactive forms of protooncogenic ras proteins. Science, 1990. 
247(4945): p. 939. 
31. Bos, J.L., H. Rehmann, and A. Wittinghofer, GEFs and GAPs: Critical Elements in 
the Control of Small G Proteins. Cell, 2007. 129(5): p. 865-877. 
6. References 
 
291 
32. Rajalingam, K., et al., Ras oncogenes and their downstream targets. Biochimica et 
Biophysica Acta (BBA) - Molecular Cell Research, 2007. 1773(8): p. 1177-1195. 
33. Nakhaeizadeh, H., et al., The RAS-Effector Interface: Isoform-Specific Differences 
in the Effector Binding Regions. PLOS ONE, 2016. 11(12): p. e0167145. 
34. Takashima, A. and D.V. Faller, Targeting the RAS oncogene. Expert Opinion on 
Therapeutic Targets, 2013. 17(5): p. 507-531. 
35. Kolch, W., Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK 
pathway by protein interactions. Biochemical Journal, 2000. 351(2): p. 289. 
36. Lenzen, C., et al., Kinetic Analysis by Fluorescence of the Interaction between Ras 
and the Catalytic Domain of the Guanine Nucleotide Exchange Factor 
Cdc25Mm Biochemistry, 1998. 37(20): p. 7420-7430. 
37. Cherfils, J. and M. Zeghouf, Regulation of Small GTPases by GEFs, GAPs, and 
GDIs. Physiological Reviews, 2013. 93(1): p. 269. 
38. Hennig, A., et al., Ras activation revisited: role of GEF and GAP systems, in 
Biological Chemistry. 2015. p. 831. 
39. Cherfils, J. and P. Chardin, GEFs: structural basis for their activation of small GTP-
binding proteins. Trends in Biochemical Sciences, 1999. 24(8): p. 306-311. 
40. Chardin, P., et al., Human Sos1: a guanine nucleotide exchange factor for Ras that 
binds to GRB2. Science, 1993. 260(5112): p. 1338. 
41. Vo, U., et al., Monitoring Ras Interactions with the Nucleotide Exchange Factor Son 
of Sevenless (Sos) Using Site-specific NMR Reporter Signals and Intrinsic 
Fluorescence. Journal of Biological Chemistry, 2016. 291(4): p. 1703-1718. 
42. Li, N., et al., Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links 
receptor tyrosine kinases to Ras signalling. Nature, 1993. 363(6424): p. 85-88. 
43. Fam, N.P., et al., Cloning and characterization of Ras-GRF2, a novel guanine 
nucleotide exchange factor for Ras. Molecular and Cellular Biology, 1997. 17(3): p. 
1396-1406. 
44. Boriack-Sjodin, P.A., et al., The structural basis of the activation of Ras by Sos. 
Nature, 1998. 394(6691): p. 337-343. 
45. Margarit, S.M., et al., Structural Evidence for Feedback Activation by Ras·GTP of 
the Ras-Specific Nucleotide Exchange Factor SOS. Cell, 2003. 112(5): p. 685-695. 
46. Hall, B.E., et al., Structure-based Mutagenesis Reveals Distinct Functions for Ras 
Switch 1 and Switch 2 in Sos-catalyzed Guanine Nucleotide Exchange. Journal of 
Biological Chemistry, 2001. 276(29): p. 27629-27637. 
47. Marshall, C.J., Ras effectors. Current Opinion in Cell Biology, 1996. 8(2): p. 197-
204. 
48. McCormick, F. and A. Wittinghofer, Interactions between Ras proteins and their 
effectors. Current Opinion in Biotechnology, 1996. 7(4): p. 449-456. 
6. References 
 
292 
49. Vigil, D., et al., Ras superfamily GEFs and GAPs: validated and tractable targets for 
cancer therapy? Nat Rev Cancer, 2010. 10(12): p. 842-857. 
50. Koide, H., et al., GTP-dependent association of Raf-1 with Ha-Ras: identification of 
Raf as a target downstream of Ras in mammalian cells. Proceedings of the National 
Academy of Sciences, 1993. 90(18): p. 8683-8686. 
51. Spoerner, M., et al., Dynamic properties of the Ras switch I region and its 
importance for binding to effectors. Proceedings of the National Academy of 
Sciences, 2001. 98(9): p. 4944-4949. 
52. Herrmann, C., G.A. Martin, and A. Wittinghofer, Quantitative Analysis of the 
Complex between p21 and the Ras-binding Domain of the Human Raf-1 Protein 
Kinase. Journal of Biological Chemistry, 1995. 270(7): p. 2901-2905. 
53. Cutler, R.E., et al., Autoregulation of the Raf-1 serine/threonine kinase. Proceedings 
of the National Academy of Sciences of the United States of America, 1998. 95(16): 
p. 9214-9219. 
54. Hmitou, I., et al., Differential Regulation of B-Raf Isoforms by Phosphorylation and 
Autoinhibitory Mechanisms. Molecular and Cellular Biology, 2007. 27(1): p. 31-43. 
55. Roskoski, R., RAF protein-serine/threonine kinases: Structure and regulation. 
Biochemical and Biophysical Research Communications, 2010. 399(3): p. 313-317. 
56. Fischer, A., et al., B- and C-RAF Display Essential Differences in Their Binding to 
Ras: The Isotope Specific N Terminus OF B-RAF Facilitates Ras Binding. Journal 
of Biological Chemistry, 2007. 282(36): p. 26503-26516. 
57. Matallanas, D., et al., Raf Family Kinases: Old Dogs Have Learned New Tricks. 
Genes & Cancer, 2011. 2(3): p. 232-260. 
58. Filchtinski, D., et al., What Makes Ras an Efficient Molecular Switch: A 
Computational, Biophysical, and Structural Study of Ras-GDP Interactions with 
Mutants of Raf. Journal of Molecular Biology, 2010. 399(3): p. 422-435. 
59. Huang, L., et al., Three-dimensional structure of the Ras-interacting domain of 
RalGDS. Nat Struct Mol Biol, 1997. 4(8): p. 609-615. 
60. Nassar, N., et al., The 2.2 A crystal structure of the Ras-binding domain of the 
 serine/threonine kinase c-Raf1 in complex with RaplA and a GTP analogue. 
Nature, 1995. 375(6532): p. 554-560. 
61. Akasaka, K., et al., Differential Structural Requirements for Interaction of Ras 
Protein with Its Distinct Downstream Effectors. Journal of Biological Chemistry, 
1996. 271(10): p. 5353-5360. 
62. Winkler, D.G., et al., Identification and Characterization of Mutations in Ha-Ras That 
Selectively Decrease Binding to cRaf-1. Journal of Biological Chemistry, 1997. 
272(39): p. 24402-24409. 
63. Terada, T., et al., Nuclear magnetic resonance and molecular dynamics studies on 
the interactions of the ras-binding domain of raf-1 with wild-type and mutant ras 
6. References 
 
293 
proteins 11Edited by A. R. Fersht. Journal of Molecular Biology, 1999. 286(1): p. 
219-232. 
64. Fetics, Susan K., et al., Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-
RBD. Structure, 2015. 23(3): p. 505-516. 
65. Gohlke, H., L.A. Kuhn, and D.A. Case, Change in protein flexibility upon complex 
formation: Analysis of Ras-Raf using molecular dynamics and a molecular 
framework approach. Proteins: Structure, Function, and Bioinformatics, 2004. 56(2): 
p. 322-337. 
66. Gohlke, H., C. Kiel, and D.A. Case, Insights into Protein–Protein Binding by Binding 
Free Energy Calculation and Free Energy Decomposition for the Ras–Raf and Ras–
RalGDS Complexes. Journal of Molecular Biology, 2003. 330(4): p. 891-913. 
67. Spoerner, M., et al., Conformational States of Human Rat Sarcoma (Ras) Protein 
Complexed with Its Natural Ligand GTP and Their Role for Effector Interaction and 
GTP Hydrolysis. Journal of Biological Chemistry, 2010. 285(51): p. 39768-39778. 
68. Gorman, C., et al., Equilibrium and Kinetic Measurements Reveal Rapidly 
Reversible Binding of Ras to Raf. Journal of Biological Chemistry, 1996. 271(12): p. 
6713-6719. 
69. Sydor, J.R., et al., Transient Kinetic Studies on the Interaction of Ras and the Ras-
Binding Domain of c-Raf-1 Reveal Rapid Equilibration of the Complex. 
Biochemistry, 1998. 37(40): p. 14292-14299. 
70. Goldfinger, L.E., Choose your own path: specificity in Ras GTPase signaling. 
Molecular BioSystems, 2008. 4(4): p. 293-299. 
71. Hekman, M., et al., Novel C-Raf phosphorylation sites: serine 296 and 301 
participate in Raf regulation. FEBS Letters, 2005. 579(2): p. 464-468. 
72. Schweins, T., et al., Substrate-assisted catalysis as a mechanism for GTP 
hydrolysis of p21ras and other GTP-binding proteins. Nat Struct Mol Biol, 1995. 2(1): 
p. 36-44. 
73. Wittinghofer, A., K. Scheffzek, and M.R. Ahmadian, The interaction of Ras with 
GTPase-activating proteins. FEBS Letters, 1997. 410(1): p. 63-67. 
74. Matte, A., L.W. Tari, and L.T.J. Delbaere, How do kinases transfer phosphoryl 
groups? Structure, 1998. 6(4): p. 413-419. 
75. Wittinghofer, A., Phosphoryl transfer in Ras proteins, conclusive or elusive? Trends 
in Biochemical Sciences, 2006. 31(1): p. 20-23. 
76. Lassila, J.K., J.G. Zalatan, and D. Herschlag, Biological Phosphoryl-Transfer 
Reactions: Understanding Mechanism and Catalysis. Annual Review of 
Biochemistry, 2011. 80(1): p. 669-702. 
77. Maegley, K.A., S.J. Admiraal, and D. Herschlag, Ras-catalyzed hydrolysis of GTP: 
a new perspective from model studies. Proceedings of the National Academy of 
Sciences of the United States of America, 1996. 93(16): p. 8160-8166. 
6. References 
 
294 
78. Shutes, A. and C.J. Der, Real‐Time In Vitro Measurement of Intrinsic and Ras GAP‐
Mediated GTP Hydrolysis, in Methods in Enzymology. 2006, Academic Press. p. 9-
22. 
79. Rensland, H., et al., Is there a rate-limiting step before GTP cleavage by H-ras p21? 
Biochemistry, 1991. 30(46): p. 11181-11185. 
80. Wittinghofer, A., Signaling mechanistics: Aluminum fluoride for molecule of the year. 
Current Biology, 1997. 7(11): p. R682-R685. 
81. Sternweis, P.C. and A.G. Gilman, Aluminum: a requirement for activation of the 
regulatory component of adenylate cyclase by fluoride. Proceedings of the National 
Academy of Sciences of the United States of America, 1982. 79(16): p. 4888-4891. 
82. Graham, D.L., et al., MgF3− as a Transition State Analog of Phosphoryl Transfer. 
Chemistry & Biology, 2002. 9(3): p. 375-381. 
83. Scheffzek, K., et al., The Ras-RasGAP Complex: Structural Basis for GTPase 
Activation and Its Loss in Oncogenic Ras Mutants. Science, 1997. 277(5324): p. 
333. 
84. Rudack, T., et al., Ras and GTPase-activating protein (GAP) drive GTP into a 
precatalytic state as revealed by combining FTIR and biomolecular simulations. 
Proceedings of the National Academy of Sciences, 2012. 109(38): p. 15295-15300. 
85. Kötting, C., et al., The GAP arginine finger movement into the catalytic site of Ras 
increases the activation entropy. Proceedings of the National Academy of Sciences 
of the United States of America, 2008. 105(17): p. 6260-6265. 
86. Miao, W., et al., p120 Ras GTPase-activating Protein Interacts with Ras-GTP 
through Specific Conserved Residues. Journal of Biological Chemistry, 1996. 
271(26): p. 15322-15329. 
87. Glennon, T.M., J. Villà, and A. Warshel, How Does GAP Catalyze the GTPase 
Reaction of Ras?:  A Computer Simulation Study. Biochemistry, 2000. 39(32): p. 
9641-9651. 
88. Sharma, N., U. Sonavane, and R. Joshi, Probing the wild-type HRas activation 
mechanism using steered molecular dynamics, understanding the energy barrier 
and role of water in the activation. European Biophysics Journal, 2014. 43(2): p. 81-
95. 
89. Lu, S., et al., The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in 
Small GTPase K-Ras4B. 2016. 6: p. 21949. 
90. Scrima, A., et al., The Rap–RapGAP complex: GTP hydrolysis without catalytic 
glutamine and arginine residues. The EMBO Journal, 2008. 27(7): p. 1145-1153. 
91. Seewald, M.J., et al., RanGAP mediates GTP hydrolysis without an arginine finger. 
Nature, 2002. 415(6872): p. 662-666. 
92. Kraulis, P.J., et al., Solution Structure and Dynamics of Ras p21.cntdot.GDP 
Determined by Heteronuclear Three- and Four-Dimensional NMR Spectroscopy. 
Biochemistry, 1994. 33(12): p. 3515-3531. 
6. References 
 
295 
93. Trahey, M. and F. McCormick, A cytoplasmic protein stimulates normal N-ras p21 
GTPase, but does not affect oncogenic mutants. Science, 1987. 238(4826): p. 542. 
94. Ito, Y., et al., Regional Polysterism in the GTP-Bound Form of the Human c-Ha-Ras 
Protein. Biochemistry, 1997. 36(30): p. 9109-9119. 
95. Araki, M., et al., Solution Structure of the State 1 Conformer of GTP-bound H-Ras 
Protein and Distinct Dynamic Properties between the State 1 and State 2 
Conformers. Journal of Biological Chemistry, 2011. 286(45): p. 39644-39653. 
96. Acharya, K.R. and M.D. Lloyd, The advantages and limitations of protein crystal 
structures. Trends in Pharmacological Sciences, 2005. 26(1): p. 10-14. 
97. Kigawa, T., et al., Selenomethionine incorporation into a protein by cell-free 
synthesis. Journal of Structural and Functional Genomics, 2002. 2(1): p. 29-35. 
98. Wenye, Z., et al., Direct Targeting of the Ras GTPase Superfamily Through 
Structure- Based Design. Current Topics in Medicinal Chemistry, 2017. 17(1): p. 16-
29. 
99. Lang, P.T., et al., Automated electron-density sampling reveals widespread 
conformational polymorphism in proteins. Protein Science, 2010. 19(7): p. 1420-
1431. 
100. Prior, I.A., P.D. Lewis, and C. Mattos, A comprehensive survey of Ras mutations in 
cancer. Cancer Research, 2012. 72(10): p. 2457-2467. 
101. Forbes, S.A., et al., COSMIC: mining complete cancer genomes in the Catalogue of 
Somatic Mutations in Cancer. Nucleic Acids Research, 2011. 39(suppl_1): p. D945-
D950. 
102. Karnoub, A.E. and R.A. Weinberg, Ras oncogenes: split personalities. Nat Rev Mol 
Cell Biol, 2008. 9(7): p. 517-531. 
103. Almoguera, C., et al., Most human carcinomas of the exocrine pancreas contain 
mutant c-K-RAS genes. Vol. 53. 1988. 549-54. 
104. Burmer, G.C. and L.A. Loeb, Mutations in the KRAS2 oncogene during progressive 
stages of human colon carcinoma. Proceedings of the National Academy of 
Sciences, 1989. 86(7): p. 2403-2407. 
105. Enomoto, T., et al., K-ras activation in neoplasms of the human female reproductive 
Tract. Cancer Research, 1990. 50(19): p. 6139. 
106. Zhou, B., C.J. Der, and A.D. Cox, The role of wild type RAS isoforms in cancer. 
Seminars in Cell & Developmental Biology, 2016. 58(Supplement C): p. 60-69. 
107. Kiel, C. and L. Serrano, Structure‐energy‐based predictions and network modelling 
of RASopathy and cancer missense mutations. Molecular Systems Biology, 2014. 
10(5): p. 727. 
108. Eccleston, J.F., et al., Kinetics of interaction between normal and proline 12 Ras 
and the GTPase-activating proteins, p120-GAP and neurofibromin. The significance 
6. References 
 
296 
of the intrinsic GTPase rate in determining the transforming ability of ras. Journal of 
Biological Chemistry, 1993. 268(36): p. 27012-27019. 
109. Gremer, L., et al., Fluoride complexes of oncogenic Ras mutants to study the Ras-
RasGAP interaction, in Biological Chemistry. 2008. p. 1163. 
110. White, M.A., et al., Multiple ras functions can contribute to mammalian cell 
transformation. Cell, 1995. 80(4): p. 533-541. 
111. Khosravi-Far, R., et al., Oncogenic Ras activation of Raf/mitogen-activated protein 
kinase-independent pathways is sufficient to cause tumorigenic transformation. 
Molecular and Cellular Biology, 1996. 16(7): p. 3923-3933. 
112. Joneson, T., et al., Stimulation of Membrane Ruffling and MAP Kinase Activation by 
Distinct Effectors of RAS. Science, 1996. 271(5250): p. 810. 
113. Fiordalisi, J.J., et al., A distinct class of dominant negative Ras mutants: cytosolic 
GTP-bound Ras effector domain mutants that inhibit Ras signaling and 
transformation and enhance cell adhesion. Journal of Biological Chemistry, 2002. 
277(13): p. 10813-10823. 
114. Jacobsen, N.E., Interpretation of Proton (1H) NMR Spectra, in NMR Spectroscopy 
Explained. 2007, John Wiley & Sons, Inc. p. 39-73. 
115. Jacobsen, N.E., Fundamentals of NMR Spectroscopy in Liquids, in NMR 
Spectroscopy Explained. 2007, John Wiley & Sons, Inc. p. 1-38. 
116. Spoerner, M., et al., Conformational States of Ras Complexed with the GTP 
Analogue GppNHp or GppCH2p:  Implications for the Interaction with Effector 
Proteins. Biochemistry, 2005. 44(6): p. 2225-2236. 
117. Geyer, M., et al., Conformational Transitions in p21ras and in Its Complexes with 
the Effector Protein Raf-RBD and the GTPase Activating Protein GAP. 
Biochemistry, 1996. 35(32): p. 10308-10320. 
118. Stumber, M., et al., Observation of Slow Dynamic Exchange Processes in Ras 
Protein Crystals by 31P Solid State NMR Spectroscopy. Journal of Molecular 
Biology, 2002. 323(5): p. 899-907. 
119. Iuga, A., et al., Solid-state 31P NMR Spectroscopy of Microcrystals of the Ras 
Protein and its Effector Loop Mutants: Comparison Between Crystalline and 
Solution State. Journal of Molecular Biology, 2004. 342(3): p. 1033-1040. 
120. Ader, C., et al., Solid-State 31P NMR Spectroscopy of Precipitated Guanine 
Nucleotide-Binding Protein Ras in Complexes with Its Effector Molecules Raf Kinase 
and RalGDS. The Journal of Physical Chemistry B, 2007. 111(10): p. 2752-2757. 
121. Geyer, M., et al., Structure of the Ras-binding domain of RalGEF and implications 
for Ras binding and signalling. Nat Struct Mol Biol, 1997. 4(9): p. 694-699. 
122. Spoerner, M., et al., Conformational states of human H-Ras detected by high-field 
EPR, ENDOR, and 31P NMR spectroscopy. Magnetic Resonance in Chemistry, 
2005. 43(S1): p. S74-S83. 
6. References 
 
297 
123. Spoerner, M., A. Wittinghofer, and H.R. Kalbitzer, Perturbation of the conformational 
equilibria in Ras by selective mutations as studied by 31P NMR spectroscopy. FEBS 
Letters, 2004. 578(3): p. 305-310. 
124. Spoerner, M., et al., Slow conformational dynamics of the guanine nucleotide-
binding protein Ras complexed with the GTP analogue GTPγS. FEBS Journal, 
2007. 274(6): p. 1419-1433. 
125. Kalbitzer, H.R., et al., Fundamental Link between Folding States and Functional 
States of Proteins. Journal of the American Chemical Society, 2009. 131(46): p. 
16714-16719. 
126. Digilio, M.C., et al., RASopathies: Clinical Diagnosis in the First Year of Life. 
Molecular Syndromology, 2011. 1(6): p. 282-289. 
127. Gremer, L., et al., Germline KRAS Mutations Cause Aberrant Biochemical and 
Physical Properties Leading to Developmental Disorders. Human mutation, 2011. 
32(1): p. 33-43. 
128. Tartaglia, M., G. Zampino, and B.D. Gelb, Noonan Syndrome: Clinical Aspects and 
Molecular Pathogenesis. Molecular Syndromology, 2010. 1(1): p. 2-26. 
129. Tidyman, W.E. and K.A. Rauen, The RASopathies: developmental syndromes of 
Ras/MAPK pathway dysregulation. Current Opinion in Genetics & Development, 
2009. 19(3): p. 230-236. 
130. Tidyman, W.E. and K.A. Rauen, Noonan, Costello and cardio–facio–cutaneous 
syndromes: dysregulation of the Ras–MAPK pathway. Expert Reviews in Molecular 
Medicine, 2008. 10. 
131. Fernández-Medarde, A. and E. Santos, Ras in Cancer and Developmental 
Diseases. Genes & Cancer, 2011. 2(3): p. 344-358. 
132. Schubbert, S., K. Shannon, and G. Bollag, Hyperactive Ras in developmental 
disorders and cancer. 2007. 7: p. 295. 
133. Cox, A.D., et al., Drugging the undruggable RAS: Mission Possible? 2014. 13: p. 
828. 
134. Zhang, F. and J.K. Cheong, The renewed battle against RAS-mutant cancers. 
Cellular and Molecular Life Sciences, 2016. 73(9): p. 1845-1858. 
135. Brock, E.J., et al., How to Target Activated Ras Proteins: Direct Inhibition vs. 
Induced Mislocalization. Mini reviews in medicinal chemistry, 2016. 16(5): p. 358-
369. 
136. Wang, W., G. Fang, and J. Rudolph, Ras inhibition via direct Ras binding—is there 
a path forward? Bioorganic & Medicinal Chemistry Letters, 2012. 22(18): p. 5766-
5776. 
137. Cromm, P.M., et al., Direct Modulation of Small GTPase Activity and Function. 
Angewandte Chemie International Edition, 2015. 54(46): p. 13516-13537. 
6. References 
 
298 
138. Liu, M., et al., Antitumor Activity of SCH 66336, an Orally Bioavailable Tricyclic 
Inhibitor of Farnesyl Protein Transferase, in Human Tumor Xenograft Models and 
Transgenic Mice. Cancer Research, 1998. 58(21): p. 4947. 
139. End, D.W., et al., Characterization of the Antitumor Effects of the Selective Farnesyl 
Protein Transferase Inhibitor R115777 &lt;em&gt;in Vivo&lt;/em&gt; and 
&lt;em&gt;in Vitro&lt;/em&gt. Cancer Research, 2001. 61(1): p. 131. 
140. Rotblat, B., et al., The Ras Inhibitor Farnesylthiosalicylic Acid (Salirasib) Disrupts 
The Spatiotemporal Localization Of Active Ras: A Potential Treatment For Cancer, 
in Methods in Enzymology. 2008, Academic Press. p. 467-489. 
141. Laheru, D., et al., Integrated preclinical and clinical development of S-trans, trans-
farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer. Investigational New 
Drugs, 2012. 30(6): p. 2391-2399. 
142. Berndt, N., A.D. Hamilton, and S.M. Sebti, Targeting protein prenylation for cancer 
therapy. 2011. 11: p. 775. 
143. James, G.L., J.L. Goldstein, and M.S. Brown, Polylysine and CVIM Sequences of 
K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine 
Peptidomimetic in Vitro. Journal of Biological Chemistry, 1995. 270(11): p. 6221-
6226. 
144. Patgiri, A., et al., An Orthosteric Inhibitor of the Ras-Sos Interaction. Nature chemical 
biology, 2011. 7(9): p. 585-587. 
145. Sun, Q., et al., Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-
Mediated Activation. Angewandte Chemie, 2012. 124(25): p. 6244-6247. 
146. Herrmann, C., et al., Sulindac Sulfide inhibits Ras signaling. Vol. 17. 1998. 1769-76. 
147. Waldmann, H., et al., Sulindac-Derived Ras Pathway Inhibitors Target the Ras–Raf 
Interaction and Downstream Effectors in the Ras Pathway. Angewandte Chemie 
International Edition, 2004. 43(4): p. 454-458. 
148. Karaguni, I.-M., et al., The New Sulindac Derivative IND 12 Reverses Ras-induced 
Cell Transformation. Cancer Research, 2002. 62(6): p. 1718. 
149. Ostrem, J.M., et al., K-Ras(G12C) inhibitors allosterically control GTP affinity and 
effector interactions. Nature, 2013. 503(7477): p. 548-551. 
150. Lim, S.M., et al., Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic 
Site Inhibitor. Angewandte Chemie (International ed. in English), 2014. 53(1): p. 
199-204. 
151. Hunter, J.C., et al., In situ selectivity profiling and crystal structure of SML-8-73-1, 
an active site inhibitor of oncogenic K-Ras G12C. Proceedings of the National 
Academy of Sciences, 2014. 111(24): p. 8895-8900. 
152. Herrero, A., et al., Small Molecule Inhibition of ERK Dimerization Prevents 
Tumorigenesis by RAS-ERK Pathway Oncogenes. Cancer Cell, 2015. 28(2): p. 170-
182. 
6. References 
 
299 
153. Freeman, Alyson K., Daniel A. Ritt, and Deborah K. Morrison, Effects of Raf 
Dimerization and Its Inhibition on Normal and Disease-Associated Raf Signaling. 
Molecular Cell. 49(4): p. 751-758. 
154. Yao, Z., et al., BRAF Mutants Evade ERK-Dependent Feedback by Different 
Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition. Cancer 
Cell, 2015. 28(3): p. 370-383. 
155. Spoerner, M., et al., A novel mechanism for the modulation of the Ras-effector 
interaction by small molecules. Biochemical and Biophysical Research 
Communications, 2005. 334(2): p. 709-713. 
156. Rosnizeck, I.C., et al., Elucidating the Mode of Action of a Typical Ras State 1(T) 
Inhibitor. Biochemistry, 2014. 53(24): p. 3867-3878. 
157. Rosnizeck, I.C., et al., Stabilizing a Weak Binding State for Effectors in the Human 
Ras Protein by Cyclen Complexes. Angewandte Chemie International Edition, 2010. 
49(22): p. 3830-3833. 
158. Rosnizeck, I.C., et al., Metal–Bis(2-picolyl)amine Complexes as State 1(T) Inhibitors 
of Activated Ras Protein. Angewandte Chemie International Edition, 2012. 51(42): 
p. 10647-10651. 
159. Silva, J.L., et al., High-Pressure Chemical Biology and Biotechnology. Chemical 
Reviews, 2014. 114(14): p. 7239-7267. 
160. Onuchic, J.N., Z. Luthey-Schulten, and P.G. Wolynes, Theory of Protein Folding: 
The Energy Landscape Perspective. Annual Review of Physical Chemistry, 1997. 
48(1): p. 545-600. 
161. Frauenfelder, H. and P.G. Wolynes, Rate theories and puzzles of hemeprotein 
kinetics. Science, 1985. 229(4711): p. 337. 
162. Monod, J., J. Wyman, and J.-P. Changeux, On the nature of allosteric transitions: A 
plausible model. Journal of Molecular Biology, 1965. 12(1): p. 88-118. 
163. Akasaka, K., Probing Conformational Fluctuation of Proteins by Pressure 
Perturbation. Chemical Reviews, 2006. 106(5): p. 1814-1835. 
164. de Oliveira, G.A.P. and J.L. Silva, A hypothesis to reconcile the physical and 
chemical unfolding of proteins. Proceedings of the National Academy of Sciences, 
2015. 112(21): p. E2775-E2784. 
165. Kitahara, R., et al., Pressure-induced chemical shifts as probes for conformational 
fluctuations in proteins. Progress in Nuclear Magnetic Resonance Spectroscopy, 
2013. 71(Supplement C): p. 35-58. 
166. Akasaka, K., High Pressure Bioscience – Basic Concepts, Applications and 
Frontiers. 2015. 
167. Akasaka, K., Exploring the entire conformational space of proteins by high-pressure 
NMR, in Pure and Applied Chemistry. 2003. p. 927. 
6. References 
 
300 
168. Munte, C.E., et al., Distinct Conformational States of the Alzheimer β-Amyloid 
Peptide Can Be Detected by High-Pressure NMR Spectroscopy. Angewandte 
Chemie International Edition, 2013. 52(34): p. 8943-8947. 
169. Kalbitzer, H.R., et al., 15N and 1H NMR study of histidine containing protein (HPr) 
from Staphylococcus carnosus at high pressure. Protein Science : A Publication of 
the Protein Society, 2000. 9(4): p. 693-703. 
170. Kachel, N., et al., Observation of intermediate states of the human prion protein by 
high pressure NMR spectroscopy. BMC Structural Biology, 2006. 6(1): p. 16. 
171. Kalbitzer, H.R., et al., Intrinsic Allosteric Inhibition of Signaling Proteins by Targeting 
Rare Interaction States Detected by High-Pressure NMR Spectroscopy. 
Angewandte Chemie International Edition, 2013. 52(52): p. 14242-14246. 
172. Kremer, W., et al., Pulsed Pressure Perturbations, an Extra Dimension in NMR 
Spectroscopy of Proteins. Journal of the American Chemical Society, 2011. 133(34): 
p. 13646-13651. 
173. Itié, J.P., et al., Crystallography under high pressure using synchrotron radiation. 
Journal of Physics D: Applied Physics, 2015. 48(50): p. 504007. 
174. Jannasch, H.W. and C.D. Taylor, Deep-Sea Microbiology. Annual Review of 
Microbiology, 1984. 38(1): p. 487-487. 
175. Fourme, R., et al., Advances in High-Pressure Biophysics: Status and Prospects of 
Macromolecular Crystallography. Annual Review of Biophysics, 2009. 38(1): p. 153-
171. 
176. Kundrot, C.E. and F.M. Richards, Collection and processing of X-ray diffraction data 
from protein crystals at high pressure. Journal of Applied Crystallography, 1986. 
19(4): p. 208-213. 
177. Katrusiak, A. and Z. Dauter, Compressibility of lysozyme protein crystals by X-ray 
diffraction. Acta Crystallographica Section D, 1996. 52(3): p. 607-608. 
178. Girard, E., et al., Macromolecular crystallography at high pressure with pneumatic 
diamond anvil cells handled by a six-axis robotic arm. Journal of Applied 
Crystallography, 2010. 43(4): p. 762-768. 
179. Girard, E., et al., The First Crystal Structure of a Macromolecular Assembly under 
High Pressure: CpMV at 330 MPa. Biophysical Journal, 2005. 88(5): p. 3562-3571. 
180. Girard, E., et al., Structure-Function Perturbation and Dissociation of Tetrameric 
Urate Oxidase by High Hydrostatic Pressure. Biophysical Journal, 2010. 98(10): p. 
2365-2373. 
181. Kurpiewska, K., et al., Structural investigation of ribonuclease A conformational 
preferences using high pressure protein crystallography. Chemical Physics, 2016. 
468(Supplement C): p. 53-62. 
182. Girard, E., et al., Toward fully fledged high-pressure macromolecular 
crystallography. Journal of Applied Crystallography, 2007. 40(5): p. 912-918. 
6. References 
 
301 
183. Collins, M.D., C.U. Kim, and S.M. Gruner, High-Pressure Protein Crystallography 
and NMR to Explore Protein Conformations. Annual Review of Biophysics, 2011. 
40(1): p. 81-98. 
184. Fourme, R., et al., Using a quasi-parallel X-ray beam of ultrashort wavelength for 
high-pressure virus crystallography: implications for standard macromolecular 
crystallography. Acta Crystallographica Section D, 2003. 59(10): p. 1767-1772. 
185. Fourme, R., et al., High-Pressure Macromolecular Crystallography (HPMX): Status 
and prospects. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 
2006. 1764(3): p. 384-390. 
186. Losen, M., et al., Effect of Oxygen Limitation and Medium Composition on 
Escherichia coli Fermentation in Shake-Flask Cultures. Biotechnology Progress, 
2004. 20(4): p. 1062-1068. 
187. Ehrenberg, M., H. Bremer, and P.P. Dennis, Medium-dependent control of the 
bacterial growth rate. Biochimie, 2013. 95(4): p. 643-658. 
188. Egli, T., Microbial growth and physiology: a call for better craftsmanship. Frontiers 
in Microbiology, 2015. 6: p. 287. 
189. Tao, H., et al., Functional Genomics: Expression Analysis of Escherichia coli 
Growing on Minimal and Rich Media. Journal of Bacteriology, 1999. 181(20): p. 
6425-6440. 
190. Madigan, M.T., Brock biology of microorganisms. 2012. 
191. Dagert, M. and S.D. Ehrlich, Prolonged incubation in calcium chloride improves the 
competence of Escherichia coli cells. Gene, 1979. 6(1): p. 23-28. 
192. Hanahan, D., Studies on transformation of Escherichia coli with plasmids. Journal 
of Molecular Biology, 1983. 166(4): p. 557-580. 
193. Promega Miniprep  Quick Protocol. 2017  [cited 2017 20 September]; Available from: 
https://www.promega.com/-/media/files/resources/protcards/pureyield-plasmid-
miniprep-system-quick-protocol.pdf. 
194. Promega Midiprep Quick Protocol. 2017  [cited 2017 20 June]; Available from: 
https://www.promega.com/-/media/files/resources/protcards/pureyield-plasmid-
midiprep-system-quick-protocol.pdf. 
195. Tucker, J., et al., Expression of p21 proteins in Escherichia coli and stereochemistry 
of the nucleotide-binding site. The EMBO Journal, 1986. 5(6): p. 1351-1358. 
196. McCracken, G.H., J.D. Nelson, and M.L. Thomas, Discrepancy Between 
Carbenicillin and Ampicillin Activities Against Enterococci and Listeria. Antimicrobial 
Agents and Chemotherapy, 1973. 3(3): p. 343-349. 
197. Jacobsen, N.E., NMR spectroscopy explained : simplified theory, applications and 
examples for organic chemistry and structural biology. 2007, Hoboken, N.J.: Wiley-
Interscience. 
6. References 
 
302 
198. Sivashanmugam, A., et al., Practical protocols for production of very high yields of 
recombinant proteins using Escherichia coli. Protein Science, 2009. 18(5): p. 936-
948. 
199. Invitrogen. GENEART Site-Directed Mutagenesis User Guide. 2017  [cited 2017 2 
Jully]; Available from: 
https://tools.thermofisher.com/content/sfs/manuals/geneart_site_directed_mutagene
sis_man.pdf. 
200. Alcalde, M., Mutagenesis Protocols in Saccharomyces cerevisiae by In Vivo Overlap 
Extension, in In Vitro Mutagenesis Protocols: Third Edition, J. Braman, Editor. 2010, 
Humana Press: Totowa, NJ. p. 3-14. 
201. Singh, A., et al., Protein recovery from inclusion bodies of Escherichia coli using 
mild solubilization process. Microbial Cell Factories, 2015. 14: p. 41. 
202. James, G.T., Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in 
buffers. Analytical Biochemistry, 1978. 86(2): p. 574-579. 
203. Cleland, W.W., Dithiothreitol, a New Protective Reagent for SH Groups*. 
Biochemistry, 1964. 3(4): p. 480-482. 
204. Repaske, R., Lysis of gram-negative bacteria by lysozyme. Biochimica et 
Biophysica Acta, 1956. 22(1): p. 189-191. 
205. Linke, D., Chapter 34 Detergents: An Overview. Methods in Enzymology, 2009. 463: 
p. 603-617. 
206. Ninfa, A.J., D.P. Ballou, and M. Benore, Fundamental Laboratory Approaches for 
Biochemistry and Biotechnology. 2009: Wiley. 
207. Arakawa, T. and S.N. Timasheff, Mechanism of protein salting in and salting out by 
divalent cation salts: balance between hydration and salt binding. Biochemistry, 
1984. 23(25): p. 5912-5923. 
208. Wingfield, P.T., Protein Precipitation Using Ammonium Sulfate. Current protocols in 
protein science / editorial board, John E. Coligan ... [et al.], 2001. APPENDIX 3: p. 
Appendix-3F. 
209. Zhang, Y. and P.S. Cremer, Interactions between macromolecules and ions: the 
Hofmeister series. Current Opinion in Chemical Biology, 2006. 10(6): p. 658-663. 
210. Nes, W.D., Protein Purification:  Principles, High-Resolution Methods, and 
Applications. Second Edition Edited by Jan-Christer Janson and Lars Rydén 
(Uppsala University). John Wiley & Sons:  New York. 1988. 695 pp. ISBN 0-471-
18626-0. Journal of the American Chemical Society, 1999. 121(7): p. 1625-1625. 
211. Boardman, N.K. and S.M. Partridge, Separation of neutral proteins on ion-exchange 
resins. Biochemical Journal, 1955. 59(4): p. 543. 
212. Healthcare, G. 2017  [cited 2017 27 June]; Available from: 
http://www.gelifesciences.com/webapp/wcs/stores/servlet/catalog/en/GELifeScienc
es-de/products/AlternativeProductStructure_17442/. 
6. References 
 
303 
213. Scheffzek, K., et al., Crystal structure of the GTPase-activating domain of human 
p120GAP and implications for the interaction with Ras. Nature, 1996. 384(6609): p. 
591-596. 
214. Laemmli, U.K., Cleavage of Structural Proteins during the Assembly of the Head of 
Bacteriophage T4. Nature, 1970. 227(5259): p. 680-685. 
215. Schägger, H. and G. von Jagow, Tricine-sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis for the separation of proteins in the range from 1 to 100 kDa. 
Analytical Biochemistry, 1987. 166(2): p. 368-379. 
216. Gasteiger, E., et al., Protein Identification and Analysis Tools on the ExPASy Server, 
in The Proteomics Protocols Handbook, J.M. Walker, Editor. 2005, Humana Press: 
Totowa, NJ. p. 571-607. 
217. Hoffman, N.E. and J.C. Liao, Reversed phase high performance liquid 
chromatographic separations of nucleotides in the presence of solvophobic ions. 
Analytical Chemistry, 1977. 49(14): p. 2231-2234. 
218. Martin L, Schwarz S, and Breitsprecher D, Analyzing Thermal Unfolding of Proteins: 
The Prometheus NT.48. Application Note NT-PR-001, N. Technologies, Editor. 
2014. 
219. Martin, L., M. Maschberger, and D. Breitsprecher, Thermal Unfolding of Antibodies 
with the Prometheus NT.48, N. Technologies, Editor. 2015. p. 1. 
220. Senisterra, G., I. Chau, and M. Vedadi, Thermal Denaturation Assays in Chemical 
Biology. ASSAY and Drug Development Technologies, 2011. 10(2): p. 128-136. 
221. Jerabek-Willemsen, M., et al., Molecular Interaction Studies Using Microscale 
Thermophoresis. Assay and Drug Development Technologies, 2011. 9(4): p. 342-
353. 
222. Renaud, J.-P., et al., Biophysics in drug discovery: impact, challenges and 
opportunities. Nat Rev Drug Discov, 2016. 15(10): p. 679-698. 
223. Falconer, R.J., Applications of isothermal titration calorimetry – the research and 
technical developments from 2011 to 2015. Journal of Molecular Recognition, 2016. 
29(10): p. 504-515. 
224. Khalef, N., O. Campanella, and A. Bakri, Isothermal calorimetry: methods and 
applications in food and pharmaceutical fields. Current Opinion in Food Science, 
2016. 9(Supplement C): p. 70-76. 
225. Freyer, M.W. and E.A. Lewis, Isothermal Titration Calorimetry: Experimental 
Design, Data Analysis, and Probing Macromolecule/Ligand Binding and Kinetic 
Interactions. Methods in Cell Biology, 2008. 84: p. 79-113. 
226. Spoerner, M., et al., High pressure 31P NMR spectroscopy on guanine nucleotides. 
Journal of Biomolecular NMR, 2016: p. 1-13. 
227. Raiford, D.S., C.L. Fisk, and E.D. Becker, Calibration of methanol and ethylene 
glycol nuclear magnetic resonance thermometers. Analytical Chemistry, 1979. 
51(12): p. 2050-2051. 
6. References 
 
304 
228. Shaka, A.J., P.B. Barker, and R. Freeman, Computer-optimized decoupling scheme 
for wideband applications and low-level operation. Journal of Magnetic Resonance 
(1969), 1985. 64(3): p. 547-552. 
229. Erlach, M.B., et al., Ceramic cells for high pressure NMR spectroscopy of proteins. 
Journal of Magnetic Resonance, 2010. 204(2): p. 196-199. 
230. Wishart, D.S., et al., 1H, 13C and 15N chemical shift referencing in biomolecular 
NMR. Journal of Biomolecular NMR, 1995. 6(2): p. 135-140. 
231. Baskaran, K., et al., Chemical shift optimization in multidimensional NMR spectra 
by AUREMOL-SHIFTOPT. Journal of Biomolecular NMR, 2009. 43(4): p. 197-210. 
232. Maurer, T. and H.R. Kalbitzer, Indirect Referencing of31P and19F NMR Spectra. 
Journal of Magnetic Resonance, Series B, 1996. 113(2): p. 177-178. 
233. Levenberg, K., A method for the solution of certain non-linear problems in least 
squares. Quarterly of Applied Mathematics, 1944. 2(2): p. 164-168. 
234. Marquardt, D., An Algorithm for Least-Squares Estimation of Nonlinear Parameters. 
Journal of the Society for Industrial and Applied Mathematics, 1963. 11(2): p. 431-
441. 
235. Hausser, K.H. and H.R. Kalbitzer, NMR in medicine and biology: structure 
determination, tomography, in vivo spectroscopy. Physics in life sciences. 1991: 
Springer-Verlag. 
236. Hill, A.V., The possible effects of the aggregation of the molecules of hemoglobin 
on its dissociation curves. The Journal of Physiology\, 1910. 40}: p. i--vii\. 
237. Goutelle, S., et al., The Hill equation: a review of its capabilities in pharmacological 
modelling. Fundamental & Clinical Pharmacology, 2008. 22(6): p. 633-648. 
238. Fourme, R., et al., High-pressure protein crystallography (HPPX): instrumentation, 
methodology and results on lysozyme crystals. Journal of Synchrotron Radiation, 
2001. 8(5): p. 1149-1156. 
239. Katrusiak, A., High-pressure crystallography. Acta Crystallographica Section A, 
2008. 64(1): p. 135-148. 
240. Forman, R.A., et al., Pressure Measurement Made by the Utilization of Ruby Sharp-
Line Luminescence. Science, 1972. 176(4032): p. 284. 
241. Matsumoto, S., et al., Molecular Mechanism for Conformational Dynamics of 
Ras·GTP Elucidated from In-Situ Structural Transition in Crystal. Scientific Reports, 
2016. 6: p. 25931. 
242. Shima, F., et al., Structural Basis for Conformational Dynamics of GTP-bound Ras 
Protein. Journal of Biological Chemistry, 2010. 285(29): p. 22696-22705. 
243. Kiel, C., L. Serrano, and C. Herrmann, A Detailed Thermodynamic Analysis of 
Ras/Effector Complex Interfaces. Journal of Molecular Biology, 2004. 340(5): p. 
1039-1058. 
6. References 
 
305 
244. Wohlgemuth, S., et al., Recognizing and Defining True Ras Binding Domains I: 
Biochemical Analysis. Journal of Molecular Biology, 2005. 348(3): p. 741-758. 
245. Kiel, C., A. referee: Wittinghofer, and C. referee: Herrmann, Untersuchung von 
Ras/Effektor-Komplexen mit gezielt veränderten elektrostatischen Eigenschaften. 
2003, Ruhr-Universität Bochum: Bochum. p. pp. 175. 
246. Wu, X., et al., Inhibition of Ras-effector interactions by cyclic peptides. 
MedChemComm, 2013. 4(2): p. 378-382. 
247. Upadhyaya, P., et al., Inhibition of Ras Signaling by Blocking Ras–Effector 
Interactions with Cyclic Peptides. Angewandte Chemie International Edition, 2015. 
54(26): p. 7602-7606. 
248. Szabó, Z., Multinuclear NMR studies of the interaction of metal ions with adenine-
nucleotides. Coordination Chemistry Reviews, 2008. 252(21): p. 2362-2380. 
249. Karl, M., et al., Pressure response of 31P chemical shifts of adenine nucleotides. 
Biophysical Chemistry, 2017. 
250. Ting, P.Y., et al., Tyrosine phosphorylation of RAS by ABL allosterically enhances 
effector binding. The FASEB Journal, 2015. 29(9): p. 3750-3761. 
251. Nussinov, R., et al., K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-
specific drug target? Expert Opinion on Therapeutic Targets, 2016. 20(7): p. 831-
842. 
252. Song, C., et al., Regulation of a Novel Human Phospholipase C, PLCε, through 
Membrane Targeting by Ras. Journal of Biological Chemistry, 2001. 276(4): p. 
2752-2757. 
253. Huang, L., et al., Structural basis for the interaction of Ras with RaIGDS. Nat Struct 
Mol Biol, 1998. 5(6): p. 422-426. 
254. Meierhofer, T., et al., Cu2+-cyclen as Probe to Identify Conformational States in 
Guanine Nucleotide Binding Proteins. Journal of the American Chemical Society, 
2011. 133(7): p. 2048-2051. 
255. Nixon, A.E., et al., Kinetics of Inorganic Phosphate Release during the Interaction 
of p21ras with the GTPase-Activating Proteins, p120-GAP and Neurofibromin. 
Biochemistry, 1995. 34(47): p. 15592-15598. 
256. Ahmadian, M.R., et al., Individual Rate Constants for the Interaction of Ras Proteins 
with GTPase-Activating Proteins Determined by Fluorescence Spectroscopy. 
Biochemistry, 1997. 36(15): p. 4535-4541. 
257. Liao, J., et al., Two conformational states of Ras GTPase exhibit differential GTP-
binding kinetics. Biochemical and Biophysical Research Communications, 2008. 
369(2): p. 327-332. 
258. Ernst, R.R. and W.A. Anderson, Application of Fourier Transform Spectroscopy to 
Magnetic Resonance. Review of Scientific Instruments, 1966. 37(1): p. 93-102. 
6. References 
 
306 
259. Franken, S.M., et al., Three-dimensional structures and properties of a transforming 
and a nontransforming glycine-12 mutant of p21H-ras. Biochemistry, 1993. 32(33): 
p. 8411-8420. 
260. Ahmadian, M.R., et al., Guanosine triphosphatase stimulation of oncogenic Ras 
mutants. Proceedings of the National Academy of Sciences, 1999. 96(12): p. 7065-
7070. 
261. Frech, M., et al., Role of Glutamine-61 in the Hydrolysis of GTP by p21H-ras: An 
Experimental and Theoretical Study. Biochemistry, 1994. 33(11): p. 3237-3244. 
262. Kalbitzer, H.R. and M. Spoerner, Chapter Four - State 1(T) Inhibitors of Activated 
Ras, in The Enzymes, F. Tamanoi, Editor. 2013, Academic Press. p. 69-94. 
263. Weikl, T.R. and C. von Deuster, Selected-fit versus induced-fit protein binding: 
Kinetic differences and mutational analysis. Proteins: Structure, Function, and 
Bioinformatics, 2009. 75(1): p. 104-110. 
264. Rudolph, M.G., et al., Thermodynamics of Ras/Effector and Cdc42/Effector 
Interactions Probed by Isothermal Titration Calorimetry. Journal of Biological 
Chemistry, 2001. 276(26): p. 23914-23921. 
265. Al-Mulla, F., et al., Structural differences between valine-12 and aspartate-12 Ras 
proteins may modify carcinoma aggression. The Journal of Pathology, 1999. 187(4): 
p. 433-438. 
266. John, J., et al., C-terminal truncation of p21H preserves crucial kinetic and structural 
properties. Journal of Biological Chemistry, 1989. 264(22): p. 13086-13092. 
267. John, J., M. Frech, and A. Wittinghofer, Biochemical properties of Ha-ras encoded 
p21 mutants and mechanism of the autophosphorylation reaction. Journal of 
Biological Chemistry, 1988. 263(24): p. 11792-11799. 
268. Klebe, G., Applying thermodynamic profiling in lead finding and optimization. Nat 
Rev Drug Discov, 2015. 14(2): p. 95-110. 
269. Kiel, C., et al., Recognizing and Defining True Ras Binding Domains II: In Silico 
Prediction Based on Homology Modelling and Energy Calculations. Journal of 
Molecular Biology, 2005. 348(3): p. 759-775. 
270. Jelesarov, I. and H.R. Bosshard, Isothermal titration calorimetry and differential 
scanning calorimetry as complementary tools to investigate the energetics of 
biomolecular recognition. Journal of Molecular Recognition, 1999. 12(1): p. 3-18. 
271. Chodera, J.D. and D.L. Mobley, Entropy-enthalpy compensation: role and 
ramifications in biomolecular ligand recognition and design. Annual review of 
biophysics, 2013. 42: p. 121-142. 
272. Koehler, J., et al., Pressure Dependence of 15N Chemical Shifts in Model Peptides 
Ac-Gly-Gly-X-Ala-NH2. Materials\, 2012. 5\: p. 1774-1786\. 
273. Spoerner, M., et al., High pressure 31P NMR spectroscopy on guanine nucleotides. 
Journal of Biomolecular NMR, 2017. 67(1): p. 1-13. 
6. References 
 
307 
274. Moedritzer, K., pH dependence of phosphorus-31 chemical shifts and coupling 
constants of some oxyacids of phosphorus. Inorganic Chemistry, 1967. 6(5): p. 936-
939. 
275. Cozzone, P.J. and O. Jardetzky, Phosphorus-31 Fourier transform nuclear magnetic 
resonance study of mononucleotides and dinucleotides. 1. Chemical shifts. 
Biochemistry, 1976. 15(22): p. 4853-4859. 
276. Ford, B., et al., Structure of the G60A Mutant of Ras: Implications for the Dominant 
Negative Effect. Journal of Biological Chemistry, 2005. 280(27): p. 25697-25705. 
277. Johnson, C.W., et al., The small GTPases K-Ras, N-Ras, and H-Ras have distinct 
biochemical properties determined by allosteric effects. Journal of Biological 
Chemistry, 2017. 292(31): p. 12981-12993. 
278. Krengel, U., et al., Three-dimensional structures of H-ras p21 mutants: Molecular 
basis for their inability to function as signal switch molecules. Cell. 62(3): p. 539-
548. 
279. Betts, M.J. and R.B. Russell, Amino Acid Properties and Consequences of 
Substitutions, in Bioinformatics for Geneticists. 2003, John Wiley & Sons, Ltd. p. 
289-316. 
280. Seeburg, P.H., et al., Biological properties of human c-Ha-ras1 genes mutated at 
codon 12. Nature, 1984. 312(5989): p. 71-75. 
281. Muraoka, S., et al., Crystal structures of the state 1 conformations of the GTP-bound 
H-Ras protein and its oncogenic G12V and Q61L mutants. FEBS Letters, 2012. 
586(12): p. 1715-1718. 
282. Kinoshita, T., et al., Raf/MAPK and rapamycin-sensitive pathways mediate the anti-
apoptotic function of p21Ras in IL-3-dependent hematopoietic cells. Oncogene, 
1997. 15(6): p. 8. 
283. Buhrman, G., G. Wink, and C. Mattos, Transformation Efficiency of RasQ61 Mutants 
Linked to Structural Features of the Switch Regions in the Presence of Raf. 
Structure, 2007. 15(12): p. 1618-1629. 
284. Baba, S., et al., Humidity control and hydrophilic glue coating applied to mounted 
protein crystals improves X-ray diffraction experiments. Acta Crystallographica 
Section D: Biological Crystallography, 2013. 69(Pt 9): p. 1839-1849. 
285. Davis, I.W., et al., The Backrub Motion: How Protein Backbone Shrugs When a 
Sidechain Dances. Structure. 14(2): p. 265-274. 
286. Shapovalov, M.V. and R.L. Dunbrack, Statistical and conformational analysis of the 
electron density of protein side chains. Proteins: Structure, Function, and 
Bioinformatics, 2007. 66(2): p. 279-303. 
287. Pearce, N.M., et al., A multi-crystal method for extracting obscured crystallographic 
states from conventionally uninterpretable electron density. Nature 
Communications, 2017. 8: p. 15123. 
6. References 
 
308 
288. Fraser, J.S., et al., Hidden alternative structures of proline isomerase essential for 
catalysis. Nature, 2009. 462: p. 669. 
289. Reichenbach-Klinke, R., M. Zabel, and B. Konig, Synthesis and structure of cyclen 
hydroxylamine ligands and their zinc(ii) complexes. Dalton Transactions, 2003(1): 
p. 141-145. 
 
